ࡱ>  BD789:;<=>?@A YbjbjcTcT ɞ>>(t!!!!!4!!!h%""!Z#:':A'A'A'y(y(y(YYYYYYY[]_vYi!y(u(y(y(y(Y!!A'A'4 ZB222y(!RA'!A'U2y(Y22\P2g!"TA'5!y,nSFTOZHZSs`1s`Ts`!T,y(y(2y(y(y(y(y(YY2y(y(y(Zy(y(y(y(s`y(y(y(y(y(y(y(y(y( : Protocol for the Examination of Specimens from Patientswith Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Based on AJCC/UICC TNM, 7th edition Protocol web posting date: October 2009 Procedures Biopsy Excision Sentinel node examination Regional node examination Authors David P. Frishberg, MD, FCAP* Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California Charles Balch, MD Departments of Surgery, Oncology, and Dermatology, Johns Hopkins University, Baltimore, Maryland Bonnie L. Balzer, MD, PhD, FCAP Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California A. Neil Crowson, MD, FCAP Regional Medical Laboratory, Departments of Dermatology, Pathology and Surgery, University of Oklahoma, Tulsa, Oklahoma Mikund Didolkar, MD, FACS Division of Surgical Oncology, Sinai Hospital of Baltimore, Department of Surgery, Johns Hopkins University, Baltimore, Maryland Jennifer M. McNiff, MD, FASCP Departments of Dermatology and Pathology, Yale University School of Medicine Roger R Perry, MD, FACS Department of Surgery, Eastern Virginia Medical School, Norfolk, Virginia Victor G. Prieto, MD, PhD, FCAP Departments of Pathology and Dermatology MD Anderson Cancer Center, University of Texas, Houston, Texas Priya Rao, MD, FCAP Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California M. Timothy Smith, MD Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina Bruce Robert Smoller, MD, FCAP Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas Mark R. Wick, MD, FCAP Department of Pathology, University of Virginia Health System, Charlottesville, Virginia For the Members of the Cancer Committee, College of American Pathologists * denotes primary author. All other contributing authors are listed alphabetically. Previous lead contributors: Charles Balch, MD; Raymond Barnhill, MD; Carolyn Compton, MD, PhD; Mark Wick, MD 2009 College of American Pathologists (CAP). All rights reserved. The College does not permit reproduction of any substantial portion of these protocols without its written authorization. The College hereby authorizes use of these protocols by physicians and other health care providers in reporting on surgical specimens, in teaching, and in carrying out medical research for nonprofit purposes. This authorization does not extend to reproduction or other use of any substantial portion of these protocols for commercial purposes without the written consent of the College. The CAP also authorizes physicians and other health care practitioners to make modified versions of the Protocols solely for their individual use in reporting on surgical specimens for individual patients, teaching, and carrying out medical research for non-profit purposes. The CAP further authorizes the following uses by physicians and other health care practitioners, in reporting on surgical specimens for individual patients, in teaching, and in carrying out medical research for non-profit purposes: (1) Dictation from the original or modified protocols for the purposes of creating a text-based patient record on paper, or in a word processing document; (2) Copying from the original or modified protocols into a text-based patient record on paper, or in a word processing document; (3) The use of a computerized system for items (1) and (2), provided that the Protocol data is stored intact as a single text-based document, and is not stored as multiple discrete data fields. Other than uses (1), (2), and (3) above, the CAP does not authorize any use of the Protocols in electronic medical records systems, pathology informatics systems, cancer registry computer systems, computerized databases, mappings between coding works, or any computerized system without a written license from CAP. Applications for such a license should be addressed to the SNOMED Terminology Solutions division of the CAP. Any public dissemination of the original or modified Protocols is prohibited without a written license from the CAP. The College of American Pathologists offers these protocols to assist pathologists in providing clinically useful and relevant information when reporting results of surgical specimen examinations of surgical specimens. The College regards the reporting elements in the Surgical Pathology Cancer Case Summary (Checklist) portion of the protocols as essential elements of the pathology report. However, the manner in which these elements are reported is at the discretion of each specific pathologist, taking into account clinician preferences, institutional policies, and individual practice. The College developed these protocols as an educational tool to assist pathologists in the useful reporting of relevant information. It did not issue the protocols for use in litigation, reimbursement, or other contexts. Nevertheless, the College recognizes that the protocols might be used by hospitals, attorneys, payers, and others. Indeed, effective January 1, 2004, the Commission on Cancer of the American College of Surgeons mandated the use of the checklist elements of the protocols as part of its Cancer Program Standards for Approved Cancer Programs. Therefore, it becomes even more important for pathologists to familiarize themselves with these documents. At the same time, the College cautions that use of the protocols other than for their intended educational purpose may involve additional considerations that are beyond the scope of this document. The inclusion of a product name or service in a CAP publication should not be construed as an endorsement of such product or service, nor is failure to include the name of a product or service to be construed as disapproval. CAP Melanoma Protocol Revision History Version Code The definition of the version code can be found at www.cap.org/cancerprotocols. Version: Melanoma 3.0.0.0 Summary of Changes No changes have been made since the October 2009 release. Surgical Pathology Cancer Case Summary (Checklist) Protocol web posting date: October 2009 MELANOMA OF THE SKIN: Biopsy, Excision, Re-Excision Select a single response unless otherwise indicated. Procedure (select all that apply) ___ Biopsy, shave (Note A) ___ Biopsy, punch ___ Biopsy, incisional ___ Excision ___ Re-excision ___ Lymphadenectomy, sentinel node(s) ___ Lymphadenectomy, regional nodes (specify): ____________________________ ___ Other (specify): ____________________________ ___ Not specified Specimen Laterality ___ Right ___ Left ___ Midline ___ Not specified Tumor Site (Note B) Specify (if known): ____________________________ ___ Not specified Tumor Size (required only if tumor is grossly present) Greatest dimension: __ cm *Additional dimensions: __ x ___ cm ___ Indeterminate (see Comment) Macroscopic Satellite Nodule(s) (required for excision specimens only) ___ Not identified ___ Present ___ Indeterminate *Macroscopic Pigmentation *___ Not identified *___ Present, diffuse *___ Present, patchy/focal *___ Indeterminate Histologic Type (Note C) Malignant melanoma ___ Melanoma, not otherwise classified ___ Superficial spreading melanoma ___ Nodular melanoma ___ Lentigo maligna melanoma ___ Acral-lentiginous melanoma ___ Desmoplastic and/or desmoplastic neurotropic melanoma ___ Melanoma arising from blue nevus ___ Melanoma arising in a giant congenital nevus ___ Melanoma of childhood ___ Nevoid melanoma ___ Persistent melanoma ___ Other (specify): __________________ Maximum Tumor Thickness (Note D) Specify: ___ mm At least ___ mm (see Comment) ___ Indeterminate (see Comment) *Anatomic Level (Note D) *___ I (Melanoma in situ) *___ II (Melanoma present in but does not fill and expand papillary dermis) *___ III (Melanoma fills and expands papillary dermis) *___ IV (Melanoma invades reticular dermis) *___ V (Melanoma invades subcutaneum) Ulceration (Note E) ___ Present ___ Not identified ___ Indeterminate Margins (select all that apply) (Note F) Peripheral Margins ___ Cannot be assessed ___ Uninvolved by invasive melanoma Distance of invasive melanoma from closest peripheral margin: ___ mm (required for excisions only) Specify location(s), if possible: ____________________________ ___ Involved by invasive melanoma Specify location(s), if possible: ____________________________ ___ Uninvolved by melanoma in situ Distance of melanoma in situ from closest margin: ___ mm (required for excisions only) Specify location(s), if possible: ____________________________ ___ Involved by melanoma in situ Specify location(s), if possible: ____________________________ Deep Margin ___ Cannot be assessed ___ Uninvolved by invasive melanoma Distance of invasive melanoma from margin: ___ mm (required for excisions only) Specify location(s), if possible: ____________________________ ___ Involved by invasive melanoma Specify location(s), if possible: ____________________________ Mitotic Index (Note G) ___ Less than 1 / mm2 Specify number / mm2: ______ Microsatellitosis (Note H) ____ Not identified ____ Present ____ Indeterminate Lymph-Vascular Invasion (Note I) ___ Not identified ___ Present ___ Indeterminate *Perineural Invasion (Note J) *___ Not identified *___ Present *___ Indeterminate *Tumor-Infiltrating Lymphocytes (Note K) *___ Not identified *___ Present, nonbrisk *___ Present, brisk *Tumor Regression (Note L) *___ Not identified *___ Present, involving less than 75% of lesion *___ Present, involving 75% or more of lesion *___ Indeterminate *Growth Phase (Note M) *___ Radial *___ Vertical *___ Indeterminate Lymph Nodes (required only if lymph nodes are present in the specimen) (selectall that apply) (Note N) Number of sentinel nodes examined: ____ Total number of nodes examined (sentinel and nonsentinel): ____ Number of lymph nodes with metastases: ____ *Extranodal tumor extension: *___ Present *___ Not identified *___ Indeterminate *Size of largest metastatic focus: ___ (mm) (for sentinel node) *Location of metastatic tumor (for sentinel node) *___ Subcapsular *___ Intramedullary *___ Subcapsular and intramedullary Pathologic Staging (pTNM) (Note O and Note P) TNM Descriptors (required only if applicable) (select all that apply) ___ m (multiple) ___ r (recurrent) ___ y (posttreatment) Primary Tumor (pT) ___ pTX: Primary tumor cannot be assessed (eg, shave biopsy or regessed melanoma) (see Comment) ___ pT0: No evidence of primary tumor ___ pTis: Melanoma in situ (ie, not an invasive tumor: anatomic level I) pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (see Note D) ___ pT1a: Melanoma 1.0 mm or less in thickness, no ulceration, <1 mitoses/mm2 ___ pT1b: Melanoma 1.0 mm or less in thickness with ulceration and/or 1 or more mitoses/mm2 pT2: Melanoma 1.01 to 2 mm in thickness, with or without ulceration ___ pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration ___ pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration ___ pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration ___ pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration ___ pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration ___ pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration Regional Lymph Nodes (pN) ___ pNX: Regional lymph nodes cannot be assessed ___ pN0: No regional lymph node metastasis pN1: Metastasis in 1 regional lymph node ___ pN1a: Clinically occult (microscopic) metastasis ___ pN1b: Clinically apparent (macroscopic) metastasis pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis ___ pN2a: Clinically occult (microscopic) metastasis ___ pN2b: Clinically apparent (macroscopic) metastasis ___ pN2c: Satellite or in-transit metastasis without nodal metastasis ___ pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or in-transit metastasis or satellites(s) with metastasis in regional node(s) Number of lymph nodes identified: ____ Number containing metastases identified macroscopically: ____ Number containing metastases identified microscopically: ____ Matted nodes: ___ Present ___ Not identified Distant Metastasis (pM) ___ Not applicable ___ pM1: Distant metastasis (documented in this specimen) *___ pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes *___ pM1b: Metastasis to lung *___ pM1c: Metastasis to all other visceral sites or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) *Specify site, if known: __________________________ *Additional Pathologic Findings (select all that apply) *___ Nevus remnant *___ Other (specify): ____________________________ *Comment(s) Explanatory Notes A. Procedure Optimal evaluation of melanocytic lesions requires complete excision that incorporates the full thickness of the involved lesion removed intact. ADDIN EN.CITE Sober200113131317Sober, A. J.Chuang, T. Y.Duvic, M.Farmer, E. R.Grichnik, J. M.Halpern, A. C.Ho, V.Holloway, V.Hood, A. F.Johnson, T. M.Lowery, B. J.Guidelines of care for primary cutaneous melanomaJ Am Acad DermatolJ Am Acad Dermatol579-864542001/09/25BiopsyHumansMelanoma/*diagnosis/pathology/*surgeryNeoplasm StagingSkin Neoplasms/*diagnosis/pathology/*surgery2001Oct0190-9622 (Print)11568750http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11568750S0190-9622(01)54391-1 [pii] 10.1067/mjd.2001.117044eng1 "Shave" procedures that do not include the intact base of the lesion should be avoided. Similarly, punch procedures may not include intact lateral borders for assessment of symmetry and lateral circumscription, which can be essential for distinction of melanoma from melanocytic nevus. ADDIN EN.CITE  ADDIN EN.CITE.DATA 2,3 The use of frozen sections in biopsies or excisions of melanocytic lesions is strongly discouraged. ADDIN EN.CITE Smith-Zagone200522217Smith-Zagone, M. J.Schwartz, M. R.Department of Pathology, Baylor College of Medicine, Houston, Texas, USA.Frozen section of skin specimensArch Pathol Lab MedArch Pathol Lab Med1536-43129122005/12/07Carcinoma, Basal Cell/*diagnosis/surgeryCarcinoma, Squamous Cell/*diagnosis/surgeryFrozen Sections/*methodsHumansMelanoma/*diagnosis/surgeryPathology, Surgical/*methodsSkin Neoplasms/*diagnosis/surgery2005Dec1543-2165 (Electronic)16329726http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16329726RA-2005-072 [pii]eng4 Optimal histologic evaluation of cutaneous melanoma requires well-cut, well-stained hematoxylin-and-eosin (H&E) sections prepared from formalin-fixed paraffin-embedded tissue. Frozen sections of sentinel lymph nodes are similarly discouraged, because the manipulation required for intraoperative handling may decrease the sensitivity of the procedure. ADDIN EN.CITE Scolyer200533317Scolyer, R. A.Thompson, J. F.McCarthy, S. W.Gershenwald, J. E.Ross, M. I.Cochran, A. J.Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patientsJ Am Coll SurgJ Am Coll Surg821-3; author reply 823-420152005/11/01Frozen Sections/methods/*standardsHumansIntraoperative PeriodLymph NodesMelanoma/*pathologyReproducibility of Results*Sentinel Lymph Node BiopsySkin Neoplasms/*pathology2005Nov1072-7515 (Print)16256927http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16256927S1072-7515(05)01246-9 [pii] 10.1016/j.jamcollsurg.2005.07.017eng5 B. Anatomic Site For cutaneous melanoma, prognosis may be affected by primary anatomic site. ADDIN EN.CITE  ADDIN EN.CITE.DATA 6,7 C. Histologic Subtypes The (modified) World Health Organization (WHO) classification7 of variants of malignant melanocytic neoplasms of the skin includes the following: Superficial spreading melanoma Nodular melanoma Lentigo maligna melanoma Acral lentiginous melanoma Mucosal-lentiginous melanoma Desmoplastic/neurotropic melanoma Melanoma arising from blue nevus Melanoma arising from a giant congenital nevus Melanoma in childhood Nevoid melanoma Persistent melanoma Melanoma, not otherwise classified The WHO list is not exhaustive; this checklist does not preclude use of other diagnostic terms, for example, mucosal lentiginous melanoma, a form commonly observed in the vulva. There is ongoing research to correlate molecular abnormalities in malignant melanoma, particularly BRAF mutations, with histologic parameters. Given the wide variety of reported mutations in melanoma ADDIN EN.CITE  ADDIN EN.CITE.DATA 8 and the lack of predictably effective targeted molecular therapy, ADDIN EN.CITE  ADDIN EN.CITE.DATA 9 practical application of such morphologic correlates remains an issue for future checklists. D. Primary Tumor Thickness (Breslow Thickness) and Anatomic (Clark) Levels ADDIN EN.CITE LeBoit PE200616161628LeBoit PE, Burg G, Weedon D, Sarasin A (eds) LeBoit PE, Burg G, Weedon D, Sarasin APathology and Genetics of Skin Tumors. World Health Organization Classification of Tumors49-932006IARC Press7 Maximum tumor thickness is measured with a calibrated ocular micrometer at a right angle to the adjacent normal skin. The upper point of reference is the granular layer of the epidermis of the overlying skin or, if the lesion is ulcerated, the base of the ulcer. The lower reference point is the deepest point of tumor invasion (ie, the leading edge of a single mass or an isolated group of cells deep to the main mass). If the tumor is transected by the deep margin of the specimen, the depth may be indicated as at least __ mm with a comment explaining the limitation of thickness assessment. Clark levels are defined as follows: I Intraepidermal tumor only II Tumor present in but does not fill and expand papillary dermis III Tumor fills and expands papillary dermis IV Tumor invades into reticular dermis V Tumor invades subcutis Clark levels were previously a primary requirement for subclassifying pT1 lesions according to the American Joint Committee on Cancer (AJCC) 6th edition TNM classification system and are commonly reported. Anatomic level has been replaced by mitotic rate in the AJCC 7th edition tables for subclassifying pT1 lesions as T1a or T1b, but in the text and in a table comment of the AJCC chapter,10 Clark level IV or V is referred to as a tertiary criterion for T1b in cases with no ulceration and if mitotic rate cannot be determined. Clark level should therefore be reported whenever it would form the basis for upstaging T1 lesions. The distinction of T1a versus T1b is of significant clinical importance, as the AJCC recommends that sentinel node examination be considered for melanomas stage T1b and above. E. Ulceration Ulceration is a dominant prognostic factor in cutaneous melanoma without metastasis, ADDIN EN.CITE  ADDIN EN.CITE.DATA 6 and if present, changes the pT stage from T1a to T1b. The presence or absence ofulceration must be confirmed on microscopic examination. ADDIN EN.CITE Balch200199917Balch, C. M.Buzaid, A. C.Soong, S. J.Atkins, M. B.Cascinelli, N.Coit, D. G.Fleming, I. D.Gershenwald, J. E.Houghton, A., Jr.Kirkwood, J. M.McMasters, K. M.Mihm, M. F.Morton, D. L.Reintgen, D. S.Ross, M. I.Sober, A.Thompson, J. A.Thompson, J. F.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin OncolJ Clin Oncol3635-4819162001/08/16HumansMelanoma/*mortality/*pathologyNeoplasm MetastasisNeoplasm Staging/*standardsProportional Hazards ModelsSkin Neoplasms/*pathology/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504745http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504745eng11 Melanoma ulceration is defined as the combination of the following features: full-thickness epidermal defect (including absence of stratum corneum and basement membrane); evidence of reactive changes (ie, fibrin deposition, neutrophils); and thinning, effacement, or reactive hyperplasia of the surrounding epidermis in the absence of trauma or a recent surgical procedure. Ulcerated melanomas typically show invasion through the epidermis, whereas nonulcerated melanomas tend to lift the overlying epidermis. Overall, for patients with stage I and II melanomas, the 10-year survival rate is 50% if the tumor is ulcerated and 78% if the tumor is not ulcerated. ADDIN EN.CITE Balch199219191917Balch, C. M.Department of General Surgery, University of Texas, M.D. Anderson Cancer Center, Houston 77030.Cutaneous melanoma: prognosis and treatment results worldwideSemin Surg OncolSemin Surg Oncol400-14861992/11/01FemaleHumansLymphatic MetastasisMaleMelanoma/*epidemiology/secondary/*therapyNeoplasm StagingPrognosisRegression AnalysisSkin Neoplasms/*epidemiology/pathology/*therapyTreatment Outcome1992Nov-Dec8756-0437 (Print)1439450http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1439450eng12 In Cox regression analyses of prognostic factors in cutaneous melanoma that include ulceration, a significantly worse prognosis and a higher risk of metastatic disease have been demonstrated for ulcerated versus non-ulcerated tumors of equivalent thickness. ADDIN EN.CITE  ADDIN EN.CITE.DATA 6,11 There is a positive correlation between ulceration and thickness. For ulcerated tumors, the median thickness has been shown to be about 3 mm; for nonulcerated tumors, it is about 1.3 mm. Nevertheless, the adverse prognostic significance of melanoma ulceration has been shown to be independent of tumor thickness. For thin melanomas (1.0 mm or less in thickness), level of invasion is more predictive of survival outcome than ulceration. For melanomas greater than 1.0 mm, ulceration is more predictive than thickness.6 Recent studies suggest that ulceration may lose its independent prognostic significance when mitotic rate is taken into account. ADDIN EN.CITE Barnhill200520202017Barnhill, R. L.Katzen, J.Spatz, A.Fine, J.Berwick, M.Department of Dermatology, George Washington University Medical Center, Washington, DC, USA. rbarnhill@med.miami.eduThe importance of mitotic rate as a prognostic factor for localized cutaneous melanomaJ Cutan PatholJ Cutan Pathol268-733242005/03/17AdolescentAdultAged*Cell ProliferationFemaleHumansLeast-Squares AnalysisMaleMelanoma/complications/*pathologyMiddle Aged*Mitotic IndexMultivariate AnalysisNeoplasm StagingOdds RatioPrognosisSkin Neoplasms/complications/*pathologySkin Ulcer/etiology/pathology2005Apr0303-6987 (Print)15769275http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15769275CUP310 [pii] 10.1111/j.0303-6987.2005.00310.xeng13 F. Margins Microscopically measured distances between tumor and labeled lateral or deep margins are appropriately recorded for melanoma excision specimens because these neoplasms may demonstrate clinical "satellitosis. Nevertheless, a safe minimum margin has not been established in the literature. If a lateral margin is involved by tumor, it should be stated whether the tumor is in situ or invasive. G. Mitotic Index A mitotic rate of 1 or more mitotic figure per square millimeter is a powerful adverse prognostic factor for cutaneous melanoma ADDIN EN.CITE Barnhill200520202017Barnhill, R. L.Katzen, J.Spatz, A.Fine, J.Berwick, M.Department of Dermatology, George Washington University Medical Center, Washington, DC, USA. rbarnhill@med.miami.eduThe importance of mitotic rate as a prognostic factor for localized cutaneous melanomaJ Cutan PatholJ Cutan Pathol268-733242005/03/17AdolescentAdultAged*Cell ProliferationFemaleHumansLeast-Squares AnalysisMaleMelanoma/complications/*pathologyMiddle Aged*Mitotic IndexMultivariate AnalysisNeoplasm StagingOdds RatioPrognosisSkin Neoplasms/complications/*pathologySkin Ulcer/etiology/pathology2005Apr0303-6987 (Print)15769275http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15769275CUP310 [pii] 10.1111/j.0303-6987.2005.00310.xeng13 and will upstage pT1 lesions from pT1a to pT1b in the 7th edition of the AJCC staging manual. The mitotic index should be reported as the number of mitoses per square millimeter. If no mitoses are found or if the average count is less than 1, the mitotic count is reported as less than 1/mm2. (Typically a 10X ocular and a 40X objective will yield a field area of approximately 0.15 mm2, but this will vary from microscope to microscope and should be determined on an individual basis by direct measurement of the field or from manufacturers specifications.) The recommended approach to enumeration of mitoses is to first find the area in the vertical growth phase containing most mitotic figures, the so-called hot spot. After counting the mitoses in the hot spot, the count is extended to adjacent fields until an area corresponding to 1mm2 is assessed. If no hot spot can be found and mitoses are randomly scattered throughout the lesion, then several different randomly chosen areas should be counted, summed, and the average listed as the mitotic rate. In tumors where the invasive component is less than 1 mm in area, an attempt may be made to extrapolate a rate per square millimeter. H. Microsatellitosis Microsatellitosis is defined as the presence of tumor nests greater than 0.05 mm in diameter, in the reticular dermis, panniculus, or vessels beneath the principal invasive tumor but separated from it by at least 0.3 mm of normal tissue on the section in which the Breslow measurement was taken. ADDIN EN.CITE Harrist198421212117Harrist, T. J.Rigel, D. S.Day, C. L., Jr.Sober, A. J.Lew, R. A.Rhodes, A. R.Harris, M. N.Kopf, A. W.Friedman, R. J.Golomb, F. M.et al.,"Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thicknessCancerCancer2183-753101984/05/15AdultAgedFemaleHumans*Lymph Node ExcisionLymph Nodes/*pathologyLymphatic MetastasisMaleMelanoma/mortality/*pathology/surgeryMiddle Aged*Neoplasm Circulating CellsPrognosisSkin Neoplasms/mortality/*pathology/secondaryTime Factors1984May 150008-543X (Print)6704906http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6704906eng14 See also Note O. I. Vascular Invasion At least one study ADDIN EN.CITE  ADDIN EN.CITE.DATA 15 has suggested that vascular invasion by melanoma correlates independently with worsened overall survival. J. Perineural Invasion Perineural invasion may be seen in melanoma, particularly desmoplastic-neuroid subtypes. ADDIN EN.CITE LeBoit PE200616161628LeBoit PE, Burg G, Weedon D, Sarasin A (eds) LeBoit PE, Burg G, Weedon D, Sarasin APathology and Genetics of Skin Tumors. World Health Organization Classification of Tumors49-932006IARC Press7 This feature may correlate with an increased risk for local recurrence. It is suggested that the presence of perineural infiltration be noted in surgical pathology reports on melanomas. K. Tumor-Infiltrating Lymphocytes A paucity of tumor-infiltrating lymphocytes (TILs) is an adverse prognostic factor for cutaneous melanoma. ADDIN EN.CITE Crowson200623232317Crowson, A. N.Magro, C. M.Mihm, M. C.Department of Dermatology, University of Oklahoma and Regional Medical Laboratories, St John Medical Center, Tulsa, OK 74104, USA. ncrowson@sjmc.orgPrognosticators of melanoma, the melanoma report, and the sentinel lymph nodeMod PatholMod PatholS71-8719 Suppl 22006/02/01Antigens, CD80/analysisAntigens, CD86/analysisHumansImmunohistochemistryKi-67 Antigen/analysisLymph Nodes/chemistry/pathologyMelanoma/metabolism/*pathologyPredictive Value of TestsPrognosisProliferating Cell Nuclear Antigen/analysisSentinel Lymph Node BiopsySkin/chemistry/pathologySkin Neoplasms/metabolism/*pathology2006Feb0893-3952 (Print)16446717http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=164467173800517 [pii] 10.1038/modpathol.3800517eng16 Tumor-infiltrating lymphocytes may be assessed in a semiquantitative way, as defined below. To qualify as TILs, lymphocytes need to surround and disrupt tumor cells of the vertical growth phase. TILs Not Identified: No lymphocytes present, or lymphocytes present but do not infiltrate tumor at all. TILs Nonbrisk: Lymphocytes infiltrate melanoma only focally or not along the entire base of the vertical growth phase. TILs Brisk: Lymphocytes diffusely infiltrate the entire base of the vertical growth phase (Figure 1, A) or the entire invasive component of the melanoma (Figure 1, B).  Figure 1. Brisk tumor-infiltrating lymphocytes. A, Lymphocytes diffusely infiltrate the entire base of the vertical growth phase. B, Lymphocytes infiltrate the entire invasive component of the melanoma. L. Tumor Regression Characteristic features of regression include replacement of tumor cells by lymphocytic inflammation (definitional), as well as attenuation of the epidermis and nonlaminated dermal fibrosis with inflammatory cells, melanophagocytosis, and telangiectasia. Complete regression carries adverse prognostic importance in invasive melanomas, as does regression involving more than 75% of the lesion. ADDIN EN.CITE Crowson200623232317Crowson, A. N.Magro, C. M.Mihm, M. C.Department of Dermatology, University of Oklahoma and Regional Medical Laboratories, St John Medical Center, Tulsa, OK 74104, USA. ncrowson@sjmc.orgPrognosticators of melanoma, the melanoma report, and the sentinel lymph nodeMod PatholMod PatholS71-8719 Suppl 22006/02/01Antigens, CD80/analysisAntigens, CD86/analysisHumansImmunohistochemistryKi-67 Antigen/analysisLymph Nodes/chemistry/pathologyMelanoma/metabolism/*pathologyPredictive Value of TestsPrognosisProliferating Cell Nuclear Antigen/analysisSentinel Lymph Node BiopsySkin/chemistry/pathologySkin Neoplasms/metabolism/*pathology2006Feb0893-3952 (Print)16446717http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=164467173800517 [pii] 10.1038/modpathol.3800517eng16 M. Growth Patterns and Phases The prognostic significance of histologic type is less significant than the growth patterns and depth of infiltration displayed by those histologic types. For example, superficial spreading melanomas, by definition, demonstrate prominent radial growth and have a better prognosis than nodular melanomas, which predominantly demonstrate vertical growth. ADDIN EN.CITE Balch197824242417Balch, C. M.Murad, T. M.Soong, S. J.Ingalls, A. L.Halpern, N. B.Maddox, W. A.A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methodsAnn SurgAnn Surg732-4218861978/12/01AgedFactor Analysis, StatisticalFemaleHumansLymphocytes/pathologyMaleMelaninsMelanoma/mortality/*pathologyMiddle AgedNeoplasm Staging/methodsPrognosisSkin Neoplasms/mortality/*pathology1978Dec0003-4932 (Print)736651http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=736651eng17 Radial Growth Phase: Tumor demonstrates a uniform cytological appearance and is generally wider than it is deep. One commonly applied criterion is presence of melanoma in situ 3 or more rete ridges beyond the invasive component. Vertical Growth Phase: Vertical growth phase is an adverse prognostic factor for cutaneous melanoma. Nodular melanomas are by definition vertical growth phase tumors. Vertical growth pattern in superficial spreading melanoma is defined as the presence of 1 or more dermal clusters larger than the largest epidermal cluster and/or the presence of any mitotic activity in the dermis. ADDIN EN.CITE Lefevre200325252517Lefevre, M.Vergier, B.Balme, B.Thiebault, R.Delaunay, M.Thomas, L.Beylot-Barry, M.Machet, L.De Muret, A.Bioulac-Sage, P.Bailly, C.Department of Pathology, University Hospital, Bordeaux, France.Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomasAm J Surg PatholAm J Surg Pathol717-242762003/05/27AdultCase-Control StudiesFemaleHumansMaleMelanoma/classification/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm StagingPrognosisRetrospective StudiesSkin Neoplasms/classification/*pathology2003Jun0147-5185 (Print)12766575http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12766575eng18 N. Lymph Nodes Removal of sentinel lymph nodes may be performed for patients with primary localized cutaneous melanomas with a thickness of 1mm or greater, and recent data indicates that it also may be justified for lesions less than 1 mm thick (incidence of sentinel lymph node metastasis is about 4% to 6% in so-called thin melanomas versus about 15% for melanomas e"1mm thick). ADDIN EN.CITE <EndNote><Cite><Author>Bedrosian</Author><Year>2000</Year><RecNum>10</RecNum><record><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="9tfsffedlzapztefpz8vzdtf5pe2eap2sd0s">1017Bedrosian, I.Faries, M. B.Guerry, D. thElenitsas, R.Schuchter, L.Mick, R.Spitz, F. R.Bucky, L. P.Alavi, A.Elder, D. E.Fraker, D. L.Czerniecki, B. J.Department of Surgery, University of Pennsylvania, Philadelphia 19104, USA.Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phaseAnn Surg OncolAnn Surg Oncol262-7742000/05/20AdolescentAdultAgedBiopsyFemaleHumansLogistic ModelsLymph Node ExcisionLymph Nodes/pathology/radionuclide imaging*Lymphatic Metastasis/diagnosisMaleMelanoma/*pathology/surgeryMiddle AgedNeoplasm StagingPrognosisSkin Neoplasms/*pathology/surgery2000May1068-9265 (Print)10819365http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10819365eng19 Frozen section analysis of sentinel lymph nodes is not advised. ADDIN EN.CITE Scolyer200515151517Scolyer, R. A.Thompson, J. F.McCarthy, S. W.Gershenwald, J. E.Ross, M. I.Cochran, A. J.Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patientsJ Am Coll SurgJ Am Coll Surg821-3; author reply 823-420152005/11/01Frozen Sections/methods/*standardsHumansIntraoperative PeriodLymph NodesMelanoma/*pathologyReproducibility of Results*Sentinel Lymph Node BiopsySkin Neoplasms/*pathology2005Nov1072-7515 (Print)16256927http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16256927S1072-7515(05)01246-9 [pii] 10.1016/j.jamcollsurg.2005.07.017eng5 Review of the H&E-stained slides from multiple levels through serially sectioned sentinel lymph nodes increases the sensitivity of detecting microscopic melanoma metastasis; routine analysis (H&E-stained sections of the cut surfaces of a simply bisected lymph node) may lead to a false-negative rate of 10% to 15%. The use of immunohistochemical stains (eg, for HMB-45 or MART-1) further increases the sensitivity of detection of microscopic melanoma metastases and should also be considered in the examination of sentinel lymph nodes. Although immunohistochemical staining should be used in conjunction with and not in place of standard histologic examination, immunohistochemically identified micrometastases are accepted as representing greater than N0 disease by the 7th edition of the AJCC staging system.10 For histologic examination, whether for sentinel node analysis or for routine regional lymph node evaluation, the entire node, except tissue collected for consented research protocols, should be submitted. For routine evaluation, large lymph nodes may be bisected or sliced at 2-mm intervals, whereas smaller nodes (<5 mm) may be submitted whole. A number of studies20-22 have suggested the sentinel lymph node tumor burden or the pattern of metastasis in the sentinel node (such as the S Classification)23 may be useful in predicting patients who have additional disease in nonsentinel nodes and thus would help select patients who might benefit from complete lymph node dissection. Investigators have suggested that the amount or pattern of the disease in the sentinel node may also serve as a prognostic factor. If such results are validated and found to be reproducible, then they may be an issue for future checklists. Although not required for AJCC staging, current National Comprehensive Cancer Network (NCCN) guidelines24 recommend recording the size and location of tumor present in a positive sentinel node. These are included as optional elements in this checklist. O. TNM and Stage Groupings The TNM Staging System of the American Joint Committee on Cancer (AJCC) and the International Union Against Cancer (UICC) is recommended by this protocol. ADDIN EN.CITE Greene FL26262628Greene FL, Page DL, Fleming ID, et al, edsAJCC Cancer Staging Manual. 6th ed.2002New YorkSpringerSobin LH200227272728Sobin LH, Wittekind CUICC TNM Classification of Malignant Tumours6th2002New YorkWiley-Liss10,25  Changes in the 7th edition AJCC Cancer Staging Manual of importance to practicing pathologists include: Assignment of pT1b status to lesions less than 1mm thick with 1 or more mitoses permm2 Relegation of Clark level IV or V to tertiary importance in assignment of pT1b status Classification of the presence of any nodal melanoma cells (including isolated tumor cells [ITCs]) as nodal involvement (>pN0) Allowing purely immunohistochemical detection of nodal metastasis Pathologic staging includes microstaging of the primary melanoma and pathologic information about the regional lymph nodes after partial or complete lymphadenectomy. ADDIN EN.CITE Greene FL200226262628Greene FL, Page DL, Fleming ID, et al, edsAJCC Cancer Staging Manual. 6th ed.2002New YorkSpringer10 In virtually all studies of cutaneous melanoma, tumor thickness has been shown to be a dominant prognostic factor, ADDIN EN.CITE  ADDIN EN.CITE.DATA 7,10,15 and it forms the basis for the stratification of pT. Clark levels are also commonly used to indicate depth of invasion of the primary tumor, ADDIN EN.CITE  ADDIN EN.CITE.DATA 7,10,16,25 but are less predictive of clinical outcome than mitotic activity.19 By AJCC/UICC convention, the designation T refers to a primary tumor that has not been previously treated. The symbol p refers to the pathologic classification of the TNM, as opposed to the clinical classification, and is based on gross and microscopic examination of surgically removed tissues. pT entails a resection of the primary tumor or biopsy adequate to evaluate the highest pT category, pN entails removal of nodes adequate to validate lymph node metastasis, and pM implies pathologic examination of distant lesions. T Category Considerations Pathologic (microscopic) assessment of the primary tumor is required for proper staging. Therefore, excision of the primary tumor, rather than incisional biopsy, is advised. The T classification of melanoma is based on the thickness of the primary tumor, presence or absence of ulceration, mitotic index, and in some cases its anatomic level of invasion (see also Notes D, E, and G). R Category Considerations (see also Note N) The regional lymph nodes are the most common sites of metastasis. The widespread use of cutaneous lymphoscintigraphy, lymphatic mapping, and sentinel lymph node biopsies has greatly enhanced the ability to identify the presence of lymph node metastasis. ADDIN EN.CITE Greene FL200226262628Greene FL, Page DL, Fleming ID, et al, edsAJCC Cancer Staging Manual. 6th ed.2002New YorkSpringer10 By convention, the term regional lymph nodal metastasis refers to disease confined to 1 draining nodal basin or 2 contiguous draining nodal basins, as in patients with nodal disease in combinations of femoral/iliac, axillary/supraclavicular, cervical/supraclavicular, axillary/femoral, or bilateral axillary or femoral metastases. Metastasis to nondraining nodal basin(s) is considered M1 disease. Isolated Tumor Cells, Micrometastasis, and Sentinel Lymph Nodes ADDIN EN.CITE  ADDIN EN.CITE.DATA 26,27 The previous edition of this checklist employed the use of ITC terminology analogous to that published for breast cancer. The 7th edition staging system defines nodal involvement by the presence of any tumor cells regardless of quantity, size, or mode of detection as nodal involvement (ie, >pN0). Sentinel lymph node identification and evaluation may be included in the surgical approach to cutaneous melanoma. A sentinel lymph node is defined as the first node to receive lymphatic drainage from a primary tumor. There may be more than 1 sentinel node for some tumors. The clinical rationale for sentinel lymph node identification and separate evaluation is based on the assumption that metastatic involvement of a sentinel node increases the likelihood that other, more distant nodes may also contain metastatic disease. Conversely, if sentinel nodes are negative, other regional nodes would be less likely to contain metastasis. In almost all studies using Cox regression analysis, either the number of regional lymph nodes containing metastases or the percentage of regional nodes containing metastases more strongly predicted outcome than the size of metastasis. ADDIN EN.CITE  ADDIN EN.CITE.DATA 6,11,28 Patientswith 1 involved lymph node have longer survivals compared to patients with anycombination of 2 or more involved nodes, regardless of the size of the metastasis. Intheir review of reported studies, the AJCC Melanoma Staging Committee found no compelling evidence that the gross dimension of lymph nodes metastases was an independent predictor of outcome. ADDIN EN.CITE Schuchter200131313117Schuchter, L. M.Hospital of the University of Pennsylvania, 16 Penn Tower, 3400 Spruce Street, Philadelphia, PA 19104, USA. lynn.schuchter@uphs.upenn.eduReview of the 2001 AJCC staging system for cutaneous malignant melanomaCurr Oncol RepCurr Oncol Rep332-7342001/06/08HumansMelanoma/classification/*pathologyNeoplasm Staging/*methods/standardsSkin Neoplasms/classification/*pathology2001Jul1523-3790 (Print)11389818http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11389818eng29 In-transit metastasis/satellitosis is used in the 7th edition AJCC staging system for definition of N2c disease. Satellitosis by definition occurs within 2 cm of the primary tumor. In-transit metastasis is defined as intralymphatic tumor in skin or subcutaneous tissue more than 2 cm from the primary tumor but not beyond the nearest regional lymph node basin. The presence of in-transit metastasis between the primary tumor and the regional lymph nodes portends a poor prognosis. The presence of clinical or microscopic satellite lesions around a primary melanoma and in-transit metastases both portend a poor prognosis, and an analysis of the available data by the AJCC Melanoma Staging Committee revealed no significant difference in survival between the two, both of which are associated with a prognosis equivalent to multiple lymph node metastases. ADDIN EN.CITE Balch200199917Balch, C. M.Buzaid, A. C.Soong, S. J.Atkins, M. B.Cascinelli, N.Coit, D. G.Fleming, I. D.Gershenwald, J. E.Houghton, A., Jr.Kirkwood, J. M.McMasters, K. M.Mihm, M. F.Morton, D. L.Reintgen, D. S.Ross, M. I.Sober, A.Thompson, J. A.Thompson, J. F.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin OncolJ Clin Oncol3635-4819162001/08/16HumansMelanoma/*mortality/*pathologyNeoplasm MetastasisNeoplasm Staging/*standardsProportional Hazards ModelsSkin Neoplasms/*pathology/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504745http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504745eng10 M Category Considerations The category MX has been eliminated from the AJCC/UICC TMN system.10 Unless there is clinical or pathologic evidence of distant metastasis the stage is classified as clinical M0 (ie, no distant metastasis). pM should only be reported when metastases have been documented by pathologic examination, that is, pM1 disease. pMX and pM0 should not be reported by the pathologist. Pathologic Stage Groupings Stage 0 Tis N0 M0 Stage IA T1a N0 M0 Stage IB T1b N0 M0 T2a N0 M0 Stage IIA T2b N0 M0 T3a N0 M0 Stage IIB T3b N0 M0 T4a N0 M0 Stage IIC T4b N0 M0 Stage IIIA T1-4a N1a M0 T1-4a N2a M0 Stage IIIB T1-4b N1a M0 T1-4b N2a M0 T1-4a N1b M0 T1-4a N2b M0 T1-4a N2c M0 Stage IIIC T1-4b N1b M0 T1-4b N2b M0 T1-4b N2c M0 Any T N3 M0 Stage IV Any T Any N M1 Note that for cutaneous melanoma, clinical and pathologic stage groupings differ for stage III. The complete clinical stage groupings are shown below for comparison. Clinical Stage Groupings Stage 0 Tis N0 M0 Stage IA T1a N0 M0 Stage IB T1b N0 M0 T2a N0 M0 Stage IIA T2b N0 M0 T3a N0 M0 Stage IIB T3b N0 M0 T4a N0 M0 Stage IIC T4b N0 M0 Stage III Any T Any N>N0 M0 Stage IV Any T Any N M1 TNM Descriptors ADDIN EN.CITE Greene FL200226262628Greene FL, Page DL, Fleming ID, et al, edsAJCC Cancer Staging Manual. 6th ed.2002New YorkSpringerSobin LH200227272728Sobin LH, Wittekind CUICC TNM Classification of Malignant Tumours6th2002New YorkWiley-Liss10,25 For identification of special cases of TNM or pTNM classifications, the y, r, and a prefixes are used. Although they do not affect the stage grouping, they indicate cases needing separate analysis. Post-therapy stage (yTNM) documents the extent of the disease for patients whose first course of therapy includes systemic or radiation treatment prior to surgical resection or when systemic therapy or radiation is primary treatment with no surgical resection. The extent of disease is classified using the same T, N, and M definitions and identified as post-treatment with a yc or yp prefix (ycT, ycN, ycTNM; ypT, ypN, ypTNM). Retreatment classification (rTNM) is used because information gleaned from therapeutic procedures and from extent of disease defined clinically may be prognostic for patients with recurrent cancer after a disease-free interval. It is important to understand that the rTNM classification does not change the original clinical or pathologic staging of the case. Autopsy classification (aTNM) is used to stage cases of cancer not recognized during life and only recognized postmortem. Additional Descriptors ADDIN EN.CITE Sobin LH200227272728Sobin LH, Wittekind CUICC TNM Classification of Malignant Tumours6th2002New YorkWiley-LissGreene FL200226262628Greene FL, Page DL, Fleming ID, et al, edsAJCC Cancer Staging Manual. 6th ed.2002New YorkSpringer10,25 Residual Tumor (R) Tumor remaining in a patient after therapy with curative intent (eg, surgical resection for cure) is categorized by a system known as R classification, as follows. RX Presence of residual tumor cannot be assessed R0 No residual tumor R1 Microscopic residual tumor R2 Macroscopic residual tumor For the surgeon, the R classification may be useful to indicate the known or assumed status of the completeness of a surgical excision. For the pathologist, the R classification is relevant to the status of the margins of a surgical resection specimen. That is, tumor involving the resection margin on pathologic examination may be assumed to correspond to residual tumor in the patient and may be classified as macroscopic or microscopic according to the findings at the specimen margin(s). Lymph-Vascular Invasion Lymph-vascular invasion (LVI) indicates whether microscopic lymph-vascular invasion is identified and includes lymphatic invasion, vascular invasion, or lymph-vascular invasion. By AJCC/UICC convention, LVI does not affect the T category indicating local extent of tumor unless specifically included in the definition of a T category. P. Pretreatment Serum Lactate Dehydrogenase and Serum Albumin Data from numerous studies have suggested that an elevated serum level of LDH is a stage-independent prognostic factor for decreased survival in melanoma. In these studies, pretreatment LDH elevation has been variably defined as serum levels greater than 200 to 225 U/L or as levels elevated above the reference range of the reference laboratory. ADDIN EN.CITE  ADDIN EN.CITE.DATA 6,12,30 It is recommended that any elevation above reference range should be checked by repeat LDH testing after at least 24 hours. For stage IV melanoma, a decreased serum albumin level (d"3.5 to 4.0 g/dL) has also been shown to be an independent adverse prognostic factor. ADDIN EN.CITE  ADDIN EN.CITE.DATA 6,12,30 References  ADDIN EN.REFLIST 1. Sober AJ, Chuang TY, Duvic M, et al. Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol. 2001;45:579-586. 2. Stell VH, Norton HJ, Smith KS, Salo JC, White RL Jr. Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol. 2007;14:893-898. 3. Sober AJ, Balch CM. Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol. 2007;14:274-275. 4. Smith-Zagone MJ, Schwartz MR. Frozen section of skin specimens. Arch Pathol Lab Med. 2005;129:1536-1543. 5. Scolyer RA, Thompson JF, McCarthy SW, Gershenwald JE, Ross MI, Cochran AJ. Intraoperative frozen-section evaluation can reduce accuracy of pathologic assessment of sentinel nodes in melanoma patients. J Am Coll Surg. 2005;201:821-823; author reply: J Am Coll Surg. 2005(5);201:823-824. 6. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-3634. 7. LeBoit PE BG, Weedon D, Sarasin A, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Skin Tumors. Lyon, France: IARC Press; 2006. 8. Fecher LA, Cummings SD, Keefe MJ, Alani RM. Toward a molecular classification of melanoma. J Clin Oncol. 2007;25:1606-1620. 9. Becker JC, Kirkwood JM, Agarwala SS, Dummer R, Schrama D, Hauschild A. Molecularly targeted therapy for melanoma: current reality and future options. Cancer. 2006;107:2317-2327. 10. Edge SB, Byrd DR, Carducci MA, Compton CA, eds. AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009. 11. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol. 2001;19:3635-3648. 12. Balch CM. Cutaneous melanoma: prognosis and treatment results worldwide. Semin Surg Oncol. 1992;8:400-414. 13. Barnhill RL, Katzen J, Spatz A, Fine J, Berwick M. The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma. J Cutan Pathol. 2005;32:268-273. 14. Harrist TJ, Rigel DS, Day CL Jr, et al. "Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness. Cancer. 1984;53:2183-2187. 15. Straume O, Akslen LA. Independent prognostic importance of vascular invasion in nodular melanomas. Cancer. 1996;78:1211-1219. 16. Crowson AN, Magro CM, Mihm MC. Prognosticators of melanoma, the melanoma report, and the sentinel lymph node. Mod Pathol. 2006;19 Suppl 2:S71-S87. 17. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg. 1978;188:732-742. 18. Lefevre M, Vergier B, Balme B et al. Relevance of vertical growth pattern in thin level II cutaneous superficial spreading melanomas. Am J Surg Pathol. 2003;27:717-724. 19. Bedrosian I, Faries MB, Guerry D 4th, et al. Incidence of sentinel node metastasis in patients with thin primary melanoma (d"1 mm) with vertical growth phase. Ann Surg Oncol. 2000;7:262-267. 20. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008 Sep 10;26(26):4296-4303. 21. van Akkooi AC, Nowecki ZI, Voit C, et al. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. Ann Surg. 2008;248(6):949-955. 22. Dewar DJ, Newell B, Green MA, Topping AP, Powel B, Cook MG. The microanatomic location of metastatic melanoma in sentinel lymph nodes predicts nonsentinel lymph node involvement. J Clin Oncol. 2004 August 15;22:3345-3349. 23. Starz H, Siedlecki K, Balda BR. Sentinel lymphonodectomy and S-Classification: a successful strategy for better prediction and improvement of outcome of melanoma. Ann Surg Oncol. 2004;11(3)(suppl):162S-168S. 24. National Comprehensive Cancer Network (NCCN). Melanoma. Available at: http://www.nccn.org/professionals/physician_gls/PDF/melanoma.pdf. Accessed April 3, 2009. 25. Sobin LH, Gospodarowicz M, Wittekind Ch, eds. UICC TNM Classification of Malignant Tumours. 7th ed. New York, NY: Wiley-Liss; in press. 26. Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer. 2003;98:2740-2741. 27. Scheri RP, Essner R, Turner RR, Ye X, Morton DL. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol. 2007;14:2861-2866. 28. Buzaid AC, Tinoco LA, Jendiroba D, et al. Prognostic value of size of lymph node metastases in patients with cutaneous melanoma. J Clin Oncol. 1995;13:2361-2368. 29. Schuchter LM. Review of the 2001 AJCC staging system for cutaneous malignant melanoma. Curr Oncol Rep. 2001;3:332-337. 30. Eton O, Legha SS, Moon TE et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol. 1998;16:1103-1111.      Skin Melanoma 0 1 9 1 E F < L > x:<=C|  0ŷߢߙЄ|nnn||gg hmSh Yuhzh Yu5CJ\^Jh YuCJ^Jhzh YuCJ^Jh2h Yu5CJh2h YuCJh YuCJaJh2h YuCJ^JaJh2h YuCJ\^JaJh2h YuCJaJ h YuCJhh YuCJh2h YuCJ h Yu5hLh Yu5h Yu hLh Yu(R 0 1 9 W 1 R L f  ^gd Yu% !gd Yugd Yugd Yu3gd Yu+ h^`gd Yu S k > R ?_.xy;}Vs 1$7$8$H$gd Yu 7$8$H$gd Yu^gd Yugd Yu'01>/ 0 X Y Z gd Yugd2gd-J3gd Yugd Yu 1$7$8$H$gd Yu08=>B[K W X Z !!*!2"ſ̰~voehWh Yu5\ hE@h YuhhRh Yu5hWh YuCJ hWh Yuh Yu hLh Yu h YuCJhzh YuCJh YuCJ^JhmSh Yu^J h Yu^J h-J^J h Yu5^JhmSh Yu5^Jh,h2^J h2^Jhh2^JhmSh-J5^J h-J5^J' !!+!8!H!n!!!!!""&"2"D"E"Y""""""#4#5#gd Yugd Yu2"D"P"X"Y""""""####%#2#5#|###3$;$<$=$O$P$Q$$$$$%&%~%%%%&&&?&@&D&Q&S&`&b&c&d&t&{&|&}&&&ºԳ蘒ԒhWh Yu5\ h Yu5\ h|yh Yuh YuOJQJhLh YuOJQJ h2Ah Yuh YumH sH hLh YumH sH hn`h Yuh Yu h|(h YuhE@h Yu5hWh Yu\ hLh YuhLh Yu5\55#|########$"$#$=$P$w$$$$$&%L%~%%%%gd Yu$gd Yugd Yu$$gd Yu$gd Yugd Yu$gd Yu%%%& &@&b&c&|&&&'E'k'l'''''''''(*($$gd Yu$gd Yu$gd Yugd Yugd Yugd Yu&&&&&''3'='E'F'l'v''''''''''U(_(J*K**"+++++++++++++++++,",0,:,B,b,g,s,u,,,,,C-K-l-m-hLh Yu;hLh Yu5>*\hWh Yu5\hLh Yu5\hLh YuH*hLh YuOJQJ hn`h YuhWh Yu\hLh YumH sH h YumH sH h Yu hLh Yu<*((((/)R))) *J*K*W*n***"+D++++++++,$gd Yugd Yu$gd Yugd Yugd Yu$$gd Yu $$^gd Yu,,!,",C,V,b,t,u,,,,,,,--0-1-L-`-------.$gd Yu$gd Yugd Yugd Yum--------.. ...$.%.^.v.~..&0'0(0*0:0B0I0T0U0V0W0f0001;1=1J1K112222 2<2=2K2Z2[2222һh8h YuH* hE@h Yu h'h Yuh'h Yu>* h Yu>* h Yu\ h*E:h Yuhh YuKH h YuKHhn`h Yu\h YuKH\]hn`h YuKH\] haH h YuhWh Yu\hLh Yu;h Yu hLh Yu3....../2/@/U/i////0'0(0V0W000000gd Yugd Yu$gd Yu$$gd Yu '$$ !gd Yu $ hgd Yugd Yu00L1r112\222<3}334A40 Dhp T $\,d4l n^`ngd Yu- >p T $\,d4l n^`ngd Yugd Yu 22224444051576V6778888888:I:J:K:l:r:::::::;;AAAAABBC CCCC C!C#C$C%CCﮦj: h YuUjh YuUhLh YuCJ$aJ$h8h YuH*jh YuU h4h YuhLh Yu; hth Yuh YuOJQJhLh YuOJQJhM';h Yu>*hLh Yu>*h Yu hLh Yu h YuH*4A4445525c5555$66cccccc.$ >p T $\,d4l 8^8`gd Yugd Yugd Yu0 Dhp T $\,d4l n^`ngd Yu3$$ Dhp T $\,d4l n^`ngd Yu 666@778G88888888~- >p T $\,d4l ^`gd Yugd Yugd Yu 8^8`gd Yu$8^8`gd Yu.$ >p T $\,d4l 8^8`gd Yu 89f99:J:K:::::::::::&C'CQQ3gd Yu1$gd Yugd Yugd Yugd Yu gd Yu- >p T $\,d4l n^`ngd YuCCIIIIIIIIIJ J J0J:JJJJJQQQQQQQQ R RRR R!R"R%R&R)R-RFRqRRRRRWSTǽǭǽ|hLh YumH sH hLh YumHnHuh-n~h YuH*aJj~$hLh YuH*UjthHZh YuH*Ujh YuH*U h YuH*hLh YuH*jhLh YuH*Uh Yuh8h YuH* hLh YujhLh YuU.QQ(R)RBRRRSS9SWSzSSSSST(T, D8p T $\,d4l ^gd Yugd Yu) Gh8p T $\,d4l gd Yugd Yu(T)TTTVVY[[\[ \ \3\4\Q\\\\]]__1`gd Yugd Yugd Yu( D8p T $\,d4l gd YuT)TTTTT'U?UCUUUUUUUUUUUUUVVVV!V"V6V7V8V9V:V;V]I]J]K]g]]]]]]]]] ^^^^^^___ `0`1`2`6```````Ĺ겧ĊĊjh YuUh Yu hs$h YuhS-h Yu5\h Yu5H*\haJh Yu5H*\ h Yu5\hLh YumHsH hLh YuhLh YuH*OJQJhLh YuOJQJh YuOJQJhLh Yu5\hLh Yu5H*\01`2`A`rr }!}-}~~~:;ӋCTU+ Jh8bp T $\,d4l gd Yugd Yugd Yu) Gh8p T $\,d4l gd Yu```````JaKaii!i"i#iiiiiij)j*jjjjjkkqqqqqrrrrrrrrrrr^sostttcuduϵϩʼnϩhLh YuH*juhLh YuH*UjdhHZh YuH*Uh Yuh YuB*phhHHh YuB*ph h YuH*jh YuH*U hLh Yuh8h YuH*j[hLh YuUjh YuUj(Rh YuU2du}}}}}!}%}}}}}} ~O~Q~~~~~~~KL?A*+; 5YZfϊ/5ʋ͋ҋӋ௨hLh Yu5>*\ h Yu5\hLh Yu5\ hHHh Yuhbh YuH*he h YuH*h2Ah YuH*hLh YuH* hLh Yu h YuH*h8h YuH*jh YuUh Yu>j=>?@ABMRSTUYtw}~.RSTUAaef5ۡDJQT h Yu>*hLh Yu>*h8h YuH*hLh Yu5\jΏhLh YuUjh YuU heh Yu h YuH*hLh YuH*jh YuUh Yu hLh Yu?Uk.4ڡۡCDdeg2xgd Yu( D8p T $\,d4l gd Yu& A8p T $\,d4l gd Yugd Yugd Yu bgd Yu¢Ƣɢ͢+7TUbefgpq23=>FGH[ҥӥFGHIJLkˮ̮-./013BF*.ҾӾԾվ־ؾپƿ疪疪jh YuH*UhLh Yu5\ h YuH*hLh YuH*jh YuU hrh Yuhe h YuCJ h YuCJhKh Yu5CJjh YuU hLh Yuh YuhLh Yu>* h Yu>*;23HGHKLk23׾ؾlm () Gh8p T $\,d4l gd Yugd Yugd YuپVWYZ[:;<=HL|>^BDhjk%;Tfhtv  !%&'()*+:׷߷h3Vh YuH*hrh YuH*h'h YuH*h8h YuH*jh YuU h YuH*jh YuH*Uh Yu hLh Yu hXEh YuH()*@jj>>>>+ & F! Dh8p T $\,d4l gd Yu) Gh8p T $\,d4l gd Yuk Gh8p T $\,d4l EƀKԆgd Yu:=E_%@Uzbcdst!"#23GHIJKMUVԮԦԍjYhLh YuUjh YuUh8h YuH*jmhLh YuUj[h YuU h YuH*h3Vh YuH*jh YuUhe h YuH*h Yuhn`h Yu6 hLh YuhLh YuH*7LMyMx( D8p T $\,d4l gd Yu0 D8p T $\,d4l 0^`0gd Yugd Yu) Gh8p T $\,d4l gd Yu %/0DHIKMfxyvw;DLNĿjhhh YuUjhhh YuU hhh Yujhhh YuUhrh Yu>*hLh Yu>* h YuH*h3Vh YuH*jh YuU h Yu5hE@h Yu\ h Yu\ hE@h Yuhrh Yu5 hLh Yuh Yu2MNfg_`CDg) Gh8p T $\,d4l gd Yugd Yu `^``gd Yu) Gh8p T $\,d4l gd Yu1 Gh8p T $\,d4l h^h`gd Yu 4789=?GV]^tfgRSbcwxyz{~ʶzuzu h YuH*h3Vh YuH*jhLh YuUj'h YuUjh YuUhLh Yu5h Yu hLh YuhE|h Yu6]hLh YuH*] h Yu]hLh Yu]hLh Yu56>*\hhh Yu6hhh YuH*jhhh YuU.Z[\]^`CD +YDJRw~͛hLh YuOJQJmHsHh YumHsHhLh YumHsHh:{h Yu6 hn`h YuhSih Yu6hrh Yu5h8h YuH*hLh YuOJQJhZh YuH* h YuH*h3Vh YuH*h Yujh YuU hLh Yu4+,GYluuuuuuuu  xgd Yugd YuI$C$EƀKԆgd Yu$gd Yu) Gh8p T $\,d4l gd Yu (6DRjxRSl~gd Yu) Gh8p T $\,d4l gd Yu  xgd Yu   xgd Yu56   9:bcgd Yu $ hgd Yu$a$gd Yu hgd Yugd Yu  xgd Yu   xgd YuEF         8:E^45 GQ;<=JgŹjh YuU h'h Yuh'h Yu5aJ h Yu5aJh`h Yu5>*aJh Yu5>*aJhLh YumH sH hD2Nh Yu h YuH*h3Vh YuH*jh YuU hLh Yuh Yu:c;<zABM n !e" #$h^h`gd Yu$gd Yu) Gh8p T $\,d4l gd Yugd Yugd Yu btv 45678;<=?@ABMN`aao}E X h j ѯ}}}}h3Vh Yu56^J h Yu5^Jh3Vh Yu5^JhLh Yu5jhLh Yu5Uhh YuCJj4hLh YuUjCh YuUh Yu hLh Yu h YuH*h3Vh YuH*jh YuUjkhLh YuU1j :!H!W!j!y!!!!D"P"_"a"k"""""""""""j#v###$$*$:$<$?$@$B$C$D$J$K$s$t$$$$$$$$$?%K%Z%\%a%b%%%%%%%^&l&ǾǷhS-h Yu5^JhVh Yu6^Jh Yu hS-h YuhS-h Yu^J h Yu^Jh Yu56^Jh h Yu56^J h Yu5^Jh3Vh Yu56^Jh3Vh Yu5^J> ##@$$`%%&B''[(:))R+,-.f/ 00\12253 h^h`gd Yu h^h`gd Yu hh7$8$H$^h`gd Yu$h^h`gd Yul&z&{&&&&&''-'<'?'C'D'''''''6(@(V(W(\(]()&)5)6);)<)))))))*** ***+.+H+L+P+R++b,o,--b.n..7/E/G/f/// 0 0 00Ҽʰҩ hSh Yuhkh Yu6mHsHh Yu6mHsH h Yu6h YumHsHh Yuh h Yu5H*^Jh3Vh Yu56^J h Yu5^Jh3Vh Yu5^JB0<0i0p000000A1G1V1Y1]1^111222292:22222223#30323537333333333333333333333Դ hh Yuh Yuhb,h-Jh/Qjh/QUhLh Yu5jhLh Yu5Uh3Vh Yu56^J h Yu5^Jh3Vh Yu5^JhoTKh Yu5^J h Yu5hoTKh Yu56hoTKh Yu565333333333333333 !"# '^`gd Yu 'A'a&'%$a$gd-J%$h^h`gd YuMelanoma 3.0.0.0 PAGE 3 CAP Approved Skin Melanoma Melanoma 3.0.0.0 PAGE 8 * Data elements with asterisks are not required. However, these elements may be clinically important but are not yet validated or regularly used in patient management. Background Documentation Skin Melanoma Melanoma 3.0.0.0 PAGE 10 3 !"#$%2ABRSTUV\]^_` 3CDFGMNPQRSTUXYϻϻϞhLh Yu5h/Q h YuCJ h YuCJh{h Yu5CJ hh Yuhn?2h YuCJh20J)mHnHu h Yu0J)jh Yu0J)Uhb,h-Jh Yuh-Jh-J5h-Jh-J5^JU1#$%BSTU`  3DEFRSTUVWXY$h^h`gd Yu 'L^`Lgd Yu % !$gd Yu '^`gd Yu 'A'a&%$a$gd-J%'C 0P&P1h:p Yu/ =!"#$8% Dp@P&P1h:p Yu/ =!"#$% Dp@P&P1h:p Yu/ =!"#$% Dp: DStell200736363617Stell, V. H.Norton, H. J.Smith, K. S.Salo, J. C.White, R. L., Jr.Division of Surgical Oncology, Department of General Surgery, Carolinas Medical Center, Blumenthal Cancer Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204, USA.Method of biopsy and incidence of positive margins in primary melanomaAnn Surg OncolAnn Surg Oncol893-81422006/11/23Biopsy/methodsDatabases as TopicFemaleHumansIncidenceMaleMelanoma/epidemiology/*pathologyMiddle AgedNeoplasm StagingRetrospective StudiesSkin/*pathologySkin Neoplasms/epidemiology/*pathology2007Feb1068-9265 (Print)17119869http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1711986910.1245/s10434-006-9240-4engSober200737373717Sober, A. J.Balch, C. M.Method of biopsy and incidence of positive margins in primary melanomaAnn Surg OncolAnn Surg Oncol274-51422007/01/16Biopsy/*methodsHumansMelanoma/*pathologySkin Neoplasms/*pathology2007Feb1068-9265 (Print)17219290http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1721929010.1245/s10434-006-9301-8eng: DStell200736363617Stell, V. H.Norton, H. J.Smith, K. S.Salo, J. C.White, R. L., Jr.Division of Surgical Oncology, Department of General Surgery, Carolinas Medical Center, Blumenthal Cancer Center, 1025 Morehead Medical Drive, Suite 600, Charlotte, NC 28204, USA.Method of biopsy and incidence of positive margins in primary melanomaAnn Surg OncolAnn Surg Oncol893-81422006/11/23Biopsy/methodsDatabases as TopicFemaleHumansIncidenceMaleMelanoma/epidemiology/*pathologyMiddle AgedNeoplasm StagingRetrospective StudiesSkin/*pathologySkin Neoplasms/epidemiology/*pathology2007Feb1068-9265 (Print)17119869http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1711986910.1245/s10434-006-9240-4engSober200737373717Sober, A. J.Balch, C. M.Method of biopsy and incidence of positive margins in primary melanomaAnn Surg OncolAnn Surg Oncol274-51422007/01/16Biopsy/*methodsHumansMelanoma/*pathologySkin Neoplasms/*pathology2007Feb1068-9265 (Print)17219290http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1721929010.1245/s10434-006-9301-8eng DBalch200116161617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engLeBoit PE200616161628LeBoit PE, Burg G, Weedon D, Sarasin A (eds) LeBoit PE, Burg G, Weedon D, Sarasin APathology and Genetics of Skin Tumors. World Health Organization Classification of Tumors49-932006IARC Press DBalch200116161617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engLeBoit PE200616161628LeBoit PE, Burg G, Weedon D, Sarasin A (eds) LeBoit PE, Burg G, Weedon D, Sarasin APathology and Genetics of Skin Tumors. World Health Organization Classification of Tumors49-932006IARC PressHDFecher200717171717Fecher, L. A.Cummings, S. D.Keefe, M. J.Alani, R. M.Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, USA.Toward a molecular classification of melanomaJ Clin OncolJ Clin Oncol1606-2025122007/04/20FemaleGene Expression Regulation, NeoplasticGenes, Tumor SuppressorGenes, rasGenetic Predisposition to Disease/*epidemiology*Germ-Line MutationHumansIncidenceMaleMelanoma/*classification/epidemiology/*genetics/therapyMitogen-Activated Protein Kinases/geneticsMolecular BiologyProto-Oncogene Proteins B-raf/geneticsReceptor, Melanocortin, Type 1/geneticsSensitivity and SpecificitySkin Neoplasms/*classification/epidemiology/*genetics/therapySurvival Analysis2007Apr 201527-7755 (Electronic)17443002http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1744300225/12/1606 [pii] 10.1200/JCO.2006.06.0442engHDFecher200717171717Fecher, L. A.Cummings, S. D.Keefe, M. J.Alani, R. M.Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, USA.Toward a molecular classification of melanomaJ Clin OncolJ Clin Oncol1606-2025122007/04/20FemaleGene Expression Regulation, NeoplasticGenes, Tumor SuppressorGenes, rasGenetic Predisposition to Disease/*epidemiology*Germ-Line MutationHumansIncidenceMaleMelanoma/*classification/epidemiology/*genetics/therapyMitogen-Activated Protein Kinases/geneticsMolecular BiologyProto-Oncogene Proteins B-raf/geneticsReceptor, Melanocortin, Type 1/geneticsSensitivity and SpecificitySkin Neoplasms/*classification/epidemiology/*genetics/therapySurvival Analysis2007Apr 201527-7755 (Electronic)17443002http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1744300225/12/1606 [pii] 10.1200/JCO.2006.06.0442engDBecker200618181817Becker, J. C.Kirkwood, J. M.Agarwala, S. S.Dummer, R.Schrama, D.Hauschild, A.Department of Dermatology, Julius Maximilians University, Wurzburg, Germany.Molecularly targeted therapy for melanoma: current reality and future optionsCancerCancer2317-27107102006/10/141-Phosphatidylinositol 3-Kinase/antagonists & inhibitorsAngiogenesis Inhibitors/therapeutic useAntineoplastic Agents/*therapeutic useApoptosis/drug effectsDrug Resistance, NeoplasmGenes, Tumor Suppressor/physiologyHumansMelanoma/*drug therapy/geneticsMitogen-Activated Protein Kinase Kinases/antagonists & inhibitorsModels, BiologicalProteasome Endopeptidase Complex/antagonists & inhibitorsProto-Oncogene Proteins p21(ras)/antagonists & inhibitorsSignal TransductionSkin Neoplasms/*drug therapy/genetics2006Nov 150008-543X (Print)17039502http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1703950210.1002/cncr.22273engDBecker200618181817Becker, J. C.Kirkwood, J. M.Agarwala, S. S.Dummer, R.Schrama, D.Hauschild, A.Department of Dermatology, Julius Maximilians University, Wurzburg, Germany.Molecularly targeted therapy for melanoma: current reality and future optionsCancerCancer2317-27107102006/10/141-Phosphatidylinositol 3-Kinase/antagonists & inhibitorsAngiogenesis Inhibitors/therapeutic useAntineoplastic Agents/*therapeutic useApoptosis/drug effectsDrug Resistance, NeoplasmGenes, Tumor Suppressor/physiologyHumansMelanoma/*drug therapy/geneticsMitogen-Activated Protein Kinase Kinases/antagonists & inhibitorsModels, BiologicalProteasome Endopeptidase Complex/antagonists & inhibitorsProto-Oncogene Proteins p21(ras)/antagonists & inhibitorsSignal TransductionSkin Neoplasms/*drug therapy/genetics2006Nov 150008-543X (Print)17039502http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1703950210.1002/cncr.22273eng^ DBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744eng^ DBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engDBalch200199917Balch, C. M.Buzaid, A. C.Soong, S. J.Atkins, M. B.Cascinelli, N.Coit, D. G.Fleming, I. D.Gershenwald, J. E.Houghton, A., Jr.Kirkwood, J. M.McMasters, K. M.Mihm, M. F.Morton, D. L.Reintgen, D. S.Ross, M. I.Sober, A.Thompson, J. A.Thompson, J. F.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin OncolJ Clin Oncol3635-4819162001/08/16HumansMelanoma/*mortality/*pathologyNeoplasm MetastasisNeoplasm Staging/*standardsProportional Hazards ModelsSkin Neoplasms/*pathology/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504745http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504745engBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engDBalch200199917Balch, C. M.Buzaid, A. C.Soong, S. J.Atkins, M. B.Cascinelli, N.Coit, D. G.Fleming, I. D.Gershenwald, J. E.Houghton, A., Jr.Kirkwood, J. M.McMasters, K. M.Mihm, M. F.Morton, D. L.Reintgen, D. S.Ross, M. I.Sober, A.Thompson, J. A.Thompson, J. F.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin OncolJ Clin Oncol3635-4819162001/08/16HumansMelanoma/*mortality/*pathologyNeoplasm MetastasisNeoplasm Staging/*standardsProportional Hazards ModelsSkin Neoplasms/*pathology/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504745http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504745engBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engDStraume199622222217Straume, O.Akslen, L. A.Department of Pathology, Gade Institute, University of Bergen, Norway.Independent prognostic importance of vascular invasion in nodular melanomasCancerCancer1211-97861996/09/15Blood Vessels/*pathologyColoring Agents/diagnostic useDisease-Free SurvivalFactor VIII/analysisFemaleFollow-Up StudiesHumansLymphatic MetastasisMaleMelanoma/*pathology/secondaryMiddle AgedMultivariate AnalysisNeoplasm InvasivenessNeoplasm Recurrence, Local/pathologyPrognosisRegression AnalysisRetrospective StudiesRisk FactorsSkin Neoplasms/*pathologySkin Ulcer/pathologySurvival AnalysisSurvival RateTreatment Outcome1996Sep 150008-543X (Print)8826942http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=882694210.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C [pii] 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-CengDStraume199622222217Straume, O.Akslen, L. A.Department of Pathology, Gade Institute, University of Bergen, Norway.Independent prognostic importance of vascular invasion in nodular melanomasCancerCancer1211-97861996/09/15Blood Vessels/*pathologyColoring Agents/diagnostic useDisease-Free SurvivalFactor VIII/analysisFemaleFollow-Up StudiesHumansLymphatic MetastasisMaleMelanoma/*pathology/secondaryMiddle AgedMultivariate AnalysisNeoplasm InvasivenessNeoplasm Recurrence, Local/pathologyPrognosisRegression AnalysisRetrospective StudiesRisk FactorsSkin Neoplasms/*pathologySkin Ulcer/pathologySurvival AnalysisSurvival RateTreatment Outcome1996Sep 150008-543X (Print)8826942http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=882694210.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-C [pii] 10.1002/(SICI)1097-0142(19960915)78:6<1211::AID-CNCR7>3.0.CO;2-CengDd x6D  3 A?"bJ!z&O f[[nSJ!z&O f[PNG  IHDRPy?|bKGD#2gIFg$0c( cmPPJCmp0712`IDATx^-J- C M9a6,.˄sY&|2m֦ƴ56{ZkGH-Y!)$έSNJ)#^{%p \.oe]w \.K`z%p \.Giz{].K%I_?^^gz%p \.(&w __ /W\.K%0akMK%p f@{O BW\.KJ`Q|É!\.H(f˜qX*K%p | Pgo+?̿\].KI%'XK%p 2K:[YޜK%p ~|WWK%p rK:䖪p \.'Ά'%p \<p?].K%0Z9r/o%p \w80.K%-99  \.K%p&!r \.Ka%6Nw%p \J+oK%p \.K%p "!eRK%p rHUR6\.K%p' K%p \+9rO7xew \. %p \,7x.K%S^`Ni\.K%p \.K%p' x; _p \.LX3 xK%p  K%p <fg5VK%p R$UR\.K% mp\.K%U^ 81K%p \.K%p ,S^`r \.@*)%p \\^/K%p <D廳ᗋ%p  w}K%p I`NgC.K%p tJtop \.K%p \.K<\.K{Ka{}.K%HWHp \.EJ`NX;S.K%HWHp \.j5p \.@f x\.K%p \.K%D x%Ί%p \pX~NK%p |k xo=>xK%x wg,K%p |_ x;>rK%p Ά}].K%萀W%p \.K%p \.o  &هp \O-?\.K%O^ ,%K%p Cspw\.K  @&Az3.K% Ct \.*p \.K%p \.HERK%p dr \.sK<\.K%0',ߝ Ͽ|.K%*O<>4K%p dΆ]\.K%*\.K%p \.K% $U$].K%^K%p I䓥p \.{H`NX;1NK%p dW$Ho%p \@s:8}.K%W^`^y\.K%p \.K%p x_p \.lpX~6QzC.K%xn x_K%p <qlx#t \.'Wx\.zF|F_÷;K%p fWU2K%p dE \.K9%Us^}T.K%}$0#Gp \.gWxY1\.ws|\.K` .K%X`]p \.#H?~Tш$\.KCs3_/_tVwGn#\]v\.K%=$P|ՄlV/|t \.Kz? \z\.K%ɛ$Ѩ%_ t p \.[ Sy.K%p tK Q/jèvEw\.K%@ dPL\.K%Ac<8~0BW\.K kL/p \.K`> _޶k;7&K% ׵''%To%p \ˑ(/U`Z '.K%xV ̕տ~}`g%p \$(OJ}٬?ۻ"%p \. ˆ)0pHK%p P)9<$z].KQ$ Q^7se x?].K%LA)pxPx)%Θ%p L\'[)>K%X psKIK%p &@*bߠ|Ϝ7p \.%0LA?:K%p \v\{/K%p zJ`Q؂].K%M% ($YttE].K`n <|0T0=>K%p d@*F( U6KސK%p %0g Ά& # K%p \J [Ooe7@!N\.K%Vsǝl'nOHuK%p P٪&<!\.K%03t0 i> *ČW\.KI W4?p[N>`K%2u؉DX~\.K%0rUgD$QY~\.K%0@X???ۻ\"޶K%p Lﭷl}\.K`r <4}un>=?2\.K p?u7 @^V @_.K%p L)G;m ? lƫ"SJv \.H S֤,xep \.@ 4AބK%p $ @q0mk wtp \.GH}+Yәix_].KQ% UG9ep \.te֨t/BQd~\.K%0TtqK%p z~1ooߌ̣w%p VYOqp \.K$P<}~-q:/K%p L,!bOn?O7p \.%0Vew:ÌZ :g Ky$ @{p \.Tolܱ.&oAt <Ni_o%p \$*oFK A@qi?oy}|{57\.[] 4"Ҏ?|ep'\.K%$QL}#7~B[H݇%_h=.%0 YC>PXN w%p \˔(X~!w60i/o%`uUzN8 &꿫anW!_1Ft -U,`Ӣ0?&>X=y;K%p ,qΆJ]@;gM 2,K Qˠ/k/^ډ\.. Pn _yzל].K%h  VsJsgN\k? 0ђr \%Z߆/6*bI]% TW?o?֗?׿x:sowK%,oX:}mU;N{9d<ޡ}\.K%%py~a-__uSw zl.сF>ǐzow @q: l_ٳx:WkIU|6?p |? |}#e7QO,l%p \ (~gs(0F\OK%@?K=rƟXM-jɸY^^Spq|.^yB$U0ax7\.K%}%px"3J}@VFl&C`f 4 =0Dpp}W%0 \.K kގK [?JUZ0~yaK-Ϭ A6L Wڼw _"\.K%0-fK J~+0x(>=XU? 3+KGP/Rx/AK`0^ނK%p *GUo&ӑa|(ooo h&8<P֚%0` z.K%Q0U\j@w8ceS,EVxQ9w$o|.]`|3KbrUg%]]o*K L_x /dDWqNI_߲It]9%\u Iዘf>]v.K`t~(8xK` 8C)?ۼW& P#@H p} pQqdc~\ .K9xK{Kr`:rS<K%pG%KB4t6.~ܓݟ?GE{W?p K ?hPkp֯ׯ[?}ݸ\%0'#Ϡ8"sk|$hp?+ ?s/6~..AVR=eq:V[U%p dsd7hq}o!l_v83 :Y!t 0d//۞@4$/Bq24cr .{XV  OGZ~K纋6m6p |? ~sl,חs|#k0wG?T#PqTrf_E|Sc$JH8XCbNEe u*0(fR7oi7ɠp"\-(;]_J~˛݉|\%\h8Vo1n \?^W#Rql@h5@!v|Qy@69}rIؑȧ5@TMsC,(BFPڴWV T5 lǫ,pRK)(mKϏ_s.J9:1ޭg@e;:["48U ]LJcIi2[]'TJǗj9{?f_.O/po+i&B~|՜ <N]HCYÝJp 䑀#[q \K̪mQRh 0 @6mPEVB+5~Ʉ o& - tU9 qW\ot$yj PbYmo8}ݳ Y0uGN}i~CMV $(S=-U6c >#%СP%Ϫ Ej'ԗT*@ K`R?N5K.^ IL~Kҷ}oKluz*_V.@& 8 N aS8= EE@V^/KPi^9G( nЁX|h폻,Ԕɺ, ^" uq5+l`Vc._c鏇l%N%p tKR /x @{Syϛ?q?7??UhOkp &9Gq_뿿o.?EN1 k# ۾Z7,?ܟVo^P^}| D.*WYs rO% Ie2ލ$P8ݗgLz݊2 7=gdB31@]7ۓ }xabWr "ą_ ?.S!czEOwnXfv؊cQ?fڽ|z].phz. {wھzg^)IU ,z;_=j.Y?sSPb:zPw,HP lo${,ON*O8>$p|k=w}/vu2:|3or <Gw' ^?`B G[E1ݙ2_ ݄~WJٰ{%Hb 4T\6VScY`8{xqǜ>]%P/'J_Qѫsx_?9 ]'_x 8̥d98￳37Ξ?>ѽ麈?o\!3{J2.몷|K_R['Wÿlק/7($/z?W_x?ԿVKӦ0G%S$H[(Pr%l{(W"?>+%ތ]Ns-7|O%ӗ0eggD7v{!X}q no-jTԊOVlTꡈ 1RvJ$lJGŵբBULҪYF/6`N (G gY#.NVU[*k%WKe(Q^ɿ@G:Z>CE$48`I ph)YvqW\Oޛ,,)vy}O-.Y@\tDЧ? PHY}y;$#ϸ`NdpOwmN J^lx2xZ .EbN\.sDz&kTG\GP) 4׈ITS@[,I9!t(=G ~b;_q@UsүgWx mFyɍH'jxȹ)ho^lCP/ښ{5dKBӶCI{ %L_?=+ǔ7; }  :zUK~֙ c9Vp)̛b]>-p[~(JU%=L,Fieǒ)XOo)c % P#-.%*jI-,Tu.Ro$mv~Zg&7_a~=sC_^˭h7Wyv ,TXxVu^ )7-U6!E'ĸr/⟶Cq,R{ةWǍ#Kz+#RH>5Zҁtϓg ]&*Zx0)?lHU0j \p`}I4D@YR-)"p/?L:r> ^z'J-ͧ?NZ9 `6GWJukF0V{rLwwuA rc͗6j9S}$|s=1,8ϐ_whޚK%$i}K D#alt x&"bP==-9˴lgD^kf }5R\p,lXほդ2.tІ1^J*+rg݋K^qQ.r͈gF )+e>૯C0W/-WcN?~/@,*;-D|2 ̇f^?Y`FDgje.(jXN_$Fy^&*.4Ļ!'ao_eW_]%4^SzJp&̩w(D s BE{b#ఁ^ׯ,S{:/$ L)&y*?8VBHԀ!3aM?}5nqC'Z Wxk!COVԮf# [.^d:} mMz5_KBnH$4fKОR9TBpάXGai)Sgϱk=+.f2HSLB Rc/U Dtr'Jn4P e՟YIyb!=~)mtݟ13ոXGh03?M.y~ F\|qMInD(J P6J2)0PS&70 >ؗEd|]0 *Ԃ@?ZMŷ\|uF4VQһjI&y^^Ւ`H շ#q1 ;SB`p@ޙz9 I|r"ۙ)\ީ|p{o[nj| B،a)ݾ=1*#IΜ储{gD>8Mt?-y߆ @HP?4Lm##OHVηk-"הƠEeM(L/h4V05)%Lh@xf]%u!w .ZEȣ D~ȿNZ#poFΔqVl~M/:4/Ay9^ian^_V(AjP{V >d1`fY4u@njYl-Y#172G俩0Ri.پ W g^#MOt1f@'8P_@GJzJJ*׏j 5,dο *]'!}9Xȼ-' Gj O}y%w0I0z@rKqiw*]8Ҽ(\mq+LP c:A8XH`NsL0$ O0@Cxr,,#[$+oKyClpv/ i($-5-|EAH?{3${cc $ h//fŚ+HuDr~g=#&C&dHQA@8`>}ŢS}Q&8 BKr Z\ጭ " fbo e3_%1"X,|ξG{̳r  Pbpޏw^yNK[9ȩ@`Lx zbA )1y l ( Q/o^o1]JQ9k=/8BxCH4o*,`p! 2VoF,hM gޥ jGCبx g#$nc1>p?q1  >j:JNz5W5ݴ8XIap\&L9j$ c!SN^_b%PfpG-2@(S j3~%p `k=$x!?M0KQi!;.8$;._ yN?z6{c8aNq}^YδWv@_tx._vkIu% vQIP)*+eGh8]#y?c&>?bv+K@Dt1\vEJTKeC- ೠt2IiϬ̢tXm9`.QL!|e: M6PVXa%.zj;:!7/'"{3#=}!(nTEH91 މ'>"E*UY*eH7 &{S12uLqJ#X%"XXvZvgy)pT{TNںxOQi}pFnP2sSXrNp/PTDb"x;nP0Z]j)I%z\}ܿŒ\<P8IO3=7 9wL#aouкGh[=pdLZ2OhqlDY @G'ZgS9E%P \Qa:k?ɇO8yI@pc]\dz{y265.pxI;/VѺlê5 A ډ*e=HN(\ۯh9Wwގ?bFnVk؂56"Yv)G4ey05)ar*)9Wj85v+_(<5VÐ20F1ftP( QXwj*_d!9(N}v'XKV+v;0<ͭ/ʛ(Ӛi:mAZk{ 3g(p w,HJ7]Hۃg5&W0i ]DP _PWy:w'kSKt%``!lbrn0(l19g{P, =# z`~e)S#e.9a4Rg1@3ItSh?]%h@LJ8m=Nj4s8lqCiC X ),hsZ擾 ,#4 |dg6o|ۧF8'$&~| $mWdDkVXb *IueJQ|6<7<Ư {R`}sH`S1H6u BO|9O}DtTd7|[#xG6Id7SVVU cHl`\Z1f> OvXzxԏ,Hpҝ)N$F55)'~ ^\*1,ŪV.7`]^ 40´*i5]z@ySO.G$`UL{o;ר҂lWV^A6,'i{Ot ҒPA:v@ZY:zzy"8ZVy G}N<ʪ~*dԳʽk0x?S^#3{m(k-N1H]өHRQ*)<E|\M]?/شG1"(E ,|- G/f_-cEF UZ\`# d`0ÌP)I1WkvBoNkңFNȻ`~pklt9~SH8}Z'n(]`p7! ZqVk?mozU]yYyA?]'L;A"nCLc53FQ3Bdou eYR^ܐ>p!3<]MXO>y^wڬpd9.ia@><xfbծ+K#WEsTCT:j!<$<8oEJ=8K  b~u+I_!Akd㽕fdCYş#x2]B9`GA E٦Gñ=t A,ʳ?T@}yߔ;|2H@% Ҡ 8İs lBR _f Xmy$!FG$]"4R_].].8q;ɧs*?_KaF]xJDJ/ߑ5D X*'Sruǯmfj ory0r;}Xu}Mά%\)WrtP#o |UN2j ,a cœ=zJ!KLђGKn4u#;1tqwBl-SW[Qen`*X!dC%I[49Ӱ.ؖ^%d z" z/֟**%Ĉ`N r## >U3մ)sPfD:P 1< eGVqoekg!O|5!`hj0ÒaV[e0]Ue2B?+ P9-w+qt:= ب_'2g'/2'{ RK T0Xz% m> 0-y1|RWBƅ0{$^F.dD]J6. U}u1H_\8,p;ro0iuB Fh Pوh#$ա\i\}Fb yQ(('d+(q*R C Գ*ZvAoG({$ Wci$r$U] S,1aȼIOOgXM`-bQf렣CJnY0ou@$cmizC!B8dڷ%u)d#2 ӛ0'ǯd֪ܼ#+!V@F`K򓽤CNFzـ+ @X4] g#*B٦ӡYEdq-ڑi>Dנ?V'@6DSC+gTT^$p H t|dI8ڧ(wӦYdC0R-]G `+A'Yp0?U;S_ I!8\C FoPDu0Qr~AxfߠzQHe[TdS|O8C8`NiSŮ?-?,F߅2M\((S@qG*bE=fۜ1YC)jWYzK'wY8v'ח# '&ҫgBJ8(+@mtl}fs@5͊n_7|߶[!X D! qDLbSGd| ilP@-,qqu U~@# adQ2`.m.0A?CUu/xt-@8L*n@p\@F{&D .'i,RZ B}ndEE`|>@pbYgBE[Ef >ٟ4<`o_rg lLܵ_BTP!)MڜUupTwD/%[^->xCn <@ҁdb=x pǺ~}%ÀiP?e =f C s k9'  }<ZV߬}أ2^!wDb\uf2/tG.@h$+d+n^Cf Аf% ̓#ilCP6ҘO@Bj=k"ǟOeC2fU33O?se,}QN8M.K&3fڿ@h:r7G(k_ch{:V\a1p2wZq UUV;YiH_J8$ύqQE[bjR؛&_ݬafZ}qW\t> \%$_Pٻ1O0.J2Q0{dӈ lMT7\nXQ3%I] ϣR5kJ[#Wm^ n©<QHT|eAo+8A _pTo^RP؏t;e!G) gd\Nm!!J̷@GFT[gUɱрb'tq-t(Tww;/,l> [ c. ';0"ǙUş[2wwOP<1G$4&_)~hj3L;@a'#Iĺ魓LԳfk o0J8%TB0!3ˌZ=bkib} T9 'ue_ {){ |mچQQ x&Q(ϸDpOd(6?er9`u[}:`:{ˋa`,}iՂP*Q}^"&O'P%<'⑶_Z8^UնѭPrQ {x%^Z$?^ E Pyf@YĄ'x=eKTFJ&> ;<]%P"Ănyvq,y_,FNxa[PFȬ=8wOA_Ae!8Ǎ?YoDPsyX9|4)DP~,]ynl9#iLqV0Z%`&N%DDAȊ/Fu{/ߕ qaopDs& \$V"Qe[oO7zg=EGI1~ r3W@ؕ xgYn{Oa8)+O`&!0x畀rJvM ?ߊ0 n,75uTq! 6TZ!̓B0=Kg(p{[Pu ]N٘bJՋX#aSy0-R ʟvL;jN5 &ɍzTJV7ͭz_[+oƚ5%b%Kˑ T 09PҹCrPxt6ŅmUFɺ0dUvwOe}]Ln%&7peO/b%v9wz&{wz˓2#=hvbVOODC%W P$S* eɜO֜9zqW"tϫU 1v bAHD XT\"Yu"w[Pgtt[ׯ kͻ9TJF}E^`%I]/PN kdp[v9OIkCCuWH×>+B٘nWaGy  &0Ǡ'iNP&(#sVƪ=$hH} (rQѓ ÅFL/,C!% 8YPC=@B)](9~wA^u{"&-+9]sx١H!1ohH3S.cGoM*  M9A ^ssaazY's0O׮ī`C"* ĸݞ5X'b uƂsۢʊ8+!{H+3 S2QdEx ,3O!T+O|=,G#feG f^6O4z4QZsI}q\'hԗ0"?ByE㮦: ӹ$pVwn֡7P@,/Ƣ-AyGĺW^ 2 V<#;Ie98>¡ȜN@jM#_s/sGoP3w:!2Nl"4MCb9PCc:PX$ZM(y_ Y("b@pR_ԟosG$1bVRABⴞ ;L2*Eßά*!!ZRܶ3'3l3{DPnFc}c58+7`)/ALI,![ܠ @4/r=Ơ%`:\@s!exg X8483%hT0C3ZM:_+YV )icUO{C{YAAX jRi-'L*l~lýٮ+3o¸+eo G/+&_rG v1*iUwZ8 )]9pb2^hgٚwR=b7?m嵾D,5 Xt"j3pIӏ@kg/Y%.*S ԣ$-]3ECu0U(fزی]sw1p^&OUXaTD(<5KU~X2=jY;X~k T{E@fNl%*),xX^[}E]Tdj[#I@@6b ix2~)<3eH Š FvSvDş%|79ҥqzG]Hx (8)KEX^f˞5R}?{ne#p^c7dmuI^͟TL\%O`"b.q, 8zK7@}}5$   )t iD{ Mo9{n.<Ό&۩s +1g>?ecv`9.K"*6#Q:Z# k,@ 8E@ NG{y}XPȔۿ7{evj!H9UJ旪J 4vCKVHSX3yM{t"a>= 5N|"+kaA; @OZ],]_ "'axT~}Zz\:Ö6Dע[xaZL=;ϠR4ݣ~n @Ҳ)cl_ԉ'j .iA./JuE ,0VGpc=[Y(wpÃ#h29F`? zGbD<fX>__wFIZ;KyzV?{J GsͧA`r 籟z ćLe:c_3X^nH4&a{>{ms8U)trTbvKP0)Fe"svz7٨aI*%MW7G`SF5jvVY ; R$0  W{3.I|vB-2"RF8$,˷VNēn9 ^xC|Z%so 3*@qɅsgɒdyA XNJY:wȮ@0mX NP*v2 Oy8Y_b6ưځy*2'@: M *Wdz]g*vp'@H/ԾN/RB El*(2G:'AڡəjIa {~tй-\^c` AO;rJ}Kf鞽B :1H}{+wO8}ZO5sKbuGXp Iͭn-C_j쾷4vVsa=KA?,Kq'9f_3PsM9~?Sofo/oeQ1эWRFhwX?\16O8$"`poy7 ȗQ] Dz Ko0b#0gݖ oiDǻmP>2l,D?\/+]Ҿ쯵?ۨ 1sA"͸V(VnA2/pr-? Dkj#sL}f\ЉLX8ZH~ނU #@UI3Q7xNI #VvA:ST'Jx1+} L!gX.@HoV57+VEP(Vv:pī@Yx}x&=:9/)K~7^YmvxDREן73\Ķ ҵk;7kg24H#-2A.5=֘)(4k]ѿf0"%FMWIdEU[vҪ^A zq%`C:>7G< EoȦ6% l}ۊc` @LGIg v \So| $X0zmD: kyT7%t72,Oˇ(Ky^?(}EKE-+ %gL L/5LOQK,\"B+@ /o!rq_24:hPѐMqK'M̴ Er6ޗO3c&tPB7<~PIyE1HTxt&ovH1 ۼ4",Re@% dl8hM7#8EevDoѕ4ak:vӹS = v\Ex^4fĠ4GDɿȉHxq>н Ǔg 7e9y$T/ $@2M[+}hcQ,e//3p@Hx^z[_9m}a$)3ao`?61X̑BКmw@T/%u@VV1 |Z$ȝEaX@֟^0-pNõS-C(Qy]k!4[۩KEà%N\&E0]/ ̐0h"bU C8,cZhGK"ѽu3d΀Vπ75~LG7AyEYZfri]91ùYKB OVeJ Peel[gN=5d /*%ܞp4ap#,_tYkH2npm9q j=dS0qBc!& 6 ܉^*R\Nz`. VXzp@\=5 \pD eF/%oa#OWP]Uyek/3sYx`qMup77m>B^Q^'xO*/ @CK|Gc<A4g1Ԣ`sBs dw" ¨ENbR#*1f%=uI82ЄGk85Q^/"@3Pp w- y!INj#Jݍu-r J9ƯU-W!JᄒOM ĥc_{BWGN,c-0^J}%Z#ƬWT¬ fZ!@ZPΌcu B8ӗr(r^ݩP!>4I" $ h7a f0%&JUB djsIa4Έ! `r+ܬKY@LP=f]<  G4`TI!O,!8;K_mUH"1p h*#Į>mj3v!WSDWS^b.T`}m'</ry;D\"G> *`GL3sZVBk- UV&$య]Oχ%gn[зB[NJC@9|6'k3 ϴI466bRTKVB3*>@CG Lwa.$ r nU4~XR,+4_b*Y$=yBlݽy ,SlaV< e@7VN{4pk5u9!xUo !< } ʯr:ʾA뒸J^P! N;z5`!IF |ԙ@'@y4PB"Oqm΋L69ncHTSo"˸B9k=GD{p.]M\,fs8"Wqb^s9/oW>"P^yqiAT:;.9(P'ԀZ3Ht F=.5-{(TઅKu~ik& gg1?1Fv̵x׹߳F,lЉź%$"kAԖ.%/X:u/hK*ㇷ5BU=؜HIN`ȴIɌ|3آ}9JLy>C oOe|by2!T W7\xv@e8OߕX,aԴUe(ozf ]>$8 Š,}? I_QL;߂/0WT6%v |mWXٿwP ) he 34]kv[jm*א?$ /F )鸇((K+v(ZX1Err" [8h sr坃Ci9|9l\4@HK hz}mos5gUCdRKM[){OBR VzFh#I=mLZyC&&yӘg Uۭ ,gրS-p/hH3akF_2v&yL}u)Sj+AH8 س & ް&GmcF ?\%"{چd6)AC'fHZLi$h%#1,'#+ {k5n-[; V#GgROߪ"9a "GS+ |IĒe$_@Pn2>x2OheH~h!ϊ'yX>0GVLHPn.aitW8dUzO24r@Jr!)Ν`˓t0ҷ` ·GuST\R}ZDڨueψSg-,ϮZB +t4Oـ,&pKLPgg 2|fY p}ejS:MURڞd:CfU(EENy(׻4鳜Dei(fΕ rJy7,R%yRqJ*C^!LecאH;ʊkn̶0^"t@RBU(Յyli* 9, C)Y ?^W2ՅQe׃bUv#*M&D`O07<|pWYa[n.]+Z'btgq3x?cu#;`@u nEWΠsg$M8oGEs/S$ez'1H%08G0Q'Re*Ѕ]JlT(% 8PPkҤv.>zCa* nuCnQ[uHgֿzy% >`ں^JHO;&3w5bTdasT&`c{<q@H7r,gN=J (Ks OX y:B|t,@Fgu`7)`fEda!q .K9-%:y:E#RI,FT278b4]QW` V;%N9Za-A'!fAbkvB)8In6"v18U&g?_ ab)ie9sVߢ`U>0/rGZ0j}" uJ v $ի@5s*SC:IgI `PUɣV2:(6>c CfI@k* `rC>6NbJg+_'12*n?`m>UWfeuK;Be#>I--|As?Wdi%jʳgZ _? ϴ:=qh]-Sf;WhmY[c]~wsR.<4M䞁\?lH^.0H#/iπ#52 q}We6\VE/DcNCOz^&G@5 |T_` U HbaF2v@ Z|(?B$-.eJఇSyU(\1d]9@gFF!>[-T-ASWm^"^$(bݱp 5*`;&jp3}}xm,vDuFS 5l9b5VFnw s_NM #ߥ:~~,]J#֪L~D& "^0Mx#Nޚ!,`2L.Wiၳr6c(8rt=^|})- ғoHKsV()nY\WWkaΙ~rP;." ]D$Vކt! o"(oT^ek]mRI$H4s8BjfiWڤ@๛#V`MEN+'BU)zw2]%/t_+5:w8ːKEK9 Ǵ735wty̟rQ@M'@czby;$2o%OQf4[kKmH9˳,a;yBzM2VUsqH=:T+`f_ #okxP7r*_@7bމ`l/8 @UÜy.*n lÄ-[{e.^;`Ybpk{vd ht@R 5 8ZYzu9׫UrS lYVo A_0,3XDr/6.m*;Baj5 tV #lj|Z]y0FE\` Tw7iLy5uퟌ`?\ 7!L#f@t:毳t;|-岪5{SnYo, }CH:~B6JUAU28V3KJPSg8A1NN`%DB~ P7$[ tOla@Ta8&@X}}ܔ+,ⱓ+t1^t% 5߹U Q{Dj]/t<#&"x#4`b=Nܿtq M;h]l^R;iY=F{Ӗu0eϺ/ dN{3,dVP.r%x+Цe!E͙4׷$(i)}\|Śj6 w!jX.c!a a)m'Ÿ1VZrD_o8 oy!tfҢf-Xӥ|iЫ@g<v&+\ b>j ^!mt,$,~ zQ^\Dr>*k§TTg2Iv˳}^__BrVH Xc 3K{lڶ}]x8 Im/Cm0т--!A*@u}MJ#I+H7 F/$(usV¢In&.KoVPi 2F=j'&ǎv>7AEJ$s>V*gT bGWslyw+ah6)l6|z.=#w}[ع'xNl(O C(+b:aD\#*UiE.8j9d~Q^#/UtCKc` aV1 諃M)@3^U 4-vgjۢjvaJLx \.3UT. ۜFXנ2 <έa P ){@)1УzsGEJLo#1Nk5Tu5ς-͒*z3pLN caN2j$_o 5w9'meW#Ў7P]Pmyy1,MRԘB-"]\̬!;"M[vX#j""5d<ƯDaPzFc[H6(3Y7,HD`ܫr GS .%I~aa,RN;8?"O.]t[V3+Uz17ס.|~ щk} 9~T\$Mw_ʾPrpqL}وf@J&^>USF&?ҿYw=n KF9AmM>6xV:vbehuWDžw8q|%lwf fk!sRNԯ29~XM/ه'R;]jmsL> ۼ~g$)uYz5ɨnTy. du1ȡ/ %M`J_: V] CzFqPGCI΄ÇInRR> CWː$Ez@$$QmO*bvFhd4+Xr|']S 2ΩPZ?3y!5EշƘ=keF$!r@}'%ϵmfkQ.~ؼJ(^w"=l]T2jCiz=Y}ÃCnK26Seےn܎ @3_O H\jk LTI{VWA ݤ77#H tϙA$讶8);Ĺ/KU›⿸sϧ q_;NHŶH#9۾Qn&|a69 F9OWj!`HUGii:]6ȹw^p[]G3CS* 2BdNuܒ?NDQjt{ME'25&/L{ѷlGrW`059Kن"0;C[X.TV&I;-75V ԰`"v*߷}<ɽTnZ#b'9ng{W= 6 r?\4+l`7M. HvY Ac}VM(nKY\W޲FD[ȸ i*)ZU.8 ( `KyM>v,IQ#R2So8t|yJ[y2*ܹ~HcfQ+CVPD Am_̨~65E-CSu5OWvhˢˢ\"Tu}JOVIˡFzzI!;Jl&$?L$?Lv;M]}Cn(a@=~x?Kn8HZoaZ ȐG MR ^8pmt!|U,vDhmA6DdxpEzy0I:7wxRFk!y+,w~ e?d Z_M ?Sz =-n `"=~Rގ{uubR4 w#PNZ=2ˍ+;- }]r7 Oj_)γZĂ=i6cDq,XayJ/-#?.>d#r=x 5LHٞ.If ΐVFi*CVX_}'K -5C !B3;2܍B5GCoVu[`*g|QBͧT;̎g9%؛%!L|EyC\QJ?w?20iSUlXD@vn*Sme1c DY Z˽қ9e! =O67왫$(!@eJV R lf"+JoEXG|uzk.M"u |i#Jx 3H\় J8g8ImEr&"z#&U}m߆赪wJpLQ\&@r.Y>y.17R9 ! 3ԯ=ɲtv9UDrB01m+`2bɐSZ"ؗNc;] x,Q G;Al! ^mtl[>}?,CBzVh\!v9H_°wPO͡1GݥO9MB z+ 1)_ ph+'aǔN?c`gOwp8 K_( rڏK15khWsaDRD0"E2ͤ))m,6 -3F;)rt!>_\p;Y(a8aTygs2{$O_Df2w= p؂oe۸ *Gy9/32 ұ^~%$巸s\<1W[o҅bvA{i"\I݆$!/סJF.[jBͰc +sK5&T'vh%XX`0USY!#Qѵ̜QmVfD:!#Z> 6p"X b JER d،uL_U ~Ip`[_q&͉#$gRDK1\k,W(r.Uu# Ӳ v=W?(dE#ˀD} G|J&Re  0+!wS:Ǹ[ [bXkKxK%BuJH7m6oe9rMJƵMwzUt)MH_7UP{VpeM ֭K|xn|-%^C E'EVghRvue 4N|Y2WH@pkNoJ_^Y`~Q'q)3c1 p땂PBG?XXM\@ECj]0dF[Xi&s8\l$9]frDZ3p@(N {N`A7 OLR4Q_$"vFCR SzV,T,8ǂ#D_KVb߰[VMՊUxZl\5|@ߛcDmi>r"8TPB&…l f}UͽFC\3|w_'`Y3FK$Ep9: Cq^)QO]%?AT24*uOvFc~j= "ER1mEW;|Xɸ{n] u$X}2@+K̈Zl p { ܭJRa]#5U&R_gs8@/vZ5O/>6x#ʗ0Jc8@PYU;>εbX7 dxC (7o/h{hJM1Kl F!EŠ4G3;^S z]T2 ?;*rRi,Nd˗܃e@ρ,{Jg1b%Fo"LOB -9DdEF7=Diߨ:! `eV=8Q@R)೩ (SYA;?J*oo8'bFU3&/`DMqg?g; $hݖB~INw(mhP#C*w-YL HG_Oqh 8,Vy( m֡6g ڔƛc5@i7,v_Xh .1V&Zp /d0 [wwѓYE\S Z"ܲDqY#ʻ }7ٖ$͟9!>VrV{-$tG8W7)Ç*l{{|3yN`*{H4` :6(8PvdV >Q"u͒.V酻X Mn RKA}Y  `Gn6^8ڊ/rgAi@aKOp 1tN9yOm7HK%!֮M/$d yxR5?P[.u\`WZz`g zP?? XYhQ?R% =-Y"!*C/(r` {)U(dnHYVu#ʆ(-ZףgjQ3yJ>r R8T7A^mK)儺o:\ICه ސ~dJpRy0? PM]ӘOBM2-ZAr\ =ȱFĺz3ƅVrT 3e,qL<w;qZRIm7 9K%~ jSMk${uM"/Ճ88rq@O ݨWQ;לAe2aDKP 6ƌdZ5bA鲨 v?-*n;8 Zk"hތP~HB$w~@㥽0HE !s |9%GXLꐳ$ @bv'[-/#[՝/pJ1vEFs9Ly$ouqͬv<50TՌ"qӍtd+ב6~-%g;UGyQ 64}H,,^sWv]p|f:|dyQwhQ0kN_w: 6=rv\//`h(#Z@CdĨS\. kVsJKfZ{bKm֫b\Ad-^چrU &o-~ 2 7~drFP#L d,f +|)9^;a 7Uo:Đ438 ѕ bъT6%+pb2/:V H?f>~ 6tD@Tjx RH+8Cþ{ rhTt$:VjO^\ډ6 h0bDR2H99)ΰe <1?baV%=IuY.`DBJ6V]`JVqvrsXf::<׬|+@<'A13@OQt=͂W^M㮧.~T3e>!/\iꃹdNXo`"-?R֎6|'sbj}A)p< Ba?4`SNR(!4sQL+!>i)BҸ,R?֤/@ٟso7Ux>?U `n^+B/Ðx( B=L~B2BOjg4tUz,C;ZC}a)mhפpթ4NElZZQsP8G^\3{o<ةԒmGfKaO$vG_pS^d+.sxC}N2"Nv ~;o$CYO'vz^[Ƽeb9@~IQuMk-;a`¦vgǯ#BzgCrDe 7\ 0~tz0gw Θ6Evp);X' YPr)%|i*4݇{<o0>|%*Z8)Pǽ>p'a uG=bm 17N.kw2 jxv윂g9!rji7;ؚ0-~R BxsXh32t2퐈b3O@fg.eXRe()4GWg|Gm/& c:$hP_Cgnc{XWcM7[l0xS h??Zkۀ LH-O ky H?~Wm=F\v?FjH`Uq(n?`B ^]xwA J:}v=Վ$r`{ ^cpu5Vzv '| 1:44dS޲4.;o`jZt61_Ӷan6ʶDFQmm Avl84(DiO "h < ;@OM}Lx ܣ,{y\g {xi>.^G:sԂO$&?A2V֌ #ԺIXn }u:ڊHKҙ;vp)ni׆> MC35JL4M-+خ8N:eO<`{$G?Ƌ[Έ:a6@+zݹ*4%ǡB;enO}~݄¥[8Yps䯊̰JYPi[_$`ʁ&!pP7 M>ڵzgT`F+Q8_DttQ{hTv:ʭC}(2i8*0HDM 8̠~X?%&NZvOq^,Qo9vij4( _o6ZN84$h0TWAX-jHoZenG)E͌nSn)My]OEیC̢`C ùmF !]tӽd,VN`7ditwfT)6ۯ& 3,"8?xqOvj~ ƿ/n6,V͐{Tʭ=i[]oJ1VZ^8\ 8lb5$xe ;Ned8UΗ(N;V1yYD\V rWV\"+`_Z9">휲FyX#Ǩ% 9P>iO#V\K|I3S$ ]# Pq ?mdbdSW/[M|ːlw ?ʷa?b7 ij9H3UDWz72!F[&nc?o ptb tSJD:Τ ,mhDhj2S]&A[ '³qo7Oղs^ Tŷ$/Ky|`9qZXy¨(צyxQt0l2?5H,`L`5j`n8rYamK=ޜVzՑeVY߻!礤yJh(R]YA ϤR~x  $O|]>:Wkyb 1WYҨDYpv9@/YO~OYf&p܋ 3 .άLfTzwb*sDC%P=h96G%;pn=X aӠ=S#0\[1X4?Uvn,"a ^r!vZ Bx&/)y9TϺЅ̷H^. Tj_D7>})h_$߬(׷ps@7`{F|ZB6,ſh` 0P;"9Z|ꖩ >aݵԬL BY54/ܒjrݏrxS{aj;mSm<`6]"X2Xt"JXStWԴD@?(!-ME k>L#'A$6ċw8'|`)3Ѕ^ ;o6`SY`3(n;A޼a6,غ eIŷf #d.WPT(waֹ,x:`@'w`:ִMd7uOE-"}kB(u DR]'(sLb.ͯe6^ ypS%ѤkVHL7>Fu3wº`;|e}@w(mr`Oj1͌`o[0``x?(o-&[/S%A}1A )F)\##P]K$DK?q!\йȥŻ^*ѤձCeLި @Fr k\醟opx{H,?[#@F5dWPA솓 C+{wYgvc@Kw#4;|dl2 !UhDփb)g sNr&y-iNXQFiXMs:<cIO??dYERa Zl&PٍRTd-!+]dc;VmeIEB%NQbd< @cTG< L|A4fhU0-3&[.蚀˟.l-Cv5m(!hˠ=^"oTb SG- h‚ c2cK#NG7<;d_>s_|p&I/c5,6p12PpޥH-*`x'.@Dۖv]W-/vgQB>v*VS\Iܳ_|˜X>ٵ蹦/o AxdPvÆ0_Κe4RIߏFơTF'tb4"@GtPԔ(ns )2fwX| v]J=Gm ,RKܒի)Fm%WrġKFbވ%=ObCҊLVbDCHa-bG5YQX܎{/G1 GO׷\An#mJtrN_o &O8W)V]r[R{#+q)qDZ;}iK{܇ه Qs"nw"b%5t>.U̓+?/%v) (fX7ʦ`ERcD|uI0:#mx؍g%TK8롋+=R#?~/< XsbG.ԢB>}^yv<9X]^hPm 6A`j~i0]':,VܤT^H2+NWTJnoyх9τo g|z Έ+}Y.#O-`镚P|=jxf^sA[N`:2H獷?Ϙ5ӆAkBjf~KalUm,CJgiw&&6w[72?fz;GT5ҏșFF !SWH{W̧l% =vAGռHwAY,~/ JBy\AYwˮ{H%KPB]о#f@wwv i}kT6:MkKooA Nũ78K-u26K{pd \-Ma%ÑFiޚqha)Yd#2Yis}vdu51931OM1oNEZ#z|ȿ'a[ECіDa 8?0B0Ck!Xk5G;CYo_B`gR.L?` BCG3KH4lFs\'tt[O]]sx7!aS&Ozq 3ӄ#ҥ}gɹ[K#ڐ ^WGr,~05A HZryqP$eL";,6B")=փK:G:}D}i2FwHg)@:: yq?xo߫LpV'?a8Cxq46R%p_ |\>y3}z8Ž@ЪU Y颳(S -.cp-$ l׳ޠ!噾~>#Qrl&ߓقn6=: [|f5~i4uZftI[鲚N Qqk_ug#ܰ߈nǤel2V-m>s$ϱ/%ciq!/7 m f(v5e7\旀L껨xYc2h$ݧ7|D$)<}<Y*? zU~PsfWQ Mg믇C/.U\ dc9|\VZ@V:ޅ&!| Qp)w"W ux|o'mMbiqYwKe?o#=ϵtGϫ (vXAEPhPaRί*xTUK-%`Ҏ7ӆ-"#]&һiu+Zj)T؝C+nࣛLjbg@j3(s<;`<_s͋T_{1%\^&}dy_;vݮ2ܰ͵c[냚4Ƅ-2!}5$9ӹ\ h(ETg_ &%\55d* B,m_H"ݲ:`,9|V)XzNw=G 0pQ!Lwɕ\oJBte VOĉ=& T ^>~2ZV P D]B,LZW3 q:D qW$sG}`SQʱ;U|n3^>@曟}u{E)R6A?ylOQm(2c($$InJfC1IF؀$e֛w/ЌC!q#Ba*ZmE(9R׭|%8>j\: 0sBr@.PHsyڗCMc/֠Ei+YvXtf@w MUfGP;S#Q\&Ȁ2DqDtט&r~v,$K[5K}/Wh29P@EHnu˫$N@%2ъY2'aX}V(`Ą'wbJ4HSӆH v Gc@K?Og ۀyK==NODa^%?2`\;c'RrVcZj|۞|C_2 P_AX8<*%-N3B2 jO鋴}8kSIR`ك(^ZBRonD^tM/چ7{ԒP{47[Bq&@6,jppqL<M] a=Ɗ>T fb\zeb&"pi˦8p=Cq!ƶjN2Fd|g/K7/Xw[mjZ&btlT${ zvt"O/gS;YR(fyz)ﭰoAɒ,~:sڗW[3ھK5@fOWK]iȎGc^o^:K q?J7iH~KTaP; }: '쁑bvD $\ ֐ 93Pc@R̾$*w0Cb.~_Fv 6[zEFQD{,?G~omv,Q٧,u(CX#P0|0{ 9c͕" Pxvi{كW-D'Y\̈"4r92fZõdaift46:Cy$707毓k8G/ ?Vd/^!g}J 1{RxdY;9$mR$q 6{C0[+\!2ˀBqPdP7OT+( wS`z1b2ϥ?pWH_6.vd)_')vy w._(z#B^\,ޘn`oBr+ =YN?# 4lc,!ȂůL \CGwo9V,/Ow[y / AKE^ A0{nZKkagyVSNMShhl؞h-RVfv;QI{ DLl{L͘ԝK̨2޽ˏ(4NlYN}T`dU 4eI7MB<C@̷k-RQ0?#g3s: ֿqǣ^Hvm7~a-S+;]8 h^ jn_\NߓG!A/@ҤAyn1mZ.@B剓I_IUE{g3yp@YAW= @뱄\f[ PMHk=V+\9%!1L bh_9#h)KaAhS2 cpxx7 mhm;V"& ǞgeL䦛 d1Xb, aM?o鱛uIS3xR[3U;+$oM>x>t we)}'Uv=hŮ=jυ8w8foowÃMIL2HX 6[k6-T欒;1VvTtzz>z/0zmt _.ݱhý:sLo7)I,1~m|Aj[4L?mSYS0L dk,]BMG.mi-4戴e0_{H4mo&SQ,/#Pm۪d4 FxSfn F#ė&ڐAgʧm+?f~4"`"TߣV(17X-jy{ӲW=[[,mdMߌma5^K}0 !饏vLh, iw}a 4걪d ȸ'[{de}. :ćH@h\bx͉䍓žJ)OvnvsTú-n ]qih[ `L}QOzK%4~He7V(#w1`w g1+cYD1$օϐQ)Ip<@"Hf s3p3uCvz-ʄ;'󎷈~7FdhWȆxLh>H2> J?̖b+*AxNr K۔!_5Zb )gwSy )sߐ:9ςIi] 2ɟCڦǑ{ʗ{`OXTdnx@ RX8G.vst-⸣T@WkuNXs&=gË8MJr 4U |OE2zS^}ru"/cv3x^'~ٰ+P;3~yЕuGV,^'MX8;:X-`Vg웨!߮t뿷YBZ6[ӷ 5'Y #l%ם):+X8O_^4pp Pm{SIh0`|0ecV(ɲv9<͂-F  &On$])>6??$t=K%B#fS;;xybp~I;w92Z=! ^̼/祌火cWfW<֖>U|}='YAE p$F#5V62Cǻd7Lp>&-3͘2r ~@N_rC,dm:j6`Tf6Q51ݐΜ~ݔiĻ34G1yQ&Wq<IޣW#ƊE7#`kcLrg?;LNvĒ%up/ sH H i !eclDWh OٙmAb؁SJ $E"4^Dl<5ՋFU`;Vt^lLYoQ3GKWwz}Sؙ |r>N؋&h Fnm S٧\:6O`j j-F 'h?Gҧo6+~?(HY74e26;G^TbO QPm@ GUpd׏9fnS4Y4 #G]{Y"\>BnX9*,2bU3S n{yYdz A+o@}o.+FLc'^#< wA@%U60Wn@חrDA8Q,})&؞ %WR1=_ov?i6ϙBwAv?f)ܯZ#&6MegSpw_ֽ{Q{NΏ}m+c[;zVQwoJ-$U0S=e Qob}4^sX-Fi݆:sMp3;Ҕe2N 4ǦA˜o =N:vVs˵)닎A/k*oRJSNVhH@(Fk kVb4KܒqRV 3,l8f@LaN֛u.iYAQG ;;q5TͰFD>mLD~ S/Ey{nC9yvHof||a|O~LCR{E![w+iV$UB+ũ'@kn& JX{Ϣ"NyW> Q"66Υ2p`%;>@dbL&k@ڞ&39-Zf74|$k]RR`]-cCC/)3*AwaHWbFń}s>'H8V R]Do@9KٽU?ppS6{`t|7%/v^‘)CxV3F~B} jTJ I#VMRq4p)¡yIs]0B&-vak{b7.Uo =6WtfFP,`ܤ|/zG6B[(M#8Xဒ0r~Oa+.t%+Ьbp(Lbm56ǜ2H~=*zgm| 9z_7Z"R8jmזYɯH?҄}Gll!­l5?F"*we='`x}Q  @Vy'+D~F餳g&9x'f3wBٿ.鼞@ZI>s뢲%YF5=i@Sc߇8m}bKG,vE8t|_}L,X J9AE4_b_.㚡&_sy&N_OŅ~i3,Љf<@[%WֿF(bj Y]Kⴃ/3Fq@c0PL)V>Mv{Ϧ}scТ 1. _[,7Bp*:K a3 ' jd݇ozٜ%D1T op/z6c 1Ї6&E촔NK7Y89t&O!Q/aGSW!J*L^xڎ aD+X"(_a 𖧯pB~urXة9~#-`{o| x^EpԎG۲o 5Q6qJ@HUߚGG+A|mA89Xϊ*@duo3[<3ZF]7) [{tDIߚ*^~ mqJ#f_4/vqй5􁌀NJr6 (o֯pmE[?hWNwƥDǭ=qKEKѥ@#(m~J?a% j\ޒ:9\s}`mױpA\!808%pN Q/kz(5C<~M+46:ۛUmfDN!eDY+GFaSl>1?sPB?ⲿd@Yk.O=(t7N N A5]UHgOFV"hY՜wpX$}Zzs>5;̪N FNu~1Ԧ`(_sPq yEFk78,ؒwφxBe|bG+~ A0txo@WMB9϶跢?۝i&|ZERu.ѷ̒r"a|d>'\@`.y.?l7D9AcnB%])6"9ê#V8 rfoV]6= @KB瓜yW`MD5Cuh_6(L <+T&)jyf9_߭>K*0w$m ހ<}p)$=oU^2U뮉r"7Ú.s%3XX cBom%QLe'/9i{fd,wf+?~on6$,/Dጛ q'_#gD%KT[u[133-(ݏ|!x-l-Kg)s╭a<ԕ*-WW}0`-)?"h k2"֭t !CTRBƴ Q @Q=}6)hW_z&"ct ?,zx <͕_`;qmާow_ɍUGPt={^ 6}PY^[XRo=&X%b|eXIGtP142VeZlv\6\dIuenmY~y1d_&3F 0^|b63@Xy򩳃{=p~B9.xdjpo!yBaӵD_ Q?1@.jV y*oS(Mi@@>`8VW/Ju׍6BXI Gяg,w-UxFTccsO =Qr5ͻ`\U09'GS% Pz&lHt Qk8~w;H(N (\X¦5s'X|>3=lӕ IzMp_.? ٠'N/Ur,SQs(M ~VQٮ]?5u SFKsk`^񇱶HW~j"N̓E"<)csy+#=Q'czg2mi:$A YGRXz[3~ 0e'%ö%4{Z|' זnkhn7P0ˢw[$WF{ŵ|7-U^ʌKS~X/b%'jzDL4MO=:}Kty{o"M[I!NZ|zع!%C鐒Qц.S_:w7Ky`YgZ&Tv (kQBd-w1>!Wo9J0*sBO2O:\ N;xl+ݚ@c% `Svl1;r/zEl;'%2_O v޸ ftگ_}2¢9 o#ͥ_yor̨Tn>.BA[q#ߎ132$G}g@+o~]I` |:AZŪx5djei<ЪPKFrn')2Em(a(ӎ;* يJ;S8x'ŒxcZl!֤Asj$a\].Jdž@xo% '@{ =,`]j+kHo 6?دW@PYw>bILp9Ż,p[4M:9,a fiq,Kx1e^¨K<$ۆ-W,wZ5 ,f̘tP*Īt8"DjY28=G GI{M >@eU_2F#R>%SQ4X'7`i籊3reNW։SCז>2A#! c O[1>, 0eDLЍ5in3N\1e--O:Õ wȣ h،X-[$ 1u`oLf|w3X@DH pL@5˻q&_!@~=vYqk" *|$mxcڟĖNf$Z:;Xb{Xq'uig\bo#MP o5Ͻ%M%ޗ9RŌ*lANV8h쀌׌ҙzN(K^LJK`0xrұ\6"pQ6a;߬#=,͎fM5#f2*y'Ng@wXos9HOq㝉7'ߦi(fp<-ek*>1FQCk <4EV T$,FGUl)ư#7 sF"a\S4ѹ U7)AaTL 󺲸E^[ "|<˶y0ܝ`9;@DqTIm^^9k ^m~iZ>$T=V)^k%tljf'O?i1uגyݰW/n]fi-Qh]ʸ*N<[~ X |~*}-^f'c^[>+oZPI},cnh",ca^aǯ6&U &cr(Ƙmjs^ ųl߳a3s,^gJ&4igQ/ i"sI _^|ڍoY#54Ȗ͛׫e{ HRƺʏ̭0gװϯy~VN S r$-l%\ec[7ى;~PzE/5%<"tm>#* =X[m 6xWۮx֏V`41BbF>De:UH`EU֧;4>]v4HFK< f,g񟮲f|9nE Jɽob%LfDRf*eK켈2Z=WUXn$ V8o)RjDA,A'x -CV X81.eƤ]Jp,+ DեWa1C8-V{( 0\kb =|`2Z?.1;pvP=C0J.gܙ$;n]2gsR$cq,'Z/J ^"1OQ?Q1_'ZS}+Ӓ -Fe˛.p yAz qѫl9Elst@$O7 b1u?:p6_ c |{ my.-)zkLLdB}І82:m7;o/ZG(g[2iZ-ͯc%Y s|mu`@"TѰJlلTMU6s < Ix/0<8tkh qw#2|kZ#)^yIe8eV4ju e!P`ܯ3lZ<9WZi>2lc^{$ /eWI9B.>s3Qa+c=A>ey'(}"h=Ī yo9Xs9#􂏣Bo_K?^h%b9 4+#GD^0s͕:a1l{d}ƥ[1Tt32xE'.or1ӡ;o^4R,3&@a}K! H=Tʃʼ/TCzjF l/|Ϟx7j|PzU$r1ٲ̺H032N: L;? S#Rʑa p~ɆbO4Ϯ̓8K(QE6ßsW@GtLE(~53!2"߼\:E4*eam]=ir~ʿ]sɋчsyw!,=O*E a"'ؿmT 6}s&>y'؟mot*@bpJM`.yw`?VPE0Pپ~{? ֆ^ˠ n^^ݾH&M?{?v'&wD!;Xx챝㘳o?aiv'o(ߦ{l'$-K? s?.uLX~$sM TY {$kC&S=°#jodDiM}qԠ 34ȢIwU.sm:1yE0U C=_ iZm?Y rwb6]ǛgO&Wi*V<Nl8,jR7z-(Fj||*'j P>N;ORj}h$@&sCoz*J\meQ<^os`,Dve= KK6sҮYg R4pshw1m{dALorh%&m(B{P{oO^ #ZxieLlL|}=cfX@BVog+ hpcHXʨ˂wKLb s oV*Jle}N5N4f 7dYi[{W?y9ڏdX҃L:&Lr\ ~?TVU^ ^3yCPhyۼo)b?ac4Ig\)*R^[ه録hJ\R3َ*YrEm .,d}oe|vgZ-dDὪܜz!3";o/ɚ$Y@}:w26.WPanQ=c7}7F;t_qmM6]Hpyz ݅I=<C"?ظd'G6z㖔cQ3SGu.,as% emqX{iFn ukvKpkf~glN8yssQYX3L2Ӊ0Pv2r PE>R/ cfehJI+Gؘ#z1Mg{i32qcnP~.?ӰRM-x/qX]H(01U@$$d??i׵tLT%Ց${Y~*65BkV}Ts<5c]mpoB|ۦ+1F%>$7DpNH[vth^K)ijZ.ji/U{fB˫ADW i9LC U3+\ {7ۗI֙n1Ipa5Sz~1ٯw#QUeDB$Zԃ<%`N'Q|>.jݣ3؝X{ǰ3D8Yd,1s{ H+!TF^.a ƛV'qJ ZlG0._v6)ӂ,}l]9߈??hB$ 9)&1!sQ;n̈bF NF˶E9Dڟ#}gC.܃Z{Ho؟P8IP۴C)qc+{A)>I8n;^ q2*7>O6THO :p,iyFOES${)$Oi5"+wcwT؂a`9,fc].()Mr2W;  et˼MWlVO 0Y0g8}SVP-iK2a8t<T@](f  \H4@&AΓCkë_QYz=?o0%M9؁Wg\e}I/L,Yug.ҲWږHe POPI+׮DDˎ{Iܚȩ,3v_5h`jg7Q3lP#+v {Ok<atU$Qiߍ^!5Һg 17ml.$37`/>onpa:?]P c8uy9G.A wmۼGQC`m̗%(ApY?I扦2SO&ݺ{e<sIFmM-) 51JH:?ccr%.)Ff}KŒJn]m능т*Sxbs,Ʒ'D' sV/]ѥ! US'(z7Yl8-64xfۀWSXaXf}^ je3OYta/ z ݘpMH.8T09 ;!?L(f/r2,(;K;^3ScĚX@5!$kJiYD@;n1Es?K ~{k>=2e~LدaNr76[ݲ1=sjۯ e EA˞ӃYJyLvxJ+Tl)L<, JDVҰS"4ĭ3X}`˟j NS;[>]c[_PP,7<* %7 ڈFҢ5ÇbcOJm9=H op1Emi$\L\j[iKd7Il䖂@jBH+8] @4.hih~ooMx"v#H3%Gvz& I. {@%m7 --١|cQpMCc9gM6Uxz_Lb@3J 1\MJ(Z-;街VTE?w!a'B[hr pڙ{{#ϒF_'29R< M l 0̤BD'= J"lc\K OOAmp@uoQFaeXj!Z,TuH5_JX bOi|˹PΥ>R]竾!8ra!%E4Qƈja/L~kMcTW~pA t!=)m7S*.{UW_K ip9Oc~{I@Ş1=鋛Ċ;|KxEأoiQ9DdϜv n/dQK}&˩ mVaߤ t8 E>HiF7Z>U)=~M,mуXQ[QL ӃpeM$$-'>+XM/xL?Qj;3KJ1P[au[Xӭ˕KHbR&p3U( aqn`ͻ_'qVa퇵>:Ƭ¹ΥA0<$CDV]tB~ +ɮI[YO*{$  B@8m؀-ST )! ig+1Q2ZKS&\-P4ӱ-Xzon ~)$$ ~=+F!j;(sEqn LKDmgIo"yGC;V[NmmS=,"/̊{DW#U+\EĵϙrI,]޳ 8OKz ;dUUr]z'O]/?3㦅c>io>;Y m ZSL+рuIP MVbf\XqJ숂CS{K fQRgl +^|a+/:XE]ǂQ6>{N}c؏.hQ~Э[[9Z@dSfw {/ucaP}K 47?'lsXJ݆":gM$W֘h?pxQ|0 ɏk뻹C*͑ը.Z  kJ:wvC+[mkNffe͘y@3zNfGL?:⢤OMBqψ_TK,#=m]1vuEZp{3cvjj/V*S͎^b#`2ؼt2cu ߣoT­>d󋹣Vst\,؅U {N5H;~ ܏e;7$K|pVc`xUeg7.O^~v-:nn܉ƟP.UB3_@22ilkķO˜zU!8$ӽKt_^Lɔާ7Ov/ϣ-o~w?ĕ&:>Oef9(LXgt( O JRu^M l`R7`h#N}UdXiħ^ϬQ1^.q9U+֭*+BTCs gp(u( HODop Rd9 2v/跖 `Q\὇98x@Ѻ|yVA- ֈY q':/ߎl;.@42pSU7hYtxef 3֟o}{LI=7p+zxOӇ\P"^UQbveVQcF>!L4QR?{b65 zCP ! AB;CBBB()0[UMj9Mb_Rx!UJ_ZE7l>F{s=x,_F̨]S_SY] ˙V齠Hm@3tdnj h-lf҄.?Z(ZU*v@"f3Y|:]Q3uve!؇њiD#ܦd=kda7+}.~S@r\3%G)&xjwCU6/Kb75ȍdsGҔbI` (Ō8Mo=ysv'"'Xӫo~f?EݭNSñ(<C͘xO1&gGʢ3|J%jgpDhdT6/ ȅ9KP;rnaMg/2c:%1uueVhQ)"JPк6&B?8Ӫ+&'/4*PL lfe,R@xc8?s^vt "0m>pP E}۪FSaNVwF0&a/'<&4E ]m-ƿ[z$!89@ h?f, @ain>>348a=t"ri`(J}hCR􂎗dViJUߏ3F`qQ`$ $bu7x+c;0Z摌̎)\(#I: jOKf9Gu,UO>xo9 Xoi تo>2-]E>_ E i6W睃0k|k:g"}wU)3nB 7Wf`]8<)n_dXSF\T r] Mꡁ^hGK8iJi`LhFS~RP_.F# b$ȎAwaO|W(99_ 5IK;|{tQ9 'i  dD o.xyτfQRj0CEwn<}tJ (2L`F1J)kl`j~ܾ`8^# ɑPBOµg!`9Β34ah#|b*mg.8ۀ恸,ǬǸ-^cqufr}'?u,>uAmJzJ65d۾y5S~>쭬q:F͖\җw,~chICf*F/#\ *í۹>׫ AKE`2Xё?-0:.G#t}=P_xo&ַ aYzbb?7Y䬙Ss.$4Y)_g_#Aav7+oe#'6!\r. {#vz c>TJZMwh<%}@t'ZI}-%)_@pDAfP@RvkdϠQ'ucf|_ѽ8} [6?xXpcMv]]3=>% mMgc@7'rONev!abkd$J%^?:[H3;ρb;nwdi!ޝ>'n?C`98sE"]9.gf<μ 2NR.~=$q nutC ${c9&nmLIuGd0pJsdn@[w VBW#?gy!\_v]0bւQ7Hs md )Q\Z~QksCpQ =5!lGkcB tv ;^o<+isMh@Ns OJ>,q'r21_3Ol67_ 3`Xj?~,>rW~d}y_4 Lç@C0Ș=ϟn)㐆Ig8nT<|[j<<l6ifM  TD:=-TsR8/vQYKf'reW;Uo7CNJ$OgoX  ]|b Q; ]DfRAԼڼ&xe|GیjT=cĮa2c+pђ6/O;n}^@AD8`J{/*K ZMs6}t ¼7kCYG֢i븯o]&.mfFyD1f~8mX*܅N:`xؚV{<'1_ 94! 'W6)n"`-0U3}d&HVuG .N7 _4-?zøڋD/J2ȎE)}uْ`nӿ]{JΣ6_Yms f9z}*THO?AL` Zvfl2MȫF9~+Cq׹ dnl6i-kͩvȧ+dff!T7Ldy6mqg]zL( G$YMf;q0]x̴a'o44θ'HFm|_M"SqpU.X2RKU%B07w\ 7[rQ}`l=EU0bmmԊ@MJֵzՍ1H7N727?8QZW\LA"GH$[.;0&K8_h1"3E`Q|AN*IK>!{wOK\(*." 3]X5Mο{l|=z%7\=uFֽ_Ⱦn^|d+﫯<B3wPX?8j! pIי[ &Ky,-{u(eLvirr¸XDg ߋV!;j`N4|G07 >I?N5ek)RlSwO,P >A9ao} ]$R&gݘEQh_h> *?![yԽ_32~=O]Rp"iY3"v2ܿ!ro)ԅl3X LGhfjUG4OŘL*xX]C UtH\Ā,5(J3#.b҄,0+~`#}!围DRD6(ZZigZ#hP!^u̓KxwݜD,΍ޱP|KFqwjtU2]͡Eri4jp%M& _[0H> qYt.]&QeopB p!@)׺3>Z+01N3ߎD;괙qs?J]-[/ڱtf5r"\OY|ׄ/T3&ُeuYgrLΝlVs' yowޒd`~:Mwv_~\&)'IWEނMHne1a:}K y Jm- X+[2$yRK3:9?-[jUߗe;sodA "%d{\r d< s|BhwY׌%ۥ%gWڒp?g uUE[ɫbQPDHW3,uCC޶V8ae HGsvXCO ~DYH*m;2t;wjQ`&{iĦL묁>`o:#72 iw0zU"6LT]8 /x~suυYk<߭1;d+W-4WuC`b۟'ň˵[wdu^N1wOf4@`::9I^-༾]˪A T Fx2AeV-CW`bWIq)' nd=?o u͆ܰv~3l5j?$`Go@;dd}ZJtw׭{K9aX!O^q7q-a07\g8^S fI]bWdʪ/m،)i1|v%}(: +1aL9=[%]12]R]E4Ϳ(rhZ.7XH_q7_Jv/;A:}k}rUMQ{d)|vwF X~A/uh$6d ;:jdr-l[ϯ0O#""8ncE(Lltg K)\(Uw L'|$ٓV?i%?ûdZ=4.tʾSɆ,;5E۪}P\.Qp2˜d) wt\w,#<-+mLO50V. djt+ '^T$a,fc O8WYR0$ ͳI}ra?#ln7$f*q/nFUKrqfNpGTIX13i?xC\>~寖ojL7gP>Üm٦XoiAW@9Y3 &v^NI%N1cGk{Xu)z`H0"~AB0ŷCȐDPt߇#ǖ8 U&ꤝw42H90wǒqT|L92l0z O:uS?P)OC&>m4BW$|n42 nuEA9/'#5[|AXgڙX&8l 2?Yx4`:g |MƼ#os K)YiKŤG9\p$v++_sqo2pлg[1o[預"xǮ]ߓ6 %qߎ@Y}tTgVηsx\Vj?\ & Q9BCe{Adw\rڥڙ*٨(fv#UbωM- BR)S-LAni &y d d ҿhK"| #RP)ZDRtok)&=:iN IxRшu~;RTnHR0o#wg-UHe5\֯l|xh L6\׉ZqTM!ζ}5 Vhm <xS3GG~^9UBHn8|@OQ(=5fv2hD>NN oBvI!s>+`~ N/?btLL{\33Q8;ܦkMͱ u$:MÌD`F4fn 3NLtkhN9d_{o18 ǔInSa=vEtOkWw2ܿ?~0KGyLm(j>6BKQJۍI+yx߉I֏Yfunf+,[ Jrlb-b20e\RȻYQnq/# )BfEOI N֨>Jp⿆;l, z$p;I,A p [ɚ1!.,Xn|d^zcǪ#O{r$ bhƂbAn^Ng q%ø2rk+Pgl_R•ڶrc/:K=f>=}L6`l!`f^Ss0ݽ570ܽ^wN!ǂ>#ESϐCbF2-n (w )3aV׺\EJf<ұa.&j;l΅pUy87_(}I>&l[N!3oۍn`9.jc($.- rכDc&9a' %b\.@c1jҭ_8kpݲulHf_rLy!E(s[T3^b ˳+2k- V~/<~dn.FVt+r%J5jlsSsv?bw&QC=2ߟi_<7,iH6!~&{<2o6;h0X4ӗ}ϴ~gHi$6Lu+<,wP5Rdv69xN+6>|EY,/BfuD\?2Ο']clٷG&&!T;!t֮,g%<W`ڏŰR=>Wc&{ 7I[ 84: D݅r^wcBR}Yd!҇~b&9Iܲ X?87v#ષR5`2gD_f[Zط+Y*Jvvݴ9xx0u] (`2(`c ;U+ۮQg}5ˎFeH-y`"Z|yJ覨hмݝ)+k )_Z⑬ׇ/QuZC6n$V7i[H)'Z?ۼZ~$gofg"h7ǵPfPjT5g!2qsef;;Q\yk 4w -_d>ݯi}$3[x$r)wiu|lry9uKqb%OAf'v]0iշ}ИfhdV[?&]V'/FƵ~'{]L;,rk_™Bee ۈ 6pN!D ZEXq!B"?@5ƚ*_ LPkg^Kk'vCё /}`ed Ěu|`e1Ӽ:bi<1mf^vt\RRS [w*<^>9A yFfMS>0QP̺ @)4P}5HCnT;^|SI}]2mh4LYa\CC}}i@|<1BNk5j2¯V3SyYSnuM0"3`6i ΞF#AV(\^oWiw8|eV䒓e\IvVPV&OZ:Ğ!yB߬X{qg5uHQ3KG| feF̃#!G$DY'rLvDHy[K8үI:_[FXj~('XmteH:{zR[&t<7er~[=;P7 m8n?x32iL.OQB(l/䆛53N1GnGǪE>t1:ڧ`:mv vǔ@ 16n͜k +L)\,[I_R79]Anv-Zخtt/#x<q93ZvJv4o; ߸?oO(/MCx0+)#P]&1ytZڿ7Ohͬr:ܖ.l^Ud/ݨ`j%2ŰY.Ǟ{";̗8Ekgi E(YFFU~#K~DnɻMkc2'dr"ar!;Lp:O}S:b"3v'Ǭ%N5h?TPEP ; _꫆]YcĶk~ 0I6i>ގm6YӀMfAaҟDbQ>B@q nu7@y"lҮHC wV&rS`0f*[2ģ2։䠅UBYxn@R:nű^{*82YSEVՎ68;, xpsJQ]y*n${?ѷa_Ę6j|QK-s|0:[۷`[`5H31yaKs* 52/ \5H13W&8YB;Y-")Sƴ(uRi מ*Rƺd)x7ra٘`cKo;{S5[ EJN3Vj qqDӍ?jgP^% l =ؐ+ϔqKl_A6JR#O~niƪb I(f0Cc̼jX&AUu@T]F/Ǎ>3`1D!ɋ2NƦR}SvJG(!,]ȸ%}p>#oW vM`?7邡6wMMHt|d(Jٶ?Qo.gc*T I,^KxpP\,TS3v N:X߯D!w5Bse0~ɭ8psnW7X>yCkrvt;BƮ>/R!U8=,әLJYQ}J>t3\z!"$R䭢rCX/+c|hHֹ'+ 7 _oT<á<%{4W^ؗ_1s2TCR 4']Hf^),*|U>y&>c}_јT4A7dWJ/Jf\S[q( `Os`BCcfZCZHf}in_vLH K -dƁw8oo?/NrXhAXamSvE$ cxHetH o&Vvz49cC^qw}8ާE*D^OzDplBL7M1?Y`-*!tF媧gg/>@\?%O1,Equ~Ot$vȢd@ ETÿ)VYXJ˛]G!Yx`{tˋ(5O)v"RI#MPUPŪoT?]x%ჿw'^b$IsQ Ua(8Jh>G*xMס1(ط7hx0YYҳwH;2F_fHm#WɂoDnW&x Bډ:Oa?) P=ON?1 ։ð7Bhq6)0_ut.uc,~k~1TH~O?s+…6.p dt&q_ qf[w'' i߃is۰{nqH(j8}wVz4"*L} GURl;,SGoW7J+sj_,I=u\մCoӢdfv#E0'T1TTZ eJt<-P)i8^w?ir?H:#Y]yA2Qh97O5]-As(lNNw&ڮ6sh1[l;N92wަz3ҿ+VW{qZƿ2%giB#8ٍni) ^)%]‡0ۘ)?3 jk,uNJD9V2"E'+͠>6=z>#:Н)ܶytGTYh{͞hWzunI}^1P^*#,؍ghDŽL;GPyʗu?z-YFBhCP=^?'rf/zIƤY yxǴ~XgWu#a?G i#i>2r(t9gdK!{M[ }lF0H]sgu 3!{f 3,Ou ^/.BrހH\w29H[N_߿ĊކWn{eGʬFذ/XicCGrYkrfꌚѠ%4*>4>X;Lh:uXgF.̹,&~/F~Vm'tFO'q|".>ǠTJ~?͖pF9:1%q^BȇtK @K#~'ig͔]9@~7qUKsQڃs@ֿIn3/j\K?›;'˜'"=#/K/+pW `շA C{ kGb ߑ}- Z"^n._{6@a 7?tZ!Eb Scj{Pj{-tڤl[<4A ?S#Bfnn;1, cE8\5\-[z,x} vpjKDɸ#eWbYs,oGW'Xx#|Џ)wH&Ȗ1 w!;_dj[.M?4v^/)7> ,[eIƯe,)P^x$gJ7m64#F*1O/S.C I*0 ShgG{+<mėL=,>6ۉxRn0#~=F‹٠YN Xb>OZRn3euIEW4 #' ~  p Qf?s?; w6f%^Ȟb*J80~FD:i\i ^))rEͲnrp`]Xy틿}f-ifx_h}EvZ2kK!3SQ]vIA8pk$SnOH+=bA!մ}3BWw.â>l5c)ހ"i(A~x0&)ݜ/>Zw )]A yCͮ[D)rԅM軍;Di&rwߑL+3G {SwfK"y: P"6Rp7q?Uu9n|]ûܝnnpy&KƤDqp4ҝTfo^Zz?TJܳ莙|ѴZ*igh:_+TzJt`hG2_qnn).9 MǼLjU Z}Ԧa=.p4euJ}9v nq7Ԉ0ٿ}E ,A}/ #=Y rwlrdgvW]͊[Fq)κS5ݟD/)9~7Zl)W^_(3gXh`2ZFBZ:(BO$ njm?-JU%%f]qE]#|hאE 3F|<7gP4ؑoxx-_ЯK`4x<՝p n{VuCrɃ$|&ήBʯs:+M)uqW(9blvg H0ff6%VODm4#&W,b Sf5 0O 5L H"j򌗜p eG}  v!>V|NT#-m_]}r^cg6n gǕ@:j`I9nw-874k+0 8C}PPP2Ӑ˪'K#)}}ec\s?r1y8ϦyHZu֜+s$E#[~ Mpu֧|Qcɭ/MIoF^m8PԯUCZT`4J/£YFI~u׻}DfR#vכ,&dHdž ?[/!U@8[SQ`&m5<,)@WddֲF/[!:OњIuyv{Glk^k%LY߮)bm AsPʴ~LVduYOvaITpYi_L0ϫ5-YSQؒl8#Hz[%)C \{Q qBS"Q с`.v!g 8 Y-JeMagI 0҂ =>\eiVKx n3JH,0Q~WhKciNMUu>RTdtuWSa M͆SgTw,XG~q,'Ow1˃ڻ \fzH@IWug>2ךD}ʂs=Y~{S7>Tdc:&79rQc+ 鶩{3y=,?;ǔ3fA`5BM.1].: ȬD?RhƋ8;/;m#`N'˖Ή<PV%˹'8<3dϢ6Ţ3yv,j{Cf$߹[|$ۗO^A$5g.9ozzl"b,F/q154x9歷)l =7o8nw*ashG l瓦wn^؂S3Lo%l$W[˒D-=:kIIcS݀cwˎ-8[uD]&g90p;~?5`5 8$u_-s6Ma\obHͷ$d=rbw9^i)#]>M$tg4%o\Y&5֙]`,P,'Gf\V;Y[(S:(]d{ܣBeH><.~ H|xUo\;! iq0`ֿjWuX-:nHZ7T`w@VqF\@aˈ~7*z@@}1[oWvPj]ZΜ7]}h? VZOV"T-2e}#nr 1нq4\>4/TffqMTmSA:Emx4BY})<uQi1K4n^V3:Tl&|h^jO>"hw `\1uԷ^dy"ʝ&D%{2/{Cxg 1~ēm({Ƈ0ux?ΐ(g( @}2̘7tDrC (xQP80cuTyՙG84ox.O/\D="UnyW?Ra=6zGYP⤐/<&E1N&[tl6</WkI̱ Xw1U?{GU;pR׋ ju.`,*XllH9Нt'N7eX8۸Zrh~ )t RCB >aus]O:RhŐ$[76J{a+ i8`B 0ڣ*$#z202!e3xC@2sc`#b Pq 20z`f{A_˄'wk0А?h &+hecymYM}If43X9uLΑ'8 r1?Br;Ȱ3bNo #xkoQDIXtR9@YyyPn(ObZL~t%BǡL?LҸOFsfmnuӾԶeSaS|$'TæASz/2 )x)jGډ V\I p<>:}YNz"'Y*-$HVYI||ZÔ8`~)v|{  wvzt c+& 0e|I;I3K  vjL1v+rq`AH±VΨ LL@r#!?*6͆甮s1[wMs"`WZ~+jg7 3Z+.d=Erw EZ tV 4ܢL1r.B Ҙw*SA o]H<$hЭ30oS[| CU03Ayu /9DhAM=mSGJ"zm5"_\0YRh1 ͝<5ceCǎl.&iڗ<$*Ms(<A$;\|g]`cU$GCrq%=Τh#3m{QB" y8yU6 vP"0ݔf%`X.Ɍ"˫TPsu3Hi[3835٥O ?:ݞ٢[ʿe/ ŗ]>`lOnKA:V IIXùpX`fп}B+ M[pHn !d4z1|ٮ?KafyٟˈHIsڛ1BncUvmڒԺ~y=j[Qx #tO$?~\mW'bZ?dɟ2%>V]NhDhp\g*+NV[e"@wuoJ7w鐂(ְ3e-AKsp["W 4w~ CȈGȀyg {݋(4,Jxqg!nOw =ʞhyM o;9qp6sF[:O\fiA[LUyS9IZȥ hooX|$[|y2߃ i)HNXE` y  Q+R#o{T_?[{Qsq3.  W^yBDMkia|#3}t^!9㭸riqLsls_~vr{9lMHdJCG"4w80̜j˼d >ekZU}X$>4@I2uҝ ƼnBݿv!?GK7:dV`}E8HZkThPoYnLM=@lА<5iX\*(ۗtJ^.ۈEO7`j]k0FSבAHKח~pK"24Ղ%uuMKUwMF@/sI0tן&¿ĆZ6IK0;1_7^,Axm3ay-&u >SԌ c~Kn6ElR#2)8(ϲ 1{bkikQ5ģ9r/q*/yӌdR!ƙh'j8˳-_RѼ12V x|;! \|3gj{)`kp+7hܸwBf47=E\w Hm &gvg@tkoa~4~J\i7RfSч^/|{ٸ1˝XRW<D+]6Wy&}VCX%NM.Lg}+!qSwB8jxϛp|zCAZh Pc',K 6nM夥l9е^|5v`[<-_*OE!@#OԨχ~4/EqÇ)!B]~X8e,?h!H?*N/j#yM^tU&.wd p0P61!c|e\@(hWh^MY1Ԅ3E0e9Utպ#u$5gyc~KD--8G!kIe`3LdA?ñ[\Su1WсU@I\/ ʷ)1RX@+`aV16*-ۙePY>Vp( sJ,0(.&K5kŷ9a]}><ށ8}O*eߓ_iMYΜ'z^#˂.vvжjݳtW4?FSλ4ъۥ"<0 Or}dT^FO[@  IĹ[3#p !~NTaÑ܍j a"!/l_㲷bk<޿o<\5r+>u\g/xʞ 0_*uVg0nvHfH)m]ڶ4ܭimz|Һs%(@"!>2H&X֝ ~z2.ZៃtYOKcʢ,|,M(=p; }Ύ蜴_}IK MVy͖ƙeZHiP>kC=2``_^_[^;Y4ZG1FT! i {@Wq!P\)ԞÅSq٢Xi ècy n @ë{M.We$/5p/ÿzO ϋ8 tBJfwucہ]o\'mW@vVF6@}j!/nxar;?/)pF>L&6(y Ԟyu:%ȶeJ+mMq4т."] Sdu$g"lRl [ 'Lee 8VEJ7W' :D` /6ge JK aCx\][6#A3m8'qףLH5ElbEMWڀs'i}A;a|No Xhˌq O.afr?T{z_2fZzR'{lYI3 @:w7$+\ce,vdmgc =ೣ|}u:eZ"*~zSlj^9`!E|D  J zl{`QymC|V {SyvoS#o4yC'̕> aZ֚"Npָ5FG̼@Vi.%3z5A|<6?h.`Bp]ܜ(ۋZ]r#?YMx B)~~y$^&Uxhq *zX[7I_2X/pݻ! r#.X~x}䏳J<(㣊),  V 1[\-=n䧱5'zӴ2w_r ƻ^Rj(lWyEi f8 ˔)ڎSLW>qҙmTmϼuxeKsc,3=!v=ʱ~7FPWLkPFٻa 3Ο\XMfŤt0z/z3Xr74 WR5_•'I rhBn8nt[wNN|c]NdcH<BKv싸|U9{ Wކ/LٽS# d52Nϝ8Mft q(_) Nk-Gx1ua^Ww]00ٝCzÅ\wǨvzI?&e3RF WhV߂hnw-vV7En0c_SJN `'P*O!?ua`a鏔YFV 0g>"?lx]& ҀI]>1*(W6R=?Q!Uf&j"5C1x: q`Hj߂m^ENn+ ˪-|&KG3B#eշťIg)3 >euҼiqo`~h|FQD׈K'ס$:5s/A(~wHY4QF?zQ3Ul_8KֵߟuYv>!ޯ\;`ݽ9 _Pcqw|_w(t?wmalq7P}fFv@+ 6xF.x,XL@Ǫ/q#8hz]]@tL(=@N\h!hZ?/;'mY8&rjTA$IJ'vkm]1 5bmt0X>WiP{eI:Mصm~&6JJ.xPG'昁ryQ/2s;j@G[6_'1A%\WR y<>p Ed{-ɱ8f:#}{yڟߣ+gK VDC zDGAr3bJYne}N .qe&]]s\7e+Spx-giL}[\SE'"sjܬ]|}ԦwR,6ZwWo IJ2Oej=ReW6(nw{ɍnL$84u","eﰠ &(3& і'N`37. r4$ # ?Xnx_?>V픐Tjg7|Mܛq4Bvؽ&ssMj&  3xԡiPIie]Μ΍?u gp&N@=Qe;4_2]i ˸ISp; 2FN$O} ܍4$>˩ SGF4#EQF});}' Z:vFD~ަ->ml*L'n A|>-1@$|7`ttL+H1Aa1/IY"óOY1aMy2žB/C`ͯF@,5soeK{+Q@.aE]+=x3=] /'T̍~y*8tں$(Xe T}-t晧KbP3>8댕[p+[R%χ` r"OsH.n)x^Vd Y0z/`'1`p]£GG( i-]KD.!mf_NGOs:g\5i=ϿZTlr7#6,?60R:Xj%Ep RD| 5ά;>ASaXユ"*ԏ{ cސ:.vLa POÀx t-Qu9[_Dxk >/;oBI2@4|6׾_/f`B(o`O=zx!aiSA kd@^82S.j 1LMdFdk@!J-2dD!h$j<(]+㍱B1jvE#'P&4V;j3mؔbhs3Z^w~,l;͐9ayZ.F7!G-@Q:~`lD2``&/.}D?j_Qo@^H~޾tp1ALy y>H{Y&ɴ&o>$")#*o.ꅇ R]'HUG!I M!^DEd{_Ԑ:e䷋GȲL&"A4ZvJACH٠{{wIK.%}Qm8_3)a$C6fjag@6Ňh=?-lF, )W1ڔu?6%D%E/E佼[Xuݞhp"~Ԥ#71v Sy?{Ruk|-h\!R48]tiݎ SSj$v:LŇ_@qsCEfotfiѵzs|"]QFX.MqJ~Ʉ݀ދ$[}p=c[#z#`v A$n^W ~en ~`x=N%[G:;c JIx|-y2է74X+qTJK|V%$a"ߚ8!B䉄O*-k܇RBJ8 W&ja8E PWDf>o3 F uf.xR 0V@HM3mP`Ya@NݐW8X?q԰t] E{›"bAeEedzǥN\F'$R䎅ҖIEdJS͈ߗS\hft:~ Pq ݀MY7Ԓh&C3=hፕtA)24Zw$x)A"[Ef(c']-$Bwg%htP&q{PV nܝ_XjnP U\ČqbG?O[v~:'_`qRjČʰ/\¿ +j t*qϥHE{31l1!1`l"ωvN( n<~VBK0>Y{ߔ:wglX ^FQ 7\nkwWMk\PXSNav>KIUܟèJz|ODނ[cH+R]IW:onR rdMn>“bἄu/-Aq .G@64s_;S F?u&~WBP:"0{`t\a?ʐ"$,h ArExԏL,jw?tPLO)g?#_MQxZw|X\4lv%o=.ڌ#~X/unsW\daSbRV-V+C,+Jbz~ sV4e’= ]r qZNp8dii$lb #NJq˙KJ'< m듆M/pyV뽗k$$cpD\j+(ݎ @&XD8{Q\~[g{m &?,$в0?fL/7ZkOB:h",-C˕q/A)r7=XFD crH'4FaKCděfC7)p; SiNA&QtVE㾩FM) .v| X%ُd. ={}Gw>޿:ق8 _ F:hz >h@y )<H)EA\"=f`CB꬚;T1ui[:*NeX73􊴹&(v&2ֆFٗ݌LC,kI+;y?uwP!|n)ut_P4D)2l7`ǎnU܃)D¥ kc$ =cϗ7Q;G-P8@WbDT*p>FnBh(`K`B\2`x+&} >u `zr21)X% =$_3`ܬcC:|đgi/%4`;&2=t1d /e&zP'cI4_O ȣ)C-vHA#$׼ w.0 3o0Q|Tg)"[j 1o\GD U5Q]*{y;wN]A{- UJwu'mzN=+lb ߫nh}0H^ yU?ߪJ{\9Ha2ǐ Lr ?2]66*mqe0u7gt1p2ݿUVCP$S(UnH8+5z;e) ].y\Jh0@" ,u Cck .0IFx5;\a3{e'IܢM~`JGOyW7T ~rXS.[e^B-=$ur>Ėt`[ =LN8ʷݱkD'c/vw,L#t|λH3sFFAo 6r0Tue%)|;{U͞sxR[sC6-Үnw= qVљ uhZCH )!\#?HY}늩@xe^uv7. {5_A Z!8@dE9oM23kvl=u8Oin.f>bL?J6+"6RK)yKa}6WUKW@ٯeyvG8aZVyEe%u;N-?A$^ݾAmD&bbɒ{KܫwuSm_v PQ]Ԕ: ~RQٓgu82N[7n̉[`3Zls+=ʐ0g.Z tr@E(e 0$f 0$&O5"`mZ w5wf\\c2&b[gML˘> (šnOspdG.AixOBAmc`'CsaTݽm* qFvf(=흁|P}d@+ hGO;7Ho />ĥM{HK걖 P[NCOk TuJH_7F4t6]vX眡@&E)I%/mb:CQҭiz7xd4uL(W^r3[%77>Y<&n!a?z]`cyg+E✅00zU{&pL5[_(1,ֵyBD(Pg݆w*qY@8@"zs,Hscj"քg>e9s$Y(5_ '`>H$SR샼hV2>%tOJObqEɻO-)Jʡ7K.e @Ӿֽvi tKO Lv)C.EP_o|uвlfw'Q) X00Oaթ+ B̸< DB @\ A0WvW]~vw%p:aցi+*79Wo[Yw?_/x+xF†7O*JVm18Mhkyr0Uxr^_Gϔlu҄Y(M U{x0/hB0i\Rht%uh&KpeV'= Z yLuvHEa@ dí>]}Do_o<>L@s"tG(7F?@ky=/2#.vŋ*+FA>^[5[ N$H_X\OV1\^h ˡEOX8, Bpm7;&1o|xeB'Ȭsb!-ͥL@X$_`rf-X藥)qn6IʌRS]p=RNIFN$~l2gR]=CI+qhy=B {}Ff)®EQ[׉!L]8( 4w!}8=O!Xif57͠6TanΣ M)ѮYZ4n%%HXXhi _1_x#76ӆ8DL&]~6pz3h?_pjU2hьO1@ RHݐw"Ye&xKK|AVb```p7oiWkP8nM'ixXGZ}' yN aؕW:) `3LJsvx*m~=,Y}y٦;t,{9/Ʃ-oF/.:^_#aI_^/R`XE|YL2!w6=)H;43Xf9l2K'_@=@{Aj0|Gp3:y>%y#mң![㰹;x00&k5:q#Rue>9E؉໻|] F&5FRheEބLg8E v_S5qrLp--yNa !. ղ[/x( (ߓ;MfW3#(Y = ,S8ppC[ഡy8VohX8C;x&y s @.OQ7ҧOǃQ9'=Rqz '+ٔxI`?ȯ{ (_?3F&>3FL/G0Qh,i,և%~JmZŴn)9ptu,E?d5.]nG$I] )Jz yȪ4'3=#H `)?#khN_@K7MX"`8φoDq)g~͂ٝ*CjC\aU*53~r e0s;G{P]Iv!j Ѣi 8;zpf9e˷16A^qKM?.Β#ye:=\سNarΈ}[ZY 9YwlvDgI"`rj x; 74ؑU#7dJ(mRFAjb>.Fmn7:~3S{l >U`*ы NH[Rz}߻8`TnTXA CR͝Q8!XOϘɉ\E'30%,%t;;a/83paD,2ݨF>go޴n;[(Fڢ/d5;$R[ZϹ+N׶DؾK]%M7g`tI*[nڀ,!9u$#!Is:c$vbJG'xŖ(Ɉ3·1!< 54?x|C*u@nhcbDZn4iδ;xSl2UL3Ta!s|VgY;ϲrDR)bp\ :uSIqb-hQӃ 1]20G-M-.$H$AKlAc ?ElyGXm%V|Cn{BJFϷV~-s)L04R@7pu)l0,KW~(XgYz{3䦤[p3 2ȶqM`]  M%JgRugtB&;J<%S>e85X9NCY/k띘޺]ߩiwN;N ˤokY*B \oEf*3*[܂ak044MЛ5;&~\^K?1FpqYaGBұHڅ!yG  R"}ѫe3߂EGNM ?cR!z8ҌR?QMF ->>U}E|{3&fyR8#J/5n[nζ?%&US+ŋ)SGs|"J`;W;-ƛAFgX.f@pqFC@HtLJvdo换BC2l]q3~{9g_)vu cɟKͧM7ѦBdOV8a4@L_G nZWNç䒠4гyМz j͐NCPHA3Z\rtB ~tnfo𘾜_ҴwP /pk2dk J =-~U%gR3& ,s{?(,Ay#Ci H`(8[(sL<յ.7&m?nKkJAB> lg% ~7 rf./T7#,,#0B25 1sY-3Ri {4Xyny$q8#1ͺW-Q[ t>;%^^x*HR;Yj${K(s/ QRG6q]wA:;$RPq:M1`֕ _!:Sqo[T{bL]A,mE3k#=TQ0Ϻe HWh;b=rUA>A+Oh+e} βng^؍{.KM)9)pIFw2!i6_+a]g,pa4VZϤ)v\M~'嶼CO. ^UP0ƏiM 7C[꿽.,zdi5Kibҍ3\WW͟nI8]лigzSma]-I}\ʷ7j)pq #b:8fc/f[B}{*@c5AEJt Mys逾 w;t$ecq̊pE ye?#;)c3&} F= H_]/\Ju}$Ai+R(] |XZr2%ޢAHXڸ= tߕBvp걳af,ѶH[.kqͭe"k]NwVtW⭻| ;٠))VY| %6/1}F樰9Zf|y6]dUH3 'կ] Xukz;|ovkM}G'? k/U\ᑰlEQ@ _gAĎ>Ca8RWN1JF9cO.؛EbH=hnl:vp _C%Kg#r~|dlz)ΡLU7$ߣBr$.'YQg48P!l6 ^c)@녆-(k $wJ\E~}]٦J j|ُ͐fx.x?7;]u9þ|D.  >F0@;O/nx}npTg1VA(%3~.1~wdU*㉃?n)<";]T;:.!wG1o臖7A^֍XLKbn G\ S1 {^a5' .F&=PLYB'BŃ=&#/xY#n]1H5Fuh1u0K{jY5$F;}8Ty/+#0G)))+"ǖwRx.ױwS ɧ zu1:ٙ}@xNzP͗\dGc7\vtZUC󽫪m#8  .gOae.B _qͻhVF¥flRYg*JT7VF3+W: p9Qy=_BH%᥷ooȡwH3N/C`QvƿKkU! ⅇ ,e?!4]KFD_yW<巎*EE]9a (:S/PDf na&fu$3F@@I!2kRc+s0dl0:CB,o},1FuOQM/ڿl!U} x@ϣ9h@T!ǴDW:aJJdeaTnR0^{Օy:qY: Y҂ɂl Gǒoc ^ o.8ZdIR +cԛTL.KT(wp`3SG7 gͲŗp)MNl0` ?ae$*2A#ts!,H>pI`80Qi ujHC#p^A~AY l4 _XFeDU#aw<3Y".cz&;.]]GBLz/a'|F5fEvz\fSlTq'32.u?#VLP߾m(Qkg`BP No,J1 -'ao78_Ö #uk؈~~BكJxw?r?-|Lj,P<>hƯYel]p:|nsv\mA@Iy*eLunh3OUP N ">-ybuC 1 pG ,SHKHb;MRdu^V8E nb|=s I{~~ cG9" * #Mo?fғY㵠ߺnLE`01K=SAhHdd <~fRzDא J짍Am3$4EeW6lLԼq|؅C7V@[tGy:Q ٽ~niM&1&Ay[ f?63̇t߬.!a =6?*zp̯_'d[ H7y3u[]PD;rHo^[6' ukEY2apˮm\9cJL ̒4++/1;L>1>J -'–uMn}'d|}ÿ +LFY-漉_~ PH6 ԑQVE"T?y PK(A3'sv۲'yLURДL-Y[;>nJ' yW'#OϰNi"Oq X]cn{4~'5i_  IYނKb9%xg|TF!)12ޤl2}ն]F v 9M #;eon]G `9V INۏ(:C`|<[GY_Oi832zq1gOAlgpFXw┻ZUE”o,֞b-0P(Md[ yyIO }?ɟ:xr-R?¦ 33y,Z]%mXֲ}|x_nLJI$WR*v>T9 '2I0ζVd`S$*L[ FsA5|y}c,'MZMnH5QDㅯ/5M3d L  X !91$8>5rwt,ĺ¬5K'i48]z7/lD`iȠy?4nKAccp0bƐ AsFiH =@?3NZhZg.y;g  &I/k IDG,`\RvV?g˨7X2 C+Q)zE\ܕQFY=QDFՕ\H!/n}dV?[5FeZqj=anOQ 0d]|1rerIDOf|x7[J*tRPKsmZӤؕf^r(mPF$oH6z 팊qh4f))xUpuvXWV.6/̶&";MOSmd>.Aw&$a|dSA[}sY2Ǩޑzn;Pp<&v!4%_C?5W7'cB\<9$ج>'n̒@k‰[:WO@,f ~`irH& .o]w(3xjsȖ:~mIOrZ.oYKhLgpBKd49Tq9Cͼ+[e2{V)o xdRϼmݦgL,l#yt _+;Ja_m娛$\0p?7 zG `Nܳa{.ԇV&NIAseĚw^YxMc>df0e*rQY4kM(7 ,v˙}U pSw-a #F`3Kbd_9mNbr^,+h`N`t=*VR5h|D:ںmÅV_á%@6I1 0s4N 4_|U`%>J{8Q"Ƴ[;?CkKq;{s)oߦ_Z/A^ܪh8"xtf$OVG!zÇT2o6V{: hziGG?JW6 `0vC[2%a4/sjX$!Ih/\ n)]!>-H<"5\iREh4W0w;/]:DL d fhht>w z@6pLC!l麡rNtwjQnz1QJdKǻǏ-7ONQ׻x ޵`*3QvK.KΚ?/ޠ .Od3q8^kw(ZĎz xڜ)4F  )!o{?=Q>e{{m S_2ps!bBDnGQ~tqI0}x_ uMF .2f -6YFzMhgg;j:&LR& G{`͡"EɠPxz[aR Xʝo Z[P[N$|= BJpkµ^4'\knIg9qȒ`W -D=J  pJRu<Fy01ЊTFY&z04?8: ܐQ#X9O+yNb;"HrfpR ۖCE`I#˴AtԵv{ALCǙ&K0~Lvd=;D=o< f`噛7?q`<=+̘xTqs)§9+[-d_Q#mjmUaiգVii?cgzspQLX`e?l7Yb@ omb@W_nd1`)`ڼކlY{S$e ;Cj_ah 22K^^T-;)QDA/]&oT-IvUR__|=v. Q]ьYs9Qxu5׮u6qQ< io"(ȃޣ)RC-=*S -1}8& #\].Xb60'9s0sC*a-ȌҜtt)AzdRـjJT£̴5!I[?g~ AN w'4ۭ9- _]qQ}!"J^=t[8M`Y18AD /C|dZƙ(53oWWJO.W@X(]gQcnwo37w@Ǿo)qFz̉5SjAE Fe[/l'S;u^Ha.L5lSm]Ixy#Ͼh(P^ in;4o w`ZݑS>A ǎ{ ( I[̿{ _Ƀye-@Zk߉zsϿSGˤufsd2wsE98FI`M9*k‚ E b;TK H%C?#׶q-biĴE|uZ#l8Pԙg:ޚ7~I~W_,Y$T\nH (gS $&X€qv*`RS*m_PWOŶxP ٍ̩nI{Ii YWQC h,a O1# TxHF&͖9!u"e(_HnRXd`S}ԟ:Yw}TVB(Jmz@ME &a6C}7>$-a~p-;d2-e@IGwxy̖Ŋ ;8:Xg{_M3`W"]xd}ZL fe NMf@ A"\ɕ &o#aZgu>'Y-L^nd:A^=n@Ldg˼L-ᗃg LսR30}JANR1UaF\x-SB1]as"jd_u7\6ȭ<=WV<$3Z ƅGGٔ c}#r_vpphV<>S*5u:Joi@6@g>O& 8 si OgbZpQ!ayLĥνMlݣ>_O9%kGn^uQF)ϑwD+d}%޳HmM«Ҥ%0zT|:< C_nWYmSz$h'x<<<~& 0_0+紎$US't/ZfxEO=Lm7E#tzo*麽;Fqg`3iTO$Aۈ^Ϛ l[J9@ R :',V pc"eۡqΘ\1a0>N! d9|B"cM-)p62)S|0~Zyam$!.3}C9j9.aњf(?>;_e(x<Ʋ]{037Aw! \5ckh} {>'b qD>i (릋_|}$e[v2JÑTcQ2eN{.2׋z+$nǬGfat31p> Z@/Gup_ E͏)<Dz󡵎t>jGnfx xx9 ܖZ$"OT"`9nd3QrlǠ\usFw&DAMyB5\I/XuJJf<2[x @ur8h t73^P;Cj ;:XF60:a,0cG>#d*#R͸Ƿֶ V:|t'/u1ף7n].K6щL5/ 7(T;ܵb|]Y灯^(gɂQ7Cg'R[>fv+,뀑(@t s=m 1mu|_0l$pD0V38جd6p5.:$6F Sn9n(4 ; bk;gjDA?]T}އ+]7]LW)غ1p]:dt=>MOijH Y]RuzZ-ǾhB>}8G)~wI<v$Ӆ=n(<bj OKa>á` %.Zǜ~+/a=9i|lNє)ܻĩ(ST(TŚ"@O1jZr898˖a(X°Q[\p?}tXL7@ cCݐǹb  m $VRVǟ#RC@}Ôw:y!(ʓśq?F,LO-[9v`|( Ӌogъ2i=9_K[`sF`/R]W(RD9vph*']c^ib)hҴWkd :6z0k? %Dh`w.r?N'lZ5$PeMy[>nc?[sN_SERD>O'IGxHhb[ZIӋ ԂTԦiqd,4" ha S~Ƣ!- vX2|`W;/LSGM+<5&N/@}P]G$"B9}$~RrUe/lЎ7"X "ܺ.۰[|\eYʆieW)ٯf[Q}/Qw*8w&%uE#-wFmY{f7Lƽ NUnFIܳʤ +j"@Kgx osr|@~j[5a/ÿo}yn*$@_ij%D{R] ޲lSh¡P) R%š)aj! @gdBp{M?Nv?b!+Ap߯U!{o+7Y(o#;\{1$1#?l<:(W8@_t߇#'T*bPьꞦ(fĺ}E{Oy!'}h߁kcؿ!\:W w͆8[$g7,aZe8@\(~P`*æοWV,<~$IGnK u }|0eCAKVv돘7qhXh'QȇC{wX9Wp?X>M Lj?{^>ࠃK"F߆0#4{TF dr ` HHT#9Цl\k׺6]Q#P0 LlnXije,SDtot0s(,DjW/_0=Ēf?CMސh{$HO _R"bF9*D4ܸ1>&Z[ [S&6&Ci|=f=VE8Z9rY.J|4@7AXSϸU9Y#vMP͝ }[fX@ɒ6uҞ=)@ r%um$qJDJXL%2O4|O/ߐvփA(#@F?$O@ e{%J`//0JDǥӍJ_pZD>tm5LcF(K(Xt>I pC gf)P\Xϗz}(I2hx> ӻbbLJ1?Oh0a.EXJ)^-f)̞^Y/muuj54i/N/Ii "=0CM9YGTG4FK*0#6)rZLz ECBwDo*.P֧-زTeXf(Jx}5Nu0mZ߿St:)˙lƷa/e@Eo\a"LD'H^`w""ѿ/(k͎Ba{LYޟyVDv12bF.{ H||V!tg chr/ZɪA#djFMXJߣ]: ׋ *v]*k,MF-g,ygHJf|3zg4[n<#$ <!!#C=rΣ&w#3ugW 0 ^y2Aſtt͛apl33o2rODn@]}`K4㊱l- 8 FٕjIj=5붍&n"38@X1ÛI BZ׿);$f!YǛ΅qR"vc.&R<씷X [JQ{~~ itAǰ`z9OҌ ou^[D$HPi%vWͲ3r$K+VW f |p"9'noa85!NJ #߿-ceܚ*420hR_B0r e?aH"#_Q0)q" ;~l ] ["Rr~Bc^sbE*S$p`pe̡F+!ADL%ц<,-hm[AUߓ">,݋GA4nvyYmİ|=_N_rʴNPfښWIX 3aX} 1 ^s9AF(OD|W4APJr2e6x.kJU@1b,5{M42$K)5 a&)pVX$fxݗj8W#V9}ěn3gm ?߳wZ ,LHTȓp_\wys9 E03`v{X~5XyǢ+g)I1Q^v'y:Cv$VbKMmC6E0s\qM$5xoF.x1\W Kx# FFs> zܓV'{/*a۶je1ҕZY o"|95U8~طx*k|8'o] `X7x)U F sHVf $`x~J%VRt@+kwBܚ:D`,l!5Ao oVyc0{3ȩ!T*N b#diC&ր̯wdi ٕY)x#@@!t9{$/_w™ƞgjBG^-aLv ~~y{Eq?itU0i[* XfZi rr(N&Ua!kT P+2$VG8 7օ: hDBDh&srRBEvwted)Ảd M/[< y"%guHy ԥXR+6 `S@!3Xh{Vb4CZyzI,?sR?@8,3 _<‚dOXҌG8mF[KHRA .Zz<^F &~:yj"ü^!qFfEϙ݄2MF%8ի.jp{K%3,a> ol ;p 9g]EI'˖"`PPu{`&3ɱqjXs} N/",x-L׮\9Ӻޡ5VdЉ3 zOu93sQ2GZ1]_p%gi_2Qc0k.4kvIa1ÒByJFo k:,95Fa 3|_zˈ'}V%_$`pdS!K7](&bDQ۰U#݅5L240e' 2 ÈbfaE=E(d}!Dkv'&@rުlS@+ "|-~ ||fUZ> LuzT?e;q)2j%U2lRwӝ8SA, 2QH8ϒa}8saaѧ6HQڇ?XA"`huZ"#P{x7֭YRR~5FV+ӝJ[8F|^_8<%Pf~*V_wGRD`)3I C\*c`Tzvʊw氰sl;]շqx2#Iѣ]3ʑemU=] hKfg&iF6 ;d6˸ lo~s~/TF՜}ZLsSPz"avGL}oy>~I:FT;j(Q?<F -EQR{Ė&0~n| t FG$Y2 Z"Xbc;1vֶ tfkQSˊ MU}Ǔ r،w5lP]iI_6zF^i%]kekkobXKcFvjN@`ƭl 559 DyS4NӚnuyɄ\{ `cj,N#߰`IDATmG]7T7Y|Ȩx2M ΢ҏ7l,toj.4$Kbu@勈.\-$`iF@gI=Y2RN(DEBi dփEs/ATx*2JGnԸ5phgѦxZ4zk2N x2,a, q>0չzGD^?& "zVߕ_K}(f TUv{S@tL74r1~m3=82M /4!kM6Ln?XLj*`BgNXRweՄ*nK19#[6k$k zc4^:xC5=aM~ަہ6m<= 7Ӯܡ*~UpM< B-cǞ- x#RCVn`Huxq7P;L h~TC f3CdGr.>٨= ]G ذ f.\Cկ*/!1]tyWWw%klhW _-IN٪;#i[H:^^C+q@ᔛҘ7fqj y<ϷXyJxv(~@DVN8]ieͿxF|{BY˖}}~C8lh[uDq]6ukJsvkVAyBy4+=5ּwR b\;Q?>9vugiXrM -ky 6 ^wkN/{8fc0%t{ؼ% jgnk4 syVC3eg[ cht7}+6W<]ܻ'$cs :6L|N0bT 8^^~hP*dRgkӼh[9[yr.߄-J 'hkJv>wT>Ù9aM_,/_zF&4m{Z@rI/&l̋]1EH8l" b3V eӹ́F3@3A%]3Tm4y ,LvBFCrmU~ߑ7X$\a0 nֻ]wP3h!޸-n@+ jy` \ieLxDfA_~_9%^:l?!p @0ϒҢٟrl bw *m:H8dFMN)xҼ~96?u^;g><DF, RibiE\ZE.J,0>Mq 6. E ,sWɖE:Y$XLEo#a-oecYغaQ ZV 0iA,mkծe:)j˄DJ T_>0A_3޼%cB^_+`"yxqIFC35mB|ׅoys8b/i:*|O)!U^`ʁYMr1woǵV򢅁J,ژQʐ?V6PXӍǒ&Yo3NW%pߙ4H֗{N6"[(82ƪ:_?d(\֐_9ABҴo(# ީF X7Ww a.3Ǻs1ӛZm?o׷ %uY\fZ~u>bI6J^C3ۦ^3{{۾q 0lRǗ 3~;# L֐7ZF(YvjzqieUvX8tVBW[;suE5i*.y;_mA@< pw̔H6 LfEii׀ŎKZ15،xp]Q I %J?!B:Jf8LXƌ\ϊ1ঐaa T^.(gRlu,GkّDu% VfӘs$]c lB1^xH2M|Woqݽ+]nm9 ж8P1Z{eyNs;)atU+\D[zU ji))|yQ>=7ڣ.LRx>j! !W8Uו`|Vƒ9wz,4#`==qU 6 D ͗RW,GHsDNJjgyTx{WC6h.`>R&tDߊX.- +[a@p Աp{~dK*4r'&R ۥ$ڍ?ӆ (2q[`V֗CLdj %/CPY `#9d *-ޗ4:/U.] Emi!9L>`td~k_:7إ}]V`O{s!-Mp&_$%SbM4^IRLZqZMB)kLd6)]"6f8f ÓPbSos?z<οfi5v=}܇ LןkMQyJoL*>?m1p8hi a/zX=:p."0G 8ٓ#Dl) elb-7)+Ϳ:0do>+K]nun_im`]b.}ǰ}葝N4@ F ssK;f#Nق`.i`9}gB p۪NS;Qy\ a&Axš\~s9= i/x~XJ^xٍo=}+ @x% ֖/VN/HzD]sic]>X{e񽂞Ky3dxXdV_s?&I3/Xt>aaCe]R0|^-imAG$MQWkRX+䢷 قChoBxY_0 Zhs:;ƄA أV"dYdAqha 0qs$`+ j15O6 n1Xup ;FTt oc1Oi]:W2I]rcxy+kNR/+aM(vBAQ[Ox[`D@bpp ?\En nivȕԷ{ΙNEVwJ9Nw`n̄)"}v :oT^ e}s}[4pj6aqz8d@/9ɔ^RUPJ?_Zc;<_pQ^34y ;"Q-)E6Q)cL˵#g@d1 vk}u6ٔrݜ`6:[ia o_¨'}tbL^DΗܝK6+r* F09PA |cyL¹6»L"ot\W(&tÂo0q'V8zaXy/v f4şh*O{\C>U]~81e$FԱdPgsE]Oz'{ILFYU<|0:xIv-*$' -K%,̑$jũJ `X)jHsmFlSH3(eߘH`ZRfQ8 Xy6NZj'["^GA Z{Xᚄr bHޒ43;0+6KJ2>Qq:7DfmEfOb:&ֵ6HzBjj\)Db)S (PS] 7(ch|z)E])7!阘Tc]?#R =ke/DPuu~}3ͫ !R@+ͶCJKcrS}0%(B\٫ u6s<,g.5ZnX $ v \.kP!DZ#-ur1#?/6g_i|>Cҹ? )>o˄h_kqKYP-͙a sYsojtt/C޹Uu*3NG'zf^ϖw GtwCt 6gI|/"]wzoے936["F٧zM}D*$4~Ȯ7GP#H7Cc6p@1O&z2Ԛє.<9x7xp! ea܆GOϟג5 ˟KDžLV۠lnWW %$NSe;$] 104 jZ{G]JCO?9)T3ʹ`d՝)9>VE/FTO\B_5h 퓇h24A#'. !z> ?) <*N]/,58m3Nd|L{d±׷K<lY_/ S_9(tO ltϬrB5K S2,_bxS3`{d 4א7a {cس/r4|~Eۗp7UOeC=UI=yOSvlijPK}:! m@qW?ByUG"'R5w<E3#8V]=D*Քg|Kx!ϴgu{>g暷-͙=fK벪 qȖ450P3ĹpAdPSjÇ\;H0D0'U(ӹ3L27>@T_H&<.tQYŢY>[3= ^巌l8ZhآV;1Cj#]4)yw,eK'htO @ lőT֨^b*Ȱͤ r Ud!od2OWڃ'JP@Ln2W4>;~"K2˻5x-h##4 c#t]}vxнHXYsaa+6 [})f lF r!8li-m!rnc|-䛾fF@3Z]D" w!?K'~>T⡍;#U_YS4K 'ƛN=1/>>)hO~4nL F u4{x^p5G {VϱfI蓼ʮ3DGRWAy6M@,荅ڡ+ߑO;WNCh&5f(U]qg-"gg2\,&,87K?CyJ\a`bU$8Ģ-'%0\77izAb.->u~iegl~4lv @ꖘʨ7|/0dd2f@ pM' 1%E5A7T}FO$-#iGs@vXb`? \Pg!բ ~.% E)]Wlm|xsEJ n57cq]rmkr_3)Ý]82 apI)ə10i@ϗP{&8 ;(H CaRAM]#ckQk/{3\hxrZ} e,eulw]jSuq`ӆBǿ{YꏝK.vuH; ov5V*paݱcM 'V3{^ .3Ez%)K [OVbR}O=:1H<^ 7vIj>]:Ӓt&7|?(M(y&~98oȫ`2M#fd `>`o39z]`&;}}IrB2`0;]5\v3ĖqYe;ƽbג ERi"\Yc# O̞_rm;bW`2l:71 &.qI5&LbNy~_J#W-,FI9n"?cs X6M.>3gz)hms ַB<w ӽ=A9o754Z :ǐ&7tn;p!UN,`x sxjhѻO;2NtR SD0Z`w#] 30_s 2f ͋qhmɡeI8y\]8do$ 9 4[Bb҃5 Qa4 q|+.y q?4ib@33w2pTXQ ˱Y1\huf': ulm4"1߂Zuè<3FfOj`p{G%骒ZˏWax#'~N +:Zmh =]4=u:$ !yWX:nޗ 6Zk:rNCM{xٺ ^yH$teW03Ҽocel)N25 6*#ue Bx;ѕjTkQ;\qMs˅[=')(}ѹ\k;$:` p@rZ?bH_?q֮,W qBC<Ϥx/vQ#~D:$Ghq~>5g$7u.P3E@9V,0<"g|x9b'LiXM{M3$9oE6]qA@OtRdV/$(Wʌ%}O׮7塍gO18~]Y5 tCrj4 23Q2?lSFco49.0 RpM-{= @(t+&12&,(@T#P/qݣ#Eʓj`N,;Xłh)KN:e )DqYӄ ͼ'qQ1[Z܉nZg&o5~ "K!|cɀmb012gY~ >%sN޿:QnI|flB4:Y&ܯp bax6b#Ǟ;4$@N0ꢺTf 0~2 ڥ d@@| C^y#H+7<>'}ݷ35m4tKR]O<RmsT<p0<̢B˥S9ma؁٭{zr[?h 6ⓓ6T@X8-oI 2|/&ߔ?FdU@Dy[mbbrB o`zEǙR| dw< k/1&^3\~Ed0D9ZOfX̹z`_b'?,$u LP!Dll}Ϳ33$&dol ګY0fW8ݖvC/p9b2OJBʿ6=FYSS}l,~ wՙc `.To*[%`ſ^_d v ~vD>8Җ%%)UxYD#;@_†ʳhfW!Z^zpA] !.6J4?5ȄuI%bNqMN`WƢT| $`0([VH6D]:#,{ƾpz yxz~g4&YF+ 7]*E\oo^ |]5!oCTwK}|rǒ]@^O-^wi"aXcLKJ!bs6w%EIů.31`+lo71#,/U#]dgZȫQiN҂ B/@@yMJW Q"0 M +|F5P/4 ;p`h| 6Mæ؈E,f5֥.$u3`˔>`m̭}#XfM>KrQ;ML(3nѱAw&":&~hly>L*Zy'r0 gZ$ưKG˭%:P.ia|GEs72X66]y0lF4N;{z>mSs͵}x2[GU,̀e&ũfy4<sNZJĿg  ThLfɡOf%Ҥxv(,-&hg?b '98 ز6Du*nJ5D ˦/oJpe?R7SRuH ^ΦI1d ,D.Lׄp<ܮ*w|Tέ\uXI/]p8 *QonC4WaNSFt3_ yOg\Oc=L9\J?ŧklJq),rlXÃ3'bahQS_N>K8(gt::Bʨ2"ȶ_׮ )Y٩uzo.njxÄdq:b8J{UlXIŤl/E,.hb/}l_jM 9>W5>]F-xzk-dxa5#tfj (|\[\GnT hWA 7dQoi= A6],4d[\~EX qRI54QXݐA_iahd0-{xtW#LHX1-=NtGbiNPdh ˆ-jE1fh[Epplډe7/`=X \SE;GdMwl>/qA+B9 l2 np i.ѶUK0,~S'@YAj֙3wx>D'K4ԣjJ Řֽ ;V3lCfJ.?N_85Uh-|DnoSv9 .B (1)u}wp{wZNBC! OYl8'CO gR?5SDB^_G_~ t9iQFjĺ:08MG`b7[Yǭ~mLЅ^Dx>x5]ӌ Zjk>ClwnU{} ~ҴU6&tBp8?dђ`|ag-Chxep6(3PN2(ffӊHwYӠjX:onG#+ؐs MU6WoXhqxR,#K } ~ ߡT[c{\#Đ&0{sw"9(Yh0%sq ̾vi#7B|Ǘ8)T+Pźr\&8/3rKyOxq[76^ȇR%3(yN+(6F?O-i|xg b:(3Ϛ6 Ȋ\i<0PnuP@@voK)W9ԭad/OzDTv~|CUV~&K1#P9=ËK:Z B涧dp(ISZ% :) Ub[9Ȃ,_vbK8S <|MY!$Z.x5&/|!{oYk׍P ~ &KO]Xr$J<)`=J[$o61[Ft4rmJrWXcfDkX0XS V##@X +`Ie?|ohP^=Lj|F k$HTu6Ygy̯a@@1y" CB~jp4$`+{㯶\8x܌1%=m3-7o1|A@኎<`l(JU΁#5FJ²ÌÜr[GE6@D1޴2=%X 'aY``VVNh@@ǿ勜ш2ǂHxG1`Ij^Dof^Mv1,EJÓa9g9MO}\la},N܇E6B]j(ז}e[k4,^d.Ełm~Z3[㍩SXɠ@9DF2&KYC2OR;ǘ47pJ @@R'Xw괛 LgP^ 5$Ң8Jk055T؁gGSW@"n=,xj9~b~ )oSJ ~kٞEadƶkD|,b] PԃՌݚ7H07$o%}?$db6*1+F?b1mLmm12,CάrD"7 )1Gf5&1zɼ }RmdUG-z7gpD;}ٙ3qސY'cdJQ {2-Ċ!%g?7V4J@[&8&S+lkMעR@0y(rfV߼ VuɈv?*ݖU4 Ș!2Z#"B}g* 5 *O|m}HBvK$MeUekcKՂ }e|FD77w_ME=C]ڿʡ]+.n9<QI43\xaӃZP`*Ǖ~~zwƚ.he Qw]Wl|,M֊|"PQ A=F09C:ճ(9eGX~^ Zқ*k] >ݲT xLbYְ(Ulz^Bcck \<1q#~ |a7:aPpE?|KGDLkުG#$[U!6+xlU8d2:9 xx0{lb su]QpA aҨ̤fN~ s[өE 9puom' B$ʄ,HςR~-`mȞL}^+" c~<]]z K!1CÑx}f"!M_$8fS{|c3:"KNnxy~T[sKc^Ğb%:B?\"|1+yK6ېQAWI|.+[muihUM `p}\e=mІ`QKM6,~qwӜ |roGLtW-R@ OK̓6spž օEb4ɁH}5s5C$Is_Cic0mmcPn_9pTD2@w5 Oec1=z%p{l@r3BÌzyGԥES!=<@nܾb2w9C7>2H~I }%V6l׿"}aJ>kIurErG Zd LN |&,ldQl@b0-xLG{# Duu,j?ЃmcW.`m5Eqg_O=wj#سGnpUT#:F'( hqo [5̾4rk P.ͦSP%n6'N|R1 18.{ Cl&sk| I2Z5MK ,akb)~idF_P4&Tkp('܄؏'@ z0F0q|L@^ӓ n/piȢA@QpA(〘.VPz$|nίi$?F,-MYwp۷@ Cd5<]qdX@0~7||^ ĸmA 5Vmuc%O4>Z[rG<KH^*w \fEx=O^)2,O !]wfC=URjXB`eg"Lb \z @׎ -_j3/{N;6sߛ1mQNJG_amY ^[@68hr GԒΡ29o NV;5!t+=`֑96g ""=9s)JFƈ-g1$eL%% 'CPvJg҄?֟6Z/$JjF@ /k#oŢƶWH=3HF[\G>Mq9:iAs)za2 >cƪpcO$cXq @C>!:D%9y-G/W8c08{="ר]Ìs3f-ܪ:%=rkܺERQ)ߚl|nʠ XǛF @:d^5̯2+Ie1,8e^S}MޞK[! tICri BC(zeS*ydj~ߴ^_iiܚc|H"4 &sU5D0•e,+@W q.k+j/;v(Z_ZĴZ/d^ ؜ePrAFq@fyK]}'5G@=3/s,d`Eh!o`ᦠ,as Y^~o W".^bÔ4I[VDA+B,{+m3V|gdeKE *c-4;f4aGlTEE+>6 ;RRPA0v_Vf~)b A"'p`U?݌8I床q;D+ jVWo׵@m5E76j'vVp9a9NYl+d7VsIα|B ߊYvQ;@{!L}c 3W>І°)]+ }Fi3fS6 5e8K=P}B5C=&/ہqڗ1Y@jQr1Cai,yZ Ȋ{,, WI^LHi;8g)m}eRkMr|No$pSl)p@]mUEWI5 yd2wp{sM^@@_2^Ri $""d P9;s1k$SWiFt8[4A.t4qlz`Ƀ᝸ͨbu8BæHDٺ dRɈA-;̕sgZ@8{ @]^]IP[ * 2MI\)D84EJy-2Ll/E7ܹssN])9xi_1LO`h$}tl{_Bf hq˶h s-@IFj`< ɓϼ#9ڭFLi=?=N%w+#@~Wv8+U 7Eo8r 8{{hӗPxX_̫5iq1P/#gnh{/8ΐ&ZL.s{uN45( W`}V3p4m{{HR|ꦗ.'/3ØbeE_i f!qt54Auh!Q0I`md%0k5}{~xf0; 9GD2[,6Orj% B̺ ?G@G",A0&xQ.C+Ċ7oin e) U^me~_pgz+9Luĝ$24T05zqnUu 3&d btD86$Lq7 "iTނ4s5!g 5OdW 6MH~^Z}"RttR9?ҖAEMZϟD2w3FcP9!ӇȵWN[yp Xcy a#IbƿS`4X!9`:mL&88o-H}{ZMA=Ub2auU=@&NoΌfY ܅[N.HnS;=2lўu Ml:O@O |c>>h8H[apq_yZpEȑ3E3 ۋ2"Y~brs}nL]!ܢ kT ego)+}5Iӊp)VYcSv#@9F^=a`x+,~SײQj|kyM>4,3kowd+]&掊vS6lTg[G U-$(fsXF}9N"#ir/QAqrhuc0'ƍKv ƉL>R"cӫ!An9Z1Xv6k[hOLuo]7b;k9Es4ɨҿ}q>6eJ2جŪt1>v/Xq !\΢cyc< Z{ytʵ~Q&Du8w3ٲIm~ǠQ a[ԪPVS2Ey:kmՑؾxt4""1Y,M~`v" t 7_tU`6 fͲ,Z0KoDkdسcE=u+tƇ⫰mv5Yxo#7c%q9}ӳ@4h5ćcMxpT /17+RB+ c2yv 6-s s\ߢ*o=bL0'<ך=I ɂe_B&&m!oxp* |=ڊc8:Pf}%n׋ORp`ɆS[dj9s]f%ۜW-]U.ѵa`w$ yjn; M#"4w|!f3mu) ЀR”5kcY%k#{ Mxmn)!w=djV9L@e/XԸj3 aD%P">Tf[uźH!mi2Ϋ! [p&fSX8 YjY4,#Z99It7XocU.c)IN:jj{]7gxC=͖^On^rJYXXWE1,ܑR/T̢?J!xo Ȉ*M {M"&GbUьH?MZTȅ ?&7: 9[R4 e>21n *gK jNYd E0̘$q,UvUABP ]'h@Kzih% "9#LNTEOj7v,Nҍk\]<ݻ/;Wj pAvuӸ,d̺pOJS"cf DCYl(Z(?GUZhuB捪k3)'T,*#r`k&Kb;#iQ=)#Ӽ,&EleFav.!9+I`dAЕ4XM`i݄:ߦyI|<ݦ %"ڑp#L>Ύ|[W4]Lk8g|$0@7Cӥ#%`1oby5a?ebf[(0I%`t!ݝ@ acWQVEmT O,)e7T5P-nDx5arj؛nAd\[v4pJMi*K֔S{;4QQ:, ^ 2_Q@D4F m<#¨Cs*D14A0Q*M곷@,jɘHp Q`=3FrMA&p`&⮥u\R `TOQ Op+/?,t/58]a\"X8 wӆ3S+VLfk c X@ݗgNK /[oV(; VHXF~LqFjKa1PU@%|s68xF Oq_ߺ8@r ;k[ >^'F7c5ͪ.TV ʌ[[71rx /kKH|DlDv:eQ%M/0C(&KF1LG|QF2VG1EZ a.W!L@tXGYŨQ|$, &` ,JE]B?σ$;zEKKؠE&G`wjf5%kJ^+7 _*> OwNܮpiIF_!h闑o챋hL a${0@zL+ϯ #l4 rlB!CF zKTzɚf5evn, rH*yr%QL&'x̋uśi7]xhľ 0)[k#(c,/G_'eg%Y'T+|ԚfFq.3mX4\M Yӻ )cZ1;/ecG:\ 8~Ml|Y&/9g_S_Yfxs;NB?y[;d'9G'x#SFX}^Y%S+!;iHQtJ};`&PACP$kiPxlApXP<͠F2:de AȰ^70 _T=LBs`kc&M_MQǞO g@c9\&Z{7ajrᧄ7PKgBCQlQX~M?  8``f]Om@ZO/Ѣ% (3Ro[wSQ"+*.8@ &˄FaZJnCc+pI ˠ_NuФ.NE3ܽ9Ʈ!D?AS5 ISVF\i L7c5<'WI,6Fdgj@'P0SYYdi$"~LQ?rOJzyUwmǺm+&:}h *e je_r:g * u-ټ܂?mJ h@hn|kpOJn9'~s.3A68f:d5̮h|&Fȓ{ݏ2+8YAu ߂}0mE2RaD 6j-9|t"kNYt*GaGVʓUld62ZIJ Wy/.83T0_t<1VE{fF2+ޡ,x]ark#g&V`#C4+%(A{|}Co-챌48<Ưb<$hbHAڈd"!3:c5OJ(G 05G17Ř_hsPF䆌+Jy`% !k%?36@]HuJoK%.I4 p(lj ~qH<G荝Ώ,*b,Zcv`y5rMq[;_cB+[mkAZhe> KwB' %;xH4^ c&63J%\d "_2vEz $`Qܖ+ܞpxO@wL1їف֝\d{*LHƊER04j"@aRIz& j +K⯒PݛL~k{ mp/.Y-WPF GuDRj?xlv`߯y6J70[/2/ԽsUU=L5pTS1Eo "3 ܰO8a7X?yď!P uL*D,RpHY>O0yy!(S r)p,&ջ' ҳ}JUǓP!{P6l7e,(t/L|5}IY b_Sv toml",O j(6|9Ա !&xO2M"gK,Rb#fO3^bxiq^﫢E\7@,#h4TLD5oF oYUaY3.P85+ku+Г*1?O0Z?v9AC3LEcFk%zB5O7yWzҒJVC3 /C;bLSBן6LJ/f-tA ӺCGB}zy˺9g  ԓDvR G1,G "j/ؿKLn}.q0G"9WTx!pBd/oX-y〜o֢lC`@3b-C"Dz# F; PpjqMT=8 A>RMvR]1$2&ƪ mF"V[Q/,E'Avn!ؐA &k=uDds]ͨrt!-{pc8 ù 5sKܛ>ŎXIc #p?k3~y8YOoVhAڳ˨?IjɳmBa ΍\ !0[geH}?S1)C ;`ɖ`~.(\b8ΩqGM&"M AGUW--$L;J;{s{[ߙT{CgpҸҧ 5%1ܡ khcNfv5+f$(1>BYھ@ίJLb9}. IT{7%OY"ǭ瓺nOàAK F򋰨ČJP#)ɡm_MN\Lo17U-&ZRBAOJc?? $^J_]ع될k@3Qc'Vz[Б dyCwY~ _RUbjk7eĴKQk3}Sڄ yEB(<>2'33hkbJވ훽$lf$$rO{15hf,K,b HYXKr:jG༲k[uI;uja*!͂6-m"ʿj~{ĥc7Nc;P]Dhg8ybhc~c hCKx6Qg;D㵹$B^`9U,=CTQ)$MGɏҔj"{VPV]/8nfor]{갈l3ps=^D:C{ol$Q082ȃ*˻O詸q5g2.bx ݞ$9a j (BX_!! 5վK11{e/%\[ .@Uw'vJ=CzXp(>_44l )CCi s@ :F_ @DOQ 7 Ӻ&xI|.eJ+Mkw˰ @vj-r[qi$_0b[SKY=U$ 7 1?콉76߇*Mڛ[(( 2 0nRz  so$xYwEg:ۄcCj eƘY5P0YD^3s4;Pu,1nZm#1>6`0kЌ/"ɷ]u'i9(Xa cd 2gno{?l@|@3 $.֬wQ ;ulZ3Ǿʄj旽R{7u$ @@˚Vy4HPXh͢`YK+y@*@LF2x;&0#@m5@!67zoa@f:8|ڗVcZ׺1ehAYzHPSDA'`tp |78fzm N)1yQ{?Gơ34E<FA76INb8 xw-S5*"Ǒ\hf]b#2 ?4$.8`EpE0I\.?Qb@J;\n}ظ$>g)܀|=k6dH2>ZxN Xa(P-ek͓*8<%ظ ؁4'*DpV"ιS e񪀇g@ 3N쾁6,Mr.sծNuo"$tϺv\22zv64%/m?ڍEڇX~v#` =S)]n@=1hF$5e +7f1 sI@c:GDf3~|pWшPf(*謹!yT])|#~ L̥-EF2PeљŒѐyPN\#U'$yTpX%_n InMr f7 2%ݜ E*t20-ʹ Ot@sFk$G: *y44rXk@10E:oy aD|k:wthG]U2#+tԒw8ak<hiLĄv<=f43|AѧohP#`L~Ȗz=y&'qـ>l(Z#9&<mBu(Z Ghg.Y[0A8DKze|  VG/CYPMdben??CGƮ~POT>t464"^W#d . "bq@ȉI@9U"wt5]Ϭ܆UXXu<dpVcK-hǼ-G{dV4$יl1aՏGܲ!43wMPg+&L.`kjY̻^?X]nv>4/gUg3xjcЌpt&Pu'݊j\CsguW"ڴ6a$Z lHp+MXRS{I#BX)s|b[Z m I!&˹wk uʧv[N&kSN,wdZ*DW'v` YsbR"cXӲރ6ݪıkuY8!q=c ~UԷ+ J5}.b aFIB.٣dADH (΍RqE F0-UA\=H2ZdSeX81FWh nc> ѩyWB# Õ%|5WIlmnZfAo:/ItmT2IGAlf;ȥf$AYz 0wæ&i\:jƋ_ӀA3$Cщ tɒ@'u[3/cѓqڕm&]} p{Plrd wBVeƣlv<gX+T `$b6"Ħ!'\?̡3ƘՑL'bb$S[]7SGNFg-AxE3(gJ=V݆K"ZLo|?la4ԧmzui_sx!@P}Oo$]^W]OzN0cO .WO<6@B a˦+20NאKCfpK(:kt/׀!_`%5<}pj`"aE;]-hVP Yo cRz`BV7^ @ScRԖMJpSa1JoPQ#fE[1rx) 6ڪFPЭ744Jis•w`JlAE]Ftnx–aT8ܵ*|\~oɏ YXczj$rd ]c~GH!-06ǬsOrø!dJҖ}"AKo Q5fDJC1SF2@1|.}.{Icb0X=1nN!cdi-n\6O8$=$@( j ڼ|7^"­Fs]lAm 2"Fr:YE)s|uyl|N&kbtMI z^#@xi oҠ tyb(4jpzMr3NFZaxhXиLRE0SU~ &tjȒ2f+;LR.UJ m\>'5p"De\>^j,WT`YRf=2mg!)dὠG u := ^3Ybt 0x*=u 0Hm7Ts] l%:mtH HB6YڽҕmIhWNDQÔcN"I<컼UϛcxGGa#,S"3%wXL>ڶM2$t,*v23O9*RR(ʆynk:R! %!$ő-GpT`sAo=]G8#$ŨIKc iH F粿ϴz1 7Fe}q]H1&Ɋ1cBqopI;nWylA5#5o^=IJQ1f:} }mK P"3翎^,Q@Km!uF`AD2 8 UR$Xڥq986{F _[?b@9 BGOѵ߃6O2 ܵLQ}%әC>s][R}T#/5T(P%nXB?9aU`wȕݶ0拀e}NvQ|4H wz˦$m0u2@hd6,/ ۞ 4M8l Cwuv%X69+6 8c/07XWj`N"uD\;Ao{S¢VM,Q2wוnncTI8KRIɥZ|zބFBzp@}M^!MKFeJu_\ ¡Vw'##E0 .?oٜ}}퍀Ҭ0pIM0 ޒ};7k:M] ֌^3WUVf#u>dxб`q(!סOPC^J=+13l!a.cEv0+ +dJ{S [˺0-vPm*L9RhvܹGr(#jnMp2㒻l#V(2] jil'] ! L\L/ qyqrfI[L.J8ANRA.xZ. Pat' D*B .c(!HvuWd5"G UŮ-AV 8_f,VF~Z~t1U[ͯ >;;D쯀qN hx"ɍ*H 5|p~H̀Bq4~9|ɘ@YrU#ufX>K ߀&3 ɘS{ᦋ_pz$-$KJH*fg [] T*fkp C!3Ci7 k0u̢w"L[05z+M_CpyLcZQa2O^eamCm^z.e>-=-! QN)טajD` *7$]]ebK< ݏrD%Clbi3FC#"fx{leH]rC} 0'sE$?ykz|pDy5JHqA=a.rZ<}6Q9&T)e'=lL{49Eczgc̀V'7 Db뿄il36[w9ּ95DsIFf4)Rp:Sqڥw @7P\ g^_`lW$E0?Ȓ\oW Հg !8zP'Q0.=U~|5 ;T=:1V7AoR lαn:}#$MJD"_]B]EyEhZG#*1PP݅D}_K-8cdN:v HNFDx]p.#eCʭ-"Iڻݭw &.v8!CB%:hѢE?BJɢ @_W0DigGHH@#9Ba3 P$t$O2Xe ҋԚQ!%X(g֝)M4)EbCJ^ayg{ƹP N22[(W5JƂVfʦvFFXFDc/#pK Y"uX]İg4Z&&A"#G~^ GmqIא #mFS(`E&'Ha@ Fbބ 39>^kGchFhz_Ku*KSm̰p6oe# C aՆH2rBm39|JU*B gP$"v"+mв 袜z*ʱix#@9_o_̋[x\rNHiFxd_@}VC6uwZqPN0c>k3Qx@rk7KC/Lq08}Fc5[)cуABBHkk #.VA]D7YJPԌl b/ *94_SyW>5&N7 ~ t:R24-_4r.C!wP z H(FfJz'*|,$Vɣjm 0;:è8dp;Γ)x͗T6Q.$ɝ3fd_5̚MgF]{(M0$Ӎ <tȑ,PiN'fhr%WTd y:խ[N i ːM۴w)DJ__g+v)G^͌RA{@ <8k Qq$wb^x.fc4t{iPR{^Iiofxl#"l@QIgb=dѠ*8vf|xHI6J&Td; szKY,#7alF8R=X"u2Y1ed*\88UŦPwVȔGKO SST "e0hdFsO0$7.:DHbUl4.J`ЍajW:OK:8(W#|(@EAl0 ![\"): j/B)/  BJA@yus4Ih0GV|2dNT6OlIo{6hk|@EЍ3V/-7p ֺ=OI61Q/4yb^dj tG(L&?bcrc8CYBOp>  0*2#Aw<~`08o/v[B=Tg^د[붔F)rU \o9hWZFpTXeo*[G) HIH>/NkEƈlz 1<[7{ + r[?Pb1O 3AZeR+^w`V|e'?Ohb6 aWnHa(-wXnt&-Ib87Rc^1/ 0]]A!&E0YgAk^{sIeN/|bYU8A}`RA2草=HhOT7s')~[nQ{+2&Ni S|j iayD []ފ(U"vbh-J*!EWE]I3l{ghD@hF}#:[W26XG` N\b,;[%>6 מDYpZ 3h Z N=;. -CeYAUq3RdIjzcMg5,(sj胅H=+Q.Rƪȳd2dȘ{P\Sô6q*ln@?J@d,  y93)r5z f4 ު > TzN`6D馑M/3rIt]3t#{6jz$֭ OI ` ;_醑e )a18eޑ`2UQq yx$ȫSձ>}xo,ǑU`΀ݳ`{4PG8C,f)$n5sPnM߆.K5h=h-\VZ.`{mE D~v*bZ?Jrȉ|H  ,35IߨXP9 mot0ۄ -FU 8w/`'y_*,3@D@뷔%;C3kf`';C 9Z.^Yϲs5uodEl11fEy[RDax/O*bJp&(m u xJKFGo#!&V\XCu*2 &0:K x;=Du rEwo/Yrx@ԫKUè)iVmlollkUŤ*"8[$`YwsH9(6K;?>&NF~_t9n%/I9I$ i$ԃ${ŏb >k|:F0qڍ@ 4sB*0e9j;ty}@1(v8e8QTws[3E:"Jo>E:_s(N.E3!k7DQb(ˍ@bCu$Rwzwڤt(kOX#)ʅIؖNЖghH1 & .kD4~Rَ؂8Fc\{M0.Qgq7}'!$wT.a2z93-)F},1# @SC )6'. Egȋ8@Pb®e1$t[Y̓`@u0󲙫EFEwh5k6SM싴r7-Yx#kOh9]Im@H~.YqA)ݗM&B0T.$}+)Byb%2C؀]Vj5fաQߴpy1PGH|Tt4ɛm`g9(m!4H&+85h)m12D<`NVg.ާ)VsȚ7GLg$v"2.:xpGƚjZ)[O@yx?zRWHpog:l[XpKf,Wh]nbCy\L~HmAc:,d0 9nAkf '''.4H4jx q$+q3}W`¦L k/\#4>5Ou7rpSD IwX2H]&Q$@x8 Le]X'ľe>&E7k)M,ʠ83c0N'A34Owi$܄t:{pIJ³(j>fsyw=\b,gIpo8.. g 2OAOi\:cX:u(B!Tn~kcu?Ru&$׸UR:с 34SGQ FE⥂4 {>tw;O/7ڊ0ʐ)q8o ,D88%QuYN|>$c[h= Fzmf1{dQS?l(Tx#8 [l~8If`wxKxrxJث3y5[4Kxݽ{ YW\R UIn-ҁ#""ಭ?F O.X$ؠQS\sZ&ܟ-$ JAP~[{8ӚIF<:o?^YvZG jV_v =vQ"p!7!AuWqia׸ MfmJVWkwd0u'[?0 %Poj{tzwxIEl*YOx1D&ˆz]31&"1E,Q!KxAm.J픀&pK(}@W`60ٙT >dȪDWFJ]M1b֟k?1nfa%93{lL}QZl9~λ:V= ˗m{6_u^U@$]2Gܗ瑊Lma#BD%E,ojx/ku~*_J4LBY JP2|q7~@_'4Aw#JŴy g #p},BtNEƔ 6q&&Y2ۮW3v. Fե{Ң.2p/8S(>8N >.9TɊ[9Ј`qvk{PK>,GsJ0<};$D4$ ݡJޥ13ri3;2Ȗ}Hlҧ>w?IGm}DJ'֦*Oϼ,wtj`~)Ǧv`Kd#2EI/T<w/衠tPHri_ZFq0B)2ǿ"'[yÙ^.]C~c1)BTxT%uhʭqڹ}ܙdR9ԙh$PH(qhXvU[Xɇ!NIE>ak-wN8Fd-ۄ{L5}+8&~{.pjPy7V.5NZ9+wƆ(<-.ﹻJ1=Va&qD7!ğ":@!aϐwGZ>lεFHGr1Gx5%r'^&wޒ_9=rÂIgr4@˕Ͻ!_ɯh@/6wyCOe0>@@[V\sv bvAjɦG.N%ZT D~tw!C 6. ed'"LUQSmW9!!K-iroV Π.O@w3. 9]cLhYGX!F\3ӳN:;m ^y4=9M0Y;MX~8\y-y˒-&`{ڥ)ykJ-och.P# ]+sA0TI0;I›e.`5nxejl:ha&x1PF`x':;/w(|錧.o3J{#b@36nlǼxzWi#!ojH 6]!&I a AL^pk,43$/!zA8$Qƛ,>?% [ju) o*Đ7KxC˦౹U_,Lw@lF`X-k$;W&#*ܺ3kQrd(T 4wb]H_w!d=ypUևMeh5[kmŤi ~ htw :ߋd<ٟiIXoM" ӊݏm8 2)g+ok{r2dmFV`Չ0k:LpYҽ"2 F1*>S)1T7i=iO q"0(.0!jy&h~#@,ە?S7 D"0$eGt5*]Aj7gE燇2_u1vOOoP.i#4a,N)x_C0j`?S֧* r3-$r6<)8.me~:0JZ>J<izζ1FĆsJTg&/Mg[!-!NR1ZKhlZ+G l 3#~9$T M̏z_g^1!#Of!MC 5/x;뉧5VшEC ̑F,27SG'0gsY]&TKUܗ %ބmTGF2d;*p/!և폙7x(\aɭȏz I԰帅|7Nw;&6< ]qC#ך!`9j7 AMUK\ xcn<ٓ'6X:I%l!7VwctDY`&{c!/mk!w& LsB17`1cp/pDxMZ0iT<6V"U5ʊApE1A vBѨQF" ACχ.;0ݗLh֤l0*4*CL>=MZU^ PsCJJo8.{omdݴ"0$ 4Zyp9Yi%ܻrEwSST=E=Ŏb7).iK-32qs[y.1`2`T S;i-KtgHLf{DrX`*V8=sZ sOC| I2(7q's{%&%Aᴕ[HlC8>]rsiR]5ͻ$"Gc`0.ӓ+V?ج@nwHJ"j&tm0=qǛ2gAhVO,S`=Rf{]W&c1'E*]ptʛn׈aAuu.v,b:XިfȎ@ J ^ <]( W6ly7K>  #@A[[?$#aN,fú"cʙ6n 3%[2KU m@j 7>c]k= H 0D H^?"+Cf4+m&rFmn{O#U'Ȭ;D2jPeV6䍩F-HLGV rVCĶlU[':|?`s{$=9`-0z;h);pB K#-7^;^0(4>p'G% 2Q`fE|+Cc\D(8J ?G4OڮC0;@CMxbGK G|;C'&c=82~H<[T$Hp"hVSL0M/8]#tAIE_ lHYd*0Fv:v.iHæ`"̬w!?K6ohL;wEa9w)?ކ^$3Li":x0]ԃh˃$@5SC1 7 աN(Gx7w +S}49=1| ΟV졠ZM lpMOPG` XECI :bXAe،~/^?mW~ӡMePS a02Q'v[nזSLXEFbl&1e ˯X>~@@U$LvNo@Ir0:j| ku`{΍(Qb!ODIo puGt%'4`o:gJ/%vInCK5KˎdGn ZUQfH#u =;hյHsRmĊx@H)gx{}ZJmr.8zz)9qVe!Wg&,W..ai pR*DG ,@2Bʡ2ŎbK@rp${LP{V4 MiF-Q\o7,a*AN|1 Mv(!]9qېϗQՠɅmAy@trgo&ާE0_@0.3W$]iorOXS2 jN=q`#ӹjM,bڡ 8@-|CY9lz ҡ+ͳRN;9yhW啨`#>iwQ} Q-|uĜ)k]ܖyʿ$rK~uSHMU},d0E_zE ~ I}H#HzG Й@4v(ษ/G ڴ{LHaLCp!K*F  Ka M BCORX$Dn;PӥfwL%oKdo>5z%W:sK:hJP4>_E)r%o]B{!}>蠢ǑGF?kPU/`ǀ`֌4rEl QSqr'7\Vw咄64uo3v ,KtqX=u"/^3%sC1,n̎Mg2mΕbBJeGh7&+bt%X9J#pX\ZRjPLr h$)U$gNyƧ4`Yڟ28vzW[J="~5T *^m^Uƒn-/fRR{k[+AЪVHM4/Paax)1OsĢ2$= wډ \]ѭ0j'E+lcȡn(}zTH-7:,K=`]9fsot$XC1g)&OsjŵU3ȑsHl:n $i{N 5 (QHVeȔf'? SU*O٫H1uM$,QU!;TGVj[905S2luσ( 5M(랠S/"FWa1Xk]N?AB4Ol0c]x3 ]lYvg-QnݫJ^-3VxyGi,ُծ2|, f+ۣ\r 6`[VZCZA厪%@2VA`&~^ ֣!@TܪwZC:C&\L $Od8Waf1)nEn M>ۭ?b 0u-9̯ʚm?qkǀU%6mu^$i8,}\<()-x':4CcCȍ=Cd? Ae\jݏIb1%ς񵔏L]%HRTAng~zSuT]H"*!|tj^ǑČ`zނjz`XC!D,ΆES!d11^!HxsX3q4%!Q؟DGmڂ գ3|bOD0#>]uz$~Q3~Y I:[O^ztF#@;f竻U3GؔHWDXI1s4l !XH?-: #8k4%;H5*@g 3GC~-?}3UMϧ$HW8O!Œ RIӃH%yex̱pC,76m|C? ݕU_xuߠ1D!GtmhiVR (\0?rV> , vǿuVeRljBe_~VdFa>8܃^ba8v\ ĺR¹+RQѸ&~GP QS*{]90ReRd&(_ n#-/#* s+WH؈; 1bB{@ ^d UlxԹ,f!i3 O{1lSN|P@=T0 yۄT:P9o Wz<:kR84"0[xT* L2H[@Gd1>;ȹm(c)Äd (頿oJ\ [gdE4v1dMu7b wEmH$ D+o^Y&"1ˏ .iPQ׽~—5=%:CЄ K4!pMg t~xר*I'x(Δzzf&bQ_:! !`!r-e(T!b`B5}U:ͱ~ZT;oÑ{Q$@oZ*{ މ^#2& 7z=쾙b7)R.QNl- ڵElT1Aስ'n 6DPC J CDM?g(đx?p MON.,z^K}1$*Cm?H8В$3738p{'•MԒsunz (G7Q a>AH˻_@8{_x3p*]< )XJ"0W\挴ؐO3 0Gb&42;ǭ# YU5yDCt cO A:v?Z/[^^E5}d+<縙qYB] `_T+N$Sk|ABZA컈ްݶ䅨1Ucq/z?yYk+#]aVWLԽ8 @~-HR+Y,n;4+,S[#pPIq(w]Xk3L^%fy ќj$ |H/wZOXL}9B6^A5 3^![W c$JsKhEg81JDsj8/u_ *38"7Z0@뫟(OO6t#R9>5G#^"Gu+[c-;X.(Ŀn1jQ bz 2G=ˋ)f+pۀ)9ƛ ¶Hش*2 L塪?PUQ# V_ʳ4>Ә>Ԕ!'&[Q1]RϫD8 %gmEC? L#0)ToC"IzVVǯ,Nš eh|{U!4aS2 #7F6|й 7+ Vnu4>%SHLy҆C6  $׸ώ?[؀O!H,מ|]UÝU Q ժ(4Kp͋Ⱦo}$8t7y [T+&٘8@VJOI{;|}P@?&H=B7uV 6WT\KeWYz낟pW^y;r=K q"@P?8Ȉ^Pc5ٕU0X ~y;/N&qR5!ѧԯk<> m.Ά[@f"vE Y&. TNRr?$>NV) V&nQE5XLw@wAed z9aRRP7סoU`rn3NӤ Q wsD0߽ӱ)k&wpnIACeo*]P/ MZg: MkHI~Bi-ø@ Dh ʺI ae)[~0䮱Y/kDEr  I Q/DžNuTz&rx\3) -+)C{S|T13?qy~6?`UT *2뻣o|^'捆z  b*Y*b*P.jޠ<4GX @ȐN(h e|ͮc:Ȭ%<O_hL5)XHD#03-WG8[6SM#2nul1`<;YGOz$LHq̋#Q6NFFrӇj_i-<.ʦИ4kdԋs G}-,[& a`,q v$߅q ї?ԏ9 Xcm$8ŖtPD2KhCBs"K"`2 za$`"y|,h'`;]G;>At(E^.#a}Rq9 Q 1xU ν&,W掀 8 2fU g&3h7Bdr@h\QPwxMtҹX![[{aQk{&L*w#Bp0݄)TGL{$M6\ɟFD&a8 ^.vq*DvdHJ IVaG` \2)v? S7%y8(\^8tn%={DCב80k"ia֜yAh[#مcÝ8F_sWI%`MjPxꦨ7茬Xp]OX=R'aYaKR@쀳G8xxxtVi f%*!iu#yiDFᲭXO` Z@)t ↻z_ ~i{MD|=x ^9as$ oA.枙џxJAƹ RE8xb.đ;3Lx,p-{S}VQ#pI&!%9eU7Dތw@(-yOSs#W,G`rV:peqBOl XQUM耻;1 ;4 a!P˄$>as !/Fv;Mn2/ċ3z)("T}LDio~g45݃L7L` ꅵ -#y@ZOƩz(̥0C`Ƨ}f1;/H>jI"j"r/:BTeWϼyǼ =Aʽ߼B57O7I{>*txç0<7GĐOn\}r1yU5jB5US|!B_nƫjsz|~~ͫ|y~^__Sםi`]nۑ^3O-Y#{XXb"V e^$x._!oL 2.zq|q~;5u?V^_e+7'6/9u|Sg~e{tfqU}uv~{z]/k/_A q|AnկUHtu3e?}??5~}]\>?_O\`<=_C'6E57)7_677r hsplW7Ї#DOU<~|Vzuaޱ(dAn^o?Ƕ/Iz6 C;vCIom0=߿t'~" QcQ1@SQtx*_ku +WPf<{$ƅֵZEۯgGd.( K'9ؤX]f"u4dOAd ECDSS!RrTq  =9aWH>).ޕjoMM "/250s,H $2R_͐6L:Mf0,^(C.Uz mxe$`ɀO; ! tlT y606s`$\lYB4b1BNN81ViHaoGӸ:$+7v~V?|LςNꆑ>!4/SJ,HA@zЈO*M0y`Xlhc$gS%u=⥄p@h*Id< IG >u0ߋg__,;ͧvZ_fϕ+qY>Ou1ptLdgMyqI7TF|f>Q/>עԌq|̟NeSn%>S>l{f^SuP}G@D:^W/ xgJu>2W$N D '>յc< W/?z.gFoW S\< Q?pΥkWXBd/ >p۬i%6:Z2vQľ|a [x9@6Ўvbo\y\y|Dg/Cx|b<5e^z'4?VpH|^3=zZk4/ppWkzuU:oϏ>/5ЖAC6 p|&ɘ Wyy"ԫ3'R˧#l6_"RBMLhrBŮ)C P |~?2vs&H1p_<ѨNf=QqyG졣`ZJ{B%н"6vQ4s6F3>AtP!'֕~~>e6HwZ4J!DwTsR!`6}0S,f`3pmIMM 7z-J—K]m$7 &6f21<^6A)u<5Oӌ GcP|7ęxM1,D!c N,pEh,G":ƍ&7DQKh! ͩ6n{) DH1flinj"Wl(o#~3ISUϰ򮴏&;SW&39M} 88]D"ٓ)̺P@.̍3ك̶+!zL[ 3 Uh6X`:Æ}6)3 ̯0"Rma}P%!se9+QILtD_1!EHnH!lN`vUp&xpw⑬/40h~89BI܏`t7+pҮ:* ֜!2UĻr`=!Ȳ^1oֻ^<Ҙ w݆fr5S`լTE.G` d&G; rP*tFO4fǧ[XEo`@S gҟw?4&/E|Hp҆V3Bz30oMSMoLiO 3 :t5,yǙ>~4v+oCni)QS lo庤\ zZD+~fR>oJpk355ݶ-!l(AW\M=:0('ѸtQ!tcFA!lShi.Hw}M,M{=-i ]}@5L`D}ID4@hhЀI: \E<'?hƍ$sjFL`*[N&I03+$p1mz) =KT zч&~.bF<(Xtt 8G'ȀٚLhp܁S>[ 2*#@pP2Ge"z:XjI|8PL?u;⭷xx8 LTW^&}[+nib qFV؟`5D.F(4xsfo z+`\lB1ETaE:S"lxRΣ K/_@ ]{A $Ki Xk ,h*x$]SVh!0a=5B/BaZ  /Cg IV }5bTN 6qwV-ܗD=VԐ0 pA;e#v_- KQ6cw0P2>c}a6ł-PékL# <a@^UHYReo:㦊5bo}ODgC߫ ' $Bq0Y@᠚ԵstйwEK[D=M}*,}i_!iLnNj#f4rGbD) U`׺W۹ J4ZXi" aĈ CwÌa`ރm*|lCcT^`'y lqXK]ݺƎXRq#<~Y\&1tK "itXM VJ$Bh(Wbݰ=aN>^yhZW/ lcazU "0\z&|im+Sz}\jiD>?!nKN|:~@@P`pyI5/'vXq"L496"v})| JL؟ [#/nE90+둹jT Omիq&S3a`TY2R+I쟍 q=X0W;s+1" uĈ% Fv,uX`8-8TٳQ;a >QRL[`D Mň>'Jy )fPQP ض|5N] ~Mۙ_ 홷#[0+O^Kb TDza,c3Ycݧ,&}%CW UdVstS%%K.*y`zLE@ C17I', ± R+55_+ѩGS`fS"VQJ>.2Vr9;R1o\Dy>Jf a XZ1 taԊOJb~,*(r{ 8u ~XA}ES~CD>% ЛҲ'ǂ BۋU[[p*#9aβ{-g{1]ch|M y:&LwF҃2f>"lbt&"#^.NJǠՇP&w\K,B|" PNcy[%Hx*L#I)ǐR4(yMhgO!U͹p 4WވbT2 sWn$t:\ܿž~|Շś.=ޤMjIr D3^KT?I?e {P5V  Nd0!\d:Yzp,=e|%wixſ̯^k1ZO# ԓ^ +ڿuHtQnZ7oa??/ ^g=ʶ^ $#+ɧ?9|? ,g42X=>WHL&{]fWfx\y{E[ N>ܑ/- Ozzyv5s^KّUS??>Snɚ7WZR{\a〔_V_bߟRl OX<ç*/^4kj488wuub<Yߴ9(F|?O=/~]XYo~c !aEPp ]>OOstʛ΅w%1mWryu;K@.QaBz"b o?ոt|K|:j`2rJ4W==?W+X&LKqG#<no{u?O'|yƤjZ0?n~iNzͮmӖcӓϪ/=~JÐbx߹[8'2g:/Ņ / n*׷;Z 'h#b~ ~Ww2Є+]o u} rs(x?Ho}}&S_ߏAx|^f`⹪\vjXpǮopZv[3t1 &{|yps1E%v!X?Ҭa9ruUs z2Z!>VE 3^_As M_24Pon'^!>C2}?ObV)Hy /_CoBx#`3P=ݸnO_n)f:B#cW>~ݗ|gg􄯟pKh&ᇕfv% dPeQw;o>by B W!+\>?w%b]gEYaPͦ/E )e,EY||e[+> zh )  9 7 |z:IʵpU?.;G5Te*wq!O+:OHWX(B#7Ֆ'g|2./ fyRgQ75PGzkJWiլF:>uKV@|*#Bҹ*՟U(7`/Ugϫ۽*yŨW?Nؿ̊hS'i'U SSs/}˗W%°[zۿE_!/-;W0 x{EN/ (Gci=xM:ޫ1ބ 8&]_aZ=zpH&\ÃC\*n\ >OOcJ 8)P@z4㑃5遻nii#ϟĦIx'T;O< ̈'1']_ v9|, V TD{PP%|#>%4 :i]KLxvѪ ~ prl@ï#~$´B W:`BEꋧUgzA==F?e_d%]%bz~ a]_eIJ`5n5\7YA̮`5 塐Uh%G=`(}z.ϫ)#w 1>s|}#`CS{,T8:U8{l"sҎ#n y#Ȼz|z|z|^>r-{B$սBx>]UdSB|%zzysʇMAvL2؟]?5לeOEQ빺[ m~8gpWhyXo^6塪sD~qkQ=@hHmJMp^ y9wb=d?{-N=l!描@‘Nҿ+Hezt7* )9oܢ!0mA N/}) zdTX (\AYȰgyg0 -UYKLw^1tEߵ;SW+ ı  S6z9V!?~"dD>~ZO6_jtX<<_7ofLpcjw±~~nhR_`{k&mHx*2J80lxT]md%^j@H0O>yD?`75(8Wp|F*%Q aQb:OUI c5CLMepEGV2ym,%($SP| S "a GeBVD +m5ށ"&h]3Nkе8]]jF|<qh }ھTdMO6(.G22$¼*Hb6\r#xx3 w7Xu@Lf\n%dGɞB<{n`53ڜ^/mw8xi &MB?h1{CTZ448ӛpUFݝxPHto471&\լ/y鷆3vEAfjkQ2Q|oӑ+,!sW ʤmفQ,2# 7{d}<5 sd;[<" mD3Z6'h6,๴18 ow&ifjpx& ҃M>pv&FV$?]` @\0uc *ZhzaAYC:S1,PV2: ;Deqh )j뗢3}VmqH%`%>VqՔyDP{P7dד;!:j?م'KOYp(?j9 ⾭r7bYnC5z 0% c f8B8VEXzp]/DkV.PT$ 끲8" YFNxOtz~ ļV[eE6@!|kƵ *{$ 3b@>WB7$ dZwX,)t\qU9wXZ`SLaȳkl~S *T-v2?#`s "$iCg4]9y 2^f|[߇0/&w]׸&:Ő-(7PʫUsћK?јx?PFͽbkeIbUx[*l_67 E}мFr=!Xή@+T$eC t.衄!L|E}5'QV>kҰ)1`eہgG/h0ai4 ^m·G=Vf:q HP<6 urӉAg|6.;Nu޶2P 6WLvnڡ1 c.OmGd? .:Bs3! q)WIB%m*Ase4PVpB-UJ*/aZkn F`OúygyRvƈO9x| `F|z_ʎL m[OA T#77R7PRT>ApևZ<vBƝI.j5+ACE|͂} l Qq_TdG xonuxȤ&=4=vd nS(767Z{hD |3Y xuworӄjUG %  / {)#إ:k|Bc64c ^:J?$Ex~w$dA LkbКK @G4z >Dazh `wMSrnlWMQ3PS3"&2ȿ_̈́Pd;ބHUMq \Eٶ"⚻r(n!u 46EkkΚ ܥ7<lX`"%F6YT{f=,/*sOXQW,-6i~O9RZ9VD%ҷ<~U)sZÌ`2 q3t$s?u-+5ĂSbM;=[j/CZ8=[?@NPd4=`r X|WHS[,ZMYGs9Ћ!-:Ոb }Ԩ>w  x=c@]bM >NBR`Dר!|j5.+3C:dd*sS@د,B3`D$1tMI8RAqC8EP Lii:ѭ 6rWE5r.km!vC42ur  AnX 3~ |p#&N9o]]t 婡4v~s n ' h_S҄146K UIQEy`v;h)j% F,vf }'om[׾&nT=8̌n NUXΈ 8sixʟE̙bB&}؍ )fjZ* u8ahBd̓3ų ܯ:ǤXsCMiJl(V ")l'`A1& XAr85* WC;4) |1ftT wtLYc:g"#c} @Mߌ(j.pLwMc~;Q=UuVT)HJ5WmpE~g?ybT-Blfg>1(\I㨆vQ#e!`BaVXI~x L&ᇱu D+" lbKfi'Caēpss mNS!`۽;'C kU0X,I}zU ujtu n-'D|}7Ax!HnUj< 0!3K4zyΙ;r+iG޺S $[!P ~<^L~J¨𱉢EhHHuʒ}P}!cTaUK9]0- /L_sĵ>!OK Q4x.rD$cchAj12P":FecNeRb ”;38&Q:'*waJG#pFoB85N< (JS'|! @k- I/nﺠ bįs/F-8z+8S@yBzTlu,7a3OgTb ߧ*,o0QjFMITЫV0d׍rqVQWqÉ'p,~HϠyh S-V b? Ѯ W` B;( cipB< 5i!ˍl:A3HȦah4; i3dȈLBڻR$Ν>kw?JqX4u[ Ő&I >%#hE? f`3yۓ8i뻕njbeIT65v0Sn!?DKiAuZӃ0e5&4Aձ%u3"Q?RzQj?N_uQyt7ceaP!z8nSU> -?4,Dˋ 5 F]}*cdm&lCi9q*C8ΐH2I׬V`0|B\ wAH:-a$Ɵ#h 86l1jTyѱZ{w7GQO`DΨjSyւdP?hP;o,*/N $ }d/mrom!ȫa'DY{~6~Trpe ]lZ[TuaS[aGyIr}ygsծAc/ a 2)H,i&!d7#XWI \ƾ#w 7[0y'x`aA(=jFb$woPFh@Θ62њ-q*=M :8 ;AmG}%0!/K1eF~K2KA^':8ĊYɃ\8MfXw "@j4P%Z31Te kdEm +:!h')&5PCb>R-ɻ ?sc%M` ₿@hW Gɂm#@l}1JD] ( V͏@ٿgEw4o6}pۏW:_Q!#8qt'mi2'i?w5/hC7=f:jo+Jsr~[=Xַ-R~觾К۬抳m-EFMmgplD6rfQn;g>]r]"2\n?_ 랄C&`2~fʝ$.mfZKDٽdN28_pIۮ~׷o.H.V)4kĎm߷R}_UJ{,osL}kKߋY_\v7J5ύn3ݶ$JOe?XZ~5+w aШEōuփ, \1%jAhݷgῬ?ltT&<,6Mhp뗹 )'CqVY#?~K$V MfFqUvXpI` H-H?|Q= (Kp0#lͱfڇRFN;]Kd)M(sAfVZ:ю_Jޑw돇n>)?be] [n:tx=_?Cx'*x4u[n/(cYM]E؞_Yd=A9}^O3C<%{-'WO6b&eF"ިk?n0et'l_ tΈh^*`5mF7$i*Aܪp# 0c4HT%9 xՕm]GQ+]  A9 *OQŸW@Y)?Nq{_T ,Sz&_@-T(>O+Gf..6S\jIɽ#k=޵J$B09$͎ v%qN!k z:V"3.nIdAȢ;w'{1|?O=#2lVGB Nw:@O/'>'xqL)]]6KTFS&dۙ/a9%GHZV1 ZVC![Ht=Vj_nTM;zKF”wTšZ ]u&r%1v&"*MPLQIO;,Хrv.oEӻ>s6H02`O? @IgqsEiU#LHrC| .JŧLV\3Rdvu|@ء3TYp0"n^(|+kIdo|G49 4 Ni &Hq"#۽A,&t +^wIGW N1GR g)!Fˍv õA.`e4 ێyxmUzS!;ɳAfC:Ѐ;gJE8< 0NF_qdNF>g,Ak *NzkjDيwE,ruu9Z2?mArNK;IHe崄78iL5b gG' G0^# k[&A SoP6#[ܯ'3Dn |`epP036!YoPxJ& Jr3/!5p`&`B;2 X7Tl [ ןŔHZj# =h-ˋ`&3 sJbrӝB_ dd ni)6bn/+ ; 4,HR`vJzJ^|Pa @rEWT$?1i_pQ=Ԩo'@6 +\A`I%[>ގn(y*'pJ0+MY jum`,,eYڑv LikX|@dJKq9Yb9(7DqFF |9 +`OBתIa.1pZ2ƍ|)@<8W:jv{ T0¨!M 3.(jF3@0-,MЩ"#@ }.֫9,"rt e{Zp-"Ӌπ %H{ !ɨ]860A*QG,-=BI;ĚxqߊkNq*aPwwN` CDDxZb멹$<Y.QĤE6-:AًNٮ v NZ^/"@LC=E9nwyLH"yK^(|0眼( E LyIjfQt6ִgR1~zw"װcѺO%L,xխH>ŧ ..?A'=ZP!+kUR )>6a\*,wB 2AӇF6P2 kM= +*IШ#@At*3~ S0=c1@Ѻ~7f_UW ᾬ_i% O^L|kjQ gLbk* -GlҚ߯uxꧼ^֟\W sR,YvZOϛMϯ﷿Z{f/v֕ˀP??2yq#3dR U^>V5k_EqUGg1x=eמZUWܧ'hůՕ4[+owr?ts]F|~yy:a8ʧ]sd7f5h_?}V_o{ۨzzWg~qu^DZsWpAD)_g"a`aTGT:?Ȗ3j_zy;-7/:>#Rn>1Y (ӵOO`x>}Y^'&(M!cxU1K8%&ˍ4̏_ rż_u仚oTd׿$Ww+~^~wjXCE'c'ٲ~y.+ȨBa,>qy@ 'Zcط_Ӧz]orSĐ W#}tqRT꺬a8][6[NB]kt@i~ήn خnhV/04"ۧ_>u p{ TR?z?4"1QqV9 k׌S/qu5, H0TzBWuZ_%o5Z9fb=먋7ۛOx_n_lVXO%tO'jؼMWOkE3k(RO_jJu5ͺQݜ~it. w^os]VӇxz\U}iɟ Iݐ~~Tݘ9y)+g}4q7wd~L5/֞XIdSkXyQtu.C%3-szJozl ߻*Z<,x??È+iPÝTԟ+\_V/  Qx?)=9q#q< rž"@JdX>^x+)pӨz%Aiߪoʲ~µBru`㙖r/1gt2Dl_@Rsl{~ΨwUV2&lA6$虤BMڄe仠=G<~د2LG>id] fEVsZ<]=eI*4΋~L{•H[9Qэ2":b6DZQ}ŲTiW)Ϙ2x=;[czAFR{ZfdI 6)Sߗ`H3]/3㨂 $QID/_Ty~*hZfc6s"Q(sl0 ƅyaAgبgI)_z0=\ ~1^Bc9Ґ ]kJk¼QX$Dr$#:ZuW%w]rm-X\cqX$@kwCg(U}Efljz>:QUp?! TΏK"s_ ՖL*ҝ^BP5o&ɖ <,jPDM ک25C+Y4SIMWgAm1CuOixR"딜w_@*B1E "*)tgA}Mblp]P^z?-Ie  NrH&;ޓ݀SM4DLj0;mVA 5+b$)׹|B ̗ Y٪=5Og@eWӜAaqj<CyXK?_M/‰?$m5ngD95vNίܗae ]DZn'O?0&36gN2%9a]9]i$~j^kp֠D*|#Qo'D-`Wݨه c3uDTbʂ^^}$Pe@ ҁ PW7IOq7.Eo\p[%-m1O r\?b$z/gFچa];6 K82#cKe@~q@,$m7g&e!ir48zއ4Đ7 /q4`}zNMh¦\(_ox]0- 7wѻK5BؼuN ,Fddg\4*i7ӷ;[s)jp6bvI%|> ̚@nf6#N[HRd"mWB')˥ )]G˨91U֩vI4$sW;$tp9V066B_xv R MZN+~Qg<-yDr=,UC(?}yz E2p)~(8! қ /%->.)ryO/yΆ,*72yo-M'Q57Bq3--eqmPHhJ 0%“ /*w IݛTHd-Qw/IStl8bKs5 *%dGPb~IqW@d;EhjC8;tk$Xhq7~'/@Kb5اj)5a4KH^Vwi~wHnZG+2>#>ôAytlw@GL0S8;M-4$z1CUقxGNz/KjO +PG 'PF?2ik ‘6B0u A1liWYڕS~7{ܫ`Vob"rBQ~o+)N8rH}Qʁki?hnrD٭LǥsH0Ÿ oiN3q}V݆i@bDb&-\fVD+#Q\\pM8ᆯmط- =G8勪6Q}p@gQ o3< >''d{GkT'{0Fl>TT T_F WtZZVVHwa˧xW*K0 c89 G&~iJaTiV"3A݈@Y$0f3Th@ga?nlu3@3wjClĩ]o'iwNmYim<78Դ@h2̣ηWBH5]ZY)7C-SF[@G~:!I85ګGԚ- WwVZNPǛm=~~Y@eZuW ѝH(y{?ndRK♰[T0Z$SZWNxqڥcS?ϠS+ES7}Mڹb JrWCaDs(W⦑&B>*@OU/#xRxD Cd,+ qG  )6o٪xX7"M0`@E\@7Ge4!?d')biw MzSS?}Z$#8'@j<͇,v&0U~(w=hCY3(Kg}9*OeA}$ hyWToubn|!Y/Ӗ9ȸ0M'JgR!0 tG`[Ke.puJW`Gp?T15 {_5h=KfG~]TdWO+̦V@qڈgPEpv =)E/E/o|.~]N~~y@+ $ouL~f[IAvvG]EKYBo {&Ӏ!22Ʈ>سoΩ)=mP#8ʫB:?4.68OyԄ ]:)(O"|oho^7 %N^4QH e` TkџNpR%kz1(Iz)4fCWW ';R W &rq=@鴨xa #lzl"!5+f09yRUǶ"ܫJ\@!}+> ZjħtиtĞ-p^`I)6@-J}Ǝf/k,tzY`ϥГH@ U(V}><5e4*,*ZOU,C_92<ֵ&A.͖7yzT XEI]b"S {i7c1m|EݠۖXڮͣq2it MVffGz5Kl]qah8 E4E~\ xYBIolA1IhNSsYfid̻A1e.[D>;w*,E; 7;LOxzm_߳~MT on)H@Q<ɜaNpUyZY#>675! ԰lsl*a3^f,OcN׵| }iӴЈSjցƁS*@69tSZ ''5ڪ$fi!5HsṴ/6PG (p8 XM\1)%sRxXM ((6:Wq\\ ^ۖT-|0Τ;5^2RCcrL_W+Y?y&5*7+n@$JaXƨ ʺHiwK*X՜&^b@EzMw)q/NKJ"-s "玂)X5:E pRI·3)5' -J{|VԳG8NM]F-IA/V6CG2`'Q PHr_J*lw O4$|:/w4RJPD"VWl$\|)];WA0Uyŋ-ꏐ SLRv@D-:< 8E&2(RroSb:%5 'M 86~dpDf!AS .`ipŤ0}Y^E+ո@4aɷ:QD\ȗPM:WEJ  tF`yy%phQfl"R>ȧ!*bOA ltzb,hJ .@8,xR)CD@ A5 ZG4[5C>,Ȍ[hQ:Fe/8uQX$%UۓpTˋ$0?֮epx"ѥ؝k^%J}0_SpSR }!kLAUCK&HJ+%?P;yN3,\[ >i;3z~kޥ\Ѷ+ rG$SqOO7~xVHyDHGТj@`pF}b8 ZA>7Hrw2x"PjcUhK5SHwe/sWRK/s+>8~DZ>@w uʅ>~Sh=g8 (UOc7Q"`Fs-RFF"O!Uz+Vug=/v@SJ 8/)(r(4yGH vcHpl+&`)CJ +7ذ\&q.S*ϡ$4)*w/(| 㒖L,GCv֧ăVRsgT[EqKE ]I"Wn"hoz@_-ivA_qodEW=I{:0mqPж 2_07.)%>K T.]ol(-7T_Frԝ QR|{D$p5P Ǧ4+UXFE6e+G]ՅXif!H }(,b68{luv8+ϳ@OGcJvv\ARpEQa5v 6qZ2rQʪ!4n5@L<LexEH%029NfwT9LTmý&<曍RH 35 `4$#9xWJNxd\R1J&13A])6q*ƠM/؀4ȅJW1"Fў?֯Ӥw4ߧ'YRRhIo9mDSȈn@W%X2[m=GA>E8a-]U٬!~w choUA@xJf ɞ, U{]VUn`7x6bk t 1x+z@ J-+7m*GF]ksP휚o7f|eݎpt= $q4R\JіX+^e]d v6  Ol~D#E0e iu 9pnԸK7on|8sJ~ c[c{X6IEfp J~FS{7c/YeR]m`~<&8nNngpvX Ear+B!bs9e#'0> y+Qg)} y3|-qu;N KD6!35^O]"5+G#X;Pυt]RE$0g4Ȋqc\@^ɫq-L ڇkUq)}# ijUe/UTbcruF j# 7V\M껮~}JY@ׂU+L6F0ś+ %*V -_2 GNyu?bVgw}|GC2;PO]9ȃy w cEff*2a(Ohȿ.,+ع@B5qQݼPuoԠ/b0 o1"]y$n 5\%k-&?gȇ6dt+%8=Q,k֋^_2ϙH5!ͅrXk!8[-' w 1iH2RL>s #WC'̒ Fܡ> /[52Iգ\kf֕xW}fՎfmItNW NsפZW=)$ tTˏRÃ$09nD&y,Ca},[w9;Jz"pI5Glk jӥDtr\ks,2UW=܁BKYSE˰rb2u>Y!]-R2+}mRd|mDY~$s弩Y Wk$H41UiRnʊTG`*Kl.pg#FŶ dvE[ @g7is0Y)YjJ^\dyKFii` 4`+/[$@۟v8t'YWoNBTt8/ʯ>=:ox8%7O8{?àYhEj?3bvUUo+g[Hod3 yU(}́`_^; N^e?<񊏈/ :<2RRF1DҺjF;g(~ &׊>I1Ghi[M3`@@ir@\aRO E`/(z%8ϜnhcʭLsB\'% o֟OY'SvӬ&*-mPVZ]w0,B5>%|;sbno;h] Qغ>.iPR6 W)0Vj!jK'".ΝWf(JUWnHbwK 5(4HxԺ;X| [3"Dem/v`nɮa `<2{~\e]t'PAjKAX]%֓F+*"۫_i €Ltjɚ"owW|5$T8 Y88w!PYm$>6-B0}Zm[wxx}r(Wyg,d=Z*]\~'1j8xm<%I:R=İ80s7U&X| 7Ye-`;[GX@`S[x1Ht#G$@@b`X(aUxbW^i;JkŴYtSW,jh?[?NفH0|D. 턽ܹT}xgH6+ɝ$} Ε[S.$;AUT(Yܕ`q-$gve "7=RS*=G i?Z#p 㾪i~TIgi•څ<PYWmj D* mǿ^?H}C-?t~N/-N"{;*}#9t(NAeytP?{#ݮ&|h]U/ўz:=BFvE Q.N_'iT+ܜrZ4 },Fwe{B =Z$j=;y:j7Jf01FN*붅 =(Q숲jQ<9}ؙ#C^!LK l*+Js/kP> I>*qRh6$,WNdTksM>NYޡMc_}B1"8r)^|,0ӭF{nlo QqdK^hyWyeEɎYycG:ݘ..\[e\̓zA)򘋗zLPܴѻPz* ,l>+읆{O6Ko/'ů$;$Vu|cʇc>Q\:("ۭ`{} PyK' ű*褺lo8=ŗډnMqrP tݮQF; aD)[]KԲt;i/Okh#\stuCj[1: ·r'.4eT\GƢT[YD?d(=i=4I^Y4 bc, 4'F|<{b+_ׄf0RstÚl"}n% F6o$;:z* {9_EL%Mxsb򅝲 Ǡu8~(K sJlp$µ=6oB'Q5k7}"{u[=WuVw)&Ka,>+hi6UAq}IKHO#. |f]G`1S9xdO±!FQrjI܋xK sVKK9vOOVE|i1Ph`f}WuXdsR~* !6N ӬT#Zֵuvt 0pk36e{Tm ؂֌}^JDJ1 uKٔ rs< 8ࠇ#@BL%KfSĭr.jaۥȟ!ZC)ݕ 9my_nK} W, ß.'䁻yf\E6rs1b5-AW{i6XR |֥Of6T[ rB|bfkBV]['jF_\%#L۝h>x(JU _J TFfɣb##ܬəZ /Sg'2' N3FEȕ2*PN6|~kQ^ qgq9`^eDyJph@P 4BDApvc7Ԋb좽  ™mL2L\ 2|`@k]ǽ>A\ N. P^/O_ʸn,lJ ܾ!+{J`e?rVS(ˍ G/*ú- :Xݑwvyo{O#\+j)ցGS P@l 7(KAנ 8G( i7jh|?G }t"^IF+vڂW~ |]Bu-ϯ. (]9Yh g(o A ԂRT ܤuF/Th׎$xBPitxW 햑*QI"qCEmqӇǀWU }R[-bI[L2/(]{ A@㬒r w ГRRc%Xwpu]~)b0_, sϴ""S )hN`)oeQ'aPiG ,&_">D?TǠzKUL]1GK3H7Ax׀W)mC@f^}KA|֍/XE&X!9X>?~5S&7(Z 1`>:#-͡$>Fe`*6 2z nI%*9 lvxQUlc&7kD^[_1տϫ+f.帢#r RK(І45;c]QDQρj9@V.؊IX`z>{҃W4SRn@wUʢ2!|x BiDʥz @/06*ٵf"A, z7gni"rW, 组  s <ϩod6NI@8E#pPE2!?z:¿uyD뢩2Qj߯>e>`H }>K3ehcV FpV~y;S f#O+H{F7"iIAװ{9"YA^}ED;21_% @:G[k[d#@i`tH.|A㭦X<A`Y^f<[<_Ѭ1ZL?ͥlRBqJ6Ǿ.}c[}i7߾.?w:[to@_; @)??އQ}/)3Kץ [ Ƿ7#>$w`{ԃgk|X$dN=_֏i[%p(8SI|FA#vu Gϟ[ #}c??K(#r#SQN>g{!Z\U`ͨjޭQ\Ϳe؁a7Y1]$ n{h8`vص-x1qC7tϔ ٫7:8e!}S<=ô)9/ Ns&5QWU1I4S7ҞzvO: =T&)M{ͤHmb|wu{_t6j+ QUGZ"83wm:5-73*^Q{_*ԗ6ѱt5/ wz[Q-b<,yhٛ)*4B.K KXr#! wɠJ=ãd\)H@ exP*Ms[֟j2h<ݼ{۴NMކq.>)i=7>+X<%˸Vo&86۞AWnvt0@ Y~/HXNz5;Xpm5 k aиm <8 !h̩qp葻lf Ʀ <[1e`]RӛZi9]:ej̥;c߫6H;A!'N-\>83@@p8۶>du^7A"q }iYؖk+01wfzP1~E:Awy~wk$Q\&0L1NI\-ID${1_(B{⠇AԾwonxiӸp~zSx1ى{Caʘ3c4Ce+oI!fa¡q8 o Akg0;zq*8?MndTX(bYVI W[g>P\1tNJ&ީ~?RSw)9;ja<~ѳx߾*k}C\"| u Y' IlmuG摊Os_ 5թGpӫ[:@pŒ r$ TikoĽs8f\7Y4n0xH(q3* ?s-̸GfGSfĺP!۴ x&g28(0 <[f~Uj[KJ 8U\ ֝7܈T,L7/|*/;C 9PoPg+қ> XQ5fXQBv )` O"L#Iƴ72C؝ڪ#AP$Qĉ{ٴhleCf"0}v=[m٭LCch.@0QdmJAG{ſ= вsXaY;:d1AF@K 6Y o T[!014 R߮|$%\2@I!B=|}X$cڢ؜hi>"|uų#)p`Ùbbݝɦf9%{9Ê"%U#24T7!K0nPI9g8"c"Հsvr1'x.`LDү8=16 FDgF[X>I'hB+8F^n`xo\m/LkHB+>$ձ 54/m"gXn\zSR:뷅fc* gyI$Pq!",]ePֻ(שG !.ô=e4_;$($~ͫB`lAvkγNnXnmː[,qhǣ٬EXvŏ%y;;EJO<+D؂Pnm@ ^S4mV1MVp'\a4Gaq|Op&&+ᙌ&>JG8CҢ d bX]kC@,RfgꛡLsfi^Qo '#^=79$ZeH!n7e!q,\^vZ43aRe+DdAp)630:E"OZtf8zMN,?[O($`n%ND~*.)PYO0ʚM'ΐ ]B)aJ) `0maYֆy``4C@D$N4on|~皓%摭#i!0NGCdU܆b B,(W4Ϸ`ٖqY.KXn^?N hd0 >P%ǰXJOo"1&yEj@)+YW>7Vb"ȻQYe3)"06d~-=@{B`PD`Y7uOsQNmtw )Xas뭆Fd_ [\ӑ`;$sl4b ^>4)zɎpO{ۆƇu X^rZN-4WW;zqoYdYi@_F+cTcI#PCW}uN}3=8|^#z|yTjcR.bzd3y'~,[Y̼-* XȕArG)-o,wɗ-rQ*]J,@`jj XZXsDv^[afmNDB_C6x[컠L`\X!u%YKi7ɾ**>W (mub[lWiY 9ܞR PX"D ӓd?j18dmBYg tB\њ&'?m `'9~N*IDs4u d@y"2U ƶn"NkhD+p!O2 iU]d"O$fbaE>Ւ]HiWk08PhVs @`ۂɺ[}V1i$0cҙCq`͛;qO3ͰZ{#I@ dC8Ug|&sXH_ZgdQBn}n`/ʭ9}XxLS GBe7E\WY*_0 "Zּ '$ ٙqogg;"¸sy{~ ]4Oݏ]+`TbO|Og(f!8E6CsO)= >U0$Ti5QȲauST:ڌ "8OJ3O>~VM#i6C)uoעpOGrmژ;cG$& ُxa*cH|ŖbO$fKDzJ>JnGkpw砫a%;qKo_#,Dᭀ6I9Ń-6nXR rf QId_f'9^hܞ㙆w:*Z_d^'skizp"\vC -50n2͕K"MIÍY/5#VAYKn=7EQջ4?H,g#Zz!ʉY/~GF&M;kE* nZ[V3f"]c(zs۝̞ pP :?gSoNwGHS}6r~'0\y vϹu5 Hgpkm )@ߦpj1IaZ$ֲinaY}E@H2,kHS/ Ĝ}zgIsd {q9\n*\+1"Lh}=cu oU)H@D";&t$ E^( mR"`SWe/+ Sb SΣa!ڰ;Uȳ}ȋ 2}jps-!_UڇE~U3y1߭9453Q9ωQ 7[Y䭷*N0V$VYVhCBH y =Mc!mo]B0SޡH`=MIiJiRd2֣[˻VFtЀyJunEצ ` lF HU er- ʃI-=$+Lظ6iƶ\@>HܟT<`9 4U.;zN=Ֆƒ$ 5B)/f=OF՚*45m3IrõMHJ<5lonXEF 2y'4O3@J`m8ȷKg]eP2/ڮ7kRU;x Y^,ysv8$>GQ`eί6շX3T1 fQHO SMEy?* \ڶQ\XGɥe6n)jK(hm[g>yWwf gfxۚd4Ll="-2dq*o8BwjxGEֹEtv]非p94=pySj(;X0:[̣{7n,-ˮd͗Wb^JfǿGdҤBP$w'dyUiXB>ou[L۰\- CgTu;0|=w:5?pfqulMkMPyA%cX2旞Ut[ zWBइ`J8lO8p3s^p&!Tx+6`phy+U J+5w-]}A18d!l3*TGOӂiJmj&+^!V]bjիz@Wӳ,sD rmYPq+uT ,oKx#c;A"C>9E9+'-6gY)Dgq?r.&,O$C(a_ce =c Q"=МR5Nf(jpj6 v,ϙ!T?<7#| dz-w.qI1`2շ#*|884WJY7Hl9M0D8ܛI'h`,XnG1#fK,?Cjyy*Us:PM=w׮)AOr> shPO%WZ_ˏMTA[_9Et<-/+ PJo vNB]-|>xieI[k9?W$:\@;,4 la۲֓$μNt#)`ੂ$"Q)PÓ3 Ez.9-T8WxpIx}qеcQA`=|6ƴ‡ii]zfX8*}^wԽƅVޞSaG{AH%j?pw-^z+`>-"&_ w r>(Oa)d3(W?^0\` tzY{h 0zXgz@QpEvaX]JEiqWgG-hy$P!$E~ uU052z hx]N52JAOA{ `HY[:C<1r<@F!PA$diLj+?[{퍏UEނI^42 [` ! XeH=l5T_orS]VC>yqs`u`pmy(SVoh}'ET/tAYTK3&=|68a hMl(|I@uIȣdd(%cu?!TВ |Le:1Gq;zהuK I@B4@2ӥo/xYm1;DjCc ()_#{!MP# 2 G6ԧI`ew[t} i"5L 3\QS ҅`*,I[pgχ#R#\5 r3䘅fq3Z6;@1x"K!J(``{h/}ρb>n~dUdx nA1We|:q1 ƳC/@NZ،vigA:` 9fr祚{Zg{نt E]𒷷䬕 u%vLm,8)u1Eٮ܌|0dtQ,>GH){uq#˄4Z-فfMNh{geHsJWQ.dxqݵlꯍ➑I[*x>Y)' 'O Lyƌ62"֦Zc+jVn"'z 禖=ى"£(ͮ*'8 ޠ4=dnHȂ!Gn:Z25Z0.-ܭ yteyޟ`Q,!l5]~"?oR(Ak z=YaUضnS?9nAhxD'\Y2DE}@$~B~s,$_iyeZA52-w;1xitrr[ȏ )x^9\'ܶ+OޜpI@(F[* 5_C}?fpfիLcOέ.+M(ݐ+v4KGM$_HԄJU 6y`*V] %YUwChEU , hE[VN7 t\vw`-pA!`Jc 5ruė<- IH3D[RowJ1@}"qG,2NC^'`l4+߼rgPI{) !d)_RMs!$p﷕:p\Y"|J`.IPc3#ZTJe@s"ض<'mYۉ_hn"mR 댽,Y|yE C0Dr;{.!pi#Z0cE-ZWlv(.mwѰ*-T^Y(pkSQ:՗:PPʵ\ۯQhwgeJ) tD T.R}{&?qXa&Z\Mm!u 5;gk)~!Zog\/RAy,8\-ozƴa" ʎOpȺ6c=3f߆ ~aⰶ3Ғ<ӡNG֦dx胢a e5XYqD|5 ,_m/:wKT}tCI-V;b:S#]Aeΰ0Vb,߼GI;k:^J"!.NB~'&x{PC* dY,. }1$o\J2"?<YB4AC 9EB J5# f3q7f ^mC|>]sK'D%M^:w`mC-m[!Z N]>?u/L\ #ĦmwÕ-i[\j)>/_"Z Ƒb| n]':;}jˈDc! mⶨ7"gNr2_??6+8tWJS)dr yd$k,1-da. vC|> 8I|Kn PDW?Br/W ۳2ɒf+O 1E>d8.PS{`13 ꍦ/E.?43=aA8Y1zMدFr$gxlYRi퉲>I V k^< DS>!tQ/H`,Ip|hr\բu L 2<ts꺛۾B*)̋/>޼h[X|c58M{DoB8-}'$W-D30"$Yؓ3Clk :@f_0%-]KUZ8HjL׷%!vBKv Ҡ{)ڌ뉕%X]8n/^!_QUhI|y#1G""t(;USYTH]j)`\iKAWQƀc噿ǃ "|ϧ&Ybt&hu։*;&BA"~M[9*#EM_wIv$߹D֑ÒKzU!m@A:w3cD{P0xbU43D,dG!pwc57j_G 3c^%B^A^J?Nl-Y똩F:uz e&ޠӝʪ? LJ~7|׿ HC`AQ۽"%ߌD l.6J O)NO^I!"<| _8/'{Qpt^*80ȁd_s@ŰNt\ի[co'dzA;{%GH"܀d {ܤEUNSP\?T^Q=8Ńx9ZmAg_鴻!Ie˨ o'T^wh[U֌" QY Bp'k rL/3~!|ZKAn\n,0 C-Nşh'Qc+=L.N 4z/gDh@@_~{e }ĽEh;-Qi(%t39p= 7Uޙv#1}Z _xa):^d_N0lh$&7| w\0?4: ~h+8C X yjkܘ7/XkN56Ud#۳LXA{2rOy~qq{_L8rq%,"bOP} ~';PvU!!3Β遄kW>,LQ![QlY`XD%텻$j8ˑV}$o?o48{1}k O:kї viavlp'/Qvc2`-ʘ] tVQ?ّ=wWaPq.%@'`\`+uRyzKH3@\gQnY2_nL/o᪲Bs>4nږaMm*z5F- d7/9q"XzD;*qvɸyIJ3{ bj=<o8+{c"o+_?KY*l&qtG#hDž"JSq4&~ߓ "&JrZ8: ~Kmc$dEkL;E.c8mӚ"7/CeQ*qKEuUXU:.dꔐS?ۮ>ThCx`xcA"s6>DDFゲ\DZƳ^6 SdDiFGVYPF"£2cd}+LbpS1Y9^>"5YUQ_RPGKs%]T).j`džVVtEaĦ+v qkW|I^UWF>H մJsa&P`^U}8Iяp1׭׷I)j B6̖WQ;O0nq_F\+>wWQPOVl6%f^jq*.R*^n͈R)Z[|lWz<&x bMlPREL@N @'{7k?bW0IH}@T uR8AA ;[/OdRӴ4)%P!:LRc%@,L5{.V1 v3I(!L!AִM!5=ilF8Ƒ[I*?1C%})G );1!C̝%ۃ~幫;OS M>p~CAb'3Z ǧ\P׶WM &gArͶr0 ; D%j:m#Ū-4?L0sQ3^97jֶ#ERxV+PʘDYpRsp,RB >#q)#XNjoLjwh Ī'sm ^g?3$lm: ׽Ockj H];/<NLv aOU7wݧ(#W^Rj=]=$! k9Н0A.Hz? KL  AcA))hԟpr-%螬b(rRò7`Rp# rl,Yug9 Րx Gq:=G"9^gV ӈAj/^}{?ۭAV:_M5TM[*rH ^8flt M sFսTRLC5ʠ} @p/_y03! TuMP[@Թ7@CGkz<%&hɓqPh|pLWLaن)`1< T{=%S)A;R!_fs5I= Sy8A0 ^$m D3D\Z WCkƃ)Xqqb փnr>ێ' 6#"SD,M(IA ]S.z3M9oŀ>BVgu%r|<ןpy~ T%ט(IxpQ"L:[_Kqiѵ_O0f7Y,bK"&b(XdOjbUr\ijm6'u@Im(uDž(j1ܷ0&Q C=+PBdB*c% >D45+ |~qD!OozJ:>컬k %B'F4G)C{qN)0si(@Q#(vңًl}˿#`btld?ԍ >t B+1{j*z~¶\z ,?G` ?Ub6>9G"T,PҏF.2<9f`gȲ}Fp lf!$fIoߋݞk2a{@\rE8NSC_AsUz-&8j%Y~^⋁dӈA:W|jk%,>޿@V S Ňri{K`N@2X>Ĕ0I-%Ij-l-b!1XrR"6o框eԁLSa{.#=yTQxGhc>\$Ǡ .09@>v؏ eIadQCZ % B(vX E!0ʢ \5ބBl$" F&,$ld-xsbr P*&B6,< CVYLa@QS;z9icQzyv_`` 4"lNa&:pU5`c>Dnܘ'緭`N-w^iu!+5/'ʹxxY~* irM D!Xi3g[Fay'Xm$SpZ徣Qm!1{83{ vp:tKtvГ8|%\W]+N7,(_ nE 2y @2g8nC5.Ǭ@({ lJP2V6$FtwѸISo)9ƅ޹%/rq>"T8IA=1N@W;`gS>TjbLA|KVeʐ#ãyY`TĞo%nW`9áx7]cCu]9|E39[Ҥ@)T7|Ԩ&MA;a=R)p<\m&К B`!;r!r8+%'=M2D<H*uƋlԶO4]'jHjir\@+{!\D$xH,<#&F !1,i穸$>j2=E*DŽ 6s> #3?R~Bs,_s $~Dm -``<ߤ%[ەfoq>@Uvbn3,?5NI 7xI=1T:S]iHH| p2$<ޝRPγH.MRҥ̃%P!yꉰ|" r6Ax\Yz{.X؀nt#Ln_nwMsL4ZP>K 3 hvO&$ 6,)p:Ғbyr s\۲ pEPjwߓKlM os&}-=53El%H tPRYR2;.!IsފIվN{n l5@ZC<>I> mMġ?$[4iH^Z$J"M2il({&T}r.N$aU{t7A!mY;qW7l#DʹF^]_DS 7RE_u&kYKb9v<9.~`k rQ0"0/_͔-^[KU(7YfX~N}SL[̯ GIqEextH1zu\!yh5ͭT3 qX88?.0 Ϭ9HyO%X,s K,ڶHsJPTJM1z hN'i@:CG]7G`5TB]͉+{t KΆW 8©gt?G0B$ o@$ cl>fkpih@]RΛ$+g aNQv}s7_w! wsB8(X&m\y⿈)#Ŀ{my3 UD" ѷ >16: 0 2[rU*̳~߻E,+9ұS&Sюl/zoNYv.qZoq÷a3$'4K4(R:aHq%h" D,A5Sv' Q@E|V Keo4s)d~@|t@ *w&No#*3,!^X}ZMp1##,}3sv. *]44Xnw W)_ ҺUDzh-l})`Cvis!MK}U) A/p9n$ 0 G%- jvr]m Pcjw{^EY$:~Gqw?;fFw]'`k]68X؛@j(<ܵmz"JŭUؿ x#_!mgagk9Y?eE<mFIt{ RnOǎZΗy#%K1b3S.’>MIǴOM7wS#NpTB@?ُ̮rp}~Li5LU{ը+ń:.^tK) |>m+tpW-C^@C\7$ƙ=@G^!gZ<ۻhmm3fHz8ޕjC`f {\G,abR"\C^y B,5yHRgѯh\-M ba>x C8*0^h|+'ˬG8ǡT%`M 'I%_n>ס&TY3ltq MK&;lٞ"nzh- /o{$\ht_L(>.ztqFqOTI`$w>HAhb9 \]WaAisi@Dx3V9D Y|| '[cVs%“(7 Шm).@]VKIA@i"ҋ?䷟O6\ F#a_}v𝙳]''1LHSirs2c]]TԎH>*g[d΍Q&/f#/Fn&m$p<لr7 }%x@%jO"h4NVc&/!`8zl"{?HjC7A(hRQiU?}sk@l#ղS Tq$)^- 0tu 1ȏo),IKFh0X ʕEGSjx5/ Ʊ cWW0Zw';PsDWy"j[p-W3O \'I:JR$7,oR.Ă- ]򫛽HUk<;ö!zs6w/B6ᜨ&}3584ta؞|h\cx7)co2N֭[ ,eM<@rY`l=8%J An s˔ST bT!DHN6 &-cKWT /dv(h,~ɑ2nښYs;P r T$ 2՗ٯ";e M4ZZM*"N,hTQim>VӜvd3㸫G0'quvXlJ,,ǹzsͳ7%F)WigU[oCk+ 3zsA`q%=^HLě izE0d^P_X(~ iǜ'r[٭Z=ɠӢZ} 3*-!eބыߤ0V3" St.[R ;mMRէK/1=]ɀIuvbԭshtEWd ,ٽtF{n}XIv{)粻}n]sUr 6BYjx: `a,!O7+_Cs eKe ZE\8QJY.TR"M+䴸𦱻i "ףx+g{N5~ܛĊYZϷy@몶yYbd'u\pRsK 433A-$K($~3OՀ 2q^+z6_xKՀE^):cbfP1a,#u=kxLe'nʶu j8w,^bGcKϖ@|<,1 ;^aG^^?fLሥ15'c`p5ٍv {g ׃cGDTEs_zב޻rs}5EA8s;T'Y$ejP`A/Ӭ߸7ϑmɸۦ+#? beBeE~q?ۃa6[×c:vޅ iz9`YI>pȧ>EyOɶ̓UiXX@(C;Ul5s#͂h2Gny]Ms9eKd Af@\Rg~,k4Y&H=öi{?, =d_]nߦ89\z=Y&%[ /S`q Os>)dQO0)P*龬_H4P.?DۍՕZL 'xH147=m=,uFx~lwIi~{,rQ2otӔ 5w. U%9i7eNI 6tM?Q"+ۿȕ3Q)W`GPʜAC'vQq^ >=~E8&GЧYԓҙMIlV54zFƂKc$oyqxpR8$-U'B>N@B@;Yp}Jvl%/lׇdV2G%8H"9?M"Nu{d * Bz5R"皏_7X6}KLp/ZʟQAb4CɄ_ ʣ]UG&k%[Xھ.G+ڝ_Pp~YMetj.yzc+9H?Ezs"!e}C|;J WF{9(b4,~6W: $RNLx^f}ϭ9X՛rOc@WCH_("h8~ugj@?$$]GItVMR. .cE"#Ja*V^= #?bʳx_*^n"7X/,X?PRHZ,]w+*-Rh`/HUSW͇{KEBnZlKw$-YDI O[ LǃK۴ᗔ5])(Hx9YZM 4b+H* @'?dE:~gJup;o^77M?1-h C[UIzr8DG<U=}I|6ΜL}2+Ҕ<;wg5$i97țt`k5vt<&(r!YH7t#=U擝u+XD1fRnKd<ފBTrͮȉ\5Y{ZDKIkUdf"C`tV_9QjZvkls`s]03 .! d7uX}s^'\{n_g7D8]TbZt-vl383[d6j**R_y14]Bը(ȘFz*ӻ&б*\,Fbfg\~:2S&]b-΢y' q?ַ‰͊29\'q 8A û$9W" o=\z6McV<>Y,l>_%Q%49=g%NǮHw9RHbeuɛL fp FS>&pC/3|6Swzb-'Љ^2Ȓ0b~WMq0cE!bfߋ vvwTFd)L<tȨ1W6g)@"dUg95@+fӺxQºuT2ֺ;f.ٚ0#0g{i_EK̯#5Aa$c R?(M"swWmznI7P fXd8m]yEzՠ,2Wa12_~^Ӊ;D# g7 E:Zȩfn`<_N c{IʏE y5̟g/ଌ;AnJxfd = |w^nUx(eqͻ7 HP80?1 i-xJIyɽ7wg;puZ%0g`Y{jqe'GJaیJWyf"D ^N9ɍT vp1i1=h38.So%kG7bl,7.8C m3'ViI^OҴ*&(3E QMӔ1s$cÝޥJfوk2-EhY+1 $J ..@1҆Y>TpniJo lI;\!J kyq$ƣel'NKi2ao#=IiQq^m#ߤ% sO4y0`Mb|Ie,L~NL3Ԙ5jֵed ' gAйpͻ<C,NY ^#wrWSN 﫤0:*Sy Fi;Sf?g:%RH.Nf4Kdo CU$Ԥ9M(!!Qfy ͫ Tg-n>e6:bٶ#ZBCӞ@V(a{#y C/KnMBS 7>I%dTSW0㫐Ng Խ+2|=!JYTd\,)Hmxu8^%B2LE)ENvl'nW{@r)4 Avt?իoFSA!ws dR x! ZuK`64]"C41,T}=NYX!w8aF^%9a57\x6(64Mm  luB[xCTiDG(kTT~PnTi,:Rd}ƃDWdxEJ淛@}}Ȁcϙ3x`EGCT1!9"x;q g~ WWwr C`w:, rjF'-a4K.(G'*Ҍz]BtյJӳBH{|8G<Pk_2 ܞ<^NzwL@|->NߙMrrdٕzĘJP#B̐=,<}H`-OR #B^ǦvTRw]Z*-Aꑅx;٫jO Fp9{1GO?/N|@wc8w6) ^ =,O3,J$M*G^iC,88it̵ą﮷V3v1/% @Y/u -p ٧e<~ŅgZoݴ|ǚa*<,N wkVx@9 &pr@GmWxQd (BS:O*t~7Fz@P& ,Գ#4-ԃضFc),0¥Z£XWgsz9 [J`t!cOwTU(ffNiX*pSPŐh|j5 ޵*l_*XxI8#ª"@yO.nl_UmTaʞy:JJɵ#RU}p|_&KffC$IӘ[Fdnw'oaZ+;&% a.j j[r㘖q{n+|`Q-2sN)r zy0r-0_ԁ܃H,#'X|h^u^;2r{NyS/'д@-=P=ktSJ@C87':i썮]gǰr/9,! | Y*!YbҺSi;5~&rtw,9Ev\`us +KvڻN \+ hJQ14RW|4CX|[i$@Oӷm݉l_Y@ Y9ϸqR]3L0ub4L֗*>֔#й7'O"c:i1zZ3CL[8XJq[}ȈRK!$\8ӱxTNэ}ӞIJVCoɇ1Y1@tlpB ¿<܍o۸s$X'qr9@&y &N^DxWDq wohd+ E.'^:[*uAG@ǓYvptu<^}6*zd؃u+,C0ŌJ@cټd_0^E?M02Ɠ5$/9122`}Yղ V^.S]Uy56g0D] &CV9~4,!"{ac$0OL П '-[dP1FEk pלo  \_wxc n4Si8 ?su,1c I ؈t't H; <[,.Y,`^ |kۛ;HOH\ h0\Gv09!aֻkuD .n _A.baD7T X'h &pvO~֞rGk_$0c0ݴ-5 PW\h)ěṳ2p<,j\K A-Cm^rT '@*Q]Q 5PqN{Ahn43B O^7tσa b =L/)뎶 &qX>cCgF" vh*lYX@lM5 XwǗ`6L2JDL9ɂXtq3 .$S浥1n" g`*INQC mS@hGJjmyukQK;C?kM(\1y'+R&0/$+|X; ^Mq2PѶ*H# ]Us_U!~xlB| <1]yXCYXB5j9w&9$ E/ TVCKQ] iXBtg*Snࣧ*Onl(JbQN5H8xyXztl!L~֦9g,{*dyp!Z40s׵$% f*dVtb&9Ozq$ ( O\&Ucg < 94.$CH>y 4fN~Q(^RtVdzMfdR?*WV#$T.YIHTT GLUDѣ~*^t{*Ӿ*@ -%J`(嵩%AbS { ' ǪhW鎝EH4WM& ۳L  +=I|8{JÎS! UUAqf/?_TfҠaEO!PE[J-)O?zJ*Q (n{2LP85ƢIRC`Ġ{^@fGg+G$Q7YٛfȮ]d#U[c~x#2>?A%|f? L]ʺ wE4Vdtd)*Ӝ_=2@_D>, sJ:p!EJJ=UPCTKP!wۡD4bBFa'eD rRѩvd#I`31l eq!$}:w='lnȞ LBxt$,cZ8`[po&Bn^*X}^XQW<03@vKw _ 0VpǖfIa9t)|S<ѝl󮚓 ë{dՓ.[iU3+<ǂά\%yxcۥ$ ts:DH` d`>.m l#Z\DY)/Kh PjN[ x,»/RcT/&b*2©Џtگn3Ad`՛Vs&9烿LvRd}H:/- @NӅ`Yx}08͞E#Qb1n˓P f \f3jb#.\ԂRs+]p"] vz l}R0#( -{Oi45SI rZ4||z Ԕnq:|0{_ځ6)@ Ư :eq@Nsx3E =IuЇty(iz?2!Y-3 6rZP=T{Y~5bH}6y_,Vw빺LP-AX8C2 y)qBA[fX&=^qV8j @#i~vp]0$<r9xT 8Am]n'V6~, Z60!g,f4ʼ= rC~!J#b>Cĸ_D,VTLoRm2-PEU3d/(J`6@$[$@ M 7_6Dz2 Fh=%i '="EG%)l[+,6$G0*Vuh<L0v?pڬptQUdGTM*q*CzȿTfv3@ʚAIÖ?^u9v1j_2j~EKJKY <dUJ4]8/!ʦ~YVT-lJt^ , 8˔}''1 ̋)?3hNRp =ވk;3qQ h2e${<Γ$HfvK_l X>3dY O%|JQSL:\xV9c,K yiÓgh%L#w=zΝG#FJ` L#{Qc!>0pgL2:D2{iQhUsgJx/c/68SlM(*T5p~~PLc MTS2x&Fpyai0(h! T DLF1^{fps}Dpã8 y)D|+JYuȈUt:gI2ڢeQcz3u端FWړ5,FJ^Irg#cDn@SsX[Z~KYI]MQ~*÷k ]\a_ŢwL#4֥[I⑲igLlDl~c7 (]D2_b[+<J<=v`Un #´KA{n/km *㫽vx @>kjrZ|0-hkwț~X]?Yi `!Ơ9K`^?/hr/S#>DJ_wF(XZI6zDN#l[<0Q9>u^|r JnG>q'Gz>ü~>':9zO= 7U{w/n#&H4}45-P;aƝB "EMqXG>KwMu`Rd^cÝ,^v!<ђyjfZ`ԒX: WNV?`E"s"tQ~2{QpIvv/:gSU5]%D_=MĽpoWr xAoKY%YfmsiSy)?tjLZ >|iFuIadTt^ۖg5S*ϹgVնQ1]넒9 i[Vl<5[v3I"ҙ^ylQ׭^]^NPNa] !k4ڇX=ZxZFI(9JdecyI EFv< Ӵ `yKVq [/V ])%sh ~ԏv|u۰;lQ>ʘU*Zztu2ÑbThΟJגwۦ,8+)-6KZ4 #> L{mH.6S!܏-pk=3t]/ gh5mJ@~9߮`;ؗןY3l[JP}IUڑ25-9UC!aPמnpܹ$Iӵ6&.J&GЙhdB_|d`VNJ}CP&w)%ZCa2YwHDJQ /<9[}p;w3%pr)y'wF^h{+\mڝEg)% +u Kl,/7V}q \~͸EOl 6땭i_g}d @zW qɹ=,T@ 3!,'I6ɝHs# ,h, ̜[ff99=/B^t'O&%gu֪ (v'C$ ^d^~TL*QX`uSzʛ?l ,7,{y^*>Z#;Vr<\@(gM+o4l#mΥ&y,֓/yx5f~29 |RXTaUI)_B,UxNXm<'2Pkx G~X$3NK2tmF`Sr.5x`xJ|M^fU+!~eB5|Ʉ~}B\aJ,/SA ^hQ#`N꣍o<*}uq((zbQ^it Y*NY/",ǠeZ 8wMVyy@e&CAbDjw2n?ڠ2{׶Pd=!P[6ei*atnKLɹh4kBC׋%=G~AƼ@\.aQ \V\j"ompmYDeL"nbhE$1y6 B#X qNq-5iT=QU~#MVnKF~4N67ֽE(_zkyr@ vgȵcX(&~n:ܐN0}4P8JrD&O U_m1;{!937ܟu~].ޒfRZmi9{mG }Q.sVԷ2zVK;y慧A7:{Qa iږv  p$n]=!9fm`m(K,ls עM vb'dҐtDȢ֠T6h$PRϷ9r.iYE[Oee)nAVـ}UvǶ;{VQl'GtYƸHI;_jeЖEh9LB&pڇ&ÇTWuNϦNbV}'dtݍ.G,63&چgOVY%[0WXUVJnIS%HG):YE|~3KODx $e0[UlN@q|q&di/:)B$<+w:+!x K2*I w[:`eBSAڛշi0Q~kW:E;> ?Y𠣙Ry@bE5 _typ*I0a &ȵ #xyEBR}LҴ~)댇A3+e=6DDD8olgޥFbf2PsGT*/UE6~q"%ƉQ;|@O;v^KR&f`^&pO4`Bƫ7[m_6 T |S/YQT}bi%7 #Z [ Z07Һf`b93؂ (6UY]AN,A@#ea1?HPC&J8뫿D?8!'RZĤMbO(Ї#Y&R:fvK,ԗQb,ݐ}u{ŋAig4;l^K+@JYyV&U(אЀ\bo1HXèLJP4"pDDj;Þa|TVEZ8}hVR/ ~+eر6=F;NL&~勵@+03$OahD:0ܫ@dk|0Rz8Pֲ\ϣP|D?;&bv|B$ d4]EV1JFh`W S?<̹?,X;{\@udD?}g̯ ЃAr+*SF81FjD2u 3;Zd?{ؤWVpۓ M )pclaAƛ;3#l}\,zG ЌY\ۅF/Axݰ"G]taF. ["_$K" aW))j?><]K\Kʓ8H~NhFJJh1?G'pG-ax?GX8NqH'j]2k|dW_?$Z'* u@c)7g::kw+xw|ˁ#tM8ԄcL"BHDLpեZ,An tCNXC%rtV> c oI=I;5oaW. -$O%f\$p@G`gZTeixF0(WaYܔo |t#ypptKY"ԇ%ț?culsb-?L( qQ6 ׺?:fP9jnLy4/qo9E\a1xʍ:j s{зQQ^CG)m:ȼ< T$R-7"Msҫ1=&Zu7ρAߤE8,.cwK3ĭhƛ,}꓁Wiv) W.;^߭XGW)%'= Y=kAb{ÙT%lŤR6A{L_V|TQf$/uEr'9\c ,@eYMIȔۢ:{H,e%t9g(U'8?('͏d0(|AO/QHe(rv~\T 7^eɱ庿g+噽me8# E[Vذ1"(fp m:$t.EI i>O>o] l0iS0':.`DP"o:U DL,\e2oxUu*ɬRMu/a/v{Cb H*s8{ypZs(૮P<hA$Ox!rw];I/r9~^d)",'=- E_$Z`d̲wV[6>G9Nq]R A f>m94=td= ן>CfpU[9Pt~Y]+mSPlElh$=섄p:[bB}{daDLY.UDkEj<d2*g1K5h9iz p`\t UN؏uUw-{l)Z+'a Y* ޻j# c~M`UwA8G. 8^繚{ClwY۴3'?m,tJzb{v Z>՟jl gx }b}$ w>5Gk.H y]pwl@+v _JʛBCG(@JWxe+Z'WŢav|0BI@-"<%tTi_a<b A20Md\Lt6d0b?ޣew@X XUlͷ$#p s?:/~DRf‹߇(ON_a~y*N`]F ߱y)P\xA=T}5yLϦXi}~4zKuʟ ޜȗ<&S<%WƜ1;!\v]_Gd+ŲO]E1Rse1A”KsM=E5]]k@q9A']glvֿˁ)Ot6ެqw*:.$ 1Q2U)֘KoRN HG27LA@z (W ɮUdRgG$ &Hu執xf&mBo1hfi5<0̰o ]#X%{x)n K`Ӻ-ksyI>[L Ѿ1jSEak5? t%-|UϤ np? 6 &T5v)cO#Kֵ,u)vO%W.B|? 'yhNf^Jt ,dN|6^$\O/΋}娨KʊH͕/RzWc%pc؛I+`._,dj󇂋ݕݞ2+G^,co0p+ӕ5$VS c b03NkNWgaj~$kӫ|(>o|\U*%Ơ$Og 6?~>=m`X܄;\n˸-)oNZ/?<BJyœ?;ُ=ΊlDڜL/<~!h&(|QSs^XRhAwNޮBߪ!> &<84y㄃v#a>|DU<A&'<<[i1 o'D\,Bㅊ'y/wt!^KT? _j)NL. ǻy2\:uU oor`;q#~LP幭XoF^IHDG~= f|#so=y&D&Ϛ'!EE5;`Mx4%I4DY3,HV ;C w+/NIgu`j0O]\_ j2 ~Ϯ8QI9Dʝj_hw;=]@IsْէP=y4Z?Cō ǝ7,܅b+/ 3狶kBZ$juqlV0T8o.{W泗ˇ;vTSM s*/vWE—_8^F16Qr> ?ϽLELDA/,f'_!/J;*7(;0(C|jdtի${iC|uG)$~Bco6K2x*$ WE~1w"BFi3uIT ۴$MMR_Uж+e!]wH=0]O֞zyȘ[ `yA15@&) `? S,)@'oRVۺ㑙BeEH559YQm 7]7}^ĵt1bqV';%oBŴ za3Zl]_u lD[GM)!:IW2bەe.a2U, n.@eEGHTU,}S&A.n|ӗ\   K04heFf` &EV$W}I_}x:NPXӯRouGw;$sIeҐhQ bL! ¹ ʲb(o.PE$tmQ"_0ʥ.BLgy=@X/k]1 p"7Ej/,,3ϲӻ`+J:"QMͭ1x4T VW !II_9Q̦ZGi6-*ti0jO(H.ܠ𾐗D9_oX/ FCswϥ'~t|v6w*RtyupM c.`+ ^F{.~ Eֿs$Aa4j~{i,K`UN0어8` `qվHWw]#?zϲm9ճ7gj&;I18{{(jf1ۀɼ 9q`6I@ųr]*2;F tk'"2ʡh MuYt0 eO7ZӪH VEZ݉@ߛ#G]AMOL:jÊ4H+/u-P'T9bd08~'M5CerG8u,I,16rt[˾×ZU}UUdEU`k69P&Mqk 528<8C..D,ld8AJl Y"z;:aqp܀}#oT!d'V07g =*̨P0 IsE ݃;?fuX̬z۬|jQɅ}"1OsO 5xo |~*Q)֠5l<zؘWE$%a5ϪjO$ٚhUENИ D8>;NيC+}4W{jV{t{cO 7@'E5_:|O1X<13y\w KhǟMCq%7WxTH uwpG$D>ˢJZ1#$H;Vm_aF<gJjdC}c3BzLu4/{>ܴ` 7Lsck-޴D/ iwd.y<޾OǙ;H+&#( .FzP0bs!}e$QlՔ W&e;"x6;+>+,r'.&~<<dG;5Kxǟ Հ m|uA+Ƌڷ:$D=:+KAƷE)~6U]{`7٪(!Fawv6W][8&!#,2Ҝ\7y,wMǂ@0!=T.RG* ۦq?@D:OQOYV0kE@Gcis jܫrCM  (&s֏V8a/`E0qqzXC}#`$p uN5 -Y&bD!v-yɎhگEwOd konADcM&ISma+I'qm5PC‚/h|E0NAdb3>O kxw8EChIMSa JmdqT:k6Oa :DĊN>{u܁B$7@[$@ !@iI_%RHB%zne@@a 2*~:=+&'p\&w wMNzaX&7@ /Ӕ Эhmo"1@pu,>A&p7G60M~+FNkp0Iw9Q |BSn3YQ89OڴvɻҊ`"[T$VQ${wP6 :IN~X{jQp* x1d·FB&l#EjPp(S -':ܼxe v"LKBaRVqM%i4p{c< wdN G_I . {RLz#yeQѝ?:/ ЦC_^OBACLſ[%B'hF=5'N8c'aϢ~X׎@#l8ܕ d}]mXP)q~ʳM|69ye܄ |8WL%cYi!avci#hC]\p'EqwtȰBM$!у^4dJ];4]=*B|| @PvXq'R2@ )ȗNtrZT3j\Q/5h{o]a_h-8]smo?p3&kfSG}T qj$ 4^|>Lh3NV&3p븓|[m#DE>c~qn4BN[T <$ ip9-!ît9L%&:cx#5% k~G@6C(V;56dtڇhU[5f􅤤LŋtD; !2snU*괴OM{1i2LW,\;!0qigX9>'(x9S||A%lT3$O}L#T)6ۤHI0ee7ڕ췞^=Yg:+@ 脇 ]Gexԕ{\!hG6~;<~/L< P5pWnj^^&gם [ēi]=bi qyBЅ<%G>zwюf$o76W> ۼ*c(ktUyJXR8א!whrYF4NG:!k8 N_;Mٽ'9.ŧO ^uL,ʼA@f_~zmpס pw]Ggu'#B>$>R{ ~x;霨кȼʲ- )~ͭ]̆aWd*ˢ+byUy`7PKpXGe!І˒nb(:^*_my]0yw]g0;J#a׼L (ꆁ7tZ  HOjS9 +ǫqE:'/O#G8@ D0Ne\e\0dH.EIUI2ˀ輛 ]}{翫C^Ql?[:gqxa>r]H_@HʟB~jmRw@J؞sLC;DjZ?)S}Od hIBMC,=*&^<1߬iy#oDF L:0_H}QDbU,zQ<{~vQr?NZp8+p8dO?Wpd&Q0hwEn ]n]ǒp<i1%S| >{C`W-uźn˘>|;4n|.(tϧ?>UFKpyssZ^> uљCں͂gOЍ8pۣi,DBz*<ٔ'6z'`v4̼~\f =93VeM fY\ }6poauZ#! ٮڮsƑ%isWi)H-{p-=!^^}d,?sH# ci 3-tX|8lG n6rk:{pœz4A͞jgl“U5rUF[%3s|z\tٚ/It\@,>TFԾ17]qXrdne+8/Yhe!=Bx|>fHWI|?clj|M+|#~[Cv8K힅\z:W\ǟ{>.11ƽ35{gO܋_ɷ2%!W*۟ik[ٚrlVxmo(jdOg9\ZA^/I_h/ O͂^]!0 - $ۈީC [Q x+ki8|ZtΒm^fkpdsw XVs^Cr(vћ:֚*~?Q3~Bm"30ׅ N )Z9p@Or 9eՒP!@ U ˓meeyI@^z>N6.ֿGpVFQ\*Ռ~X_ ޓΠSYvwnܹk8"4K,]g^C#qIawv]_Mw\GI ϭ~~!W;Pinڷ~љ; 647ЎW;  yz>߿m h?xպ,iɕC zҗC@fp_nYƄUv& 8QUQu.ڇr%78j0Z3 c@D§~.6o=ySu <l9AO@91>ѹ먺 K=zT"C>l{~"Go4l|?;o?O=,qJb_A+u!vw9s=XA{G4YFh+D OقSlRkK& u?ь"W?I, qϋ XTGACn&#7B|=HH_]"n.$=rA}9Eٹʷz8/Y), >\Ob]Z(l&~!s a=#[[8a>Q(q'Cm}Z*_6dy7^*p!BHW)~#|-)T)<)nN~{i8*K+y%3 ciq6!e7sh>A ޔ]B$XWNٔѯ@oG0C`H 0[2Gtp#qV;ҭ{ gE@&"'Q XU@:'t?Qlfd?Ɣ@Dy=x>Usk%g^Vݤ¿}[CTW"yA@56, ~pP|"I֒< C$bJu-6%;_!䎈01uW׈tSsM0XqD_;?METw\0 S_/c4's{`=[>y&n)_эFDCڱߟ f ~,~dͫ|ಐ(to0bHҼU4N J~~&m wrUm "O{ᜄAKq,O&A@l:J'e_A$E&_q{sQ]b,M Ct1@]4G;w56 `xgb,kuKR0||]0.f#~@qھ G޳`^ f!^1mg Ɠ%L$Gh KtO!R /@{ejq]7ؼHO{S^,+I@]K{wI 3}WW. N=*'k3s XE%e}+L!e^? `K z^t{bZOʕ+t!Hv?a>1K2^{8?@9m)~Tw*.K<џo!ӑ(Ada . Y=#x{k^Bk S-.w|}M twO"(xGاY$'I(~GA8 ɫ|#ohnGX![مL0C0:,l'5Y)Z$.6Kz~We^<Ī; f/ꉢdXTphxFcc! Y} N'WA(N1KCIdpoOF;YA|˽/r4|wFp21h TUN |UTE%6 #˅kԣv9`YG?$ՐUo?ggڔ+ₕEr~vV0 5{!{V$nz U 1Z^tL@D_wbT>WIM ]Qt-"l:0AXҹvcC>I6ZLPwK(F:!ŧR ^y9re4GڤLɽmiI6v_w g3׋9f^%D>(ϞA?RdFa_iE⽝Yl]Z%Z7M#o$Tz5p!?=e| 2ѽ{#o02aK`&8p[6y]4@H¹ƅT.`\K24Ef$/Y|vA&@6,+WIZo-d2pnUG2]yHM"a @S V4z,U4fυTRaNU"6q^ԓzM#&o[_,wj3S.Jc<[J M,v|޲kei^l9(>~$S. OED&Af*h0<tخ8X=?:25#vjXr*%Tn^a/˝;';s$U}$W!\kÏ E0I?Û x25pVVQkymy$A'p@V˜MZʏ@ahDx?XNFp!*7Y}Iwô \/*sKgA&aHsF8k/-D[\/;tʶiJ2h`VZ9 vMA`9@?W^&B68T <q z艏+KwG?BL&AH+LڌvY+aIY\g¾'ҽN&c^8oO&* ecO~AIܤ/ Rf  (9jmL\W $!H~$Y^@iWT5-=vO'ɠ[K.\GB`@<ܿ\TUyId&1:r|CF,CՖMIwssY}|]#":ߦymfmN'̛K7%Q{,~p#P p_|3iNO9+f'5V/ 4EuMyDpVD/,ih.VutZJ82>DOSOd_ʄIDk᷹]v..cRDLR V")`Hz1<KcgK` lyG/3 ,p0l+@C)^Jx=B%lãY0.ojM0uu24"0 <mc|[A8˯)zֳ ;_'ԩВ$ͳK5Qpפxf!MP{IO1b g*)qyɿ3H& sCnM*2BU ?_Wm quKl[˿*P#?A31 rv>6\D$,g,W!@q=$+:^L & (acoTT$$^@A3@th. 5!j8"cvy4#(  <Jb*P&#T8A5DB3 HKh"svGl)6[TRdp#,aS61(. SG:=٧Ot]7(yV2 9${P*ɋJh+ ~ռH\s2K@: UD/iǬ*XGK? '$\oUK{!3ZCeSOGй#Q؈[Z䯪XAD*)ʬ s3xؼnCIӁ%d"WKADCNx2Xs?J{ᛞrђ'[pbLzXj U.9a ID0WЃhU#C81Tf{&W5h`W'DFu^ps lם2U0ʠ0; -O2/K9;q 8#"6]!/R8~{n!sE2׭\ ~]rm ֫-N\Ep b+5> ?^ls,;3(XʌBG& nhMHzJ){=-tG7oZz!2v*2Jao\ngf* mLuwQiVeqF@!!`x*Nk05՟|Iν"+ fMH x/>]ThIjߣ szP9rGWիT]KwP殚rڑ0~`o[ :!d {dmѿ꽹 eCLA ZUo{x  -ge8Czvzft"uzp>4 abb $l9}Չ>OOI[K @_V&~l˨R>j@+4!D Vq\ PU:xFOfq:Lr]Q [Wk(0b{ycc!_ZpI 4R8FWꮥC51Șϳ:1`y _9(O)4Q+nO^`'. H8TQ<-yS,GW(4!w\R=@ao;{UA}>08Sx0|C}BlU]=f-}A&a %D8f?~IyA (xe s+2zXūIpˢwr cB\ЁZp'Ov{3Grlph hUyQ)](W%e:%a;!CP;U0ldDDsenW-o CvWmJ݌ 7B$"Pv'h+k*q] t".]_[(y˔bQAM[Axѣ<_V|v x4~ˢ P\De,d3vj0dWO--PR39>Mf f}?,EQ;}pt䴍8wk+]W*l,}IՈ]6F!z1[Qc# cHv1=ˤێFAl 7]#TxB6Ϲ‰Ȭz&c'N_2* RnnbUgRe0J"F.ޜ #;t_M7GumMȐCIfWiX22s M@~v?UJ&XX[kICL⯭ڕT{Rlq9rC#lU%@#˔sU`?$'b#Ďi_MdNww hM94Vr}@ahGJb$l[,a?GRRovq,l3cݐE7TiEF?+dC!U#YKkXu{9Lxu,e"ɧPR&'s`o& h&#dʈDYϫ^P SÜ]yT@>9+-'Eʝa]&}=;J>*d O7UiI?]洈Q'6j Yntzb0\}m\Ӯ8quwH$)$=I0Zq*kCr,hz. ֣/iX )xD4f*0?.%k}^ i4=m]O'Ѓbt3ށOdh!z t]I$˷4~Vn I4ϳݑ> zz Њ`Y@Z| .ZS@v608wO޵$D2j'GY+QUߧUֶw E4@h0NYHH3K儴6/mt󺕜Ĭ6( V%TФ΍],'.!_ےqi hUۈp̯>76*+R&.')o~& IؤQWZi׭4%1 Dq-`::8 =APd8( +U2DV`pҴөr9-w B{OViRdy#*I‚.#0 ;@=b|> Y ګ@;$VkkB$1ݬq.Y6 Wa0}lX(b?7X!h",h>m^6<^PDÓ3zi5Exb*u0>f&NP|[g/+=nO˗"}D˅y3v\snzCw}Z?gs%3V~ˣscE/7sƮ|e]u-W7[3?~cb{_3:iΧ7 y테-|6--UB{|pVy]/e\GyiyOOаuz6?GC;gPIkOi6yWD,ӴQ܅,g̓$52DntZbOh{m+Jw!#o;)047mmߖw,Ua;4= ϒX᧴|W{Ѿ`hDuõh1,~g;Dl/gN~y+<6 Ti7{0m;W8aR$ÅLE6W7e7h]m,} AuwعNqhlg*ڝ'E ŠejU{4T=FI&A-iT:2Fi Iky "es4 3u @VyXЇsj_9MmO^,oG,oKէ$_q]ӂn%˛ꢙ 2ǏT<_L'l zbC% Uㆌ̮lSe F@F=!=,j=yj:N_8bo*оJ {$L[$ *Q0u|?3۱ŭć}[l??yژ ?RP=JAĎFd:n!t]ez;H~txM!Nn/aƔ<قH0슝 -4`Y)|=_ھ% l߫ s&= W 4 ǼM&Ų 2/٢3Maˆq\iy <c n>ϓq [-8Y,#f<ըNơ MLzNN`n^0oѡ<[yAo/;\pjv>yf]2qF>-7Ftt[Z b?u4_9Cl"R }2F˷> lVww= Fn1J} B SgʋJL@]V G*7|͐-8b 쾁Y`xZ_sm9~0|r撘o՝b@%e ]wHa<6L ?皎:}@%.g?hr YUɼYkˣS4KrBfIk.IMon aEK?af_ΙΔaTTI.GXKL:!c.k B^U|g,7d&m{hX.bf0cch>?ػFdN ߧ%\*`bI'L61RkXCVpʺAXp61#geVXY{ymv\A@~nKiCvXM{ ]H gלz*|w}eú&N5ł-˷?`{YY' gDЯt4]~7}kTSt"{6 =(w1RN)+2^Ol/Qf,a%@dga׼>EuhG}r|OE,&SmmS(>]7Eyv]'s"Ois;6 bSAFX<뽖b=9ʒ xyMC۟DIhW|m7 hg"Vnr=.9&nM;l*r1_!oi:8WwQ+ wARymFVM$+:5t| ق'=dF;/ 6Un \Pwjf,.6Ɨr ףr/~棺 6wԪAGϚo8ܛO?֑$:k7R]_}Tbʧ}(|z͵]6YE. MPG{&0=c۲(#{mW!Uf-e,^ȭ) VS̻*zcS(&>H|A-4jq[z7 ;?NG4>W `Mdg Dp:;P^Ƌ@3TBqֲ8O(~^ q懈q>i+)~BawU8b|6m ϓ5e"A k{hHXwBFnVb"Z3H̞`ַVtOy=IggZS,FTZ 56I֝4_M:33(RiָKg2/SG :DK_Xl̤3LSu8^aN{Еa'<ܙ·$ē09{+}] i5ZC/גӣ=Ǔ8 7</9_UuJ]`'KQ5z@?n]&;L@U4n ('"̞}Ϡaԣ49=#MHAd+^0e6IIn!D8`WWE^a$Vض"mCx9ү:p!6c_ҔhШa.촰ږ RvҕAU%MAB(Ugw )eY,-gd&Ҷf_8~P.(8@e7QbCil&}|=0Y lA?to,Zy-Ɵ+mސa/1~Q =c,e2FAȏSB xفD$/GհcaX==&kt oP(ɳ9e^o<_^SϚԐ2/goXW@<ݔ#5XtEl$U:뎠iU.B*xv$Ċ>]ufvEQX=k SL+{"0(N Y%^}UU6E_v|l{ IMf6nlf#`̍ l30ړF:<ۖ ~[WD?RydC'(Y rh\ n{_M [ . @+J_BP1Et UT^^DD2\#tzbrV{ܞDFYVb+XnbIxT@ISbՂFJ~[b-k@eSXmHꓱQGt5pv@x0jV iҮA9Z\TnJYJ9؛t:Ы ^ _No,Vtٟ+>fBQg$mC u2Ygxݫp!} sS {K`!r̋On*JZ쀱wτ!I1S^#_k\Yxg)8쳚הS%vP#1ջ0yxt,(ILT5hY`wuй7J5\@4_gEoħĿu]$qk0.|h!G'%f$־Au[o NB<IPo<2~jiMа2} Zʐ?a+Ffq™?m"1F!殙6Cf\ 3$eL;i". ]$DƧo,GheR?X_e8h! 9@ùa2N'aJ0ղ̂/2_ɍ?~ BCo$G&  |,]MB0?!:@r$Hz̏dư4(TN5diiIba+ 9A;JxQ<)`;' r; SLSΣG_47|&+6֪b ?x}n]uEuG@zPLH9"SPOD' "J?m|L손BIs?ewfy͊4KzSV?8&qLړgn .*{IjU<#$l\iDa wc F;SwSpIɯ>-d:[L8/}KGl}viU t87 \]NWݢϵPFw\ B¼UY(3ap=ƵcnJSeIq'[6z-ſϟ馶_y{8=׬d6h:?nJJ[3ΟI:fzL nmtImyYYLmEun^eUT}GQ[EqS-F 3ا$ÅƆ}>:|ST8bV$g UfifE+WɊ?/o*zT I2v9ʛx|7Hˢ_kJ}hɥ A"~tK0sWvW%,l%쳱#B`#;ۡgִ!aI &}6v='9o8k%% I?\n(yX23v ͯ ,Ֆ5܃g@Zydγ>,Glm^OE ;#+,2OaF 1kg6?3V. $پ"#TR 6tb7XB0\I/cC 4dX W YycmɚͻEc&kʃ+HMPR/d27OQkq<. wXö$>lS&Z苔%U|CV 5w! nGja!КH !RJO.HIJlpB'(wpFvT7)=O=. -pP}P )Aoz_i9+\*7 {c- oiٶ`c C?;Z<, t§_\DWQ#ѩBD`§ <@Sy1waΕ[cڞM5Ru"?PQjLvm?iH*"0$ K(_U _@-'͈to>"(ohf5V;=|u!&a[sq݃S>'q1,Až f{,~{0^֍Cc:b-|ws͜8H NKa‚)پ"=C1O[|?NVuFPYux[ ˢϱ'KO=oכꭊٙȠZ{G=HRyv*,EyJN ARuk?B\.CTnj4?ĻCf/hDDϥ+\/lBlIa&\vF`s<,C2قKW,W$&)yvӊĕ _oKdPd Iw$!|Է"V Ad-xxdHaPxR=/ѧP&9?ٟQ_Brs95f LwB# 1= 07BHq0dЁ&{S9oV$*;ڍAV,g^3y_-o% D@0IKu90?$^Y#]HdG͏dYu"uҒN|{a7iM;H8̫GpW/q|◛U1f[Q4BXNQªkk&nSjJȊ08LlsmG~iN3m;5^8.?5,_wm2/V=tLj'+ 3a0*? @jJ.lM.{wlٓVIBdˎMRv-M&>cQndd%C-2 ZTP*7x0=koQ-0\o>S Jn&I hgO,EO"8Kh`"X#+d;Y5eziw|?KnglO\2 iȵIQ @cFO-=QWfX W>^D+vBfg!xsa}Uze:^ wL٭ ״]kd|e8j6 Y]k .,)t8nk tC!)}|^fao Y }ؿVz޿l.pn5 m=z-C/ǧ/?>8OQ4!et 7WE!~\9$ @%s5fbriR_\q\A@zpM;Gg.󖵶5%#/A`鄵% {d#2C˵9k":ƌ@|XqHfomy9~*ύ7k }.'?x2;W0N4WlI n:/(HzI)l+3^2>h&(#Y6$:alIfG>p62[,PZNO.-?&G3rJ/ӡE״|F/p=:tig@iFUiT&Q!ㄱE{N[~Ḭ~ZK}^V{b ޓtMie)E`}ʞO?x~ Ţij{ObQ=Aq#D`o *PK1y=+??d$d?o>8 6 ׺S L*䋼8OyP6%ġ!gSh謬H8tP{}G:'=JCyUƴVhއ}3-yVA A#&PـGuL jFЗ?r'-_qzfd[ f{ +.ӽSg|܀.$ڭj%wR}HisG9_>gZUϛWwk7:j 4m0z+EּMz객Üel|{gEh?LXGUXi˛3+BlVd< *jt쇁Fy'/) Z~y0t#nkf o_ ?7ѠkME9W;!|ն5WT7%-#w;8X]܂hɼ=,\O7$bS$Oyp$-UtF;iNBez%Rw!R!1*TQWpYm /_c{ua/r)4 O6޹/vMۜ;!#thkEi( uI>ns p1D3nGa0ю0'Eܺ Ar+O5D;RY pY]_5M2kO 1=II,;kc6nydƋ!~ ,$umB2 4!ЗnX}/)ͣF X1mcA9h僜ƶj# ֟}F&ln/)HsM>I;Hl{w˪\oj<;&{-fin wf-8)MDV:Y]KbJD7+(e u[W:jJ{n`>Үg~1Ư'$IfSJUUM>< t8Ɖ#i8QJ5>[@NeTW TAF>?] |o] B&u\ԾyݓIQ Z clm'S@o*LW wdY;"7XNGKK%bqfҷ; Aۆ zڏ@p-z?14,Y\l^7? !PN~3 ~EU eA]`Um"wVW+/'DUd7,/+QkmZ`=!DE&mݧj53g }o~hLwGw\GXWY*qGûi_n]@⤸]|Vݵ5YZnW.^"ó4/C?' 5<§]=EOaw^ſ)ÌE}Ӆɦ;7S#bB~+6/Dގ3VAI? v3,s7Ms浯+n2 iЫ ߧk+ pi*6ֆX=mrƖRb_ޡpr!D5D1[<Ӣ>Ĭ̷Ij ^  )׬"ቀNөk q-L?-… N5H7CM8yA@޹?@rn7i L룄(ra8jߺX9O>ҶS[i.Hk'?Δϫˬsנ7PDɫ^yVЃdA&#(_a?*vfX-7 uCmS9qQL%/s]G$}c% bY >Sq4k"h^uO^h&Ѿvz,Lm ~.!KD.kb}&W:ҲU\-Yxm(V Y ,-.A, &`2u &Qfh2  7k^|WjUNOQW]ueie(*1 _AU]wkL\8B_}ǚ_cHа>b~W؅I}7m0Lg7~LZ|0ҺE 7xվuytg!v!;E{rm*״Ib% xŵ*꥙gϬؔmZ'=}zU#(@ /9^E"&9HmS䵕J嵰4E ?4DaHE8ƴCɒ$#Ehڠn@ikR[ 0ܾ jLM .uOj+4l[\ӅE7stMǁc5lKK!wxڞ4^zpz(ڼM<&'“v ʘlS[oAő2_}UWU>d@(Rႃ%fR"nrt!(Ne*XCtFbm4j~Yg-ZjUտ!V; @}B<B>.vUn)-Sk\7Qo&Bt2Eyegہ6ΧĞFQn2:k5ծ:c]KUz_O{C5A8`O{8=U׉[smPlmaY=-V@ޮ_gIT>8N-B_it^9ΊZe䈺7IOivAy˯w)e< wjNaPQ]"@ÃW_MZL B$=~m"pHHY䶉=vlh֧3$PBpfͪ=hppz>D"_H Q emGF_*nlS>$Ѐ񎏣b4gU*؂]m֏` 80 $7pYF6)W,1<Ċhl%W%wފ$lv;ӺK<Jz;j Cm>A3`/O`*8H8_K_RJ>Ͷ& څS wQ]{!0 l `nE횬Z"ᕦͷg\0Vx4X24G$k WZ@~䋶vY¦һbU)U ۱-vuH* l(\c$Q2Ei+>c4}Z0٣^MAD@Q[Ͼ}>)b8ykmHSh:L57Cfp!^;Ӏ# [aw Dί1zK:qk`+UZWax\1wDw὿&ORFU[k"3~v(nhEzK5+Pf'(QNJpr~} 'H. !pm&\]6qMY?5kLZ-H|oZL!爛o!{t̄gW5 ߓ0~2ud: r&<ژfY@.&7Efj>֢T'Sy!8qP@70Y*yMSȤzg fqӑn&)/I[w9g%/ɑ z%-ZsudWoIw[:LfJdbd$;^^LmT( P2J"V Z5!4:e]>[ ٞfυ<`2ITq-7[."ka{w#qX⪐Q}+e&'>Kb˗n˒Hreͦ@*b/t 0Z`YRjVp&r6G_Γjˤ.  z19z{׫Axa#eŷJ))"W5,_ sCPOS+Ug3|e2l {5 ߬LE<+ff&~EV;l\6<)wȒ¨,se{kk !T ;5Pka+-İ@i~]MITiA@@җO/Z aK j؅8Nѳ3ĕtnZGatͳUQbVbczSJ`5~)UO5\@OޣBgwNܶo ]]Z8Y O%7fHtvd)ϧ1zy[.bMc05ɬi֮2?03o^'ܞ's~B!emqޓ WXyj/Y~Zo@cjNZ]-׿b?qk؝:ʛ"|l6w ֭>#=O] j|χܛ[eȀ$yBl|{WrjȾȻKpy:h}ql/4_h"O`1al.u"B3(O[~':co@œ : ہl=wG|Ώ jQ/k[v]8,/nzCutyqC< ] bT}W뚟7,/6p'q:-!Sc[4ԯ`S 䖐i)K\kKfga 5銀MKcWY\h?c G|irܩDbRt`(gk1?>xx(^T?`Dg~:O?WvlSbl+|#_C1[Sۈ ׻ <>&p{Vcq"E}KucyPB%r]2fGa[\omZio'bp$'!f'ͪn<$(2PU"~lyÂӠ4y6 H\Cge8m0M::p@vd!"6~E㹑xcO JSˣIDqCW;2)=/rWy*^eP/NgO vL&P~l$^FMʱ:"NJ~ވ_tUv~ju/f¶߼?YP:_/=UR,!FS$| wqC?FDŽVh5RŚ*`[ܴD T=^ ݫʌ]to֟v_F|O+Jál,[5(t43`r?؜*6m@џ")=wI?kpLrC?:@_=Q^\>X';47~@fya3}+ܧ*]Osͳg[[3Tj&4D:sI 5֩wPx}Ig.p}f+_/p}jrب|iRJ~iikD2;v$f`8J+'-A xМjux˂Vm1ڭFL/j1U \@]uz}k[0$ffq(4{QG;bk㥂),#oW QRXUI1˜8j2X&uW8U,2ry8 >'HO<5x6:%wg ,uo{Kr> a.Xqf<!?/f#bo?0*,kt8ľr~!7wP=iͦ:8♍([-!I"n١8.! c-M@$m|vsݎ%]]8=KS>WǏ@ I2TUB/_ⷣlG0d@!IJl]8w{8LNxvɱ\qQӷX!"nJƢ5qio>x>FLvIJ}R,^?_q4h-}*#HKSv]^nـ$Ї".tElcSDp+ Ц`:G^#R4S1:1+ Y K_͂11^VS66bdȏNՉ_^`|{=={J|![q]k&QJWr5 44 _Rq[s,p8 9=|ѠkH ANMRXD@!l/ )[ӕc:'œhs&8H?vonGBy9MY;d7t͝I5jx48eJ@fO/cd=#hru|Xm%Zt\^ϟu]Ʉ< .JGf2CLi0P}[Cqd/̀⹡#`9:~*WM?:%Z4J %7/JY5k,Tc_VBè@0R,Q ]̻<u'c}p]lYO+K(6 u5'w/VO<|gG s^($3[+DPUJ aN]q.Bg;!Ǒ? g#ӭ[Wk 4Y7aeRӽBpƭJ\^ BAcf&]S  _V1Ch,w!ӥ׫> 2 R\q8Av^ 7#4̷]mJg(fd2k=Lj#Y!\# TjM~>Ŧ˅ PC!d+ bUxgtww#;Ƿ$ge8] )aGm3|#-ҙ\ZLCk&Cl#}ܿAw665ύy'jWNH8:ɒ+ tk&xz'ALWbϥɶE٤A+;[]&iLn,2ب.գw#5d2C ed a2+ITShpezYu7G#%z}PZG{5k݃WiJٙ 8rq2_lkl u;|z+opV>'"eX|鷴dENOl .i[~|q<襬^>%kxA kA'躿?)AS/32}?B͑iv'yӪ\{ "4 ݘJ\ڄDžWTG8 K%ĚtBe|WhkwjXW/>¹~j< XVɀuҽ?)<w0׵{(B,Mz(F),Sf%~ikm&YQ%'m-$9mE_J6z{WT^4a0N ;&S'5Kʦ/= ==F\F$NƿpY*a(";o5~Ys* 8uzM &q|q^Q'יYYWY6Nrih,ik!O`,np棫 b(QAׅ\ի]\o#E O=("(EݤZ,<ݼJwT9W3 irLN99zYYW>7G+lr $63OXağw~f PqaDNJXWC%2PꊮyfwC54)~|'ot%þWt-Kz'5yv¤xM(q;Xs,ۦ[Pi6z+m^qRs #5u{ad:jܑ[5ד: $yGMRN sKpӽaV >'K /G,C[|tm&>F8=E|GȊKR6,_k7@6E,{<*Dum^2BΆ,+Kσe׌ y Fo y :ҧBr[+=XV6W\7 UY>$1+u~lb̞uήtZ%M8RQf"d[ ˷mX$Qp}`\^&כҼVvo2 H*`P&7FVSBHȉy/^Hhfo8l2Vd*ɇN'7 # r6G %ۋi=>$x?R)Eyq`J`p(4~e-УTkA,yih,rШ\hRy1|F{"a8[4je𩮂5Bl~e$e4VL_sGFAϮ,H-^Ξmuv{u*<.|zOA Cj@K{I ]w`@x=!A"Z{z~; kwitW/4JbM1GwT/DHRW7](}v. A>eDb>m~?xԘ`D3iuI4la; 芛=e% hpԗqtf1.xEfܦ?ls64 v+gdE؟:}+$]CStѵ7@ymUhn9*OkRdNlKAs]5AYEň&!XsKxGRb/HZ@rC#/=гwŸ!@U?Udϒ \%Ν ҶH:˦AY7PmZD5K.tZ=W!ۡgh2[.&&bb A"&rfiC #V'apS/,od3ыuKΌ-5Gؘ)cRڄߠqɝ,` G"i:ʅ|+['5uHդ;faEm%!A©-~0򪺓u񬁭g\0֤ XEN.JƋ6+Jpp}~wߢƀ mnغf"h JB fB*"gXvo.WU0x7]qٴѦ\N iow;uA O4|rS*/V]5^+$Q1iJ|PǓ<=rG6Fr݁eSmV\HDر6jkM1'UQ<_~*gĽsn" b{DAoxBL\Nd~ZE5t I<Bתh^#t6󲵽0G8"X vj?M$0Лmmj~GA]Xyn+Ftt|RōJk/ gda-g(.@xo<ԤYD8$*}[-$k?R}Drxv71Qtnz}$rL*,>jN&cٱ2tC!p@X};oG\j=x N4C!pMOc1!1op74 5Q APV5LkZUG'_t!AWdW!9K@'$Y$e-Νh4[:+~<\ijSuIʹ0FDn2EyFCk\Mwc/úNHfj𮢇(7h%ӖPp&]8k;O5AV~]]ocjws0o ?o5qHGTteo==H/p~h@耊]jYQ\/ڍH-P@iYl>ⷨ1dT[oz3 #ЧUՙY1[mBg˷랝ͲСd/o:0\+X{7C+. @WG؞F'>]?o\Lvks!ߌpϳ&$(ӔU EGpuȯn!=tn{A`_$>l!|y$B=b50 Lil,nV!knn-,_qPN#˗9R rVȌ~1N&nhR\&63D*Mצ&z<\Em22εy"[ CkU|pa6Hh 4*[sǩરm>{d5\G=v`8Ք&_6odM0ku_5 +EjQ [Նg}tɲkFNP;Ijw!ƪ3|.QvC( 'GBpTFL9, r9dk%BЯ8UT5]o@C&M#^ P;5{ŸVΔ'?Ww+Pٸ5ʸ"ލc6ϟ?~nvYt?)X*7ĈFZMrg$!QJtI%ؽ3G?>Iܤ60{m=:Ku Ɣw'iqYTsuZpYZ!nLtx9 ~&t3wYuQ?m}Ӧh*pHVE?OIE%+_!/&MHUkDfJPTC s|d?ˑi 3\|9&Sv+:̠Ht{){CK ':mcc\oMS?%2 S+*\zd|Jz`0VB"|{܄ 0EgxiR9HBϏ\1"03f@av2@vs]'ܕC#M=j$Z@HqÍT7c@3gfhi'xҎI[oG.X\j_-zy8\[~62΄ӊSok,c rF͏l@4nK[0+`(>mB-[A᫕ c/!Scth#՘1fWtzx#(i[ʆAOYh*m*;Z%3v}xA.}Z[)c?&߅u8TR$~d:J43$O@klz1Vۃh 99#cx*L?P`R7 ~\II:2UǚQeq~ݢ?CЊf#5&x/jīS%.U y _ fGUfx)+IW0Gk>G1@Nߗ0 NC`ۏYb[5`nN3#r2G|7V6۾i{Ǐ-nH@2Ͱi 'Ŋ4 ٩kH Q}`p_QBڷ%}bR'͟߿I . ;n*oڔ54S0Ajh].}k`ôB@Q# !׾ƖUCN/`Fxaj2tW?ʅ]FQ`eJi pʍ)rY\8dm'yNtsĶmMʄyfz=Me"nZ CM'$hWET>CSw[(5OSg쥴N&HZb}_컿I9Z{[{k`eX}"%{}'|}?EScgUk &W~3F@bz&PHg sߢE%w rzmه#VU8N!sj{Zo6__( p㰺iH}bo:DDaX`h?_ >*K!l@>5yfYi6eE3?9c }s ΚP`åpқ>/N"I4 %+L9'Wy_C!lG`;3ȀDz \m/0zTRpV,Mrc/_ބ @`NZ'ݏ-%,hߦ#R"t:Uz0w=<60_lM-G nJ~H=f980Э.ݠ j=guUjdA ,hi-^ojڶL׶eX8*4V#?_--q_yހ W F.d 68x5|!vbY͕;-4vuяP/R[Ac,O"3*fhY0SN D0K<|3q R#.,@#/OAٯĖ`AʧQ>2v~8*Q^/CbE`*QÖ@`ֳP{"p7ң8rn p>~]dK*/v43Gz0 ʠ)8_寽)#a:V14֎EE"@iq"(j1`i,?%['HRngxE83.$}E.$X'1UxƱpO|Yvݲc&&)?۱cq0|o4Ps6PDžR`W#e1],CrE}{ U $Pʼ֮fr*V ]<< C"i2![ܢ4-\B/"VWe~_ ?Z(YJa~\QxeP>-USAU=;dxcykT` %݅wϺ.=7$9p7z cChO'>NHi<&Z|p"FH *qU2#u`Ak3؍\~at_8CnY6.Cg1!:SF88MY..БWTT6C+RJ}?cl=ˑ:s0Xv ~{@n6kMakr'Nve* I4ҶجӃf:%B sG~9`@ŭg86Kl;|Ҍ5tX:rMi"ؗ_VoD^;mE)6X zb%馤c Rgk ӘFIPGCvD+cMCl*"sW_WVy@*c" o6 mgO1y(Z?&Z*s@N&F`dx,3*I^)vK:pox*z?\#&bWN'yXywt;Wd$UX̙홂nWH]:]t燂:Nnpd0-Ϲ2e 腀+S /;QUg|yH(T[_t,L^rVH!9òDdxq-bus \  .xIDAT YlEzC,P ޯj %6ј=} צQ]h"荤ȝM`PF#"r- Ҋmm3L8¶2k0GisV jGFc=H0VuN<0"bxs̗l-F (tN^Ҿ(.fYAh5jci۞` w] yyG/gI pAwITVI6Z yMlu/}7d4eכMZ'-G];Z91WEۨ/q\I3j"SU)ֱ#@=x"N- AE Sh2s7_Yj%14тeYrΊMpqԃ>Yf7%-P{O[nXP7lL9(:福9-wdcـʤFF P$)iH& rzptH^O-1!Z]vF2Yތq='_S`Ii=e0awNSy |(CKoEw.3ϊ|gLsњfKSz]?ս,()!,uW76s0ȃ_x.vL=CFpC 즭nr#Nm`hGl@"N_q߉15l1S u:4Ȋi:yhF։rqFcUé/9io6ICx"ʩ'lySNKԛ㉈LiTmWp Bz $-Jx\Ou |Ë 'q] tvɔWA;~i.I F̅)}3ݧ- Y@oJ`C4fV9G%h;+UOM 6zpjRO7.5@b8/F8/aEVF}UZ(ĵIY*_ /hǓ[8@shDNh*I|#Pye |+׭}Fz sɏH]>$gm~ؓ' h덍D-|,T |kj 'su^ƤW<96FKz3tTf}˚3V]U;6vk4}ѨGPl̿4uL5sq}l?{aϪy"z] &&n3M8j+!kx{;mȰ !h6ޓ =ks=pIQb= Yފ {,`B@scV!{員Ry¾g6uʐ!W.]zㆌ.>?ͺ2D|i| Ѹ5]٤8Q wI iV&Qj:S;{eP[CAFmA a9AnF#9EN" 9/r_> %$%>FdKA( X֛~:\۹Ex|Kz߿ ?b&FE߿CLV<!/83Ɓ`ښj#.䶞E@ @ &[ 9}E_e p%CTΨy(~޼\ 4FD'F+hWH5 N譆\ƫ_0-+`Uzq<ёHr>t= :h֩tMy=2w0hx#Tg'0rꔗFky(2kƈWe]"zf(kBZNeݔO !!N"P0UKc ZYrEe+n㽯>.'@mKv8Ρqq5ȍI/}_ Q7(s(v#`v<:AJގ}\BhVeY}lPVW `Lc5EYRPC~co/끳M)[ywX3%5PVQxMoܤ2v֩k2"b4dlMF1N9qcii,|.mj!-z:@1i] o2@|4-f[e!ٺ39nfxk:rt6TK޿C/vxH(wrHި^gRQHKvwWgIqB8Px[}H;+=)nxx0 i۹E7C;cqoI4ؒ!T“aQ 6T,O5":;F-0ZwZPP+) Vk2زǶ|G-  4#mx0^[4T-+-JnܷXQw[XjǼDŽVJ1Χ3N>vĵ KM~iѪ&--hl H^W{7GJon&}]~L9<0oi5=_Nt'P<=WOsBXr kW8ZJਗ਼Ǔdߡtv7@3IK7ZWGgpCJb? 6 L=uenJPзȈxoV#7i#ʸj܈yhi_3YfDds]X"6KV)`{GB=MJI؏S(ưsf&;BR% eG96\[Q;?W4[E=gD%ooo??A?d2;!3ߌ㐛} v ؉nmrm7*jnMJ`pz\xD֊z"Ro]]|=SQwyv`ZKJb?_J`O8F=!{?9$MMQbXM**N5fWcl۵YbEoߒ,rzC>MzI~>NURɶ{>>(Al"i%y?r ̪nLA}uf0,' `0"j"&'݂`U"Pf󫶂<6 McH" mBhsΠplà -4E|%#YmA ? )jsb$$:cvDt3.mC_m+ƔmK0 #ti{YGcތhaz 4p(iX! mR6IkL$~gVIs}|,u;G\ ,۔ilӈ>e{ZG ֜B<1di.6cj[%&x.@Z.|}җL&D {~}T=hBzCk, {6g,!+6'~;x֋se<8 "X%:&`̧In9nVuFFj􎥤I/Fb.) $=t# yX^5Б, dQt(VjМc' pr) 5h Ϛ,m;ul0;q!zø<]yD<]#Ƌ>T 70Y,B,9*17C9Ê+} `$l?ܽ ϱ,?KDB6m* c>^,CF[+p+w rg\pQ}~x6m ṮN8#r Oz:/`SBhP/;9wT?ePmږ8Ю.X d'DAO'~yuw~Hu[ϋ@@"`RRמK.9v/? fO*EYY0g9W HpM>jS)D[@o@XTv`//T'bM 0UU@f䲄 nYۂ `VZǫ˞gcla]n/]@rS֙luyB˖E~_)'-@:Y{ZYEܪye 5ϙeO8ˠ7 xZ!h?syi궅\t:ɸo$44Os 5~hdY`)|v]nXQR j;+8"|m@pIE!ѠxaF űe<'[\U.#&ugIq+r-0@ɻZ>``C^k]}U?70 Z = FJfFɩy9 Uq4l<1YL)';n ş;Z+ʺ J+"0{[ծVG̻ȅ|̣@;…9"{߻;, Q-q[E{> (L#((<ԜH]J7AE[LޞUk5^~CͿI3oAA_ΒdP+C:#?KgkhRv^f\H`#ʶjZ!p-B~/k.۔9Pڛ'f%!yq\1 cRK|UWOgT>y agޙ i6_i|_H#u>Y߆ [L}|̺M }?wOxc%= }Ȉ3{9'*73rp/˒$u(վX7(M9M#- wB] $MC"iQ>V7X Baz4KeiSez׀Gycm?V?48eIB_;1ዷY wy({# LpVGsH$9S씶w$> 1FiEnDꪰ}.!i{z$jlrYQA &V0Ij1q!Q_y$&liE?cX0*BvI")+kgW|WFhϒ,6a|~mcgUFkd4R =o,ॖ!48¼d'`A4vZl/O&dY/N@̾^D**lГ`pIYZExαF`ߛUxH aM |=e/M ;GqJ@06:|ۘE` ss3Mw@cFKT VnI;'= (B8+"gBN٣?~of2=]=!v)t!j# tH}IvjIs#1<`+lӿ1%;+]P.+ <:ָ"r!-…A@J'8Rݲt&*榏&ӈ߂y!Uߤ00LN+%lGA -, ̕%`]^[{'S e!J޻t34 jS,%#]ˈ+ ֹ}a.}̷=u;l+&Kp >yr&R(ZiN 4}+V2H6c:3E z1d \ Q - Eo96C =:P\'RWRl)X]fvdoyE\zȡۘyi+'XE6m 'BE`m\e1ֵ 2^`< ɾ4@&}wQ{hFcs\oDPʵذ+y!Bp@zӔJs`qx˥0hxNUoJ1{m3`H#P%u$%TB9=3\tqeXgk.r)K8DCռʪ?hsSO(n}ZM0F`+sw=;riNzǚn3׋~g_TuzLek8y`^`\/ he$#-XP2Tƍ8 >S2;MH; Jxe<.69p 3dk)mڝ#I XD_$9㜔!wiiGp.{:{bba{2'41p .4"R CAZ[/¤Xdžf` XzmQ}FG7v\2.,H(#p .n[t~pJ]׮"ņȂԟCcuHs~D_ a#AWh57򃫦f1r=!pT/`}d[%>άdk ɞБgkmtX7-NKՄ˚UpW1ʹ nC߳ :֡ANJ*p~^o~k}FPR0򶋹#h?GO_~"`X~SW4~kuNy(7:1GRD_zz.֫bSH\@ٗ,yY:۽Eoݯ#;N4Ùg3F9?@>}ڝK˻½qcI~ ifp``WtyhWxt4\$o0f婲L&[qhc.@w0’w$?wNj1J5b U`i^iC!iH$hB!=[p:&>YkYzЈW2vOBU| h)$:!Sn΀H)L6}-=y$%-ԁSNk~Jm_ ѼR/‡fq?~'[P ]_?aL-uU_Hz܎%ZN`Oט!Q^qЃX:D^[YX݂;"UJgl2B{vP'3f?Kp$QF҅? k[J㷿A ۟}xiN6@TհEW'eƐ={|ˑm){}Hf<6 M=EU~phP2{7ras\SIU=.g+,9J_U<* %-"3'S0[奲ygۏ6< {C˜ZDq }¿?[;U@nZAP+r85Y5A@ ޯC̓Mzb:lL³}a۟o _f?_,?~%gTl@[(R^QZk-$Cr!OX%{AwNajoOϕhӾtad?_^SM\p<*wd(η`+*a(+VDFaF •3<<f0)@]@t; f<,nrL$\aΒvߟ?&'E) W,+;?,{"RGt[oϐжP DjڪGLbz+xf___w*Z~Žᚇ3bG֎V7eX[(1(n蓯Ythb/i"Mz3z SweR3b d'pvf bc3Bıգy i KG+wJ$9'pmTxHcjZ(O1/q Q `mrlyLi6 SdWѲݍ:]C⺞?LӌIFy(B#\,"iAKT3-^|~ŮZH&"[Rpqc.`Mi;,R [ Yri1Hr%9%8X:b]/(*OQ?ft"`Yq0/Yl 8+tߕWUz`u4Œ V 7Aq`֛  vxF6ֶsb_gzļ4SgK2T%+;Hk-TMN$9w <>P`GX :.:3@?rcKX uP~V $c?#,_,$>WӀ.yPDf#JJlfoY$Z_w`mm6rv;j?Y 'y߹S-׸;z}ܴ5Ulj̼ۙ6EɆ+ayE"C͑*旓t4rW}4 jf0q6!:uGQo˖x `)b1:MZ#HyzB`6ubA3HSkEj8mTns{yub?\m3FbdCr窶2p'៛1x:^]$;(O"4EfbV9AuhQ[0t RUppT!pj_v|[z;W s򫕟G,aKp*S;r0\Flx!>AzmZ(=+ϓ샢2֌<(쥅ȩGBȻ[r( #r!trISET¿!·3T z3ok~M1u9 ˀ/T*ӚNkE.KuAW8be*#a} 1CE˕dD9;;-/jǗ'(iA.!|fQfܻ0I~,*{SkH Pc&X^ ,+JVSNQ 'ciW $4& /O{Wv.0H> /G%w3mX12"Uf8RA,SBB&!iIo㥞MK 5grfil?@m4lJ)gs> sy i(Bp&lYH3u H OtE6Oq=N{z#ćXB5GwnnkB|{x ^ d>䏐שЗR_I4 ]#~_hO~ J: !N!Uz4lG{"wt> \!p5Ӳ6ٶccxdAs> }LS55YZfZ) TU`]D`^h$ 21Fl `x9~3+# C<;,L2X͆us0ϼa-¨Q&u#Uث}SY6>vs/Ȩp+>J`}ofs:]Y Su~t^A4=byȊZhR8<7u'f#3"PD6~3˿;ŕ4ý}a\/oăv9V^x  H|Uq,ޱ awم\Cpzfnq=C@Tij62eMH]"#NÿD_iubW Vhs}J!z_C z!C Bz!rG.\%ZKW~P4Br" Tfg8jK!0 c9{һ"2bGKoq]$5 ,J>Գ,P,P0.*o+I.S)*+̆u?I#pHH;$*P5ELnC;DDV9] GQHя7J|JPMڝ'/Aqi/ssY=A@;ߵ`;j"8CS`y@fEnD' Za8g''~9q<>x"8"ڝ4cpo.~T=G!>g?zi VPwZ;MDw+|^ܰl}ó^8Fy< tY=Bջ> AlA/ q Y{xVd@B.Уȸ``DnWBtۍPnWAN[hoF #TYD>4n+,eEfr}B\81RL&: %ie2lK !,Sg9_2c~ހr᭚VOgB2Ma ]emP}HQ)B\, HD, #022pEޙ1 x1{K3_=*&%Xwj`@ r&gTq|$ ` mvv@|RST G%w1WRnw #,PoQݵ%@2Wd`Cu[b-#Y&!Zr#J  [Mșths{:gm{! hu@M"mom&/l6*o$Nv/nTR-įq]~M4:`~MJ+TP2&TI`a!?f<@,:9 P+A'c^BzP2K?!bV+D_϶t85;<5">B0<\EaM3DL18hf_w(l瘌)÷1\'},@u_Uo%R,V"T`I.'_؞v\&~ŧ{o aϗoP"U p Ks|/$"q :P=jkBL8?ZVHm'c9(B%=כ_m6_6ߛS9M/+%x٩ځA-a'u"ʓ2M'Ϣ&=Phн|/taxgxi<4/a[@Vg7Џ|XUz n?]I& *>Wf&BxAyڠ;j۝7)w8=+`@2sy?~'$`< IIW (jx |QrX:'y=^rb9adn 4l'dך鳏lVƙ#@kwG\̄|KmɊÅǫtG h%ZU:t=gm`ST*$ŸloYeזxwǔ\7wmhC kٰ$܅T«ɏUe-q5=9Z ;, ! n 8MCED!~p"-س,VbX_\cqu.+xڮ Z8H[@tV4 %;u$M킹%ݻٷ\ g1cKh1O W%6t*¤FLT16}И?N"خ-"hT6#sU.~E Ȏ`[֔"|O| 7}>N?shޮ??Iz9<`j}PKfPoY#(̰d@z]LJ.m.hR:S!Mf$ܺՔEŕQ[7ڇm"`>;=ia970^kY^cwzW"a frTE wgyj!n!U,\wlD P Oc1楣 ??wj6 I^y29fxتS#hbs4u{}V]ol~?D߮~#UpY1|NBpWQk +Θ:7Ȱ.Dzނz7i'UE0ɦ&AП:ΉE@ Q1LCO!5@KiNI#YsE=A0QT#g}tJp[2!b3DP!*r=ZBxzhٯK EgLB$\8z_,]{ÉW(ޗ^gtbDyhp~m7hutQɰI-RL>WeU[ mΌ}DYŅ< 7P_'1[.Tq V2,3"PHU{ƎQNvb-(3 qgYY \xqJYE2UOFw8d^r*rw9;C=g!57OC{< E4*ZgxAŧ}mUY.w(JFu࣠оxtHqm`i3N<~R"ĉi;i9,syޥ~cvH|HBȗ.6 Kn<߻܅ ?4x$i{Sc&W)wD ޕ8B_i^832 L mN iĀ]K)%o#!sCGTQċH燪t"ŃMyFMˎN{%+i!0wn]A&8;w>&rcGݐ,MQ }"`Bd 샑{d CcB$xeIuȲSX StLx洺`XyrվI %Ѥ(yLlZt1~էx0 Ǔl—zFacX&Y&x2!jҹYNM8 $e~m\j"B8y)pd7&s, [,wvMAvQk;M]pGY6.eYcL,pTgDaj+#Mm,zZN1۾@R*'-lОJ&@ƍӆy֐*pR@aٖ4ͳ6!iOH;Drʧ+orS澢:D޶A/ ?뿮>$+E v&^IufB&uVnϓg9fP=}xu&86_j{&!mt1߳ kvdg ;#ӏ&wHh{cqߨFRY5|)% 9\U 9cb|xĈ] C!&H@TNp۬`8P^±hpQVp,r^;VhЋ>؍d R&}Ks|\G؁R yҊ>q^%|T'/yJ\?rJɡtm~i!a݇VYl WËoK m\G1a2]HNu _Xy1R 7 _gܛ&dIg]pйnQ'p8"P%yձq7#? IwD+y3כ`/ۘJFrY*݁D_%"ME&\D*K&Gx<'v;)6i8p>G_F7#۰V^CSD_j?sx _hthx܋u'hr+ Y, -ͨ{"44#ƼJ'E8MCj Fj|C,v9ƌ؆ZiQѡZD;6sO( _=A~4v;8cmr8V4g8VMxkdL.ñjkL aײ|8}ӡԳ-j/x(nT{5ig~$WXTXBE3%40f5$Z_Hqj3Lz[{`ERNҶF?0`wmc' |o xӠٯ^%7QIRԵp@~F˰W (@@Fr9$rL Pq,H~oFҀJ_Y,/&m>ˢ4AfUViTdpH&X{Dj4q홓YL1/3>uoUzN$g9%~ oFHaTP.[C>p ]A! v1jɕV\[j!2KvV\kng,4SY $>3M("^x !q{GcFe2͝y$J?9!&,.'։AHO N8T4E*c=r&ws `5"P}U&؀C8 IdraD[1$$\X0$Q%2IO$Q#)`)T[+U%0W~~C $l] 'he`%ʠc>TNe,6@ !p극K8|27~yϱ`~VULbynb218{r}t".ZUtu^Y!Qb7'޵KU"bE;tQ2WZ<@ӵ $4NZ޾U{(,i` tK%0U cHBk8:NSeIƉZPl`=e[(GVр#ݲh#p~W eKNcxExaj:O cWz@eޣ@ ~W6C+#Ȑ8j{:0$ȣ PRGw1msE6m0he)N=&t!mC\ӎ3{@YNn݇0ڔ !?Wn WJsάV3W|Q8l[9{u-?d0; Zj$RK пIFJ:[I=tte<Lm sΆ:{绚:>Jʨܲ<H}+tb*Np;["Ѐ@0jgJmh*X/8_:VCT=qyfrODIZ"xZ wـ),ɳ#>zk5-$2ȭ*,##0e0d>Z'ɚKhp)Ӛj # >^.iZ(iˋ+uƋ_u(un0/9+J%qal@'0"ȃgŞ$C"yT"QO犆Pǚ,X3;<8I\HhI+؂!!X4]fY"wПiip=ވ=J ΅mj|T4#5ߜh%q9v K^nEL̽[" 7P{͗yi*[hN,@7#OBFL()浬{V.U DVh40G#PW ilEfxщǰ.G ۄ+/ q'v jxh0+? 5ȆFQxMēvNErX^⠳QbzfYW>ހC'vC)v Pn뺽z.uW;Xl (&ѷK-sq|s:B4­cd1xY6^8dqnwfEmמIGO!C66 3e)m&c,?Y~]߶ ,UbͲܤz4UM!0R/!2ßN&B^uxw[ hN[OԵ(18$+:9,rcR ?r 3;hqؕBDS^Ktkc0,uXf&8u89Xp Kgj3&T7l+*g;ze^ ɖd N1aώ bɃѸIGs7?[ԿxǶ:%xh]'flVon')5DGc:_=/Q]IPӴC o`Cc׽v %o1Hwc±[EHpL*Ck ^=MyV+ьA-$&o;mvuCx~&@[EYtv}^.ypYVe\:?چx܍4PwDYPgk<rLU*ç2!P{>ѫ tq|t~DzMw)5ydzN}_qҴ+n'v! ssMвT)Lŷw!u,-SGއHӏZ%)P;I]O}@c e;c*0ֿ8g! ~m9ȇ( {NzANRR%/-@`nv (9{LR<9[\Ôvp𤉞J" ke84VmgA`ce٘l礨k>۫1=P߂_+^v7}=ҺMA%o~V2ۀF 94C&~$$i}{7 XG/8r;1Ȓb|7b4xx_#CjFc]j..UZ YRHjRu?|6fT3nL&-=kʄy(J4^ wAZrEW/REJIevhsª)R>7X:,Su@@CD4n[J 2^NцԌNe"jӝjLJQ:¥Jofᰭ'$%] B-&yͫ{P./'gE) *8!a?ve()UɎ2`*Zta I!J!`T ' W0 ~=|gn"`2k}`NNmYӂR K)$}c')"DZό0npa4O2dח&Z< óbG:I[eP6J-]ghHPْ Uyu;?'+FL.Ys-toЌ=U3@N<Meъ"(}t{sU. qi8Q )JySǢ'Hp/^xg]~\NG4P.ĭ3ѿ 1pvÖ!bAQ[<l'C~n?,ڲUU 6V6^w?wUC[g3&@KC5dNācUǫ&h=iXa ?$~J+P4栔ςԔڜ/Ғ2{<&d=V]u@"gJ3yS/oz RJZk$9|XG_rrE.r8^hŚ+8I֐+gik^+uDr8Rυ߀ ;M],,OSq٢!^day1#goCZO^^}a4-;hb尒MU63v5sl+04^~dh,hӮOu6켑 p`p"vjSJbP"$R?#03V|^|tiW>'lNyso8W<τi2) }5wפ/W˷M9˶o(8@J Z}::6I3I[=a\>8};%ѾLtBY@#WXs {ue1fۏ+w^ ב­['mW6*cT+>?)zR- sKo<#oUU_oVS{6I|-7ܺXBߺ⡖jDu=NV`?.Bh~l( n /j Qc=)d=WSEayzCcX7D Lx?R_\@ZM4Ӝ dM%C= =z艞+>ՙp`RxRJ33'mLOʭr\*nnTŰDG-5Y2 =X9$4K>~@欷d ZH-.*K ALL V;e#l1íUd$Z#TYXPkky84Zoе GS>V~T.`'sH2/w&{qq4cZJ_7Su uXkZ>O}E\.] ʀ0Hb&30C:ŷ?zVȢ.!5B[" 8B-cFB(AMBE@uLT@&ڹh u ^$: "XFu 6 2`ƗmdjD@7"mRJŒ" {B҉P`.kGELihHP"^7VfGr y%-pW4`a\0YC4yYἵm9ޝYՉȩX`bܟ"Woށ(ΰM]O" 9u=W ŀoLc_TU_֬<+t&:,f^8T0Lg<$8la'mT8=e9rky,0#`iV#K\p`8.)˟}ˋn]nI q]2ݾ[TU8XD(h h;BP0/.Z3%a=6ʋaQ}ePCkc@>w61n;:8Gq%YDZ3R7ЬHUn{p˒ }:K7k=W PDx9Qӯ&&Nd[ `NCl,u>l.9Pyn!{; xP"$.#KUnM8yG':6d`YҢ KhXzܓ"!O:# Q5 <; ()lXy㸶8jM3e Ω u]sZh Q.e*Tj~ٚsG@A0l(6`~jrj +IҔe݁@8eSBB8XhȬC$>:Sx*Yʄ*"4p,.3r) {3!oa]=/ )NjuT])蔱gFs05lKX ! |ѪHJ `)'{lg6@)^)l5ކ_sY2.#8Նa}딼mJJ.St %} +OZC }op=FGPV8͑^#HZ&\. {mOEdaiL݅o6{p\ }0O׵^f1䟹.WC#dj/{Pv  n旒|( ">w%Ifs |fn6ڑ$vt u28WwZЫ?D&!B5`L y/D]<s6tx,Ӟ'YGV#zwB4 "Cngw؁*\MnF/ќx&YZTpvgM)bY )# V34U&t&UM%s#3\o'Cܻc i KM]grY `vp|/nQ+wtG zUZC8 ڳ*0Vԣq+C>%;u[۞v@b` }b9v`C?2Y@ '@yY恌<2G)PܨEFV4j:-K G"^;SlYBGvm7_RL~S[Xh&4Txh}&jpҫE!$g7ؘ <ޘkd|)\tEݿDžo_y)pgXk9"m8)8sLbwepq/;kml"aqu2?b8FY,&-7JT/0E@q>a`^| gQ 觚n,t 2=2C\pTALSEE suc 8xj 0pB [y2 xu3 Hx GkaYCmIV2"./"Ŝ&</PK$"7@bH@+~A!'*4 ]y 9t%iM q%Oݖu=kE{*5h۞lM"J;24GVgpJ!9ͦȦ=`no..z}id]n,#+qJzAzZcf$IgXd.?t%lI'u2@OM!ᅤ# Ky^ 7wDQegA.2Q4f1K)Tm ]STbOxWu w~8c*!T=$.1hSX#'&idZ8+ߤL/]SAJd VMf7ϡj,;^n)܃!ݔ<7Z,P`7X/zc:Mﶼ3K |3rqp^+6H}F@2&8FI`v,ԭ=Aw8d:C`}xf0K󝆶>m ␭Ux2'B@C3EGx)/ꀜHEz;zB>F8yn9cIǓGrSFs1ĶȮ7  ꤂ʋ}p^:l=YOe z²qiz}*"/ȱb?<Gyw8l1^ݫ{e\}QcyUh&˯[ JktiĬ7\"R_ ;BJ;=rjЄAFJ+ڰ[S믯grrnl:ƧX[r<e ~m} (zNW"pul8;7_'uʇ\Y|5mW3#δt]\%)Bp4ZA@iG۪E`$8l!3a !VᠡP1Oky$ok , ɾ7s) Hk=.a;C̝D=EÛS Y}m_5Og&|6nY_ ]}__ wC5k`ǔqU!ڂB@֡1:~Yȓ'(l vV]龍x*HWG[zLtϷqFG&y|(2-sy7I{5`0}r(\`.Lyr0- G!-e%3Lt=yj-s:*J(99U{d6 VV<~t"$5~-&X4o?&sҤx=k>,J{k([V;%iI w쭔)a|џŇU(92B͟VK4pTE"0 Q{FH;Z3LU#ߡebĔDWW&M,=W-?~hi=Lf%uF(ɧv z~")n>7Pz}"}uKhQE9(Qn$j%8h )f>&1Ө%=x䶁y!RVWzB2'nE@ JsA1yzꑷ؄`yI&\ˉiW>\1 瞹УT6Sb/J "ܞڒ>bĻ,n.-AxaqL"sv>m'jO-k+ 8=⚥9g̓ST?gvy,5g %nFnP% qvHvÂq%8^4-M(^`.%Z:`.Xr r:4wSsal3QR D՘rci)Fߚ5GN ~_-"zӓpmdy`0xlc D7TQ"Q%5>Z_v!}8DIŰZw.BnQJ ʏ%=(Vd"`noVD{3-"\R` a?C'Z&epEAұtYRvz=A,ݺWOG&\-܄K<݈b u*lk;Ces/S(k4\.8Qo BGe20ncx?SIf2~h/V˕J eA``C̠DZ թF=1c\dH㴦|2bfŹ;څ\6Yʛt>q׮AXQVtу?9ǰ< 60/UkB4@% M TTX]4Oi2$yء- en=]BݑαJQ]s 6FoFx;w["wo7FfbE{` k:DÞ[&nxYտn [Uvrq@`*ܵu@6E^D) U8_I釟ϭϗiW2©TtΗ]+E& rKڤf@yi9^s=E0XM}'d+}ed<Sepr$7%NU'Ȱx돽劤nue_@8\]TyH>9 E  c@9 0 .`WB|[ƕpSdV} k; r Go֮n(ױoʚzNig^E&ݷ @JҞdM:u`9^r= !}*q& ?WND-E1ha@v9Sጴ9W4>Ѽ>~|Nj?\/\Ty.f2{֚5_ Aeo;xkϽǗEJJod)S8~hyTNP uK#ήV3uPQG6ih@|x4ҧhH];"\iGa}Ӿl{xxrsF1CڪćeW:g=p!|RB¯lfiҶ@"XDRgqx f&@yz1*7?\Mhm˜Ohc%:A2}k%ַ~ypK ^8n%,bZyo, su;cpXHnxi/~ڶv(TD'E@e!7 ?sCQ{r P{8au\J yժR@\B=Լ+3i_嗀YPiht(1V Hޭ:' IFRk (%96 2td b!}Ӫq Ce"8 vG_m* U<2yzᑇo )fV[4qj/K45k_WHp~wh<X0 BK9NuфŠIX h6_b+*H.Nh@K}n?$ w~ c^x,3O((g5uKI@;L< pY4q*ek*A,.%=m$'?3G@\V/J?*jpWq JEﲴ pEXqb(ȤjSfx >z'nW bi $q,>&+=K4çu'"gFi{7.T"`@h\ ZOC~]]ٍD &KR,1-"o CWDŽYC$ ٕcfh;.Ac lR*4V heQcO/TohT-REV&Ɋu10.$e-B,W 8 z}t8x7T3˲J2ϟ{YAB[92 _3tv$ဒVIكvp(Fj6XE+̓$vR}*2#.dL?vZM&Aع +D@T=!K0'%0̭u5#{JW٩Ej޼φ$i TzYbULDEr;.04qfl\/Zr3 v\KI8u%q0s)T[7ɶJ`+}59ql)K8ϥ`hظ`rWm3)< Ҡ7CYdlH _o{@`ʫzC&fDQP|~n0pٻG85-L${ 3{dI+F"D;MGc_7J~[]UZ QfvE+#9RUO;t%6Y'ʴX <>mte Gv"= mJcph`F4Oܫ^q  ݭS%1MU4@Tb>۳TLRx`_m-0> ^dx#Ke<睗I^vi@mz|p!ٻnW`JvR0!X5:Cm65>ݏNj`B_JӣҰ-k8G@? cڅ795h2vXƠ=ǫQW(؍w] 4,@epyב4PyuGo65;Jn@o=AM@;HȪR$SpU~pGFKu3 [`ڒjʇ#k80}sc C3hak٣LR'j SnjE[Y5cgٍ|.~QtUcڂXyJl\uf t;v|3KPnt7,v݌.IWo8DZo7{J P`\Yf^9(WasPjBGE`j=F8hz]ꞁ G7lJOem4Va皚Um3M}=lVcό|Yy5ws(<p.vQ5>^;{ҽuzHE~=ά@UU"0.p!Ѹ_:#(yG zLD6-Bn6J@@` NdMG[ !s$!AP"Ԟ?Vu@"s':uב-?pvWA"˨m | .O uI׃]9l orTAp3;ga3D𩇊é, D徭mMX]3 Y^JT72&rv\Kʀ &mmet!$ʡCuZ?|Yi{~]%9z:<ٶ-c;p|XI`߀\rr]dS֟v-v) C.&fjs) |uWEdyWZf ^|YB4>ၻ-$:'G`RVퟂ$hZZW L/: TyNpXr7K9z@{h\? UW.ϨEeK G`nY.F4f92ۂ~T;3w}(GoDVv0MDk! ?}%eg @,e7#՛'n oz=W W /ݝ۴(vU" B)]Vk'ABC+ LUA J C\z| ߛ& !M!^Eחp)9^t2..>/<?T2`Ҽd7+Ѱ[^᪍5hs1<Y{h FSsӪ@>v+3Si[=)DBh_c.CCD^:@n(Co[__*L(Y|| NXCձG ׏m8W{mϧo%OP,#= syR AW9E.8EC4"ԙK>SNy1&bsxn N+DJ%æ 4*Ppnysu,g}XTrJW*?9!E y.?R!jۆE  &=ij|l$#acAm\4,ɏXq'[H۶g8~W g1l8lZJnX,ɢqلYiy5I󼥳7q6♩.;dW^T3Atu,=x {=>5!ρ.(t%> qV:`#,*o8GF3t3\fQ %p&\:/>3U=.Tr9dDhs qۯM7BtjyBy`"rP@aH];wz xNe'z鴐?Z j=Y湹clhpƎ;Vs0)x_cHL dS_Cuׇǿ| 5y9kL=<SSxXxǐ_uQOZt&v*<qx=Z0.bkU';=9H[_p7TSF;Ԯ@t˚C@ $=~vmp}:cc `W(J/[wo؎7yQ"<ʔw({%7{=HT^!x0p#o+F,6 @:`+>Jx/ZE˔l!`>dڡt R,I!SzR<&w:p8O`-d&p[/{ ">[0Jx,FFDzùE  O;+*(bI@B0'o#C6au?Y>^p)!ndēϺůt]B2(@Bos ԁ*/Qiі"0aWnòtgmwe]7%M2t&GfWehyO3@}9("u x*Q- 'A/ilw- "`d?{,FƮ2p8v}#SAJ09 ^z\RbK EJKq ]`YZ_{`2BV_%2oBؒY`9fe›z_*u%ewlA"HJ>8Z5I!&@+ r].v]ъ3NWS:n3wR L`Dۄ>S25=Tyұ^]R!ㇴeqZQH^ rߥ^-,LSA&䎞 ƺY&DA kKZvjaJלm`j'ڟP}']]z~UaR%;溼hD;# ^-%e(<ֱ ;o&6 ʒeM#q FeɰZv] \A@#A86\@_[n].|XWx~@yɮw0 7'=v rU2:T{֟2 L۾O)ӧ#VGZC(@yZZL?ǮPEB`7@see)Kʒ|ԥk^?)piR{^p8:xo#`)H=CMAjRQigXc>{:c?;do"9%] :W$9KfeA7+G3ݮ<:ztբ&ɀW̫cL =#!҆zЇۨqb':z<^xpbZG=GUVP|ëݮEqw;tc5 Nr7R@P^j Ie\a@ڪhv3I)`)!=gG@ y 9x:2dlJ-^69>q%,fx ݏ`z\s/j)R{qUA<CI)SHL 5@櫹ep9O4GڽCA8㢩B.`Ͷ<$ͼG݇z_ s~Mro_K"p;'c5 &OVRɞDe)U-Ho\,swl1E`r*  !oڪ8\in}T#9ˮ>[JkwQ萛|Wr5(u ܀µ)OVEG[3;@@n?"VAiOi#?>?b#EaH0*^i/kѱl۝3)9Onn@Yorۜ\cȯ\ʭ#P6J,2h(c9pϑ yM\F5#mYٍtR~@٩8E*$©B ׇa*)SMCS ]q=v]_DXxCDb,UwB}~,EYf0x|1,˂J#Ü1ǽ g7'ʤ) Έ`^*2Ҧ.l1Mܑ߾hit޿ PgT20&& *4$dk]Js KVaOw9(읁9pp.|UcTp}? %]!rQ`yZ]'پ_L b{2?s^JGbs*2? HJp&vGp;꜀D`2@Is#!2A|lSp,*&`;jp1VH{9:lW))ߑLhvQ jpK4MR O  -8dxsI+-^2 ۋ2,5a`mm`8 mBT&NNG=x9@j7E㞥)Ueo|}yrJAے'yXj`"- "~!sVphe[|t ă B@}Oax5f8,Gee6b90Y "xLm =S3[Oy$m(4x^p[R| e¼INp<"z ЧuXMKRt*}F g` ^ϠۘVӿbON@~Fe|# 53y+ˋ ^ $[oKz_-ZbY.!7c~ b^ɟ;x ^3a4 <*&M3N3FY҂CjOuy%WA!ݔ;#P聁^/KuXbxi6 fcj|tI,ɲgnYIRvsBK_ucY9_D-T;A% ɢB-Kәu$k_ps)=+4\LW|;t櫢r^u9$w}kmV^Ք. FBykYLIOU̹}\H{NKvN!ٴ6cusK1xy t~";{?Vd&8.EyJۍ&PghvLVmS2/ NɳO{(;r wݖnEPvU V"ⷎ WP9#p y,'!17(P0 P rK9r~oh:@RUtYjA.~TM@6xY+dYHȓ ;Ϛ\ )R6#{^:hL 3 <\ޞ t @@{ `Ld߫<C@~o Jz&]Q2}HU<^=6&N!5A @["EI*΁v' 9N{aUJv\:#ZE!_KN/CAmD)<:5=ė}k Q4  C le $~3S%5Y=Y7o,pܰI,u@G!C^^d>;$FԴ Z9${A1iyQ`P;2H[18Ei*fyQQZB}tgQBYQ _mˬ5^1SZ & J} @*7YQ>^_? qJd.)p(vC:)bt+ MYϔ<'=U}so즢eyԼvlf#= 퇿i5<yW; +nJ`*x< sA+f0hË!.J,B6"+ƶ<)s/ڹ ~D[b\Kq z$8Bgg M8QJ ߾ndWXӁJCQj7H~MD>w7=!E;Ws:oQg!Y.T X3@Z ¡{qi8oj56=;0|oK~{g՚hGcx1G[PcWYC# @7o Jkms-t*i/bT>kQQUUm;Q~ e`wYeIq8EZVtl\dn鿩 7PY~\z9c80DA D5 `@s*T\ιt-xnXVŒƖ*RE"R{"W걢`,JGɕj6YY:vSezk—=~`G rxi3 <Pn}&E7%qԘ\%0 .CAV|w\,1e-MZ{A{94~LSZy.eeղ MK2̰fc%^]@oxKݵgjˋn@ ub/RY5n$u Լ`ߏݕw,E3]z~WEpl{Sʞ!T[hhɌ:qosA!0Mb57OOP\S%igItOwZFĺcaQ9+ H l%;׫ 7HʏxѰB( "5GUsOjFNb֦zM.W={+͒_w0Z:! ט yl__?#ӋTP` bbp@[:zLҞblC:^ 96Hϗ2E$!3PfOᒮ1 X@w؉?ID n]=+tiSo9o|˂7 Lۦ@XQehw'c+X- [3n Qbt8 #℅|՗R u^Ce>G# ~cF|xL(04b?(%2" k*?]$!\f;jR{l˅pT0/noZ4vS75~iJUzkxB`Y4>,cʩ@뎊tHQ :xLϑoOkql7b7۰uVxt9Uطc7"eX;~2#'Homjfđ=<4V! L9cy7KoH6xG:u#K#L"G'ۇ JcڼP$ <<e{$1acECF1z_!nKyy[}HeGIFm%: #_ piBdק4}%)9[Csq>luMDm8*I؏>"~}^IZ|$tDtoHO vѺ}+Oʿ7GICy;%YokʷzCaCHk9s[Rz38[$,,8(T*OjɓYI_~n)Vycݕ?z=|/9N!Eҏ.C ڸr;`,_9_?>c&7 ": \U-R͠\oE5ֶɂAHܤ*E]Տ*{BOqWq4k/,f`4bĂw.ۧܳz  #{O2Ӝ??KV;}W3"~S>N\`a ^>SHk83{_VY璒b5XXiiU(8'Z,^"ˆɹe0.#C+2d&ENk2 oX U՚ɎDywS@ bhԨ@㑙:σȓ+RoMT>΅gtZ|YBhEWSvg--f]$xUW{sųRےsBvh%dnHyR}q\H?|Eg4zd5S߾ߚ$os$ %2bU0C{l} a罺^ ުٲų߽|.ُ}[vҰͣ"o=s쫊N "ϳJk Tm pAK gI@ٚ=G'4**Je(X/.̉8nm5;D[֪GϢR=%/nQEȍ^;dɗ/Y>}vUy~㓯[b日X琲bMiEǨ~|^ EEEuj]8(;(ҍ E!٤Xy?zUwD5#vF]! 2 E#$nxh u12kziskj6Ʒv⑊c@.EuFgm  bp*A,*UN>bb;)eUx{? .cuI6b `bS5ɳK`  5nd.yN`k< q\;~W5EanF>JJ1̾yPv::?s"IJ.qu~M[*0P8//,EB e4b 0AIlft2%\.nf2nO kY"A(l {#oLvAkoJ7UU,:%Qp4 Y²s@\AxE[:ܩC?/ryQQbQ@Qu`uw|~C}W}Ol-Fg?`+u{ G*Qr 1axqXݿY#x!v:sk↗7TFM$`\(O3(.w?Io"}m gbP(eR;')Lx5R Jvp[|Oؗn2߽I@N˕S^eoJRv ̥M2!&|fѳ"l;ԥ;OgȳR_qh]7)oHU{bVުeQl,f`t3oPe?RUNPd4֭jujWl[Ԥ(kfJK9/2((W348nP(3 I\Ƌ818^]K"˰O{YB\qrk>6RmUFn9ƫ2c*p Ip~x|{(eozx_ nɥp^>}Z {Rm>V_ @uDm4+սt>%|f 6wΧŢTШ]67E$(gg^ݾ{[O;P^MaAw >%>)Y`L "G*}kO_)<;0A3'`+ kE/w*s3{=n]'/:SXsy˩:˹R$(f^=!WIN~/h Uq W?Q*>ʋMy5l _~Gm~ɄET"58.c]+$4Dn]wC~:P?_d6 mu p{<[B#^piMy6$/ȵNAj@}w:g? {,w6K~ ^WqhܙMXp2^u &K@r ~9M/7PfS&U)NTy6=c 4sZ-}&L@kݳL3wkK _,9֢npL/$(,GO+!9OfQwM\ənT]0-SCFd:X$|2-h bPv.zpiT\fz>LK}5'n{~1az p#rӇz2"{#tjL< /$ #,I6[zE[i^/i^ȹzIGڣ8}2$3!Ӓl)_ɉ/[)͛oAե$*RryL836?~HH`xhVK>b˞4+'2O[{84xA=Uzc=|DsLoU:r7M$I$MFġxWᮔg| MnfiZ$&  :[MtFo҆@ N>f;Ჽ J].4 У'hQLU%AYw!p+yǠG %ܛHhPXDYl{]F.һ[] MM`6,u#^-IN!aN1יӄw?>5婫4Ǎ NH^nת-(v ͋IGFߏ&-W/ п%GfKåeiQᨨ;M wRҫg0+j'"Z,]5^.eY Bɘ/wVq]eF9kUIw?)wYfKDs{yr[Y*%L,uϠT*r_Yn-Wݦ?`@ qx#1n?.ȎW'U7h3eUK+E4k ",U/kvcUlwՒPJB.JfK.åm@ H24i_ TSiX!r?9K]AG(fljnq6{Au؅qBig.[E**'r.mCK*Mk(d6W_wN֥JTػiK]-Lr6.ښ*~H Wg Tir!+a (\DSg"sêգQn B%^hۯ.n ~"AY2w@W.<5a @3lgP4hGn Uƃ2j;1pMC ݯ4Ojkb:cYDvbn1uAp^wmt̳b5sZZ>ʗPlahi~a>q͛#hŧv.KV뺾zIGĎn#Wnw}zG*~SX%/}mɒA d[8rUEM5@݀C+CyzU)oNgJ W ,*(n!(҃gCyatĚ_JL;%~h~Tl3Q\!Bݼz^(|~YزkQP=dAFtAm%Ѭ1*uslyc">//}VaЧ§<\|4Xm]"#+# _Wy.aNl4]ڥP^ x@4}?o" @w &q f[cǺ zVB݈"M7sd7nn_- ạ5Jԭ(H9 P|'0 4AuLmW5+y&1Vl<ſzwR/ucc3U曹3(3>tztЉ|}ʱ{Oo,uUo6Q۴nMO z:#g)at=jq^LS[N,^Щ;{vnZ ;)=`=),/hN/t^;"OKW( ?1>q8XtlX![wMV[tGdqljՀ/Ezů?H,|I~7yڡO+Sͣ@-6mDP|*6Z!xiQxhB庬j˂ݛ_:E}&=,߷ S,Tlg0XTxz$Q5(Wob:/&-4|79pdG[gөI((cϣ$6ht7(h~ R l+u( _{qyŇ[vܛ5ݨg=)OD?OR#D.nᕟmφ}Σ>P.-(Z>}C}'K^ |<ک^H8GfnR ogs\jVJ7m6̆@ɁIJ4ꇙ@Ú,#KHW &m4E{e*/zbg;7~ۮj̻QgufW%'|`N( Bo#VҊ3Evkdv?<= >6^ >'שM @l}uݡa}<.jQ 8 j2uDx ZoFpu #j+Jόo5D_i*\;9gXgw1}{}A' FAr[#x[}I7S!}J yzf-_:"hT,W9lU!ڕ,AKLߏD֥Pޕ!,2P:#qϩk].PӬ5z%."_6 ܈0i>-[d]T <.RJvJJ[؍ U').#~;,mvL fI?F9Q=!/5:K}@-$]T ↡:3!K`_R\Q ϲOi M;+OOUƮs~zl!Na-)E0U gi=h#p]T]9Z(\qEg,˸CDG2vD6[Eܸ^oi|B{F}W߿(77Õm;2Srqawb)&QBGEq'suOiP\@r;18"J&P4;;bUׂ%!SWY $ED7|?`?4P-X#p, -}Y' rAN{( 39=hgeZ0ּ 9n_ŋ#}$Vsκ%vt0w wZaFu X:^%UK)xk}ikuiZ cJهyĖu\I 0j 0~Ж"Sme>%:UGTj"vr%;z-!+@ ( 0Ν\^ͮõkS%ct |KR7p+Z٥|)I^XuPWE:đݶb-,HRԥuOpggy->*a)ދpu).//ҌojG<X/<tCTIPFWM6+VFeZ_9m*|qsӨ[3/ViGް´1FM]N9mC6\{ ie!(%qc9 j3&N#>u)*Kwe@?Mb4l~U~Fs䨛cA8m%{TGNS,!r\ kj/ YZk%q+,K޾)&$usFuhE?0#`+ l'%!馗x9x:uASG/l)q]Jw84jA!$<3JRuӣ<]*w M}!3IP0*;*?%<]T :'!85,j01<X!z$2 b_d f^_^GygyQ!֏qب'ГvZX{Fa4բt*x szՑN2.BFwATݥyN> Q/^d)1sjo XDY~m,t U"sZgg~ qe`Cҙ#@}<:OnQ|Ntúԇgt;O)=.-&4'! _XFEo;Z{^@.NOWļBw/ Z"\(e .)v9sO9(jF^m& P*ʇ&hDx$T9;I+_#ƫX'=1+ւbjh[Yr 9旫v=|3< *׻;{/n|yM6 ߵߝ1:zK#å,y.T2Aԗ,k8toʢN,)ѽ:ˡ!eVGִ懌?YW8d88^ױA-W/rc<;8/6 eἆ-m,[3:N(\)7|i-VYc[Hk` 5>'[MqkF`d}% @C S#t- !ɓ!Pwn1FGwvWLbSңTK˅Oym;ܩ~_G2HTYC_"* M 7oc|"4ΈeM>+)pn3"~>N] E||U`j >po?in4DviZ< ueEEnTq좛@en/ `B}yFҧeϺCґI \ +u:\&e A nLJPy4Veϲ'̶Ͳ] Q_ 0Br)9X6ۤУޟ,fY Q.E\݃[!E8Nl-pRLҤ.}9/pɮ1;DuN?E^K3`*6)GGu3}gM](4>&> (E"wE]`rjgR% ?j`,:fBs"P*b?9BdYA+?ƍ%_vX$w0AI7O݆9(5J>PuvJlǍ&k,a]S.]b)9 |&i֧_&U4sAR_>#tUJ")-l'ؑ|* Ul,o*3N`BN5hX3p])LV5%9%8y/foFbq 4(SH>ńUwm9FSf:H0(ppKkPLX.Hgbyʘj_^ͧ !0z \"+]v<wIItƳx~fj^"8p!ҥ tt©QD:)Bj8/pRU Ls˽A C1aAi--ֆ2{ԥM7Ct“n,~l KO/[Z":b~ liyNZʸjk<+;EvkA! 7Y)9ؤSJ<`<1ώԕeUYftInt ovY+> \Hs璋ϼb<ݧɍ JCN>2qUlfzi9$5#+Ueζ(. l2ڕ (Rx?^k86܌RuTKW^B2t( 6 iEQߴ P;9=YϊRd&/6)a|zW3tQve%PEye)饨]}%a.*-3,f@+V3C<9MÖq,C)9 G J85|Hcǂ`pIwP;\П52cLnPt|1pqnuiȥXC#n,!z{=|Z$T4+qIJO _z$%IGIx%RFDr73;P 7ۺIȧ͖*tAi" X&B0H6;Q-&ۍ|wUKlͤg^s|DžH Cy#s ZO*Fi0E~7jfT@mo?)d_c:Mgp1AEt!A 0}A >H{g :(lvQEj'E+$5"(?ە!ݴl-ToaxAW{aV@w ClټnZ\= zV+BXj(Vo|r+{f>yyZ%dXDMzuvއ&^Ih"GEeS:1(`;|e1NjS/~gݰjlV) 2izB,To rzRճLUMF\/dR6[i67f᪺.P8c2@ t݋,xHj{h6ѫ,0yH?^Dq;˔ 02F5 oHGzE|/"8 B-@1v>"U8 "V֛b ?tJ8H̘OYql)`zW2BC R%[ŷ^r*U &d)qFNrv&M rb;]PЦ&kdd/Gʴp]A6^S݊X&+QP_+xFF&VolQl6Du)D!k>t~vqQ Gur}ipDUu7;O 0M?^٣ Wt2Ur fˢ]JgfgQ Do8 {%Q q|?[w$5 k=̞ED]\ɁBcK#*=Z_c6"Ex%F &^u2M5ۃHD:o $A%j6?* z604?#ݏ_hfM#uVKO.>ywIFT=h8xX[9h@BW1s;醮('nÏ֗wd-ή5WF =n#-I =kL⚺(~$5#@!:P"ò9Y&ت'ƥS'۪FHl1nog|:AFH֕j[Qesl*5 җ}'jW 1%o~viU~L\EjFT'󫡄N !GI7fnⰹtj@ieֿJ 95vE1(y7fKMdV WZգR'R@e<GFo'`$1L''|"If{׾lW / A& ^*1F|"B7iݣ}?uߧ^2-rgE\/;}hRWs!v:7C!Y# [* (<3_}_GϳY!/[T> rC Yv yQrR \J sȓ-U܅+E~S>wQש]^ul-R!lW.3Քzɻ٥5yc^xu,'?YɥH8wϞ}egQ2|ڤRnD?6ywdAgn^/?~N ѶMY,훳wߒ1ogҏ4+ k ;uͽIkjI~Y_[,\,㗇lɺ#5)O8HGpe%U{ )L*^5+*P8yDܺ\$r$"@V>FQ+AK7?KKA&@vXeG\ k]x]@,n}eNdA ]BvKtgұ9$ >F /[L./%;ASvwW*b/=o/^Fy'YrA'_P FsUYEsyЃ7OK % oi+KZ$/G\aL|}{B ︪tNR#[eEsk2ZU' fQ +rCt=!$r7ebe]^̘)B(\o?i2\#SMbd;W“ܥeD@1xA\Ȑ? 4̓ mE,0Dvg"ik A 311_)Y1 }K! 7j}=ȉC0HDP=P:0/~ /s H},hlSD(_E\[`qHRĭn~^:>A I2r~AoֹMC%& Z=AJ/:O&2@S[q> d4(5[`ŒtBكgxRZ|4n Qk:%m{B݋ y'::E@4so#1m%ݓ8En6 eR HN8u7oK]?~UhYNbJ# ~=# dbԊ=8gdH3ܺ;H[X8s2L;L>šefhn:d kx&Fs"d{\Vs^GV(d)BE_8‰d<_M.puWJgB?zM\{(G`S7/xtbJҜsIIZQ/. oyȶ1W -6*~r}R'&' ,N~zBd䪸mû="n,Uqf"}"".?h o,Amߪ?{e}Ȏ| O?y=OCOd K~h eN6O}k܉H=4|cK o,S<Ґy~y֒ ˌĦ %1f5M&ůǫ<_ :'(er#`k/-(Uu{~N3PFM"u|?7u}DȤl b,//ƖcѲp G_ mGN oGxr v~e)^='h2qo|Vna^LNp+,\p,rE]>2\J y#cJ@Uv@yi\&ߦu,IRk鬄;},e[Q6=j*ll.lV|(0!f0Ap\swSs k{%7:|yyt r8!W8&F#4Yd̒Sf0a~Ԧ{}nk nNW&7!%GJ7y›v~yxiFxFHIFiX*֝' i=iIzHrg4:bAc`6~%< 5G9Ԑx05b]\=mNyI Pfqtpt%R2-/0)?gB I|xj}L'"n.65X\֢?aX/6kz7porȓWMa%40t'YT($&?OR @^kP€fǛi3߹RHA-*"L·Pvehen)A2A{]T6G(2jByn?hи@ ((l|]IQLP;$:h<O +(Ne8!֣8lݾ+c?.s7nnZ~f 4(ZڽKL}Yg9UuraqxS5IR?jiFqF>[ 5\̝L~Z@fܬv0!?M5+rӜj1 ZuX?>a }pO!&r;?[eT},Kլ&`\OCD4&*Dr Ӕyp8$7n;{$]zt J-E? 5kjO7^(gWX}&ȏ8_kԎ#6jl7vzfG-f 3cΪ#IA@Y0)qPNѧO;P-PqwjzE ~]WRǿ;ok&ã EZFJ@Э5nm%h zpaTU!/1^1чFMx;\ת{2J*J߆傞[@AR9# )^m.3C T5#6~63 UAIԖ Ժ~0VM)]LO5as ݇J _\A1uF\7 ]E;}k-*GUJ㏃ yIͽÃuzaD 6 orz8۝*&J0q!p/b~/^R#E!P# 2hϊVu{?d A(vV?jv+͋ҦT7a6|#ye NgFOf-^P`wbW| 8:5{J#-E+D{1oOod3-O_|Hbm3Q`UH}RP2 ߀@#Uh*mK@4wn?6t3rt P3=W-蟾Q/-s<_4q[#v ^n+2μ!;Q]bPf2Ђu!V |Ӿ(wQ!u%AdO]2HOU$ו!6cw<{C#PN]^k mUChIC+"X/~a.J!, pE|ߤ{07XQuYP,d?h'ҤN PҎx L.[etH@]a|Qz VTx@`$,f`4.|ut=˽o=ߖO4Дp:#jQ}U6]UPmpv{VԜu$ˮGayyAy"~ѯW[ *~‹ @s mrrD1`ݼD>e3:eӣ"/i{/9r鯹;Dq3Rɽ8z{ wdyu ◗?xjsqo`//]8?&U+QKD%zXifE)3$H%w <f8:cnܳїk;ʪ̂6A d娸gk@40{Ѝ(fN]}&X~Uzn]%m\+xs;x<I>'!j*,+[KhvE+ 0pG\x7AE~e{:07˝H]T7| UQg&U)Tq-fPN"nv'ȪW9b²SƎhH&][@T;~/Me<u8F:l/<ϋlYEQꐺڵD N[`ƴE1@u[˕Rn)_ jLo'Īra60Pap(S%_(3-_|.~؝3v 3Psq\s^/wNU՝>̘Z4;,թ`F&:MsNY Ԟz_ 4V%jUWZWeHA&q11FNYYKSJ)n=9[DzKKD}t @n7563GX}dj'af/+vq~|eb. 7~|~nś2~vWO&`3 @X=y19d7H(I~/'<ɏ=/O;1xx@@ @|JNL^dHg-,~޴wMSR7=iHGF.d+?Ukn}}u A`$bS Ml[,M\(X_;,ι}xPUcC⃀&hk'zaB?9Qj3KnYK~>L@ AS|L1  }$K@lgD.kՋə贑f τㅿ-YyL?)oUct"@?c,BNx!8h,r̉,-odCpQ0F11Gt /yoC24~_nEaA 0f閦|fh7B10RL%Y~}D& ׸(efM`EY(N rXDQ>/{bW=g6yn*ɯÅc%jD{l|$B`LǑE!A4WjPn͝@ Y}E^Y@j%*{ m]"$xviS<!@&|TOeG,oRU]MZkNoa:Sk?yaT Drxl_ð~q4)um? ^y ȸ -@C(BWCž'OYLHtN~/j} <$@lh?d[0y-˾[{ KSfvZ*d2kIDژ SNm(X=;j ژ 96toOfo&3!U|Ieb1QdM'< Xk`P@?dm"4ERGt0ja~}m%hpVOy&=׋tYXyA% }Z@x@z"@ S,4j# ߖJf%Bm 06XcL@ʑ`:t7曂e%/O7g @WЄ.6I0$i0dѡzz'C}፹-v80S%ৃˤɅؔ C8x1E}wb|ӽ1 iGfdiA`4ןN3\}s Tp8(ɎsJY<2q{mYzŋA7g3Op(^ir)!-{tTjxgJ:h`@?c=[è˩921l)dl@Iȶ_[j}nT>Nkx{W_&A-p[b*ghHěs b^`+E@$[y(_.Q(Eq9 W E)w >~nq 0xqYjt'[Ũ$:ɟ"s0ɱ2#ĹC+kyUCb$m޺bONt b& gAue})`3h¢L`cb?i )c 6J/MDzjj7k\kM\@ O^m|a^E[l_r2]2G.+PksA9~G 0q?  @[sjK$K3 ~Eei Gqlg+tu|{E1-{e?_t +f+sBy d2wox0N("N45{"K)̃zbU[ݲ!`_Qe7E ?ްV41-kd P; 0=n6k-9d_@h#r@Zpsޕ7|{3Ɉ)꣯G c*]k]!]p!?Eȸ,"¦Yt<IA@Y0@,5/O7]bڐBr_/2<|.v*ˋ蝷ժߔvՓy#6&mQ[]C9@B _Ozh^g _4 ~ @+pJ_EݨNMA'?uл)P%/"#+R_{Kϯ |>Y<#zͯ$>Y#D?-A)+.>cA|Y>5u#ᕒS^'77 X)ڱR Hc#@?^(% z+$Jӯ>G# pE`Y05cVN ;]m#ހr=9$K QPV Z_)`>>Qld?rĭ-! ooFMv?ªK<|զ-!:`9d&Ed<ܑqF^|#Pby}}t_KX38xL@ U,-xtT9;XfPKP=a}vo?ugl.ߟg䡵BiGLg$9dyBAPsvF;=6Rk3`$ç's/%ar 4jyl Ϙ~w`4nlA:{g 0 % & ϣnSK~ 'R?]?XDq>}u ShB'`6 qH)ݞk)99L3ߧGJ(A? *v`#[竦Drc~a:3ڲ B&4٨E,5d2(En%6 j'$ K)B$`{`ݢ09,UHc"wWw=͏h۶E*lk׏j~rO4W\4x89*\F{g] pp_Uv8϶jkڕp^Dmnݎs|ͨ3G&uq(Nצp RvJ Z~ؠZrn`NP±hjW@`6`6] E{& Cܵ^Gf)}-. dXXcvJa`~o[3<(QNgbLdZ/ ߢOT" с*@!h>A;$*`Gg7Y Hܫuvq#H d!Ŭ!OE1/c'^u_8YRH,پn-ڎ%hf$&<WF3Y6d?iCs#(t[:CTLQENn@ %F%nȲByȋZOT\'56UZɱ-n zgLg=nM*j["e ~e~ cc V*wNi  Ty ݞV ʇE7(10{1t#M)J̚4K1[&UOޘB%Œ2HCpǫuD,LRCFBId}ޠ#'PIMRҪSSA_-1HQ)&5 x_X|Qq(ٿY\d0qz/7;d&o!YI>%0_fˁ:5\<"&8ۜZbK)HL9PԸAI[m&.rDO3YZ?uӓ"$&)I  x TT@u"r'|xy`0![6~M5o9lG/J|^_R(r2Y#ptrT]= Q*U &s EI5|fcћ"ED()PYv"Nz' ;S17:) Lk~{nF́4(TlC爔>M)B X}(Hg}#~( UX礗+֜`PeeV+ `ꃹHʂ_wvIQoU~u¨[C0a ;gL:],1jEBFvyҖb,eYI.$d94(ȝq|RJ@qŋr$L@!-P>i+oNwBGqҍ.XvicTplKo3 0[(LN*8C E©xU^^Æ6d8yIˋyyu }zr^$(~YƋ2 ^{"p_ Kh f0rիӥw&/)sOJAp-P[7 ͽ:scN &U.rlg(y۴,q0TM!ZFE `xe0V; }wY!G[iJ[S #|}i'OӬ(l_ENB7}BrWwtAd= y19h,8zZ4K?\'S2?kՌG},pM(y3GYvNPANWx}yN:L C0~ x6ꏮג8tZ8eu:se"vM"ߗyˇPrg^?y$[5Yp/ E@@, s$@ `lJ\ֿWy1t]{^֋j5K k.wOGM٧o`B?N}O' 9\]M>O4ݱZ:A_y|wPɗ߲)֎"08waZt0ٌe 3O K~yWT]-$s{^~A4Gi[Y (4L"=Mūa\.&&]%lN/[…ﻴt0/7&{y B]lNƆo sL@V f]@uxxh&B@lxl#-X)oFUf hF@`kda=!GOئ:P q^A,?_!}d8[hvmF8cW _c_0`D9|#1c7Pl4ͻ[[{{$Ug?Dksݏ@9kj@6*L@\moGEV{Ge;OzMЮDW 'Q- JAϤ! 4=kv>% ׻\F!*K_D W_,\aoid tFc/j ӻr. U=ɫ@9-Q#.C}_j|O,3s0@H֘{`'` ^]cKLT3^/3̄GTQre-}>h#uHn(V d9>#XU|cNXQ 41Iu5k3VPLC^3 xDdieS;Z"?q{|ʳ |zt]ѹ}tagФ.p`~py݂+5ΌU779'*xn^__ ݣ^eskO5@l~Q'\v9|쏶 +c AТ/( B|<4׺dwPp!88jOX~ڶ(  p?P :m)2x! ߜE@ \Zh MA@t&ཇkQԁ:UQp*@ |S2+ @@6@_b(t {W5㳨#wD%IVw]ĉ1D uoUiH2בi5] \2λ5s*}/.Ë4u>ZP% \6߮,4|E߷Eo!22[ix}xJS;d"Kg>~ 3znn!(E]eY*'OSbz=Y=#PvB<+~Z ;? j~?h0M՛;x" c)ی0Yi1PDs%݊p_F;]|ŦXIy.VaJnqHz85Q wawA`xu =6+?"-ޚW-51) A`>翸pyhg$@S,fy0,/&i}D6~'0S%Ju{,<.(bͯ1W8뗢,pp\ iK,H67";o(XZ5wt5I)|daMig{ȟ_`5"6;6gcMsxC8Tzl~{Xɍh׋m6ݧDGFMw xkQP CHl}^?8%oCsa*"Rr9_7GH\e7ui$]Q 4 =2euHlkysVD$V{{"zg>)^W-AY>E7@n=x$h-Di*0UX!0)7VɏA4 vQd`c,*ٹhC[t(єj-z,c2 ԻZ ?P,p%Tz2Џ;p_ W0 T#! ,8D'Yӂ/¶7Eˉ,M=Cr>OkD^ e9_Tucx*84 ?&'C^kU}+a5^( }@..Mik:cPQd؝NSo_dTr-ЭkD~+F$ 0A'H9*ItDȎV+n)5OsPux*-&-rx d %8@÷} Eoןg.%AS_1~l qk`/: pb—eMAU݅[xN.^Qt++| cxK?Nx5PxBpV)yӧTݫVȏΔ%"BD~AIFo^pP@lsXW44G&SU{حoS ;%$ A[+(+a$eF1/L'uxR ޸O9;N4X+g~_NMOUץg]5 sgdvC \kd+%(\l 0^5Ex?貒|ѺaFA?dB)Wy K~[vlM;71{/xA)$$gU]혔WrE lt[7|@IXpaW6ӕ={<鴕b]^/Y{>y.V4" ؗ8nw1]r T[{sKܨ1EQu3@/TPE馜U9!dIYsBҍ1 $~xPӽkF2x9<"U] -@Yz@*A@ _Ѻ< tڈtE;@ l@O]VE"E39Q d RX-=&867U~> (&.Be؁șp^{krYѫhZ a*jmd0Dl6TgAb0A~FZ퇉̷:5$#O?$P+̅Oo3cJwO3|E .ڠ ,{ U9!ɭUS٦FGK'@_&'PTd4 P̀rw\K pI@5Qz30^Z 0*t }Q5;@@XPv}USb"ƢJlټn"Rs!Hcc-ȴbY *D@!^H?ܝeh'_F;#`OZڈ>}[WokQ+HJ (6(~ZGVD( /C?j6M'ʊjďJ9w3egXX4'? ݇N@F@<)M.mԛh}6'wi{Rdлh&F_^ImϬ?SH3U o;8 pl>΂ A'55H,:RfEQl$z'C|w(J@?:18^6  `j@`f3h O*{,S)=>_,A  :(^xH?|IߪuN> ȶcJLi-Yb"y(E#C&l6IZ%p⏏U=!MY5+  -hg/ 4_fk` W&S=ڡAQ3lnʕLvfC- 0WN}wU^Ⱜ<ۼ>Vun*0Eb9w  "/}ѿ*T,PՋ[|%n@*)+-jzJYzc$P0<٣>藀h^m̍QYIܗN20ÎEYZ *Qo0F;oWcP~?4~uԓڄjQmAq GEO귡 {Bd,i2d`0$*kF?z т&N qWe)(φ ᭷y_J= d;l4Q͈0Ά$(ˋ0>~0 _ݱ*_]LyvTƩzY'h9ӵ<(JJqqdos')~/C0 Sa | E 0cfF _rU:n8ISg0,yXx~!-tI.åfcMz>QPJKM*B__$(~aQ(_%A t/A0uWeSHc{Kz-bf@`w+cgA@Rاttop:EnDs|<;$q|V7,j45b8e&p #̚[F.u\(<̩."#l׷PeA`vf`v} I[ī<@U+a* ,!?:qwe~)c|eak8T1%UʃrFCS&NQܽ^=9Z,)U4u%,Eʵ;zijYzJA6l/ [U9E8PчXpá,\,,cK0t]KN8 @f1 @$e4.E s.Ü.@G ̋zVjXc]͝m=~c0zRW2}:6h+G[i)ې)HzP9jӋ򣭾R /XMXkhPg"3jEX]i_(4GЍF< !@?ǿ" ٝMdv!]mɳyhSU,5g4MbD!눱T h \ G$@uH x|,mI) Џ[# @O[J@G?]H)Gzʛ2h8Ȏ lx"1n\aݏOt%O Ӟ۠ @(4+Y,w@ye& i/Tgպ%SqZ,lLeDD& !ud < o0a|_ o>l35UOm <  _Zhlmܽ\T_8 DB)&.0FvncUDkx_$C f_ % {7Z@ <`hXE8z62oƔ>yBcDORR( c&`F(>EX2ȀB+ tsqO?L 0x#{ AOjH `Qצ) 8mU)Sb] z@=Vc%c @FL W{e=z_sF v*Tz6"OqךnLۆpF 3R> 0k̺|;Fss~$G`n>8'ft:oǏ;ՁA4_ƝTexM{6eEmo\}_.V HG2A/ zol|-@\/\A.8ZF?llC-͚D_ogN@:\of%Rm0ހ,#&>[L&([D9%|;*4 &tYcW KW1=/c&~|@ƺYDEs&Nq!~]=;B&eeQ_Nr6ӋÌh@~:>5r}sQ)%0Y6MQ d&QNϓMK k}f&vh2F.&O7Kc߈!Hq8RT8?\pwD5iX?wE-. Hay Mlw!aF@`2?R~@CMkh39ۋ4I_hϳ+˯2 LAqX CYxS8^8l:w0ɠؙ"* P˔2 NTFG_d$ }%/B `EV^E}l6z|O.+ՃGl |[2˕N@U`6ER>~7堆:=w@`jc~e(|Y2УuX6PGNX ^YpP/W=w>,ݥE]U)fj/փHZ~ҩh?+$8<<+%Vldu{Kϼ@`dX^Iӄowv#jP!EoǏ^AQk~TkeNq=+W>Neϧ .4o-0NN&~'+aԘ2 0t>~r[z/Cqv\͋zW/>" LMǪ'ѕB%uK .uyIO!5Wpo`vP ѫ{CnVhwSS Լ1Os|,+ςv'Dt.Wbdɫ.EYeY7J^C]/~{@6ʁ ]=+s=ā@`xܰ.Z%f5Ҫ ( =`+eA+7O}ԥC0A&)n %+Ժ,z%gX#6@'`+<=7 ӻ`( > P@Ah'Uik3GImh_dyɓ)NFyxy}'8jǎ p;VV@ _~D3?>5guOX%+ڵDY,nkƔh[;{\-2sq3/6Wl]et_,eE^IE&4;tr5|y_{2rM!>2k3 @! 7rCqDW3шzh@JXq w?,]DŽ4EԹlL\[nX)_U=/߭|_C P:^q(`QU#x% x|+]j(vhGszSDN-ʃ){0]ApÊ>P20zACob0h lMMc'$[͎D\N=( h ι_%&|蟼Q^l`"+ k_CnI7kb ?^> Kj1H]A,̲hűdEّ5rp43%%}!s0vN/d[S~ˋ}^5k~4'׆f?|~=ʤ4D!Y<YցJ9H:rIYL]=fϐd[uD;؏?6~XaicXt95놞ƸO-OJuzVa=l# @`bJ|a7c @1@{gqaKwx{{x{(4Ǐjώ "۾ncz?k8}+)8Qom a#⁀Ul_lѪnsl _Y:-CTM]aK7XGQ{38ֿ[ ,x[|3l 1B6/`ԴsB =4*A@L\{n(]6X=Ǭy2NK<Q`w!Yg?^?8~%x]MBVA99Q @@O\( <o^l|_c&)*~ƉiiC/a;%{GYfr Hp~T:h,=|(=r8"-g"1{Coń:x^L|8g1N ` BSI lsV] @+M>W:A j yg8PPWlS 7hi xS%^KFx~F _lfK35@ANX >IR4kCg@e*G;M_t+5@pGuAI ·5Y } 쁞~ uD"ٟl6Ot M`l:ʴځd3dt" 0Iq=^7m75Zidc(,j G <M1^,)gWH0`@@J\B eK=WU6qvHèIGAL8Xvfsl]8p ҁz`1.)lWݓfif `id'j GiQ5OBgdCda#XdC 4{ GdPrm UP% Е7@Iovx@@&E`hgY׷&5 [t K6S&ߤ22#"`0",@@AYORr)1Lx2Iu̷̗4L}.yհ-YPnD` Y3}_E33dA@8@@fg/~L% sp3EfkIFd[CߩnK 7:Q /u׫pTtb=&|'oGĠ,H'5۹&@.R5CmS* yv%Kk2LL5ZOk㪡Bt`]@`X0\b ^ୁe VVU\ %@w>T?[7y_kx"a_~s#@2a  x^Ev" |O@',z(D~5{r:1|}#W! Zi! HBY ?xS՗3H@YB$)bA+V@B; _#W u$!`~V`w1zS a0ıJ|k M<<< ^Ү8 5{7{-͸CyƝA@wp 10M*Vr.Ci*FIs(͜ВZDM  3",:{s/֍3jJ1B kw^0?> d4 0wOGfFY&6GlXOXWҾ_1痿 lS 3Ȣ?&]դ0B  𘀵o::D`fđ#&B uW맶W3.LԘ7&,!6+LDi S!,SI1{l-+=P3Cpj?=@'E`H|ZaNY3D 0 Qj(E l4SZ0 c4-ECͰ~E\_LF(2!@@o7aǿoFWC C~> }9@@@r>=4.~uXpTE޴Bs!\zBOů Ae0DYN 04Px4?M, 1с t&oУg0hCϓ:g~E+$G$`" @,Y+Em $?'9MZFߎ˶8r$ НqAZDGwZ"^|)2 |{%>YhyΖ{_`HF268#EA@ 65Eg!/ J@!O+#H-ߵ5kWn  M^с)ttx@@@`q =cO`_m( pF;.lj4T ,%7cA@@fBY&Lԓ"Im?JIB<^G?CK@v,VՅ8;n r{BT    x@v0JLg rŠ0aCU L[Zlt1o33xzp5M1V  '`0~Z@@` 0};V_ P _\8e (:pN0Ԯ\3 7if7ȓm1 c* # qo=8g1n6  d wKJA[ "  XhwW[_\1*:0LDs'`ϯZo< 0y YfFֹ(Ea  pfA t BhecR(D9YP h@!T+ f~Zh4 &`m@Q  0֦<kD/@+amXr <k6 H " ڨː87Հ$ŴFD ٢|m"*5DH ( "0Ť@[RY,F3  0{+f֌ }ȏ:A@`xY^L[",F2MWCQa{2]LǬ4fV eA``41:@@@``lBEMPD ?`jbP nC   ,,#kkuY`Ȃ  `3Ԃ,F00G93 Cf& 5A@`p8CuDfI> @TQ'L'ӕf} G  O!,OFA@`,AO$XF0 '"CaKh4  ='P شQM$Ƈhޯ Y,F3   YzRՂX'-uChY @@ n'    ΀:,X+YQ)ij0T <"L&Йt4&dfB+LB/ 'v4 | TaCy,wh   0ֲXC5h@ *d,;ep88Oh@,GX@J\ Tg"|hh o>jtg@ J469"=q1,Uldž@@@MY=@Z!rc@@@@LY0@@@ip ;I`dI:I2P @L0ӃG]   `,X8X`,Iu{  0-}}}?ހ6 0`(,w`F1Z $Tu@'@0J` YM00qT %k1  0F 9Nf1A@`B2HN)F ^^M%A3+6jNso  $`|`!L7L.`2 ]:F]b S"OUo04/]۝ڂT S cg !OUWڴd~GP@@`lg#c   S!`0f@@C` YL XWh @YDQ;~"m[i#L3L. lfjȲYh@@`~mC0~;i}EA@ #@W =mC`cҢz Dp  L_<AP* YZ{@@@@@@@``t}uj?I`~  f`e&V&j>uX@@9逽y`)j)Lmf0ѳX;8:FS7tH  d8B>ҝ,ш2߸#fAPI@ $,T 0*XƲ5*5`WWBJ3 jmV|fo귍,&"05)6eho@@,f0! @@@`@Pg@c3| ` mk _]*Ƙ ˃́ %>P09M_ a    !@@iْSklfY( jߨlo@@k Z^5DLX棩XB  l@  <kyliXLmwD@hB-dG?AJI} $\1`% ؕ Obǘ౒34^  0#3_Il`4PŌ#T8 wgTcǴ4EQL@: H=Nw o@;}j`C2}mk+YOC%6J*7=osH0h"j @@ -$lNSmk77lR5`>=Dklݨ SYn_'2MD W@@@0Ob'эP@ SY}}2@U     c'{'f[݅a?;2ޖlF a -0~b3h 0`9Kgh>K6r]*e   0~rI, 0,2}K  3"oVf U  PNգI 4ĎL  02La4vR clKaB!r &թcDsZK ƭP@@){dЁ  `՝!T󔙷5E2]j >  c#p1>s,c1@@̼Ƥ|k }gÁ0FOkd*-bW  0O {-]JU0  0jйz] a?@@,0No?fQ!̂tf;#D eDA{7@  0 YmxvP@&K@}ԥlG]1t{~hy b)1m힂HPeFA@}B- "ڰd t)O /% A[3TgY>)ži  0y6/F2lHH:b@Ww%x|A-   0ڍ}j# 7 ?d1Z8P^(   0V$n1YA@B@yi@+(@@@`tVa  #`OƆ   D末$lad%r  & ~5 cDuFY@$. (  c"0I}d;0lh :̊Io#BϡM8AG=dxHeϡ{E+ k# :L̲X\"Mv@1`wjy=V , %ҘF5YX ̉?=N=V=sG\za`({D{b-GnvbQ )X1Y!!!xCi4(k{=b7PU<>4~\pdk xY-ѯqͮa[Zpq[0oB&@ @gu~ M*NrN, @J lMQJI%ltzg 6> Dv@OQawd-^6plP"Zy  @`^֒chyWͺ47  ,h k8Io1x  @@ɽkQ8. k3 |p). @`G]v5{;o  @`2<%L2LqhG]*$BGoi&㻘:ߐM&wAm!i`&ؒmwL"P7s]rF,2F8WHuVKξ/R L)2mɃ03T i=~.i/> @"5֊ h+Ugtȗ @ @4'q@?<1kb&@?D6H% C@y 0= b7{ߛt b @`k]N @?H% @]"A ui @`{]/ 0@ͿXO{ w x2$U  @]Ƹ*J8 @ } @S9 _NDDDg2X S⮬ @τ*p:2' @*~ @tٛy3gH.P/'_Qix6RDžuh! @ 6o К0 Ebr( R@it|Q~!H  @@.un"@z@o7֞L@U@]3o d:Iu28M\@Bnm=v,q>AGn˓Se] T}\vdUmj\XvIil^z @~ U.dɜ@^UF/dש" A<]b ӣ zJ  ^S3p/'%7Ky .ʧ :GYłt )r <1یRzVlzrV@Ί9v.%$YBC@+[dV&!0^,T\C&-&@]fʖX  @w.ю1@x3Yo!WŐIx.K[h'}v|D8% lxpS߆LomFF3G-]y NL>WAm<XOW]N{t]N)YeD< {^  @@_yd9>BR8dˈx U Smd5@r &'@ . XN E9 O=شlTO"pWsWC d @G_IqV||rN#0}n0UKVe473Eo5,-п |GδUY]$A@ ]ZDi  @@5  Kv0P1Y2!dm!@ oh%u{1K^E][9ĵkgW( ̚H*9ib΅Dfv|8:J@VC`#[0S]wxzfHs =?ϕu ^  @tXׯוe-\UlN"@ l9[[wnz= l|y0#Dc @-Į |R.͉ĵh @@.>ɍQ  ,v3@qaT8]6°:[v&> .?.f&@ ]p|~~|эH) ֎0 צy hnǤ'%Mj@XͶX+`2N#@ .v‹Me x*srT@dEzr"8Z,E*!@ޝ @xI65O- qM4 Q`Yy6"Q9reeXJ`ha7M"_*l%9/9r % $؍mL)0 b&@}Ѩ$'q?9U5p C̴@ @ۿrlZShOdhLF̀7w 1Ƒ 0H 7AI6- x؟0i뇼Zl'b\B~+p}G([ݢv~']]߻Q'-Na @ S;MF'ʓy"y*R(0y"9w"& @@&wjP-D Zcx)tgkdHu:ҙ*أ,뷜lcYV:tgkdHu:ҙ*أtP)e @]{'(Hv]w4! @s]_w;Bns!uQz,{,q;9}!t[Q&Ļ>wt,{,qvH!  ~\[igSg` 0\@)xoiS#0 lbM @.iK7贩?hM6[CDρ &0Ѧ (;Xo 0r] {\WKwʉ6e]_bcG@m6 @ߌk[tbIkt7Mޢhb-^F]om{:& wM p,0pCp=N#~3TT0+gPtS{{qXPvCX’r uZ I @.mU=4 u8 'gqMgzK܈ 44 @@&[ݙ2/;-`K7"TfAN x:?K#.}A@$F @^ȧLۮA/۵[UQ nXf R.RX))dM%D8=t衺ܘvRjA"]#HeT|I^?tN zL69 Dv> eiԜb TdL9)Z`S 8z2W}Kz-5WKT.%XW͔u S Țh*ॣgJ]޲@Yf0m&& wXZM|ː;8gv/Szqh܀Rl4lY @@)*& M(יĒC s,WyV*&;tAW$tP pU`ǧ#Ώ0b}$@&w&D*ЪNIM`̱YdF`m4(9KFtŏf]G9m<]fh|x̱Oߝ{y"`AL#1SyèRq>r 4MZh ,:\aFdݰ\6z< l5^Q̈k2d .nρ!ћsOx9JG@Yq4.K@Ԩ9l( Id ,c]ɞ\pdN& p^y3t(Z8)yI^Y]eIs]{d~e< HMdv]f%L &L!{)#O$@t @2 1+b"@]zn>bUc] gJ|~#ΕR&`D D#[u^_r}_<{~lvO: ܔu  Up|ʊ$"%#Z @C.  pOf$I @d{"p]vv^.}N]A2 =&-s%:H&ƭ @8)׏IN&bÕӻ\POL J @Ef/_f9#s^&@]Z@OiSLPҺH"-t8)!m`bxi ],"tZ @ Ec @=$ B5uY&@ěġX~rY{%3\  ku^H or)B0C)1&+,?sFVcY30{Y|/Yc[??PC`^$@fPpOe+Gom&i3JE7*zf=\74L С .DXG 7U׵N[ 4H COJzu]u9⬈∘cdY$l9Mp xs3pIR<#"H+(b3u8J_'@@@̽&xQK'F:Sxp)xn[^g$@R=m f窰fjACeoRV("@#[Q6:H,Ш 9|\;'3(~N Dv8X%D8 /Ш @۬x|3c|=c#R03;4 x/0OA $$0bS 6Qo؊W*Mki#8 sP{k,f Mpo9r`ai׬&%@ݦ0~0 $p 0% koem@k!pjS`9;61[֬*޷# 4h @ @]ctztKa)`X%/ͺ .Q @lfeeicl+A% @٢ίu.GzE#@ =24X!\PL@;}K}PO e:E;]ʒ 9( i4-6B7'pZ֜BmFQ-nvbۉghVfh&'@u]jJ T`Wo%a @67P.!@ {I pk\%L[ .{/l @ w;y`XcrI8ef.3+ m ˁ l#>w?2K|d:[鎟T %1)\r6q/7 xj!g_{d ]Ss;(vR.&uu(Jcw/-JR`\LM HgרXE@U2ihp=a}b(p;=YtS12C S5V`LZVUE/5j!IU\ lUlN\`.6+  @ Y9lOټUU'-~Z!N x9Uxm! 0X~=8Y kfEy\*ת2ْ:=#@@]0 (0,D K/ 3pn]6H% .@뭘ʁo]) ØٶǸ&оJUG]VFI%[f$QPzېŒ D*T1"P0'^ @$>Jھy#iZ[QpcYqִB26eMthje))`cQ7/(Gsh o(1jg {^YVEݣ"cÕL9X3wٰzQۏHϟ|??wzA/~x6_ϧ^463Xx4빇#}8Vvbr'g.Q⇬|?*_?>"-8*aOgB7K.>^5q),=qo%pj>srrSul,OK<ޞ]wo .ųMɥt>Ѿߔ>i/}Y);ڽ넯W?oG??G Hěg GCt4ȃ t0ǖ;5h5yηD>~X3E,.Yק7-є5[ݣŝ*Wӕp{K]laUkኞU!^ GU_F=0}w~W|x^I⧨U{^ xyɗhH*0E2 FðGÐ E7-/$e7^ʿf$8L E.5? 4D ILeBoit PE200616161628LeBoit PE, Burg G, Weedon D, Sarasin A (eds) LeBoit PE, Burg G, Weedon D, Sarasin APathology and Genetics of Skin Tumors. World Health Organization Classification of Tumors49-932006IARC PressBalch200199917Balch, C. M.Buzaid, A. C.Soong, S. J.Atkins, M. B.Cascinelli, N.Coit, D. G.Fleming, I. D.Gershenwald, J. E.Houghton, A., Jr.Kirkwood, J. M.McMasters, K. M.Mihm, M. F.Morton, D. L.Reintgen, D. S.Ross, M. I.Sober, A.Thompson, J. A.Thompson, J. F.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin OncolJ Clin Oncol3635-4819162001/08/16HumansMelanoma/*mortality/*pathologyNeoplasm MetastasisNeoplasm Staging/*standardsProportional Hazards ModelsSkin Neoplasms/*pathology/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504745http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504745engCrowson200623232317Crowson, A. N.Magro, C. M.Mihm, M. C.Department of Dermatology, University of Oklahoma and Regional Medical Laboratories, St John Medical Center, Tulsa, OK 74104, USA. ncrowson@sjmc.orgPrognosticators of melanoma, the melanoma report, and the sentinel lymph nodeMod PatholMod PatholS71-8719 Suppl 22006/02/01Antigens, CD80/analysisAntigens, CD86/analysisHumansImmunohistochemistryKi-67 Antigen/analysisLymph Nodes/chemistry/pathologyMelanoma/metabolism/*pathologyPredictive Value of TestsPrognosisProliferating Cell Nuclear Antigen/analysisSentinel Lymph Node BiopsySkin/chemistry/pathologySkin Neoplasms/metabolism/*pathology2006Feb0893-3952 (Print)16446717http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=164467173800517 [pii] 10.1038/modpathol.3800517engDLeBoit PE200616161628LeBoit PE, Burg G, Weedon D, Sarasin A (eds) LeBoit PE, Burg G, Weedon D, Sarasin APathology and Genetics of Skin Tumors. World Health Organization Classification of Tumors49-932006IARC PressBalch200199917Balch, C. M.Buzaid, A. C.Soong, S. J.Atkins, M. B.Cascinelli, N.Coit, D. G.Fleming, I. D.Gershenwald, J. E.Houghton, A., Jr.Kirkwood, J. M.McMasters, K. M.Mihm, M. F.Morton, D. L.Reintgen, D. S.Ross, M. I.Sober, A.Thompson, J. A.Thompson, J. F.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin OncolJ Clin Oncol3635-4819162001/08/16HumansMelanoma/*mortality/*pathologyNeoplasm MetastasisNeoplasm Staging/*standardsProportional Hazards ModelsSkin Neoplasms/*pathology/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504745http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504745engCrowson200623232317Crowson, A. N.Magro, C. M.Mihm, M. C.Department of Dermatology, University of Oklahoma and Regional Medical Laboratories, St John Medical Center, Tulsa, OK 74104, USA. ncrowson@sjmc.orgPrognosticators of melanoma, the melanoma report, and the sentinel lymph nodeMod PatholMod PatholS71-8719 Suppl 22006/02/01Antigens, CD80/analysisAntigens, CD86/analysisHumansImmunohistochemistryKi-67 Antigen/analysisLymph Nodes/chemistry/pathologyMelanoma/metabolism/*pathologyPredictive Value of TestsPrognosisProliferating Cell Nuclear Antigen/analysisSentinel Lymph Node BiopsySkin/chemistry/pathologySkin Neoplasms/metabolism/*pathology2006Feb0893-3952 (Print)16446717http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=164467173800517 [pii] 10.1038/modpathol.3800517engDCrowson200623232317Crowson, A. N.Magro, C. M.Mihm, M. C.Department of Dermatology, University of Oklahoma and Regional Medical Laboratories, St John Medical Center, Tulsa, OK 74104, USA. ncrowson@sjmc.orgPrognosticators of melanoma, the melanoma report, and the sentinel lymph nodeMod PatholMod PatholS71-8719 Suppl 22006/02/01Antigens, CD80/analysisAntigens, CD86/analysisHumansImmunohistochemistryKi-67 Antigen/analysisLymph Nodes/chemistry/pathologyMelanoma/metabolism/*pathologyPredictive Value of TestsPrognosisProliferating Cell Nuclear Antigen/analysisSentinel Lymph Node BiopsySkin/chemistry/pathologySkin Neoplasms/metabolism/*pathology2006Feb0893-3952 (Print)16446717http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=164467173800517 [pii] 10.1038/modpathol.3800517engLeBoit PE200616161628LeBoit PE, Burg G, Weedon D, Sarasin A (eds) LeBoit PE, Burg G, Weedon D, Sarasin APathology and Genetics of Skin Tumors. World Health Organization Classification of Tumors49-932006IARC PressGreene FL200226262628Greene FL, Page DL, Fleming ID, et al, edsAJCC Cancer Staging Manual. 6th ed.2002New YorkSpringerSobin LH200227272728Sobin LH, Wittekind CUICC TNM Classification of Malignant Tumours6th2002New YorkWiley-LissDCrowson200623232317Crowson, A. N.Magro, C. M.Mihm, M. C.Department of Dermatology, University of Oklahoma and Regional Medical Laboratories, St John Medical Center, Tulsa, OK 74104, USA. ncrowson@sjmc.orgPrognosticators of melanoma, the melanoma report, and the sentinel lymph nodeMod PatholMod PatholS71-8719 Suppl 22006/02/01Antigens, CD80/analysisAntigens, CD86/analysisHumansImmunohistochemistryKi-67 Antigen/analysisLymph Nodes/chemistry/pathologyMelanoma/metabolism/*pathologyPredictive Value of TestsPrognosisProliferating Cell Nuclear Antigen/analysisSentinel Lymph Node BiopsySkin/chemistry/pathologySkin Neoplasms/metabolism/*pathology2006Feb0893-3952 (Print)16446717http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=164467173800517 [pii] 10.1038/modpathol.3800517engLeBoit PE200616161628LeBoit PE, Burg G, Weedon D, Sarasin A (eds) LeBoit PE, Burg G, Weedon D, Sarasin APathology and Genetics of Skin Tumors. World Health Organization Classification of Tumors49-932006IARC PressGreene FL200226262628Greene FL, Page DL, Fleming ID, et al, edsAJCC Cancer Staging Manual. 6th ed.2002New YorkSpringerSobin LH200227272728Sobin LH, Wittekind CUICC TNM Classification of Malignant Tumours6th2002New YorkWiley-LissDSobin LH200227272728Sobin LH, Wittekind CUICC TNM Classification of Malignant Tumours6th2002New YorkWiley-LissSingletary200328282817Singletary, S. E.Greene, F. L.Sobin, L. H.Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4095, USA. esingle@mdanderson.orgClassification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging ManualCancerCancer2740-198122003/12/12Breast Neoplasms/*classification/pathologyFemaleHumansLymphatic MetastasisNeoplasm Staging/*methodsPractice Guidelines as TopicSentinel Lymph Node Biopsy2003Dec 150008-543X (Print)14669301http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1466930110.1002/cncr.11865engScheri200729292917Scheri, R. P.Essner, R.Turner, R. R.Ye, X.Morton, D. L.Department of Surgical Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA, USA. essner@jwci.orgIsolated tumor cells in the sentinel node affect long-term prognosis of patients with melanomaAnn Surg OncolAnn Surg Oncol2861-614102007/09/21AdolescentAdultAgedAged, 80 and overDisease-Free SurvivalFemaleFollow-Up StudiesHumansKaplan-Meiers EstimateLymph Node ExcisionLymphatic Metastasis/*pathologyMaleMelanoma/mortality/*pathology/surgeryMiddle AgedPrognosis*Sentinel Lymph Node BiopsySkin Neoplasms/mortality/*pathology/surgery2007Oct1068-9265 (Print)17882497http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1788249710.1245/s10434-007-9472-yengDSobin LH200227272728Sobin LH, Wittekind CUICC TNM Classification of Malignant Tumours6th2002New YorkWiley-LissSingletary200328282817Singletary, S. E.Greene, F. L.Sobin, L. H.Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4095, USA. esingle@mdanderson.orgClassification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging ManualCancerCancer2740-198122003/12/12Breast Neoplasms/*classification/pathologyFemaleHumansLymphatic MetastasisNeoplasm Staging/*methodsPractice Guidelines as TopicSentinel Lymph Node Biopsy2003Dec 150008-543X (Print)14669301http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1466930110.1002/cncr.11865engScheri200729292917Scheri, R. P.Essner, R.Turner, R. R.Ye, X.Morton, D. L.Department of Surgical Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA, USA. essner@jwci.orgIsolated tumor cells in the sentinel node affect long-term prognosis of patients with melanomaAnn Surg OncolAnn Surg Oncol2861-614102007/09/21AdolescentAdultAgedAged, 80 and overDisease-Free SurvivalFemaleFollow-Up StudiesHumansKaplan-Meiers EstimateLymph Node ExcisionLymphatic Metastasis/*pathologyMaleMelanoma/mortality/*pathology/surgeryMiddle AgedPrognosis*Sentinel Lymph Node BiopsySkin Neoplasms/mortality/*pathology/surgery2007Oct1068-9265 (Print)17882497http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1788249710.1245/s10434-007-9472-yengDBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engBalch200199917Balch, C. M.Buzaid, A. C.Soong, S. J.Atkins, M. B.Cascinelli, N.Coit, D. G.Fleming, I. D.Gershenwald, J. E.Houghton, A., Jr.Kirkwood, J. M.McMasters, K. M.Mihm, M. F.Morton, D. L.Reintgen, D. S.Ross, M. I.Sober, A.Thompson, J. A.Thompson, J. F.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin OncolJ Clin Oncol3635-4819162001/08/16HumansMelanoma/*mortality/*pathologyNeoplasm MetastasisNeoplasm Staging/*standardsProportional Hazards ModelsSkin Neoplasms/*pathology/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504745http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504745engBuzaid199530303017Buzaid, A. C.Tinoco, L. A.Jendiroba, D.Tu, Z. N.Lee, J. J.Legha, S. S.Ross, M. I.Balch, C. M.Benjamin, R. S.Department of Melanoma/Sarcoma, University of Texas M.D. Anderson Cancer Center, Houston 77301, USA.Prognostic value of size of lymph node metastases in patients with cutaneous melanomaJ Clin OncolJ Clin Oncol2361-81391995/09/01AdultAgedAged, 80 and overDisease-Free SurvivalFemaleHumansLymph Nodes/*pathologyLymphatic MetastasisMaleMelanoma/mortality/*pathologyMiddle AgedMultivariate AnalysisPhysical ExaminationPrognosisProportional Hazards ModelsRetrospective StudiesSkin Neoplasms/mortality/*pathology1995Sep0732-183X (Print)7666095http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7666095engDBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engBalch200199917Balch, C. M.Buzaid, A. C.Soong, S. J.Atkins, M. B.Cascinelli, N.Coit, D. G.Fleming, I. D.Gershenwald, J. E.Houghton, A., Jr.Kirkwood, J. M.McMasters, K. M.Mihm, M. F.Morton, D. L.Reintgen, D. S.Ross, M. I.Sober, A.Thompson, J. A.Thompson, J. F.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgFinal version of the American Joint Committee on Cancer staging system for cutaneous melanomaJ Clin OncolJ Clin Oncol3635-4819162001/08/16HumansMelanoma/*mortality/*pathologyNeoplasm MetastasisNeoplasm Staging/*standardsProportional Hazards ModelsSkin Neoplasms/*pathology/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504745http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504745engBuzaid199530303017Buzaid, A. C.Tinoco, L. A.Jendiroba, D.Tu, Z. N.Lee, J. J.Legha, S. S.Ross, M. I.Balch, C. M.Benjamin, R. S.Department of Melanoma/Sarcoma, University of Texas M.D. Anderson Cancer Center, Houston 77301, USA.Prognostic value of size of lymph node metastases in patients with cutaneous melanomaJ Clin OncolJ Clin Oncol2361-81391995/09/01AdultAgedAged, 80 and overDisease-Free SurvivalFemaleHumansLymph Nodes/*pathologyLymphatic MetastasisMaleMelanoma/mortality/*pathologyMiddle AgedMultivariate AnalysisPhysical ExaminationPrognosisProportional Hazards ModelsRetrospective StudiesSkin Neoplasms/mortality/*pathology1995Sep0732-183X (Print)7666095http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7666095engDBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engBalch199219191917Balch, C. M.Department of General Surgery, University of Texas, M.D. Anderson Cancer Center, Houston 77030.Cutaneous melanoma: prognosis and treatment results worldwideSemin Surg OncolSemin Surg Oncol400-14861992/11/01FemaleHumansLymphatic MetastasisMaleMelanoma/*epidemiology/secondary/*therapyNeoplasm StagingPrognosisRegression AnalysisSkin Neoplasms/*epidemiology/pathology/*therapyTreatment Outcome1992Nov-Dec8756-0437 (Print)1439450http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1439450engEton199835353517Eton, O.Legha, S. S.Moon, T. E.Buzaid, A. C.Papadopoulos, N. E.Plager, C.Burgess, A. M.Bedikian, A. Y.Ring, S.Dong, Q.Glassman, A. B.Balch, C. M.Benjamin, R. S.Department of Melanoma/Sarcoma, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. oncologist@aol.comPrognostic factors for survival of patients treated systemically for disseminated melanomaJ Clin OncolJ Clin Oncol1103-111631998/03/21AdultAgedFemaleHumansMaleMelanoma/mortality/pathology/*secondary/*therapyMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesSkin Neoplasms/mortality/pathology/therapySurvival Analysis1998Mar0732-183X (Print)9508197http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9508197engDBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engBalch199219191917Balch, C. M.Department of General Surgery, University of Texas, M.D. Anderson Cancer Center, Houston 77030.Cutaneous melanoma: prognosis and treatment results worldwideSemin Surg OncolSemin Surg Oncol400-14861992/11/01FemaleHumansLymphatic MetastasisMaleMelanoma/*epidemiology/secondary/*therapyNeoplasm StagingPrognosisRegression AnalysisSkin Neoplasms/*epidemiology/pathology/*therapyTreatment Outcome1992Nov-Dec8756-0437 (Print)1439450http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1439450engEton199835353517Eton, O.Legha, S. S.Moon, T. E.Buzaid, A. C.Papadopoulos, N. E.Plager, C.Burgess, A. M.Bedikian, A. Y.Ring, S.Dong, Q.Glassman, A. B.Balch, C. M.Benjamin, R. S.Department of Melanoma/Sarcoma, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. oncologist@aol.comPrognostic factors for survival of patients treated systemically for disseminated melanomaJ Clin OncolJ Clin Oncol1103-111631998/03/21AdultAgedFemaleHumansMaleMelanoma/mortality/pathology/*secondary/*therapyMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesSkin Neoplasms/mortality/pathology/therapySurvival Analysis1998Mar0732-183X (Print)9508197http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9508197engDEton199835353517Eton, O.Legha, S. S.Moon, T. E.Buzaid, A. C.Papadopoulos, N. E.Plager, C.Burgess, A. M.Bedikian, A. Y.Ring, S.Dong, Q.Glassman, A. B.Balch, C. M.Benjamin, R. S.Department of Melanoma/Sarcoma, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. oncologist@aol.comPrognostic factors for survival of patients treated systemically for disseminated melanomaJ Clin OncolJ Clin Oncol1103-111631998/03/21AdultAgedFemaleHumansMaleMelanoma/mortality/pathology/*secondary/*therapyMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesSkin Neoplasms/mortality/pathology/therapySurvival Analysis1998Mar0732-183X (Print)9508197http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9508197engBalch199219191917Balch, C. M.Department of General Surgery, University of Texas, M.D. Anderson Cancer Center, Houston 77030.Cutaneous melanoma: prognosis and treatment results worldwideSemin Surg OncolSemin Surg Oncol400-14861992/11/01FemaleHumansLymphatic MetastasisMaleMelanoma/*epidemiology/secondary/*therapyNeoplasm StagingPrognosisRegression AnalysisSkin Neoplasms/*epidemiology/pathology/*therapyTreatment Outcome1992Nov-Dec8756-0437 (Print)1439450http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1439450engBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744engDEton199835353517Eton, O.Legha, S. S.Moon, T. E.Buzaid, A. C.Papadopoulos, N. E.Plager, C.Burgess, A. M.Bedikian, A. Y.Ring, S.Dong, Q.Glassman, A. B.Balch, C. M.Benjamin, R. S.Department of Melanoma/Sarcoma, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. oncologist@aol.comPrognostic factors for survival of patients treated systemically for disseminated melanomaJ Clin OncolJ Clin Oncol1103-111631998/03/21AdultAgedFemaleHumansMaleMelanoma/mortality/pathology/*secondary/*therapyMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesSkin Neoplasms/mortality/pathology/therapySurvival Analysis1998Mar0732-183X (Print)9508197http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9508197engBalch199219191917Balch, C. M.Department of General Surgery, University of Texas, M.D. Anderson Cancer Center, Houston 77030.Cutaneous melanoma: prognosis and treatment results worldwideSemin Surg OncolSemin Surg Oncol400-14861992/11/01FemaleHumansLymphatic MetastasisMaleMelanoma/*epidemiology/secondary/*therapyNeoplasm StagingPrognosisRegression AnalysisSkin Neoplasms/*epidemiology/pathology/*therapyTreatment Outcome1992Nov-Dec8756-0437 (Print)1439450http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1439450engBalch200166617Balch, C. M.Soong, S. J.Gershenwald, J. E.Thompson, J. F.Reintgen, D. S.Cascinelli, N.Urist, M.McMasters, K. M.Ross, M. I.Kirkwood, J. M.Atkins, M. B.Thompson, J. A.Coit, D. G.Byrd, D.Desmond, R.Zhang, Y.Liu, P. Y.Lyman, G. H.Morabito, A.Johns Hopkins Medical Institutions, Baltimore, MD, USA. balchc@asco.orgPrognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging systemJ Clin OncolJ Clin Oncol3622-3419162001/08/16AdolescentAdultAge FactorsAgedAged, 80 and overChildFemaleHumansMaleMelanoma/*mortality/*pathologyMiddle AgedNeoplasm MetastasisNeoplasm Staging/*standardsPredictive Value of TestsProportional Hazards ModelsSkin Neoplasms/*mortality/*secondarySurvival AnalysisUnited States/epidemiology2001Aug 150732-183X (Print)11504744http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11504744eng^9 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH D`D NormalCJOJQJ_HmH sH tH D@D 0 Heading 1$ h@&5CJ@@@ 0 Heading 2$ h@&58@8 0 Heading 3$@&>*DD 0 Heading 4$<@&5CJHH 0 Heading 5$dh@& B*CJphnn 0 Heading 69$ P !$dh@&^5CJDA`D 0Default Paragraph FontRiR 0 Table Normal4 l4a (k ( 0No List VV 'bEHeading 1 Char"5CJ KH OJPJQJ\^JaJ XX 'bEHeading 2 Char$56CJOJPJQJ\]^JaJRR 'bEHeading 3 Char5CJOJPJQJ\^JaJR!R 'bEHeading 4 Char5CJOJPJQJ\^JaJX1X 'bEHeading 5 Char$56CJOJPJQJ\]^JaJJAJ 'bEHeading 6 Char5OJPJQJ\^J0Z@R0 0 Plain TextJaJ 'bE0Plain Text CharCJOJQJ^JaJ:Pr: 0 Body Text 25CJDD 'bE0Body Text 2 Char OJQJaJ<+@< 0 Endnote TextOJQJJJ 'bE0Endnote Text CharCJOJQJaJ/ 0 WP Defaults= 8`0p@ P !$`'0*-CJOJQJ_HmH sH tH xBx 0 Body TextL Gh8p T $\,d4l @@ 'bE0Body Text Char OJQJaJT 0 Block Textg D8p T $\,d4l dh]^`CJ@@ 0 References0^`0R !0Body Text Indent 2Z Gh8p T $\,d4l hdh^hRR  'bE0Body Text Indent 2 Char OJQJaJ,W!, 0Strong5^JS2 $0Body Text Indent 3_# Dhp T $\,d4l 0dh^`0CJVAV #'bE0Body Text Indent 3 CharCJOJQJaJ4@R4 &0Header % !5:a: %'bE0 Header Char OJQJaJ4 @r4 (0Footer ' !:: ''bE0 Footer Char OJQJaJ2)@2 0 Page Number^JBB 0Text* h8p @ LOL 0Head!+$ hh^h`5CJ @@ -0 Balloon Text, CJOJ QJ BB ,'bE0Balloon Text CharCJaJ00 01..^`00 0a./8^8`22 0(1)0>^`><< 0Grade1`d^``F'!F 0Comment Reference CJ^JaJHO2H Head 23$<&dP5CJ6B6 0Head 3 4$$a$68R8 60 Comment Text5CJJaJ 5'bE0Comment Text CharCJOJQJaJ:Uq: @y0 Hyperlink>*B*^Jph@jQR@ hRComment Subject85\PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] R*PPP2R*E 13@BDDtt))))eesssv02"&m-2CTY[`duپ:j l&03Y  5#%*(,.0A468Q(T1`U2(Mc #53#Y399:;; ;$;;AABIII JJ!J%JMMMMMN!N7N9N;NNQQXXXXXJYa!aciijjjjjcmuuKw=@}RTҝFI˦-0ҶնUVY:<&cs"2HJUvRbxzZ]E4  57?M`(R*QQQDQQQQDQQDQQDQQQDQQQQDQQQQQDQQQQQQQQQQQDQQDQQQDQQDQQQQQQDQQDQ3:<t{}elov!!!@  @ 0(  B S  ?H0( k%k% R*>EJk##' ''''((((&((((())))1)))AALLNNRSTTaabblkxkIQ7E_rdsvdfYkl~')57CEJKQ~VZ  Zgos        """""b#d#n#p##G$f$%%%%%)%2%a%h%%%(((((((((((( ))N)X)?*J*M*N*P*S*<j69{["a"##G$J$$$$$Q%T%F'I'((((((((v)z)6-9-000022";$;#J%JNNTTVVXXjj,gpq"%bc!"Ykl~')57CEQ~t9?u|^gNVDQV^jw|$+09?LQY^mry'.3;\FI,4    b!o!{!~!"""###G$e$$$$ %n%p%A&H&M&U&' ''''')(/(((((((((((((((((M*N*S*333333333333333333333333333333333333333333333333333333333333333333333333333333333333330(((((((((((((( ) ) ))));)L)N)X),*=*?*J*S*   1 E5 rBk =   > g2I r   ( %)dED^4Rl:08pz@+ : >E *CJOJQJ^Jo(.  ^`OJQJo( ^`OJQJo(o pp^p`OJ QJ o( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJ QJ o( ^`OJQJo( ^`OJQJo(o PP^P`OJ QJ o( 88^8`OJQJo(- hh^h`OJQJo( hh^h`OJQJo(hh^h`^J.hh^h`^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.^`^J.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.@hh^h`56>*CJOJQJ^Jo(. hh^h`^J.hh^h`^J.hh^h`^J.hh^h`^J.hh^h`^Jo(.hh^h`^J. hh^h`^Jo(.hh^h`^J. hh^h`OJQJo( 88^8`OJQJo(o ^`OJ QJ o(   ^ `OJQJo(   ^ `OJQJo(o xx^x`OJ QJ o( HH^H`OJQJo( ^`OJQJo(o ^`OJ QJ o(hh^h`^J.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.0^`0^J. 808^8`0CJ^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J.@hh^h`56>*CJOJQJ^Jo(. $ $ ^$ `^J.  ^ `^J.L^`L^J.^`^J.dd^d`^J.4L4^4`L^J.^`^J.^`^J.L^`L^J.hh^h`^J.hh^h`56CJOJQJ^Jo(.^`^Jo(.^`^J.pLp^p`L^J.@ @ ^@ `^J.^`^J.L^`L^J.^`^J.^`^J.PLP^P`L^J."!1bp1xG:08Bkcbc V@+ :psOr dJC< yED^4z6^6D|o)jG >$&I @X]lVg2IC< yC< y=  (G\]?r)ڬ @h v^v`OJQJo(ڬ @h h^h`OJQJo(          "D *wjLh nԒͺ\*p~ܨ         ^S i|*R"#ղ?D          2b,/Q Yu-J((EN.InstantFormat EN.Layoutr EN.Libraries`i w<ENInstantFormat><Enabled>1</Enabled><ScanUnformatted>1</ScanUnformatted><ScanChanges>1</ScanChanges></ENInstantFormat>T<ENLayout><Style>Archives Pathology</Style><LeftDelim>{</LeftDelim><RightDelim>}</RightDelim><FontName>Arial</FontName><FontSize>11</FontSize><ReflistTitle></ReflistTitle><StartingRefnum>1</StartingRefnum><FirstLineIndent>0</FirstLineIndent><HangingIndent>720</HangingIndent><LineSpacing>0</LineSpacing><SpaceAfter>0</SpaceAfter></ENLayout>K<ENLibraries><Libraries><item>melanoma.enl</item></Libraries></ENLibraries>@d !(R*@@<@*X@0@UnknownCAP User Caryn Tursky G* Times New Roman5Symbol3. * Arial7.  Verdana7K@Cambria7.{ @Calibri?= * Courier New9New York7"Chicago5. *aTahoma;WingdingsA BCambria Math"h&&{KԆN,N,a4dC(C(2qX?! xxCutaneous Melanoma Dina StolmanCAP User                           Oh+'0  , L X d p|Cutaneous MelanomaDina Stolman Normal.dotm CAP User2Microsoft Office Word@F#@2=E@N3@N3N,՜.+,0 hp  MUHCC( Cutaneous Melanoma Title  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&()*+,-.0123456CRoot Entry F 5EData J1Table`WordDocumentɞSummaryInformation('DocumentSummaryInformation8/CompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q